{"date": "2024-12-29", "symbol": "JNJ", "type": "income_statement_annual", "result": {"date": "2024-12-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-02-13", "acceptedDate": "2025-02-13 16:07:39", "fiscalYear": "2024", "period": "FY", "revenue": 88821000000, "costOfRevenue": 27471000000, "grossProfit": 61350000000, "researchAndDevelopmentExpenses": 17232000000, "generalAndAdministrativeExpenses": 21969000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 21969000000, "otherExpenses": 0, "operatingExpenses": 39201000000, "costAndExpenses": 66672000000, "netInterestIncome": 577000000, "interestIncome": 1332000000, "interestExpense": 755000000, "depreciationAndAmortization": 7339000000, "ebitda": 24781000000, "ebit": 17442000000, "nonOperatingIncomeExcludingInterest": 4707000000, "operatingIncome": 22149000000, "totalOtherIncomeExpensesNet": -5462000000, "incomeBeforeTax": 16687000000, "incomeTaxExpense": 2621000000, "netIncomeFromContinuingOperations": 14066000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 14066000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 14066000000, "eps": 5.84, "epsDiluted": 5.79, "weightedAverageShsOut": 2407300000, "weightedAverageShsOutDil": 2429400000}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "income_statement_annual", "result": {"date": "2023-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-02-16", "acceptedDate": "2024-02-16 16:12:22", "fiscalYear": "2023", "period": "FY", "revenue": 85159000000, "costOfRevenue": 26553000000, "grossProfit": 58606000000, "researchAndDevelopmentExpenses": 15085000000, "generalAndAdministrativeExpenses": 20112000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 20112000000, "otherExpenses": 0, "operatingExpenses": 35197000000, "costAndExpenses": 61750000000, "netInterestIncome": 489000000, "interestIncome": 1261000000, "interestExpense": 772000000, "depreciationAndAmortization": 7486000000, "ebitda": 23320000000, "ebit": 15834000000, "nonOperatingIncomeExcludingInterest": 7575000000, "operatingIncome": 23409000000, "totalOtherIncomeExpensesNet": -8347000000, "incomeBeforeTax": 15062000000, "incomeTaxExpense": 1736000000, "netIncomeFromContinuingOperations": 13326000000, "netIncomeFromDiscontinuedOperations": 21827000000, "otherAdjustmentsToNetIncome": 0, "netIncome": 35153000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 35153000000, "eps": 13.88, "epsDiluted": 13.72, "weightedAverageShsOut": 2533500000, "weightedAverageShsOutDil": 2560400000}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "income_statement_annual", "result": {"date": "2022-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-02-16", "acceptedDate": "2023-02-16 16:01:53", "fiscalYear": "2022", "period": "FY", "revenue": 79990000000, "costOfRevenue": 24596000000, "grossProfit": 55394000000, "researchAndDevelopmentExpenses": 14135000000, "generalAndAdministrativeExpenses": 20246000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 20246000000, "otherExpenses": 0, "operatingExpenses": 34381000000, "costAndExpenses": 58977000000, "netInterestIncome": 214000000, "interestIncome": 490000000, "interestExpense": 276000000, "depreciationAndAmortization": 6970000000, "ebitda": 26605000000, "ebit": 19635000000, "nonOperatingIncomeExcludingInterest": 1378000000, "operatingIncome": 21013000000, "totalOtherIncomeExpensesNet": -1654000000, "incomeBeforeTax": 19359000000, "incomeTaxExpense": 2989000000, "netIncomeFromContinuingOperations": 16370000000, "netIncomeFromDiscontinuedOperations": 1571000000, "otherAdjustmentsToNetIncome": 0, "netIncome": 17941000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 17941000000, "eps": 6.83, "epsDiluted": 6.73, "weightedAverageShsOut": 2613597000, "weightedAverageShsOutDil": 2663900000}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "income_statement_annual", "result": {"date": "2021-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-02-17", "acceptedDate": "2022-02-17 16:06:50", "fiscalYear": "2021", "period": "FY", "revenue": 78740000000, "costOfRevenue": 23402000000, "grossProfit": 55338000000, "researchAndDevelopmentExpenses": 14277000000, "generalAndAdministrativeExpenses": 20118000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 20118000000, "otherExpenses": 0, "operatingExpenses": 34395000000, "costAndExpenses": 57797000000, "netInterestIncome": -130000000, "interestIncome": 53000000, "interestExpense": 183000000, "depreciationAndAmortization": 7390000000, "ebitda": 26751000000, "ebit": 19361000000, "nonOperatingIncomeExcludingInterest": 1582000000, "operatingIncome": 20943000000, "totalOtherIncomeExpensesNet": -1765000000, "incomeBeforeTax": 19178000000, "incomeTaxExpense": 1377000000, "netIncomeFromContinuingOperations": 17801000000, "netIncomeFromDiscontinuedOperations": 3077000000, "otherAdjustmentsToNetIncome": 0, "netIncome": 20878000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 20878000000, "eps": 7.93, "epsDiluted": 7.81, "weightedAverageShsOut": 2628965000, "weightedAverageShsOutDil": 2674000000}}
{"date": "2025-09-28", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2025-09-28", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-10-22", "acceptedDate": "2025-10-22 16:04:17", "fiscalYear": "2025", "period": "Q3", "revenue": 23993000000, "costOfRevenue": 7303000000, "grossProfit": 16690000000, "researchAndDevelopmentExpenses": 3672000000, "generalAndAdministrativeExpenses": 5922000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5922000000, "otherExpenses": 0, "operatingExpenses": 9594000000, "costAndExpenses": 16897000000, "netInterestIncome": 209000000, "interestIncome": 227000000, "interestExpense": 18000000, "depreciationAndAmortization": 1777000000, "ebitda": 9288000000, "ebit": 7511000000, "nonOperatingIncomeExcludingInterest": -415000000, "operatingIncome": 7096000000, "totalOtherIncomeExpensesNet": 397000000, "incomeBeforeTax": 7493000000, "incomeTaxExpense": 2341000000, "netIncomeFromContinuingOperations": 5152000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 5152000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5152000000, "eps": 2.12, "epsDiluted": 2.12, "weightedAverageShsOut": 2428600000, "weightedAverageShsOutDil": 2428600000}}
{"date": "2025-06-29", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2025-06-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-07-24", "acceptedDate": "2025-07-24 16:04:24", "fiscalYear": "2025", "period": "Q2", "revenue": 23743000000, "costOfRevenue": 7628000000, "grossProfit": 16115000000, "researchAndDevelopmentExpenses": 3516000000, "generalAndAdministrativeExpenses": 5789000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5789000000, "otherExpenses": 0, "operatingExpenses": 9305000000, "costAndExpenses": 16933000000, "netInterestIncome": -48000000, "interestIncome": 260000000, "interestExpense": 308000000, "depreciationAndAmortization": 1943000000, "ebitda": 8742000000, "ebit": 6799000000, "nonOperatingIncomeExcludingInterest": 11000000, "operatingIncome": 6810000000, "totalOtherIncomeExpensesNet": -319000000, "incomeBeforeTax": 6491000000, "incomeTaxExpense": 954000000, "netIncomeFromContinuingOperations": 5537000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 5537000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5537000000, "eps": 2.29, "epsDiluted": 2.29, "weightedAverageShsOut": 2419100000, "weightedAverageShsOutDil": 2419100000}}
{"date": "2025-03-30", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2025-03-30", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-04-23", "acceptedDate": "2025-04-23 16:04:45", "fiscalYear": "2025", "period": "Q1", "revenue": 21893000000, "costOfRevenue": 7357000000, "grossProfit": 14536000000, "researchAndDevelopmentExpenses": 3225000000, "generalAndAdministrativeExpenses": 5012000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5012000000, "otherExpenses": 0, "operatingExpenses": 8237000000, "costAndExpenses": 15594000000, "netInterestIncome": 128000000, "interestIncome": 332000000, "interestExpense": 204000000, "depreciationAndAmortization": 1772000000, "ebitda": 15607000000, "ebit": 13835000000, "nonOperatingIncomeExcludingInterest": -7536000000, "operatingIncome": 6299000000, "totalOtherIncomeExpensesNet": 7332000000, "incomeBeforeTax": 13631000000, "incomeTaxExpense": 2632000000, "netIncomeFromContinuingOperations": 10999000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 10999000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 10999000000, "eps": 4.57, "epsDiluted": 4.54, "weightedAverageShsOut": 2405625000, "weightedAverageShsOutDil": 2423800000}}
{"date": "2024-12-31", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2024-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-02-13", "acceptedDate": "2025-02-13 16:07:39", "fiscalYear": "2024", "period": "Q4", "revenue": 22520000000, "costOfRevenue": 7128000000, "grossProfit": 15392000000, "researchAndDevelopmentExpenses": 5298000000, "generalAndAdministrativeExpenses": 6253000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 6253000000, "otherExpenses": 0, "operatingExpenses": 11551000000, "costAndExpenses": 18679000000, "netInterestIncome": 144000000, "interestIncome": 281000000, "interestExpense": 137000000, "depreciationAndAmortization": 1896000000, "ebitda": 5920000000, "ebit": 4024000000, "nonOperatingIncomeExcludingInterest": -183000000, "operatingIncome": 3841000000, "totalOtherIncomeExpensesNet": 46000000, "incomeBeforeTax": 3887000000, "incomeTaxExpense": 456000000, "netIncomeFromContinuingOperations": 3431000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3431000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3431000000, "eps": 1.43, "epsDiluted": 1.41, "weightedAverageShsOut": 2406922000, "weightedAverageShsOutDil": 2427100000}}
{"date": "2024-09-29", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2024-09-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-10-23", "acceptedDate": "2024-10-23 16:02:27", "fiscalYear": "2024", "period": "Q3", "revenue": 22471000000, "costOfRevenue": 6963000000, "grossProfit": 15508000000, "researchAndDevelopmentExpenses": 4952000000, "generalAndAdministrativeExpenses": 5278000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5278000000, "otherExpenses": 0, "operatingExpenses": 10230000000, "costAndExpenses": 17193000000, "netInterestIncome": 99000000, "interestIncome": 292000000, "interestExpense": 193000000, "depreciationAndAmortization": 1846000000, "ebitda": 5377000000, "ebit": 3531000000, "nonOperatingIncomeExcludingInterest": 1747000000, "operatingIncome": 5278000000, "totalOtherIncomeExpensesNet": -1940000000, "incomeBeforeTax": 3338000000, "incomeTaxExpense": 644000000, "netIncomeFromContinuingOperations": 2694000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 2694000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 2694000000, "eps": 1.12, "epsDiluted": 1.11, "weightedAverageShsOut": 2407298000, "weightedAverageShsOutDil": 2427900000}}
{"date": "2024-06-30", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2024-06-30", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-07-25", "acceptedDate": "2024-07-25 16:02:29", "fiscalYear": "2024", "period": "Q2", "revenue": 22447000000, "costOfRevenue": 6869000000, "grossProfit": 15578000000, "researchAndDevelopmentExpenses": 3440000000, "generalAndAdministrativeExpenses": 5481000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5481000000, "otherExpenses": 0, "operatingExpenses": 8921000000, "costAndExpenses": 15790000000, "netInterestIncome": 125000000, "interestIncome": 395000000, "interestExpense": 270000000, "depreciationAndAmortization": 1782000000, "ebitda": 7800000000, "ebit": 6018000000, "nonOperatingIncomeExcludingInterest": 639000000, "operatingIncome": 6657000000, "totalOtherIncomeExpensesNet": -909000000, "incomeBeforeTax": 5748000000, "incomeTaxExpense": 1062000000, "netIncomeFromContinuingOperations": 4686000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4686000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4686000000, "eps": 1.95, "epsDiluted": 1.93, "weightedAverageShsOut": 2406800000, "weightedAverageShsOutDil": 2422000000}}
{"date": "2024-03-31", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2024-03-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-05-01", "acceptedDate": "2024-05-01 07:09:36", "fiscalYear": "2024", "period": "Q1", "revenue": 21383000000, "costOfRevenue": 6511000000, "grossProfit": 14872000000, "researchAndDevelopmentExpenses": 3542000000, "generalAndAdministrativeExpenses": 5057000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5057000000, "otherExpenses": 0, "operatingExpenses": 8599000000, "costAndExpenses": 15110000000, "netInterestIncome": 209000000, "interestIncome": 364000000, "interestExpense": 155000000, "depreciationAndAmortization": 1815000000, "ebitda": 5684000000, "ebit": 3869000000, "nonOperatingIncomeExcludingInterest": 2404000000, "operatingIncome": 6273000000, "totalOtherIncomeExpensesNet": -2559000000, "incomeBeforeTax": 3714000000, "incomeTaxExpense": 459000000, "netIncomeFromContinuingOperations": 3255000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3255000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3255000000, "eps": 1.35, "epsDiluted": 1.34, "weightedAverageShsOut": 2408200000, "weightedAverageShsOutDil": 2430100000}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2023-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-02-16", "acceptedDate": "2024-02-16 16:12:22", "fiscalYear": "2023", "period": "Q4", "revenue": 21395000000, "costOfRevenue": 6798000000, "grossProfit": 14597000000, "researchAndDevelopmentExpenses": 4480000000, "generalAndAdministrativeExpenses": 5510000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5510000000, "otherExpenses": 0, "operatingExpenses": 9990000000, "costAndExpenses": 16788000000, "netInterestIncome": 212000000, "interestIncome": 363000000, "interestExpense": 151000000, "depreciationAndAmortization": 1843000000, "ebitda": 6820000000, "ebit": 4977000000, "nonOperatingIncomeExcludingInterest": -370000000, "operatingIncome": 4607000000, "totalOtherIncomeExpensesNet": 219000000, "incomeBeforeTax": 4826000000, "incomeTaxExpense": 694000000, "netIncomeFromContinuingOperations": 4132000000, "netIncomeFromDiscontinuedOperations": -83000000, "otherAdjustmentsToNetIncome": 0, "netIncome": 4049000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4049000000, "eps": 1.68, "epsDiluted": 1.67, "weightedAverageShsOut": 2407200000, "weightedAverageShsOutDil": 2430700000}}
{"date": "2023-10-01", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2023-10-01", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-10-27", "acceptedDate": "2023-10-27 16:11:34", "fiscalYear": "2023", "period": "Q3", "revenue": 21351000000, "costOfRevenue": 6606000000, "grossProfit": 14745000000, "researchAndDevelopmentExpenses": 3447000000, "generalAndAdministrativeExpenses": 5100000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5100000000, "otherExpenses": 0, "operatingExpenses": 8547000000, "costAndExpenses": 15153000000, "netInterestIncome": 182000000, "interestIncome": 374000000, "interestExpense": 192000000, "depreciationAndAmortization": 1829000000, "ebitda": 7238000000, "ebit": 5409000000, "nonOperatingIncomeExcludingInterest": 789000000, "operatingIncome": 6198000000, "totalOtherIncomeExpensesNet": -981000000, "incomeBeforeTax": 5217000000, "incomeTaxExpense": 908000000, "netIncomeFromContinuingOperations": 4309000000, "netIncomeFromDiscontinuedOperations": 21719000000, "otherAdjustmentsToNetIncome": 0, "netIncome": 26028000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 26028000000, "eps": 10.32, "epsDiluted": 10.21, "weightedAverageShsOut": 2522900000, "weightedAverageShsOutDil": 2549700000}}
{"date": "2023-07-02", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2023-07-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-07-31", "acceptedDate": "2023-07-31 16:06:04", "fiscalYear": "2023", "period": "Q2", "revenue": 21519000000, "costOfRevenue": 6462000000, "grossProfit": 15057000000, "researchAndDevelopmentExpenses": 3703000000, "generalAndAdministrativeExpenses": 4996000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 4996000000, "otherExpenses": 0, "operatingExpenses": 8699000000, "costAndExpenses": 15161000000, "netInterestIncome": 109000000, "interestIncome": 326000000, "interestExpense": 217000000, "depreciationAndAmortization": 1934000000, "ebitda": 8457000000, "ebit": 6523000000, "nonOperatingIncomeExcludingInterest": -165000000, "operatingIncome": 6358000000, "totalOtherIncomeExpensesNet": -52000000, "incomeBeforeTax": 6306000000, "incomeTaxExpense": 930000000, "netIncomeFromContinuingOperations": 5376000000, "netIncomeFromDiscontinuedOperations": -232000000, "otherAdjustmentsToNetIncome": 0, "netIncome": 5144000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5144000000, "eps": 1.98, "epsDiluted": 1.96, "weightedAverageShsOut": 2598400000, "weightedAverageShsOutDil": 2625700000}}
{"date": "2023-04-02", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2023-04-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-04-28", "acceptedDate": "2023-04-28 16:07:02", "fiscalYear": "2023", "period": "Q1", "revenue": 20894000000, "costOfRevenue": 6687000000, "grossProfit": 14207000000, "researchAndDevelopmentExpenses": 3455000000, "generalAndAdministrativeExpenses": 4506000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 4506000000, "otherExpenses": 0, "operatingExpenses": 7961000000, "costAndExpenses": 14648000000, "netInterestIncome": -14000000, "interestIncome": 198000000, "interestExpense": 212000000, "depreciationAndAmortization": 1880000000, "ebitda": 805000000, "ebit": -1075000000, "nonOperatingIncomeExcludingInterest": 7321000000, "operatingIncome": 6246000000, "totalOtherIncomeExpensesNet": -7533000000, "incomeBeforeTax": -1287000000, "incomeTaxExpense": -796000000, "netIncomeFromContinuingOperations": -491000000, "netIncomeFromDiscontinuedOperations": 423000000, "otherAdjustmentsToNetIncome": 0, "netIncome": -68000000, "netIncomeDeductions": 0, "bottomLineNetIncome": -68000000, "eps": -0.03, "epsDiluted": -0.03, "weightedAverageShsOut": 2605500000, "weightedAverageShsOutDil": 2605500000}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2022-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-02-16", "acceptedDate": "2023-02-16 16:01:53", "fiscalYear": "2022", "period": "Q4", "revenue": 23706000000, "costOfRevenue": 7765000000, "grossProfit": 15941000000, "researchAndDevelopmentExpenses": 4624000000, "generalAndAdministrativeExpenses": 7412000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 7412000000, "otherExpenses": 0, "operatingExpenses": 12036000000, "costAndExpenses": 19801000000, "netInterestIncome": 77000000, "interestIncome": 254000000, "interestExpense": 177000000, "depreciationAndAmortization": 1772000000, "ebitda": 6150000000, "ebit": 4378000000, "nonOperatingIncomeExcludingInterest": -473000000, "operatingIncome": 3905000000, "totalOtherIncomeExpensesNet": 296000000, "incomeBeforeTax": 4201000000, "incomeTaxExpense": 681000000, "netIncomeFromContinuingOperations": 3520000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3520000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3520000000, "eps": 1.35, "epsDiluted": 1.33, "weightedAverageShsOut": 2613597000, "weightedAverageShsOutDil": 2663900000}}
{"date": "2022-10-02", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2022-10-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-10-27", "acceptedDate": "2022-10-27 16:02:59", "fiscalYear": "2022", "period": "Q3", "revenue": 19996000000, "costOfRevenue": 6172000000, "grossProfit": 13824000000, "researchAndDevelopmentExpenses": 3485000000, "generalAndAdministrativeExpenses": 4675000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 4675000000, "otherExpenses": 0, "operatingExpenses": 8160000000, "costAndExpenses": 14332000000, "netInterestIncome": 99000000, "interestIncome": 150000000, "interestExpense": 51000000, "depreciationAndAmortization": 1685000000, "ebitda": 6908000000, "ebit": 5223000000, "nonOperatingIncomeExcludingInterest": 441000000, "operatingIncome": 5664000000, "totalOtherIncomeExpensesNet": -492000000, "incomeBeforeTax": 5172000000, "incomeTaxExpense": 862000000, "netIncomeFromContinuingOperations": 4310000000, "netIncomeFromDiscontinuedOperations": 148000000, "otherAdjustmentsToNetIncome": 0, "netIncome": 4458000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4458000000, "eps": 1.7, "epsDiluted": 1.68, "weightedAverageShsOut": 2616882000, "weightedAverageShsOutDil": 2661300000}}
{"date": "2022-07-03", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2022-07-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-07-29", "acceptedDate": "2022-07-29 16:14:39", "fiscalYear": "2022", "period": "Q2", "revenue": 24020000000, "costOfRevenue": 7919000000, "grossProfit": 16101000000, "researchAndDevelopmentExpenses": 3703000000, "generalAndAdministrativeExpenses": 5926000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5926000000, "otherExpenses": 0, "operatingExpenses": 9629000000, "costAndExpenses": 17548000000, "netInterestIncome": 26000000, "interestIncome": 64000000, "interestExpense": 38000000, "depreciationAndAmortization": 1744000000, "ebitda": 7622000000, "ebit": 5878000000, "nonOperatingIncomeExcludingInterest": 594000000, "operatingIncome": 6472000000, "totalOtherIncomeExpensesNet": -632000000, "incomeBeforeTax": 5840000000, "incomeTaxExpense": 1026000000, "netIncomeFromContinuingOperations": 4814000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4814000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4814000000, "eps": 1.83, "epsDiluted": 1.8, "weightedAverageShsOut": 2629032000, "weightedAverageShsOutDil": 2667900000}}
{"date": "2022-04-03", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2022-04-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-04-29", "acceptedDate": "2022-04-29 16:08:24", "fiscalYear": "2022", "period": "Q1", "revenue": 23426000000, "costOfRevenue": 7598000000, "grossProfit": 15828000000, "researchAndDevelopmentExpenses": 4072000000, "generalAndAdministrativeExpenses": 5638000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5638000000, "otherExpenses": 0, "operatingExpenses": 9710000000, "costAndExpenses": 17308000000, "netInterestIncome": 12000000, "interestIncome": 22000000, "interestExpense": 10000000, "depreciationAndAmortization": 1769000000, "ebitda": 7641000000, "ebit": 5872000000, "nonOperatingIncomeExcludingInterest": 246000000, "operatingIncome": 6118000000, "totalOtherIncomeExpensesNet": -256000000, "incomeBeforeTax": 5862000000, "incomeTaxExpense": 713000000, "netIncomeFromContinuingOperations": 5149000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 5149000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5149000000, "eps": 1.96, "epsDiluted": 1.93, "weightedAverageShsOut": 2629384000, "weightedAverageShsOutDil": 2666500000}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2021-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-02-17", "acceptedDate": "2022-02-17 16:06:50", "fiscalYear": "2021", "period": "Q4", "revenue": 24804000000, "costOfRevenue": 7955000000, "grossProfit": 16849000000, "researchAndDevelopmentExpenses": 4720000000, "generalAndAdministrativeExpenses": 7654000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 7654000000, "otherExpenses": 0, "operatingExpenses": 12374000000, "costAndExpenses": 20329000000, "netInterestIncome": -47000000, "interestIncome": 13000000, "interestExpense": 60000000, "depreciationAndAmortization": 1843000000, "ebitda": 6739000000, "ebit": 4896000000, "nonOperatingIncomeExcludingInterest": -421000000, "operatingIncome": 4475000000, "totalOtherIncomeExpensesNet": 361000000, "incomeBeforeTax": 4836000000, "incomeTaxExpense": 100000000, "netIncomeFromContinuingOperations": 4736000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4736000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4736000000, "eps": 1.8, "epsDiluted": 1.77, "weightedAverageShsOut": 2628965000, "weightedAverageShsOutDil": 2670200000}}
{"date": "2021-10-03", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2021-10-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-10-29", "acceptedDate": "2021-10-29 16:05:20", "fiscalYear": "2021", "period": "Q3", "revenue": 23338000000, "costOfRevenue": 7250000000, "grossProfit": 16088000000, "researchAndDevelopmentExpenses": 3422000000, "generalAndAdministrativeExpenses": 5800000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5800000000, "otherExpenses": 0, "operatingExpenses": 9222000000, "costAndExpenses": 16472000000, "netInterestIncome": -7000000, "interestIncome": 13000000, "interestExpense": 20000000, "depreciationAndAmortization": 1814000000, "ebitda": 5683000000, "ebit": 3869000000, "nonOperatingIncomeExcludingInterest": 2997000000, "operatingIncome": 6866000000, "totalOtherIncomeExpensesNet": -3017000000, "incomeBeforeTax": 3849000000, "incomeTaxExpense": 182000000, "netIncomeFromContinuingOperations": 3667000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 3667000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 3667000000, "eps": 1.39, "epsDiluted": 1.37, "weightedAverageShsOut": 2632600000, "weightedAverageShsOutDil": 2674900000}}
{"date": "2021-07-04", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2021-07-04", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-07-29", "acceptedDate": "2021-07-29 16:07:51", "fiscalYear": "2021", "period": "Q2", "revenue": 23312000000, "costOfRevenue": 7587000000, "grossProfit": 15725000000, "researchAndDevelopmentExpenses": 3394000000, "generalAndAdministrativeExpenses": 5973000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5973000000, "otherExpenses": 0, "operatingExpenses": 9367000000, "costAndExpenses": 16954000000, "netInterestIncome": -28000000, "interestIncome": 12000000, "interestExpense": 40000000, "depreciationAndAmortization": 1839000000, "ebitda": 8541000000, "ebit": 6702000000, "nonOperatingIncomeExcludingInterest": -344000000, "operatingIncome": 6358000000, "totalOtherIncomeExpensesNet": 304000000, "incomeBeforeTax": 6662000000, "incomeTaxExpense": 384000000, "netIncomeFromContinuingOperations": 6278000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 6278000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 6278000000, "eps": 2.38, "epsDiluted": 2.35, "weightedAverageShsOut": 2631989000, "weightedAverageShsOutDil": 2671600000}}
{"date": "2021-04-04", "symbol": "JNJ", "type": "income_statement_quarter", "result": {"date": "2021-04-04", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-04-30", "acceptedDate": "2021-04-30 16:04:02", "fiscalYear": "2021", "period": "Q1", "revenue": 22321000000, "costOfRevenue": 7063000000, "grossProfit": 15258000000, "researchAndDevelopmentExpenses": 3178000000, "generalAndAdministrativeExpenses": 5232000000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 5232000000, "otherExpenses": 0, "operatingExpenses": 8410000000, "costAndExpenses": 15473000000, "netInterestIncome": -48000000, "interestIncome": 15000000, "interestExpense": 63000000, "depreciationAndAmortization": 1894000000, "ebitda": 9386000000, "ebit": 7492000000, "nonOperatingIncomeExcludingInterest": -644000000, "operatingIncome": 6848000000, "totalOtherIncomeExpensesNet": 581000000, "incomeBeforeTax": 7429000000, "incomeTaxExpense": 1232000000, "netIncomeFromContinuingOperations": 6197000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 6197000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 6197000000, "eps": 2.35, "epsDiluted": 2.32, "weightedAverageShsOut": 2632702000, "weightedAverageShsOutDil": 2672700000}}
{"date": "2024-12-29", "symbol": "JNJ", "type": "balance_sheet_annual", "result": {"date": "2024-12-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-02-13", "acceptedDate": "2025-02-13 16:07:39", "fiscalYear": "2024", "period": "FY", "cashAndCashEquivalents": 24105000000, "shortTermInvestments": 417000000, "cashAndShortTermInvestments": 24522000000, "netReceivables": 18927000000, "accountsReceivables": 14842000000, "otherReceivables": 4085000000, "inventory": 12444000000, "prepaids": 0, "otherCurrentAssets": 0, "totalCurrentAssets": 55893000000, "propertyPlantEquipmentNet": 20518000000, "goodwill": 44200000000, "intangibleAssets": 37618000000, "goodwillAndIntangibleAssets": 81818000000, "longTermInvestments": 0, "taxAssets": 10461000000, "otherNonCurrentAssets": 11414000000, "totalNonCurrentAssets": 124211000000, "otherAssets": 0, "totalAssets": 180104000000, "totalPayables": 14083000000, "accountPayables": 10311000000, "otherPayables": 3772000000, "accruedExpenses": 26129000000, "shortTermDebt": 5983000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 3772000000, "deferredRevenue": 0, "otherCurrentLiabilities": 4126000000, "totalCurrentLiabilities": 50321000000, "longTermDebt": 30651000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2448000000, "otherNonCurrentLiabilities": 25194000000, "totalNonCurrentLiabilities": 58293000000, "otherLiabilities": 0, "capitalLeaseObligations": 1200000000, "totalLiabilities": 108614000000, "treasuryStock": -75680000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 155791000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -11741000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 71490000000, "totalEquity": 71490000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 180104000000, "totalInvestments": 417000000, "totalDebt": 36634000000, "netDebt": 12529000000}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "balance_sheet_annual", "result": {"date": "2023-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-02-16", "acceptedDate": "2024-02-16 16:12:22", "fiscalYear": "2023", "period": "FY", "cashAndCashEquivalents": 21859000000, "shortTermInvestments": 1068000000, "cashAndShortTermInvestments": 22927000000, "netReceivables": 14873000000, "accountsReceivables": 14873000000, "otherReceivables": 0, "inventory": 11181000000, "prepaids": 4514000000, "otherCurrentAssets": 0, "totalCurrentAssets": 53495000000, "propertyPlantEquipmentNet": 19898000000, "goodwill": 36558000000, "intangibleAssets": 34175000000, "goodwillAndIntangibleAssets": 70733000000, "longTermInvestments": 0, "taxAssets": 9279000000, "otherNonCurrentAssets": 14153000000, "totalNonCurrentAssets": 114063000000, "otherAssets": 0, "totalAssets": 167558000000, "totalPayables": 12625000000, "accountPayables": 9632000000, "otherPayables": 2993000000, "accruedExpenses": 26213000000, "shortTermDebt": 3451000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2993000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3993000000, "totalCurrentLiabilities": 46282000000, "longTermDebt": 25881000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3193000000, "otherNonCurrentLiabilities": 23428000000, "totalNonCurrentLiabilities": 52502000000, "otherLiabilities": 0, "capitalLeaseObligations": 1100000000, "totalLiabilities": 98784000000, "treasuryStock": -75662000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 153843000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -12527000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 68774000000, "totalEquity": 68774000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 167558000000, "totalInvestments": 1068000000, "totalDebt": 29332000000, "netDebt": 7473000000}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "balance_sheet_annual", "result": {"date": "2022-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-02-16", "acceptedDate": "2023-02-16 16:01:53", "fiscalYear": "2022", "period": "FY", "cashAndCashEquivalents": 12889000000, "shortTermInvestments": 9392000000, "cashAndShortTermInvestments": 22281000000, "netReceivables": 16915000000, "accountsReceivables": 14039000000, "otherReceivables": 2876000000, "inventory": 10268000000, "prepaids": 0, "otherCurrentAssets": 5830000000, "totalCurrentAssets": 55294000000, "propertyPlantEquipmentNet": 17982000000, "goodwill": 36047000000, "intangibleAssets": 38489000000, "goodwillAndIntangibleAssets": 74536000000, "longTermInvestments": 0, "taxAssets": 8947000000, "otherNonCurrentAssets": 30619000000, "totalNonCurrentAssets": 132084000000, "otherAssets": 0, "totalAssets": 187378000000, "totalPayables": 12109000000, "accountPayables": 9889000000, "otherPayables": 2220000000, "accruedExpenses": 24298000000, "shortTermDebt": 12756000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2220000000, "deferredRevenue": 0, "otherCurrentLiabilities": 6639000000, "totalCurrentLiabilities": 55802000000, "longTermDebt": 26886000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3991000000, "otherNonCurrentLiabilities": 23895000000, "totalNonCurrentLiabilities": 54772000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 110574000000, "treasuryStock": -41694000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 128345000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -12967000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 76804000000, "totalEquity": 76804000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 187378000000, "totalInvestments": 9392000000, "totalDebt": 39642000000, "netDebt": 26753000000}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "balance_sheet_annual", "result": {"date": "2021-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-02-17", "acceptedDate": "2022-02-17 16:06:50", "fiscalYear": "2021", "period": "FY", "cashAndCashEquivalents": 14487000000, "shortTermInvestments": 17121000000, "cashAndShortTermInvestments": 31608000000, "netReceivables": 18984000000, "accountsReceivables": 15283000000, "otherReceivables": 3701000000, "inventory": 10387000000, "prepaids": 3701000000, "otherCurrentAssets": -3701000000, "totalCurrentAssets": 60979000000, "propertyPlantEquipmentNet": 18962000000, "goodwill": 35246000000, "intangibleAssets": 46392000000, "goodwillAndIntangibleAssets": 81638000000, "longTermInvestments": 0, "taxAssets": 10223000000, "otherNonCurrentAssets": 10216000000, "totalNonCurrentAssets": 121039000000, "otherAssets": 0, "totalAssets": 182018000000, "totalPayables": 12167000000, "accountPayables": 11055000000, "otherPayables": 1112000000, "accruedExpenses": 25707000000, "shortTermDebt": 3766000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1112000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3586000000, "totalCurrentLiabilities": 45226000000, "longTermDebt": 29985000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 7487000000, "otherNonCurrentLiabilities": 25297000000, "totalNonCurrentLiabilities": 62769000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 107995000000, "treasuryStock": -39099000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 123060000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -13058000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 74023000000, "totalEquity": 74023000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 182018000000, "totalInvestments": 17121000000, "totalDebt": 33751000000, "netDebt": 19264000000}}
{"date": "2025-09-28", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2025-09-28", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-10-22", "acceptedDate": "2025-10-22 16:04:17", "fiscalYear": "2025", "period": "Q3", "cashAndCashEquivalents": 18231000000, "shortTermInvestments": 331000000, "cashAndShortTermInvestments": 18562000000, "netReceivables": 17611000000, "accountsReceivables": 17611000000, "otherReceivables": 0, "inventory": 14146000000, "prepaids": 0, "otherCurrentAssets": 4292000000, "totalCurrentAssets": 54611000000, "propertyPlantEquipmentNet": 53375000000, "goodwill": 48048000000, "intangibleAssets": 48737000000, "goodwillAndIntangibleAssets": 96785000000, "longTermInvestments": 0, "taxAssets": 6666000000, "otherNonCurrentAssets": -18621000000, "totalNonCurrentAssets": 138205000000, "otherAssets": 0, "totalAssets": 192816000000, "totalPayables": 11553000000, "accountPayables": 9625000000, "otherPayables": 1928000000, "accruedExpenses": 28957000000, "shortTermDebt": 6387000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1928000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3972000000, "totalCurrentLiabilities": 50869000000, "longTermDebt": 39408000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 5988000000, "otherNonCurrentLiabilities": 17274000000, "totalNonCurrentLiabilities": 62670000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 113539000000, "treasuryStock": -75887000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 167281000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -15237000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 79277000000, "totalEquity": 79277000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 192816000000, "totalInvestments": 331000000, "totalDebt": 45795000000, "netDebt": 27564000000}}
{"date": "2025-06-29", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2025-06-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-07-24", "acceptedDate": "2025-07-24 16:04:24", "fiscalYear": "2025", "period": "Q2", "cashAndCashEquivalents": 18577000000, "shortTermInvestments": 303000000, "cashAndShortTermInvestments": 18880000000, "netReceivables": 17846000000, "accountsReceivables": 17846000000, "otherReceivables": 0, "inventory": 13412000000, "prepaids": 0, "otherCurrentAssets": 4360000000, "totalCurrentAssets": 54498000000, "propertyPlantEquipmentNet": 21949000000, "goodwill": 48117000000, "intangibleAssets": 49835000000, "goodwillAndIntangibleAssets": 97952000000, "longTermInvestments": 0, "taxAssets": 6801000000, "otherNonCurrentAssets": 12189000000, "totalNonCurrentAssets": 138891000000, "otherAssets": 0, "totalAssets": 193389000000, "totalPayables": 11129000000, "accountPayables": 9464000000, "otherPayables": 1665000000, "accruedExpenses": 28227000000, "shortTermDebt": 11526000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1665000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3298000000, "totalCurrentLiabilities": 54180000000, "longTermDebt": 39235000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3799000000, "otherNonCurrentLiabilities": 17702000000, "totalNonCurrentLiabilities": 60736000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 114916000000, "treasuryStock": -75713000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 165371000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -14305000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 78473000000, "totalEquity": 78473000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 193389000000, "totalInvestments": 303000000, "totalDebt": 50761000000, "netDebt": 32184000000}}
{"date": "2025-03-30", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2025-03-30", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-04-23", "acceptedDate": "2025-04-23 16:04:45", "fiscalYear": "2025", "period": "Q1", "cashAndCashEquivalents": 38474000000, "shortTermInvestments": 307000000, "cashAndShortTermInvestments": 38781000000, "netReceivables": 16020000000, "accountsReceivables": 16020000000, "otherReceivables": 0, "inventory": 12659000000, "prepaids": 0, "otherCurrentAssets": 4091000000, "totalCurrentAssets": 71551000000, "propertyPlantEquipmentNet": 20871000000, "goodwill": 44468000000, "intangibleAssets": 36755000000, "goodwillAndIntangibleAssets": 81223000000, "longTermInvestments": 0, "taxAssets": 8492000000, "otherNonCurrentAssets": 11534000000, "totalNonCurrentAssets": 122120000000, "otherAssets": 0, "totalAssets": 193671000000, "totalPayables": 13762000000, "accountPayables": 9545000000, "otherPayables": 4217000000, "accruedExpenses": 26693000000, "shortTermDebt": 13897000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 4217000000, "deferredRevenue": 0, "otherCurrentLiabilities": 2551000000, "totalCurrentLiabilities": 56903000000, "longTermDebt": 38355000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2428000000, "otherNonCurrentLiabilities": 17876000000, "totalNonCurrentLiabilities": 58659000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 115562000000, "treasuryStock": -75906000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 162635000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -11740000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 78109000000, "totalEquity": 78109000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 193671000000, "totalInvestments": 307000000, "totalDebt": 52252000000, "netDebt": 13778000000}}
{"date": "2024-12-31", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2024-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-02-13", "acceptedDate": "2025-02-13 16:07:39", "fiscalYear": "2024", "period": "Q4", "cashAndCashEquivalents": 24105000000, "shortTermInvestments": 417000000, "cashAndShortTermInvestments": 24522000000, "netReceivables": 18927000000, "accountsReceivables": 14842000000, "otherReceivables": 4085000000, "inventory": 12444000000, "prepaids": 0, "otherCurrentAssets": 0, "totalCurrentAssets": 55893000000, "propertyPlantEquipmentNet": 20518000000, "goodwill": 44200000000, "intangibleAssets": 37618000000, "goodwillAndIntangibleAssets": 81818000000, "longTermInvestments": 0, "taxAssets": 10461000000, "otherNonCurrentAssets": 11414000000, "totalNonCurrentAssets": 124211000000, "otherAssets": 0, "totalAssets": 180104000000, "totalPayables": 14083000000, "accountPayables": 10311000000, "otherPayables": 3772000000, "accruedExpenses": 26129000000, "shortTermDebt": 5983000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 3772000000, "deferredRevenue": 0, "otherCurrentLiabilities": 4126000000, "totalCurrentLiabilities": 50321000000, "longTermDebt": 30651000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2448000000, "otherNonCurrentLiabilities": 25194000000, "totalNonCurrentLiabilities": 58293000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 108614000000, "treasuryStock": -75680000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 155791000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -11741000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 71490000000, "totalEquity": 71490000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 180104000000, "totalInvestments": 417000000, "totalDebt": 36634000000, "netDebt": 12529000000}}
{"date": "2024-09-29", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2024-09-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-10-23", "acceptedDate": "2024-10-23 16:02:27", "fiscalYear": "2024", "period": "Q3", "cashAndCashEquivalents": 19980000000, "shortTermInvestments": 317000000, "cashAndShortTermInvestments": 20297000000, "netReceivables": 16174000000, "accountsReceivables": 16174000000, "otherReceivables": 0, "inventory": 12603000000, "prepaids": 0, "otherCurrentAssets": 4175000000, "totalCurrentAssets": 53249000000, "propertyPlantEquipmentNet": 20479000000, "goodwill": 44799000000, "intangibleAssets": 39490000000, "goodwillAndIntangibleAssets": 84289000000, "longTermInvestments": 0, "taxAssets": 9349000000, "otherNonCurrentAssets": 10921000000, "totalNonCurrentAssets": 125038000000, "otherAssets": 0, "totalAssets": 178287000000, "totalPayables": 13788000000, "accountPayables": 8954000000, "otherPayables": 4834000000, "accruedExpenses": 29889000000, "shortTermDebt": 4462000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 4834000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3620000000, "totalCurrentLiabilities": 51759000000, "longTermDebt": 31289000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2952000000, "otherNonCurrentLiabilities": 22129000000, "totalNonCurrentLiabilities": 56370000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 108129000000, "treasuryStock": -75619000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 155179000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -12522000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 70158000000, "totalEquity": 70158000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 178287000000, "totalInvestments": 317000000, "totalDebt": 35751000000, "netDebt": 15771000000}}
{"date": "2024-06-30", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2024-06-30", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-07-25", "acceptedDate": "2024-07-25 16:02:29", "fiscalYear": "2024", "period": "Q2", "cashAndCashEquivalents": 24878000000, "shortTermInvestments": 597000000, "cashAndShortTermInvestments": 25475000000, "netReceivables": 15794000000, "accountsReceivables": 15794000000, "otherReceivables": 0, "inventory": 12169000000, "prepaids": 0, "otherCurrentAssets": 4379000000, "totalCurrentAssets": 57817000000, "propertyPlantEquipmentNet": 19748000000, "goodwill": 44250000000, "intangibleAssets": 39725000000, "goodwillAndIntangibleAssets": 83975000000, "longTermInvestments": 0, "taxAssets": 9004000000, "otherNonCurrentAssets": 10544000000, "totalNonCurrentAssets": 123271000000, "otherAssets": 0, "totalAssets": 181088000000, "totalPayables": 13157000000, "accountPayables": 8848000000, "otherPayables": 4309000000, "accruedExpenses": 28078000000, "shortTermDebt": 9855000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 4309000000, "deferredRevenue": 0, "otherCurrentLiabilities": 2843000000, "totalCurrentLiabilities": 53933000000, "longTermDebt": 31636000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2635000000, "otherNonCurrentLiabilities": 21346000000, "totalNonCurrentLiabilities": 55617000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 109550000000, "treasuryStock": -75689000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 155360000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -11253000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 71538000000, "totalEquity": 71538000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 181088000000, "totalInvestments": 597000000, "totalDebt": 41491000000, "netDebt": 16613000000}}
{"date": "2024-03-31", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2024-03-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-05-01", "acceptedDate": "2024-05-01 07:09:36", "fiscalYear": "2024", "period": "Q1", "cashAndCashEquivalents": 25473000000, "shortTermInvestments": 745000000, "cashAndShortTermInvestments": 26218000000, "netReceivables": 14946000000, "accountsReceivables": 14946000000, "otherReceivables": 0, "inventory": 11383000000, "prepaids": 0, "otherCurrentAssets": 4455000000, "totalCurrentAssets": 57002000000, "propertyPlantEquipmentNet": 19632000000, "goodwill": 36616000000, "intangibleAssets": 34286000000, "goodwillAndIntangibleAssets": 70902000000, "longTermInvestments": 0, "taxAssets": 10305000000, "otherNonCurrentAssets": 14125000000, "totalNonCurrentAssets": 114964000000, "otherAssets": 0, "totalAssets": 171966000000, "totalPayables": 11492000000, "accountPayables": 8174000000, "otherPayables": 3318000000, "accruedExpenses": 26505000000, "shortTermDebt": 8550000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 3318000000, "deferredRevenue": 0, "otherCurrentLiabilities": 2178000000, "totalCurrentLiabilities": 48725000000, "longTermDebt": 25082000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3172000000, "otherNonCurrentLiabilities": 24967000000, "totalNonCurrentLiabilities": 53221000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 101946000000, "treasuryStock": -75710000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 153378000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -10768000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 70020000000, "totalEquity": 70020000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 171966000000, "totalInvestments": 745000000, "totalDebt": 33632000000, "netDebt": 8159000000}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2023-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-02-16", "acceptedDate": "2024-02-16 16:12:22", "fiscalYear": "2023", "period": "Q4", "cashAndCashEquivalents": 21859000000, "shortTermInvestments": 1068000000, "cashAndShortTermInvestments": 22927000000, "netReceivables": 19387000000, "accountsReceivables": 14873000000, "otherReceivables": 4514000000, "inventory": 11181000000, "prepaids": 0, "otherCurrentAssets": 0, "totalCurrentAssets": 53495000000, "propertyPlantEquipmentNet": 19898000000, "goodwill": 36558000000, "intangibleAssets": 34175000000, "goodwillAndIntangibleAssets": 70733000000, "longTermInvestments": 0, "taxAssets": 9279000000, "otherNonCurrentAssets": 14153000000, "totalNonCurrentAssets": 114063000000, "otherAssets": 0, "totalAssets": 167558000000, "totalPayables": 12625000000, "accountPayables": 9632000000, "otherPayables": 2993000000, "accruedExpenses": 26213000000, "shortTermDebt": 3451000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2993000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3993000000, "totalCurrentLiabilities": 46282000000, "longTermDebt": 25881000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3193000000, "otherNonCurrentLiabilities": 23428000000, "totalNonCurrentLiabilities": 52502000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 98784000000, "treasuryStock": -75662000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 153843000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -12527000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 68774000000, "totalEquity": 68774000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 167558000000, "totalInvestments": 1068000000, "totalDebt": 29332000000, "netDebt": 7473000000}}
{"date": "2023-10-01", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2023-10-01", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-10-27", "acceptedDate": "2023-10-27 16:11:34", "fiscalYear": "2023", "period": "Q3", "cashAndCashEquivalents": 19728000000, "shortTermInvestments": 3783000000, "cashAndShortTermInvestments": 23511000000, "netReceivables": 14798000000, "accountsReceivables": 14798000000, "otherReceivables": 0, "inventory": 11198000000, "prepaids": 4196000000, "otherCurrentAssets": 0, "totalCurrentAssets": 53703000000, "propertyPlantEquipmentNet": 18821000000, "goodwill": 36124000000, "intangibleAssets": 35021000000, "goodwillAndIntangibleAssets": 71145000000, "longTermInvestments": 0, "taxAssets": 9259000000, "otherNonCurrentAssets": 13133000000, "totalNonCurrentAssets": 112358000000, "otherAssets": 0, "totalAssets": 166061000000, "totalPayables": 11254000000, "accountPayables": 8355000000, "otherPayables": 2899000000, "accruedExpenses": 25909000000, "shortTermDebt": 3870000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2899000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3337000000, "totalCurrentLiabilities": 44370000000, "longTermDebt": 26051000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2623000000, "otherNonCurrentLiabilities": 21789000000, "totalNonCurrentLiabilities": 50463000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 94833000000, "treasuryStock": -75648000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 152536000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -8780000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 71228000000, "totalEquity": 71228000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 166061000000, "totalInvestments": 3783000000, "totalDebt": 29921000000, "netDebt": 10193000000}}
{"date": "2023-07-02", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2023-07-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-07-31", "acceptedDate": "2023-07-31 16:06:04", "fiscalYear": "2023", "period": "Q2", "cashAndCashEquivalents": 21183000000, "shortTermInvestments": 7322000000, "cashAndShortTermInvestments": 28505000000, "netReceivables": 16777000000, "accountsReceivables": 16777000000, "otherReceivables": 0, "inventory": 12888000000, "prepaids": 2397000000, "otherCurrentAssets": 0, "totalCurrentAssets": 60567000000, "propertyPlantEquipmentNet": 20576000000, "goodwill": 45440000000, "intangibleAssets": 46246000000, "goodwillAndIntangibleAssets": 91686000000, "longTermInvestments": 0, "taxAssets": 8779000000, "otherNonCurrentAssets": 10078000000, "totalNonCurrentAssets": 131119000000, "otherAssets": 0, "totalAssets": 191686000000, "totalPayables": 13130000000, "accountPayables": 10443000000, "otherPayables": 2687000000, "accruedExpenses": 26277000000, "shortTermDebt": 11701000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2687000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3062000000, "totalCurrentLiabilities": 54170000000, "longTermDebt": 33901000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3627000000, "otherNonCurrentLiabilities": 23579000000, "totalNonCurrentLiabilities": 61107000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 115277000000, "treasuryStock": -44217000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 129381000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -13135000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 75149000000, "totalEquity": 76409000000, "minorityInterest": 1260000000, "totalLiabilitiesAndTotalEquity": 191686000000, "totalInvestments": 7322000000, "totalDebt": 45602000000, "netDebt": 24419000000}}
{"date": "2023-04-02", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2023-04-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-04-28", "acceptedDate": "2023-04-28 16:07:02", "fiscalYear": "2023", "period": "Q1", "cashAndCashEquivalents": 19170000000, "shortTermInvestments": 5443000000, "cashAndShortTermInvestments": 24613000000, "netReceivables": 16350000000, "accountsReceivables": 16350000000, "otherReceivables": 0, "inventory": 12809000000, "prepaids": 2921000000, "otherCurrentAssets": 7695000000, "totalCurrentAssets": 64388000000, "propertyPlantEquipmentNet": 20174000000, "goodwill": 45575000000, "intangibleAssets": 47448000000, "goodwillAndIntangibleAssets": 93023000000, "longTermInvestments": 0, "taxAssets": 8817000000, "otherNonCurrentAssets": 9567000000, "totalNonCurrentAssets": 131581000000, "otherAssets": 0, "totalAssets": 195969000000, "totalPayables": 14175000000, "accountPayables": 9909000000, "otherPayables": 4266000000, "accruedExpenses": 25988000000, "shortTermDebt": 17979000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 4266000000, "deferredRevenue": 0, "otherCurrentLiabilities": 2231000000, "totalCurrentLiabilities": 60373000000, "longTermDebt": 34928000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 4417000000, "otherNonCurrentLiabilities": 25382000000, "totalNonCurrentLiabilities": 64727000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 125100000000, "treasuryStock": -44183000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 124558000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -12626000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 70869000000, "totalEquity": 70869000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 195969000000, "totalInvestments": 5443000000, "totalDebt": 52907000000, "netDebt": 33737000000}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2022-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-02-16", "acceptedDate": "2023-02-16 16:01:53", "fiscalYear": "2022", "period": "Q4", "cashAndCashEquivalents": 12889000000, "shortTermInvestments": 9392000000, "cashAndShortTermInvestments": 22281000000, "netReceivables": 16915000000, "accountsReceivables": 14039000000, "otherReceivables": 2876000000, "inventory": 10268000000, "prepaids": 0, "otherCurrentAssets": 5830000000, "totalCurrentAssets": 55294000000, "propertyPlantEquipmentNet": 17982000000, "goodwill": 36047000000, "intangibleAssets": 38489000000, "goodwillAndIntangibleAssets": 74536000000, "longTermInvestments": 0, "taxAssets": 8947000000, "otherNonCurrentAssets": 30619000000, "totalNonCurrentAssets": 132084000000, "otherAssets": 0, "totalAssets": 187378000000, "totalPayables": 12109000000, "accountPayables": 9889000000, "otherPayables": 2220000000, "accruedExpenses": 24298000000, "shortTermDebt": 12756000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2220000000, "deferredRevenue": 0, "otherCurrentLiabilities": 6639000000, "totalCurrentLiabilities": 55802000000, "longTermDebt": 26886000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 3991000000, "otherNonCurrentLiabilities": 23895000000, "totalNonCurrentLiabilities": 54772000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 110574000000, "treasuryStock": -41694000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 128345000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -12967000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 76804000000, "totalEquity": 76804000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 187378000000, "totalInvestments": 9392000000, "totalDebt": 39642000000, "netDebt": 26753000000}}
{"date": "2022-10-02", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2022-10-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-10-27", "acceptedDate": "2022-10-27 16:02:59", "fiscalYear": "2022", "period": "Q3", "cashAndCashEquivalents": 11355000000, "shortTermInvestments": 22724000000, "cashAndShortTermInvestments": 34079000000, "netReceivables": 15890000000, "accountsReceivables": 15890000000, "otherReceivables": 0, "inventory": 11675000000, "prepaids": 3592000000, "otherCurrentAssets": 0, "totalCurrentAssets": 65236000000, "propertyPlantEquipmentNet": 18152000000, "goodwill": 33383000000, "intangibleAssets": 40336000000, "goodwillAndIntangibleAssets": 73719000000, "longTermInvestments": 0, "taxAssets": 9392000000, "otherNonCurrentAssets": 8625000000, "totalNonCurrentAssets": 109888000000, "otherAssets": 0, "totalAssets": 175124000000, "totalPayables": 12139000000, "accountPayables": 10153000000, "otherPayables": 1986000000, "accruedExpenses": 25974000000, "shortTermDebt": 4424000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1986000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3006000000, "totalCurrentLiabilities": 45543000000, "longTermDebt": 27603000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 4946000000, "otherNonCurrentLiabilities": 22433000000, "totalNonCurrentLiabilities": 54982000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 100525000000, "treasuryStock": -41146000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 127917000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -15292000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 74599000000, "totalEquity": 74599000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 175124000000, "totalInvestments": 22724000000, "totalDebt": 32027000000, "netDebt": 20672000000}}
{"date": "2022-07-03", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2022-07-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-07-29", "acceptedDate": "2022-07-29 16:14:39", "fiscalYear": "2022", "period": "Q2", "cashAndCashEquivalents": 10983000000, "shortTermInvestments": 21585000000, "cashAndShortTermInvestments": 32568000000, "netReceivables": 16139000000, "accountsReceivables": 16139000000, "otherReceivables": 0, "inventory": 11437000000, "prepaids": 3703000000, "otherCurrentAssets": 0, "totalCurrentAssets": 63847000000, "propertyPlantEquipmentNet": 18354000000, "goodwill": 34166000000, "intangibleAssets": 42408000000, "goodwillAndIntangibleAssets": 76574000000, "longTermInvestments": 0, "taxAssets": 9514000000, "otherNonCurrentAssets": 9435000000, "totalNonCurrentAssets": 113877000000, "otherAssets": 0, "totalAssets": 177724000000, "totalPayables": 11745000000, "accountPayables": 9765000000, "otherPayables": 1980000000, "accruedExpenses": 26054000000, "shortTermDebt": 4305000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1980000000, "deferredRevenue": 0, "otherCurrentLiabilities": 2717000000, "totalCurrentLiabilities": 44821000000, "longTermDebt": 28292000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 5015000000, "otherNonCurrentLiabilities": 23239000000, "totalNonCurrentLiabilities": 56546000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 101367000000, "treasuryStock": -39136000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 126216000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -13843000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 76357000000, "totalEquity": 76357000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 177724000000, "totalInvestments": 21585000000, "totalDebt": 32597000000, "netDebt": 21614000000}}
{"date": "2022-04-03", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2022-04-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-04-29", "acceptedDate": "2022-04-29 16:08:24", "fiscalYear": "2022", "period": "Q1", "cashAndCashEquivalents": 10463000000, "shortTermInvestments": 19925000000, "cashAndShortTermInvestments": 30388000000, "netReceivables": 15594000000, "accountsReceivables": 15594000000, "otherReceivables": 0, "inventory": 10990000000, "prepaids": 3452000000, "otherCurrentAssets": 0, "totalCurrentAssets": 60424000000, "propertyPlantEquipmentNet": 18701000000, "goodwill": 34935000000, "intangibleAssets": 44420000000, "goodwillAndIntangibleAssets": 79355000000, "longTermInvestments": 0, "taxAssets": 9936000000, "otherNonCurrentAssets": 9939000000, "totalNonCurrentAssets": 117931000000, "otherAssets": 0, "totalAssets": 178355000000, "totalPayables": 11017000000, "accountPayables": 9309000000, "otherPayables": 1708000000, "accruedExpenses": 25978000000, "shortTermDebt": 4297000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1708000000, "deferredRevenue": 0, "otherCurrentLiabilities": 2098000000, "totalCurrentLiabilities": 43390000000, "longTermDebt": 28851000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 6424000000, "otherNonCurrentLiabilities": 24981000000, "totalNonCurrentLiabilities": 60256000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 103646000000, "treasuryStock": -39034000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 124380000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -13757000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 74709000000, "totalEquity": 74709000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 178355000000, "totalInvestments": 19925000000, "totalDebt": 33148000000, "netDebt": 22685000000}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2021-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-02-17", "acceptedDate": "2022-02-17 16:06:50", "fiscalYear": "2021", "period": "Q4", "cashAndCashEquivalents": 14487000000, "shortTermInvestments": 17121000000, "cashAndShortTermInvestments": 31608000000, "netReceivables": 18984000000, "accountsReceivables": 15283000000, "otherReceivables": 3701000000, "inventory": 10387000000, "prepaids": 3701000000, "otherCurrentAssets": -3701000000, "totalCurrentAssets": 60979000000, "propertyPlantEquipmentNet": 18962000000, "goodwill": 35246000000, "intangibleAssets": 46392000000, "goodwillAndIntangibleAssets": 81638000000, "longTermInvestments": 0, "taxAssets": 10223000000, "otherNonCurrentAssets": 10216000000, "totalNonCurrentAssets": 121039000000, "otherAssets": 0, "totalAssets": 182018000000, "totalPayables": 12167000000, "accountPayables": 11055000000, "otherPayables": 1112000000, "accruedExpenses": 25707000000, "shortTermDebt": 3766000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1112000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3586000000, "totalCurrentLiabilities": 45226000000, "longTermDebt": 29985000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 7487000000, "otherNonCurrentLiabilities": 25297000000, "totalNonCurrentLiabilities": 62769000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 107995000000, "treasuryStock": -39099000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 123060000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -13058000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 74023000000, "totalEquity": 74023000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 182018000000, "totalInvestments": 17121000000, "totalDebt": 33751000000, "netDebt": 19264000000}}
{"date": "2021-10-03", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2021-10-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-10-29", "acceptedDate": "2021-10-29 16:05:20", "fiscalYear": "2021", "period": "Q3", "cashAndCashEquivalents": 17604000000, "shortTermInvestments": 13397000000, "cashAndShortTermInvestments": 31001000000, "netReceivables": 14911000000, "accountsReceivables": 14911000000, "otherReceivables": 0, "inventory": 10387000000, "prepaids": 3590000000, "otherCurrentAssets": 0, "totalCurrentAssets": 59889000000, "propertyPlantEquipmentNet": 18478000000, "goodwill": 35569000000, "intangibleAssets": 47776000000, "goodwillAndIntangibleAssets": 83345000000, "longTermInvestments": 0, "taxAssets": 10646000000, "otherNonCurrentAssets": 6870000000, "totalNonCurrentAssets": 119339000000, "otherAssets": 0, "totalAssets": 179228000000, "totalPayables": 11122000000, "accountPayables": 8961000000, "otherPayables": 2161000000, "accruedExpenses": 26495000000, "shortTermDebt": 3798000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 2161000000, "deferredRevenue": 0, "otherCurrentLiabilities": 3146000000, "totalCurrentLiabilities": 44561000000, "longTermDebt": 30130000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 7147000000, "otherNonCurrentLiabilities": 27118000000, "totalNonCurrentLiabilities": 64395000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 108956000000, "treasuryStock": -38525000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 121092000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -15415000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 70272000000, "totalEquity": 70272000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 179228000000, "totalInvestments": 13397000000, "totalDebt": 33928000000, "netDebt": 16324000000}}
{"date": "2021-07-04", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2021-07-04", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-07-29", "acceptedDate": "2021-07-29 16:07:51", "fiscalYear": "2021", "period": "Q2", "cashAndCashEquivalents": 14332000000, "shortTermInvestments": 10974000000, "cashAndShortTermInvestments": 25306000000, "netReceivables": 14871000000, "accountsReceivables": 14871000000, "otherReceivables": 0, "inventory": 10100000000, "prepaids": 3492000000, "otherCurrentAssets": 0, "totalCurrentAssets": 53769000000, "propertyPlantEquipmentNet": 18632000000, "goodwill": 35819000000, "intangibleAssets": 50244000000, "goodwillAndIntangibleAssets": 86063000000, "longTermInvestments": 0, "taxAssets": 10804000000, "otherNonCurrentAssets": 7172000000, "totalNonCurrentAssets": 122671000000, "otherAssets": 0, "totalAssets": 176440000000, "totalPayables": 9904000000, "accountPayables": 8704000000, "otherPayables": 1200000000, "accruedExpenses": 22935000000, "shortTermDebt": 3173000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1200000000, "deferredRevenue": 0, "otherCurrentLiabilities": 2709000000, "totalCurrentLiabilities": 38721000000, "longTermDebt": 30310000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 9016000000, "otherNonCurrentLiabilities": 28813000000, "totalNonCurrentLiabilities": 68139000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 106860000000, "treasuryStock": -38594000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 120154000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -15100000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 69580000000, "totalEquity": 69580000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 176440000000, "totalInvestments": 10974000000, "totalDebt": 33483000000, "netDebt": 19151000000}}
{"date": "2021-04-04", "symbol": "JNJ", "type": "balance_sheet_quarter", "result": {"date": "2021-04-04", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-04-30", "acceptedDate": "2021-04-30 16:04:02", "fiscalYear": "2021", "period": "Q1", "cashAndCashEquivalents": 12671000000, "shortTermInvestments": 11948000000, "cashAndShortTermInvestments": 24619000000, "netReceivables": 14938000000, "accountsReceivables": 14938000000, "otherReceivables": 0, "inventory": 9952000000, "prepaids": 3024000000, "otherCurrentAssets": 0, "totalCurrentAssets": 52533000000, "propertyPlantEquipmentNet": 18367000000, "goodwill": 35688000000, "intangibleAssets": 51110000000, "goodwillAndIntangibleAssets": 86798000000, "longTermInvestments": 0, "taxAssets": 8321000000, "otherNonCurrentAssets": 6538000000, "totalNonCurrentAssets": 120024000000, "otherAssets": 0, "totalAssets": 172557000000, "totalPayables": 10380000000, "accountPayables": 8503000000, "otherPayables": 1877000000, "accruedExpenses": 25142000000, "shortTermDebt": 3350000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1877000000, "deferredRevenue": 0, "otherCurrentLiabilities": 2060000000, "totalCurrentLiabilities": 40932000000, "longTermDebt": 30263000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 6507000000, "otherNonCurrentLiabilities": 29021000000, "totalNonCurrentLiabilities": 65791000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 106723000000, "treasuryStock": -38466000000, "preferredStock": 0, "commonStock": 3120000000, "retainedEarnings": 116508000000, "additionalPaidInCapital": 0, "accumulatedOtherComprehensiveIncomeLoss": -15328000000, "otherTotalStockholdersEquity": 0, "totalStockholdersEquity": 65834000000, "totalEquity": 65834000000, "minorityInterest": 0, "totalLiabilitiesAndTotalEquity": 172557000000, "totalInvestments": 11948000000, "totalDebt": 33613000000, "netDebt": 20942000000}}
{"date": "2024-12-29", "symbol": "JNJ", "type": "cash_flow_annual", "result": {"date": "2024-12-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-02-13", "acceptedDate": "2025-02-13 16:07:39", "fiscalYear": "2024", "period": "FY", "netIncome": 14066000000, "depreciationAndAmortization": 7339000000, "deferredIncomeTax": -2183000000, "stockBasedCompensation": 1176000000, "changeInWorkingCapital": 1837000000, "accountsReceivables": -406000000, "inventory": -1128000000, "accountsPayables": 1621000000, "otherWorkingCapital": 1750000000, "otherNonCashItems": 2031000000, "netCashProvidedByOperatingActivities": 24266000000, "investmentsInPropertyPlantAndEquipment": -4424000000, "acquisitionsNet": -15146000000, "purchasesOfInvestments": -1726000000, "salesMaturitiesOfInvestments": 2462000000, "otherInvestingActivities": 235000000, "netCashProvidedByInvestingActivities": -18599000000, "netDebtIssuance": 10051000000, "longTermNetDebtIssuance": 5207000000, "shortTermNetDebtIssuance": 4844000000, "netStockIssuance": -2432000000, "netCommonStockIssuance": -2432000000, "commonStockIssuance": 0, "commonStockRepurchased": -2432000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -11823000000, "commonDividendsPaid": -11823000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 1072000000, "netCashProvidedByFinancingActivities": -3132000000, "effectOfForexChangesOnCash": -289000000, "netChangeInCash": 2246000000, "cashAtEndOfPeriod": 24105000000, "cashAtBeginningOfPeriod": 21859000000, "operatingCashFlow": 24266000000, "capitalExpenditure": -4424000000, "freeCashFlow": 19842000000, "incomeTaxesPaid": 6714000000, "interestPaid": 1911000000}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "cash_flow_annual", "result": {"date": "2023-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-02-16", "acceptedDate": "2024-02-16 16:12:22", "fiscalYear": "2023", "period": "FY", "netIncome": 13326000000, "depreciationAndAmortization": 7486000000, "deferredIncomeTax": -4194000000, "stockBasedCompensation": 1162000000, "changeInWorkingCapital": 2507000000, "accountsReceivables": -624000000, "inventory": -1323000000, "accountsPayables": 2346000000, "otherWorkingCapital": 2108000000, "otherNonCashItems": 2504000000, "netCashProvidedByOperatingActivities": 22791000000, "investmentsInPropertyPlantAndEquipment": -4543000000, "acquisitionsNet": 0, "purchasesOfInvestments": -10906000000, "salesMaturitiesOfInvestments": 19390000000, "otherInvestingActivities": -3063000000, "netCashProvidedByInvestingActivities": 878000000, "netDebtIssuance": -2734000000, "longTermNetDebtIssuance": -1551000000, "shortTermNetDebtIssuance": -1183000000, "netStockIssuance": -813000000, "netCommonStockIssuance": -813000000, "commonStockIssuance": 4241000000, "commonStockRepurchased": -5054000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -11770000000, "commonDividendsPaid": -11770000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -508000000, "netCashProvidedByFinancingActivities": -15825000000, "effectOfForexChangesOnCash": -112000000, "netChangeInCash": 7732000000, "cashAtEndOfPeriod": 21859000000, "cashAtBeginningOfPeriod": 14127000000, "operatingCashFlow": 22791000000, "capitalExpenditure": -4543000000, "freeCashFlow": 18248000000, "incomeTaxesPaid": 8574000000, "interestPaid": 1766000000}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "cash_flow_annual", "result": {"date": "2022-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-02-16", "acceptedDate": "2023-02-16 16:01:53", "fiscalYear": "2022", "period": "FY", "netIncome": 17941000000, "depreciationAndAmortization": 6970000000, "deferredIncomeTax": -1663000000, "stockBasedCompensation": 1138000000, "changeInWorkingCapital": -4011000000, "accountsReceivables": -1290000000, "inventory": -2527000000, "accountsPayables": 1098000000, "otherWorkingCapital": -1292000000, "otherNonCashItems": 819000000, "netCashProvidedByOperatingActivities": 21194000000, "investmentsInPropertyPlantAndEquipment": -4009000000, "acquisitionsNet": -17652000000, "purchasesOfInvestments": -32384000000, "salesMaturitiesOfInvestments": 41609000000, "otherInvestingActivities": 65000000, "netCashProvidedByInvestingActivities": -12371000000, "netDebtIssuance": 7452000000, "longTermNetDebtIssuance": -2132000000, "shortTermNetDebtIssuance": 9584000000, "netStockIssuance": -6035000000, "netCommonStockIssuance": -6035000000, "commonStockIssuance": 0, "commonStockRepurchased": -6035000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -11682000000, "commonDividendsPaid": -11682000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 1394000000, "netCashProvidedByFinancingActivities": -8871000000, "effectOfForexChangesOnCash": -312000000, "netChangeInCash": -360000000, "cashAtEndOfPeriod": 14127000000, "cashAtBeginningOfPeriod": 14487000000, "operatingCashFlow": 21194000000, "capitalExpenditure": -4009000000, "freeCashFlow": 17185000000, "incomeTaxesPaid": 5223000000, "interestPaid": 933000000}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "cash_flow_annual", "result": {"date": "2021-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-02-17", "acceptedDate": "2022-02-17 16:06:50", "fiscalYear": "2021", "period": "FY", "netIncome": 20878000000, "depreciationAndAmortization": 7390000000, "deferredIncomeTax": -2079000000, "stockBasedCompensation": 1135000000, "changeInWorkingCapital": -4238000000, "accountsReceivables": -2402000000, "inventory": -1248000000, "accountsPayables": 2437000000, "otherWorkingCapital": -3025000000, "otherNonCashItems": 324000000, "netCashProvidedByOperatingActivities": 23410000000, "investmentsInPropertyPlantAndEquipment": -3652000000, "acquisitionsNet": -60000000, "purchasesOfInvestments": -30394000000, "salesMaturitiesOfInvestments": 25006000000, "otherInvestingActivities": 417000000, "netCashProvidedByInvestingActivities": -8683000000, "netDebtIssuance": -990000000, "longTermNetDebtIssuance": -1797000000, "shortTermNetDebtIssuance": 807000000, "netStockIssuance": -3456000000, "netCommonStockIssuance": -3456000000, "commonStockIssuance": 0, "commonStockRepurchased": -3456000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -11032000000, "commonDividendsPaid": -11032000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 1431000000, "netCashProvidedByFinancingActivities": -14047000000, "effectOfForexChangesOnCash": -178000000, "netChangeInCash": 502000000, "cashAtEndOfPeriod": 14487000000, "cashAtBeginningOfPeriod": 13985000000, "operatingCashFlow": 23410000000, "capitalExpenditure": -3652000000, "freeCashFlow": 19758000000, "incomeTaxesPaid": 4768000000, "interestPaid": 941000000}}
{"date": "2025-09-28", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2025-09-28", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-10-22", "acceptedDate": "2025-10-22 16:04:17", "fiscalYear": "2025", "period": "Q3", "netIncome": 5152000000, "depreciationAndAmortization": 1777000000, "deferredIncomeTax": 2218000000, "stockBasedCompensation": 347000000, "changeInWorkingCapital": 15945000000, "accountsReceivables": 111000000, "inventory": -748000000, "accountsPayables": 1997000000, "otherWorkingCapital": 14585000000, "otherNonCashItems": -16270000000, "netCashProvidedByOperatingActivities": 9169000000, "investmentsInPropertyPlantAndEquipment": -1157000000, "acquisitionsNet": -1000000, "purchasesOfInvestments": 2438000000, "salesMaturitiesOfInvestments": 489000000, "otherInvestingActivities": -2311000000, "netCashProvidedByInvestingActivities": -542000000, "netDebtIssuance": -7109000000, "longTermNetDebtIssuance": -13491000000, "shortTermNetDebtIssuance": 6382000000, "netStockIssuance": -4029000000, "netCommonStockIssuance": -4029000000, "commonStockIssuance": -4029000000, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -3132000000, "commonDividendsPaid": -3132000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 5343000000, "netCashProvidedByFinancingActivities": -8927000000, "effectOfForexChangesOnCash": -46000000, "netChangeInCash": -346000000, "cashAtEndOfPeriod": 18231000000, "cashAtBeginningOfPeriod": 18577000000, "operatingCashFlow": 9169000000, "capitalExpenditure": -788000000, "freeCashFlow": 8381000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-06-29", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2025-06-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-07-24", "acceptedDate": "2025-07-24 16:04:24", "fiscalYear": "2025", "period": "Q2", "netIncome": 5537000000, "depreciationAndAmortization": 1943000000, "deferredIncomeTax": 825000000, "stockBasedCompensation": 410000000, "changeInWorkingCapital": -4921000000, "accountsReceivables": -1357000000, "inventory": -510000000, "accountsPayables": 1240000000, "otherWorkingCapital": -4294000000, "otherNonCashItems": 84000000, "netCashProvidedByOperatingActivities": 3878000000, "investmentsInPropertyPlantAndEquipment": -1043000000, "acquisitionsNet": -14458000000, "purchasesOfInvestments": -2864000000, "salesMaturitiesOfInvestments": 735000000, "otherInvestingActivities": -634000000, "netCashProvidedByInvestingActivities": -18264000000, "netDebtIssuance": -2376000000, "longTermNetDebtIssuance": -3000000, "shortTermNetDebtIssuance": -2373000000, "netStockIssuance": 107000000, "netCommonStockIssuance": 107000000, "commonStockIssuance": 107000000, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -3129000000, "commonDividendsPaid": -3129000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -267000000, "netCashProvidedByFinancingActivities": -5665000000, "effectOfForexChangesOnCash": 154000000, "netChangeInCash": -19897000000, "cashAtEndOfPeriod": 18577000000, "cashAtBeginningOfPeriod": 38474000000, "operatingCashFlow": 3878000000, "capitalExpenditure": -1398000000, "freeCashFlow": 2480000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-03-30", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2025-03-30", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-04-23", "acceptedDate": "2025-04-23 16:04:45", "fiscalYear": "2025", "period": "Q1", "netIncome": 10999000000, "depreciationAndAmortization": 1772000000, "deferredIncomeTax": 2172000000, "stockBasedCompensation": 288000000, "changeInWorkingCapital": -11024000000, "accountsReceivables": -926000000, "inventory": -146000000, "accountsPayables": -2126000000, "otherWorkingCapital": -7826000000, "otherNonCashItems": -33000000, "netCashProvidedByOperatingActivities": 4174000000, "investmentsInPropertyPlantAndEquipment": -795000000, "acquisitionsNet": 0, "purchasesOfInvestments": -251000000, "salesMaturitiesOfInvestments": 218000000, "otherInvestingActivities": 531000000, "netCashProvidedByInvestingActivities": -297000000, "netDebtIssuance": 15051000000, "longTermNetDebtIssuance": 8387000000, "shortTermNetDebtIssuance": 6664000000, "netStockIssuance": -2127000000, "netCommonStockIssuance": -2127000000, "commonStockIssuance": 0, "commonStockRepurchased": -2127000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2989000000, "commonDividendsPaid": -2989000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 487000000, "netCashProvidedByFinancingActivities": 10422000000, "effectOfForexChangesOnCash": 70000000, "netChangeInCash": 14369000000, "cashAtEndOfPeriod": 38474000000, "cashAtBeginningOfPeriod": 24105000000, "operatingCashFlow": 4174000000, "capitalExpenditure": -809000000, "freeCashFlow": 3365000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-12-31", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2024-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2025-02-13", "acceptedDate": "2025-02-13 16:07:39", "fiscalYear": "2024", "period": "Q4", "netIncome": 3431000000, "depreciationAndAmortization": 1896000000, "deferredIncomeTax": -16000000, "stockBasedCompensation": 238000000, "changeInWorkingCapital": 798000000, "accountsReceivables": 853000000, "inventory": -90000000, "accountsPayables": -1092000000, "otherWorkingCapital": 1127000000, "otherNonCashItems": 636000000, "netCashProvidedByOperatingActivities": 6983000000, "investmentsInPropertyPlantAndEquipment": -1612000000, "acquisitionsNet": -1000000, "purchasesOfInvestments": -262000000, "salesMaturitiesOfInvestments": 290000000, "otherInvestingActivities": 265000000, "netCashProvidedByInvestingActivities": -1320000000, "netDebtIssuance": 1535000000, "longTermNetDebtIssuance": -649000000, "shortTermNetDebtIssuance": 2184000000, "netStockIssuance": -282000000, "netCommonStockIssuance": -282000000, "commonStockIssuance": 0, "commonStockRepurchased": -282000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2984000000, "commonDividendsPaid": -2984000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 391000000, "netCashProvidedByFinancingActivities": -1340000000, "effectOfForexChangesOnCash": -198000000, "netChangeInCash": 4125000000, "cashAtEndOfPeriod": 24105000000, "cashAtBeginningOfPeriod": 19980000000, "operatingCashFlow": 6983000000, "capitalExpenditure": -2145000000, "freeCashFlow": 4838000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-09-29", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2024-09-29", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-10-23", "acceptedDate": "2024-10-23 16:02:27", "fiscalYear": "2024", "period": "Q3", "netIncome": 2694000000, "depreciationAndAmortization": 1846000000, "deferredIncomeTax": 90000000, "stockBasedCompensation": 295000000, "changeInWorkingCapital": 1829000000, "accountsReceivables": -96000000, "inventory": -299000000, "accountsPayables": 2264000000, "otherWorkingCapital": -40000000, "otherNonCashItems": 1239000000, "netCashProvidedByOperatingActivities": 7993000000, "investmentsInPropertyPlantAndEquipment": -1836000000, "acquisitionsNet": -338000000, "purchasesOfInvestments": -280000000, "salesMaturitiesOfInvestments": 466000000, "otherInvestingActivities": -1140000000, "netCashProvidedByInvestingActivities": -3128000000, "netDebtIssuance": -7401000000, "longTermNetDebtIssuance": -970000000, "shortTermNetDebtIssuance": -6431000000, "netStockIssuance": -539000000, "netCommonStockIssuance": -539000000, "commonStockIssuance": 0, "commonStockRepurchased": -539000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2985000000, "commonDividendsPaid": -2985000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 1043000000, "netCashProvidedByFinancingActivities": -9882000000, "effectOfForexChangesOnCash": 119000000, "netChangeInCash": -4898000000, "cashAtEndOfPeriod": 19980000000, "cashAtBeginningOfPeriod": 24878000000, "operatingCashFlow": 7993000000, "capitalExpenditure": -2279000000, "freeCashFlow": 5714000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-06-30", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2024-06-30", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-07-25", "acceptedDate": "2024-07-25 16:02:29", "fiscalYear": "2024", "period": "Q2", "netIncome": 4686000000, "depreciationAndAmortization": 1782000000, "deferredIncomeTax": -695000000, "stockBasedCompensation": 341000000, "changeInWorkingCapital": -452000000, "accountsReceivables": -884000000, "inventory": -391000000, "accountsPayables": 2932000000, "otherWorkingCapital": -2109000000, "otherNonCashItems": -29000000, "netCashProvidedByOperatingActivities": 5633000000, "investmentsInPropertyPlantAndEquipment": -976000000, "acquisitionsNet": -12633000000, "purchasesOfInvestments": -554000000, "salesMaturitiesOfInvestments": 727000000, "otherInvestingActivities": -251000000, "netCashProvidedByInvestingActivities": -13687000000, "netDebtIssuance": 11543000000, "longTermNetDebtIssuance": 5855000000, "shortTermNetDebtIssuance": 5688000000, "netStockIssuance": -136000000, "netCommonStockIssuance": -136000000, "commonStockIssuance": 0, "commonStockRepurchased": -136000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2985000000, "commonDividendsPaid": -2985000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -878000000, "netCashProvidedByFinancingActivities": 7544000000, "effectOfForexChangesOnCash": -85000000, "netChangeInCash": -595000000, "cashAtEndOfPeriod": 24878000000, "cashAtBeginningOfPeriod": 25473000000, "operatingCashFlow": 5633000000, "capitalExpenditure": -976000000, "freeCashFlow": 4657000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-03-31", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2024-03-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-05-01", "acceptedDate": "2024-05-01 07:09:36", "fiscalYear": "2024", "period": "Q1", "netIncome": 3255000000, "depreciationAndAmortization": 1815000000, "deferredIncomeTax": -1562000000, "stockBasedCompensation": 302000000, "changeInWorkingCapital": -338000000, "accountsReceivables": -279000000, "inventory": -348000000, "accountsPayables": -2483000000, "otherWorkingCapital": 2772000000, "otherNonCashItems": 185000000, "netCashProvidedByOperatingActivities": 3657000000, "investmentsInPropertyPlantAndEquipment": -807000000, "acquisitionsNet": -1601000000, "purchasesOfInvestments": -630000000, "salesMaturitiesOfInvestments": 979000000, "otherInvestingActivities": 1595000000, "netCashProvidedByInvestingActivities": -464000000, "netDebtIssuance": 4374000000, "longTermNetDebtIssuance": 1000000, "shortTermNetDebtIssuance": 4373000000, "netStockIssuance": -1475000000, "netCommonStockIssuance": -1475000000, "commonStockIssuance": 0, "commonStockRepurchased": -1475000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2869000000, "commonDividendsPaid": -2869000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 516000000, "netCashProvidedByFinancingActivities": 546000000, "effectOfForexChangesOnCash": -125000000, "netChangeInCash": 3614000000, "cashAtEndOfPeriod": 25473000000, "cashAtBeginningOfPeriod": 21859000000, "operatingCashFlow": 3657000000, "capitalExpenditure": -807000000, "freeCashFlow": 2850000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2023-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2024-02-16", "acceptedDate": "2024-02-16 16:12:22", "fiscalYear": "2023", "period": "Q4", "netIncome": 4132000000, "depreciationAndAmortization": 1843000000, "deferredIncomeTax": -2412000000, "stockBasedCompensation": 178000000, "changeInWorkingCapital": 3247000000, "accountsReceivables": 227000000, "inventory": 124000000, "accountsPayables": 1682000000, "otherWorkingCapital": 1214000000, "otherNonCashItems": 875000000, "netCashProvidedByOperatingActivities": 7863000000, "investmentsInPropertyPlantAndEquipment": -1589000000, "acquisitionsNet": 121000000, "purchasesOfInvestments": -925000000, "salesMaturitiesOfInvestments": 3603000000, "otherInvestingActivities": -2412000000, "netCashProvidedByInvestingActivities": -1202000000, "netDebtIssuance": -1096000000, "longTermNetDebtIssuance": -1049000000, "shortTermNetDebtIssuance": -47000000, "netStockIssuance": -216000000, "netCommonStockIssuance": -216000000, "commonStockIssuance": 0, "commonStockRepurchased": -216000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2865000000, "commonDividendsPaid": -2865000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -478000000, "netCashProvidedByFinancingActivities": -4655000000, "effectOfForexChangesOnCash": 125000000, "netChangeInCash": 2131000000, "cashAtEndOfPeriod": 21859000000, "cashAtBeginningOfPeriod": 19728000000, "operatingCashFlow": 7863000000, "capitalExpenditure": -1589000000, "freeCashFlow": 6274000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-10-01", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2023-10-01", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-10-27", "acceptedDate": "2023-10-27 16:11:34", "fiscalYear": "2023", "period": "Q3", "netIncome": 4309000000, "depreciationAndAmortization": 1829000000, "deferredIncomeTax": 560000000, "stockBasedCompensation": 296000000, "changeInWorkingCapital": -602000000, "accountsReceivables": -252000000, "inventory": -706000000, "accountsPayables": 1725000000, "otherWorkingCapital": -1369000000, "otherNonCashItems": 1097000000, "netCashProvidedByOperatingActivities": 7489000000, "investmentsInPropertyPlantAndEquipment": -967000000, "acquisitionsNet": 121000000, "purchasesOfInvestments": -293000000, "salesMaturitiesOfInvestments": 3910000000, "otherInvestingActivities": -230000000, "netCashProvidedByInvestingActivities": 2541000000, "netDebtIssuance": -7421000000, "longTermNetDebtIssuance": -7675000000, "shortTermNetDebtIssuance": 254000000, "netStockIssuance": -920000000, "netCommonStockIssuance": -920000000, "commonStockIssuance": 0, "commonStockRepurchased": -920000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2871000000, "commonDividendsPaid": -2871000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -105000000, "netCashProvidedByFinancingActivities": -11317000000, "effectOfForexChangesOnCash": -168000000, "netChangeInCash": -1455000000, "cashAtEndOfPeriod": 19728000000, "cashAtBeginningOfPeriod": 21183000000, "operatingCashFlow": 7489000000, "capitalExpenditure": -967000000, "freeCashFlow": 6522000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-07-02", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2023-07-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-07-31", "acceptedDate": "2023-07-31 16:06:04", "fiscalYear": "2023", "period": "Q2", "netIncome": 5144000000, "depreciationAndAmortization": 1934000000, "deferredIncomeTax": -799000000, "stockBasedCompensation": 382000000, "changeInWorkingCapital": -2401000000, "accountsReceivables": -545000000, "inventory": -217000000, "accountsPayables": 1511000000, "otherWorkingCapital": -3150000000, "otherNonCashItems": -78000000, "netCashProvidedByOperatingActivities": 4182000000, "investmentsInPropertyPlantAndEquipment": -1124000000, "acquisitionsNet": 76000000, "purchasesOfInvestments": -5914000000, "salesMaturitiesOfInvestments": 4111000000, "otherInvestingActivities": -925000000, "netCashProvidedByInvestingActivities": -3776000000, "netDebtIssuance": -7097000000, "longTermNetDebtIssuance": -1000000, "shortTermNetDebtIssuance": -7096000000, "netStockIssuance": -381000000, "netCommonStockIssuance": -381000000, "commonStockIssuance": 0, "commonStockRepurchased": -381000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -3092000000, "commonDividendsPaid": -3092000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 4579000000, "netCashProvidedByFinancingActivities": -5991000000, "effectOfForexChangesOnCash": -97000000, "netChangeInCash": -5682000000, "cashAtEndOfPeriod": 21183000000, "cashAtBeginningOfPeriod": 26865000000, "operatingCashFlow": 4182000000, "capitalExpenditure": -1124000000, "freeCashFlow": 3058000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-04-02", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2023-04-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-04-28", "acceptedDate": "2023-04-28 16:07:02", "fiscalYear": "2023", "period": "Q1", "netIncome": -68000000, "depreciationAndAmortization": 1880000000, "deferredIncomeTax": -1543000000, "stockBasedCompensation": 306000000, "changeInWorkingCapital": 2263000000, "accountsReceivables": -54000000, "inventory": -524000000, "accountsPayables": -2572000000, "otherWorkingCapital": 5413000000, "otherNonCashItems": 419000000, "netCashProvidedByOperatingActivities": 3257000000, "investmentsInPropertyPlantAndEquipment": -863000000, "acquisitionsNet": 40000000, "purchasesOfInvestments": -3774000000, "salesMaturitiesOfInvestments": 7766000000, "otherInvestingActivities": 146000000, "netCashProvidedByInvestingActivities": 3315000000, "netDebtIssuance": 12880000000, "longTermNetDebtIssuance": 7174000000, "shortTermNetDebtIssuance": 5706000000, "netStockIssuance": -3537000000, "netCommonStockIssuance": -3537000000, "commonStockIssuance": 0, "commonStockRepurchased": -3537000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2942000000, "commonDividendsPaid": -2942000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -263000000, "netCashProvidedByFinancingActivities": 6138000000, "effectOfForexChangesOnCash": 28000000, "netChangeInCash": 12738000000, "cashAtEndOfPeriod": 26865000000, "cashAtBeginningOfPeriod": 14127000000, "operatingCashFlow": 3257000000, "capitalExpenditure": -863000000, "freeCashFlow": 2394000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2022-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2023-02-16", "acceptedDate": "2023-02-16 16:01:53", "fiscalYear": "2022", "period": "Q4", "netIncome": 3520000000, "depreciationAndAmortization": 1772000000, "deferredIncomeTax": 825000000, "stockBasedCompensation": 213000000, "changeInWorkingCapital": -1239000000, "accountsReceivables": 301000000, "inventory": -650000000, "accountsPayables": 957000000, "otherWorkingCapital": -1847000000, "otherNonCashItems": 259000000, "netCashProvidedByOperatingActivities": 5350000000, "investmentsInPropertyPlantAndEquipment": -1587000000, "acquisitionsNet": -17130000000, "purchasesOfInvestments": -1221000000, "salesMaturitiesOfInvestments": 15285000000, "otherInvestingActivities": 256000000, "netCashProvidedByInvestingActivities": -4397000000, "netDebtIssuance": 7293000000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 7293000000, "netStockIssuance": -1320000000, "netCommonStockIssuance": -1320000000, "commonStockIssuance": 0, "commonStockRepurchased": -1320000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2954000000, "commonDividendsPaid": -2954000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -1319000000, "netCashProvidedByFinancingActivities": 1700000000, "effectOfForexChangesOnCash": 119000000, "netChangeInCash": 2772000000, "cashAtEndOfPeriod": 14127000000, "cashAtBeginningOfPeriod": 11355000000, "operatingCashFlow": 5350000000, "capitalExpenditure": -1587000000, "freeCashFlow": 3763000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-10-02", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2022-10-02", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-10-27", "acceptedDate": "2022-10-27 16:02:59", "fiscalYear": "2022", "period": "Q3", "netIncome": 4458000000, "depreciationAndAmortization": 1685000000, "deferredIncomeTax": -139000000, "stockBasedCompensation": 281000000, "changeInWorkingCapital": -30000000, "accountsReceivables": -205000000, "inventory": -620000000, "accountsPayables": 1311000000, "otherWorkingCapital": -516000000, "otherNonCashItems": 29000000, "netCashProvidedByOperatingActivities": 6284000000, "investmentsInPropertyPlantAndEquipment": -952000000, "acquisitionsNet": 1000000, "purchasesOfInvestments": -9105000000, "salesMaturitiesOfInvestments": 8690000000, "otherInvestingActivities": -335000000, "netCashProvidedByInvestingActivities": -1701000000, "netDebtIssuance": 119000000, "longTermNetDebtIssuance": -2000000, "shortTermNetDebtIssuance": 121000000, "netStockIssuance": -2165000000, "netCommonStockIssuance": -2165000000, "commonStockIssuance": 0, "commonStockRepurchased": -2165000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2970000000, "commonDividendsPaid": -2970000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 1091000000, "netCashProvidedByFinancingActivities": -3925000000, "effectOfForexChangesOnCash": -286000000, "netChangeInCash": 372000000, "cashAtEndOfPeriod": 11355000000, "cashAtBeginningOfPeriod": 10983000000, "operatingCashFlow": 6284000000, "capitalExpenditure": -952000000, "freeCashFlow": 5332000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-07-03", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2022-07-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-07-29", "acceptedDate": "2022-07-29 16:14:39", "fiscalYear": "2022", "period": "Q2", "netIncome": 4814000000, "depreciationAndAmortization": 1744000000, "deferredIncomeTax": -1423000000, "stockBasedCompensation": 366000000, "changeInWorkingCapital": -3000000, "accountsReceivables": -959000000, "inventory": -657000000, "accountsPayables": 1647000000, "otherWorkingCapital": -34000000, "otherNonCashItems": 83000000, "netCashProvidedByOperatingActivities": 5581000000, "investmentsInPropertyPlantAndEquipment": -863000000, "acquisitionsNet": -271000000, "purchasesOfInvestments": -13040000000, "salesMaturitiesOfInvestments": 11331000000, "otherInvestingActivities": 204000000, "netCashProvidedByInvestingActivities": -2639000000, "netDebtIssuance": 9000000, "longTermNetDebtIssuance": 2000000, "shortTermNetDebtIssuance": 7000000, "netStockIssuance": -973000000, "netCommonStockIssuance": -973000000, "commonStockIssuance": 0, "commonStockRepurchased": -973000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2971000000, "commonDividendsPaid": -2971000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 1674000000, "netCashProvidedByFinancingActivities": -2261000000, "effectOfForexChangesOnCash": -161000000, "netChangeInCash": 520000000, "cashAtEndOfPeriod": 10983000000, "cashAtBeginningOfPeriod": 10463000000, "operatingCashFlow": 5581000000, "capitalExpenditure": -863000000, "freeCashFlow": 4718000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-04-03", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2022-04-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-04-29", "acceptedDate": "2022-04-29 16:08:24", "fiscalYear": "2022", "period": "Q1", "netIncome": 5149000000, "depreciationAndAmortization": 1769000000, "deferredIncomeTax": -926000000, "stockBasedCompensation": 278000000, "changeInWorkingCapital": -2739000000, "accountsReceivables": -427000000, "inventory": -600000000, "accountsPayables": -2817000000, "otherWorkingCapital": 1105000000, "otherNonCashItems": 448000000, "netCashProvidedByOperatingActivities": 3979000000, "investmentsInPropertyPlantAndEquipment": -607000000, "acquisitionsNet": -252000000, "purchasesOfInvestments": -9018000000, "salesMaturitiesOfInvestments": 6303000000, "otherInvestingActivities": -60000000, "netCashProvidedByInvestingActivities": -3634000000, "netDebtIssuance": 31000000, "longTermNetDebtIssuance": -2132000000, "shortTermNetDebtIssuance": 2163000000, "netStockIssuance": -1577000000, "netCommonStockIssuance": -1577000000, "commonStockIssuance": 0, "commonStockRepurchased": -1577000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2787000000, "commonDividendsPaid": -2787000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -52000000, "netCashProvidedByFinancingActivities": -4385000000, "effectOfForexChangesOnCash": 16000000, "netChangeInCash": -4024000000, "cashAtEndOfPeriod": 10463000000, "cashAtBeginningOfPeriod": 14487000000, "operatingCashFlow": 3979000000, "capitalExpenditure": -607000000, "freeCashFlow": 3372000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2021-12-31", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2022-02-17", "acceptedDate": "2022-02-17 16:06:50", "fiscalYear": "2021", "period": "Q4", "netIncome": 4736000000, "depreciationAndAmortization": 1843000000, "deferredIncomeTax": 485000000, "stockBasedCompensation": 215000000, "changeInWorkingCapital": -1568000000, "accountsReceivables": -584000000, "inventory": -70000000, "accountsPayables": 2255000000, "otherWorkingCapital": -3169000000, "otherNonCashItems": 21000000, "netCashProvidedByOperatingActivities": 5732000000, "investmentsInPropertyPlantAndEquipment": -1415000000, "acquisitionsNet": -60000000, "purchasesOfInvestments": -11551000000, "salesMaturitiesOfInvestments": 8197000000, "otherInvestingActivities": -531000000, "netCashProvidedByInvestingActivities": -5360000000, "netDebtIssuance": -3000000, "longTermNetDebtIssuance": -348000000, "shortTermNetDebtIssuance": 345000000, "netStockIssuance": -996000000, "netCommonStockIssuance": -996000000, "commonStockIssuance": 0, "commonStockRepurchased": -996000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2791000000, "commonDividendsPaid": -2791000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 354000000, "netCashProvidedByFinancingActivities": -3436000000, "effectOfForexChangesOnCash": -53000000, "netChangeInCash": -3117000000, "cashAtEndOfPeriod": 14487000000, "cashAtBeginningOfPeriod": 17604000000, "operatingCashFlow": 5732000000, "capitalExpenditure": -1415000000, "freeCashFlow": 4317000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-10-03", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2021-10-03", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-10-29", "acceptedDate": "2021-10-29 16:05:20", "fiscalYear": "2021", "period": "Q3", "netIncome": 3667000000, "depreciationAndAmortization": 1814000000, "deferredIncomeTax": -1879000000, "stockBasedCompensation": 259000000, "changeInWorkingCapital": 3499000000, "accountsReceivables": -252000000, "inventory": -360000000, "accountsPayables": -11217000000, "otherWorkingCapital": 15328000000, "otherNonCashItems": 930000000, "netCashProvidedByOperatingActivities": 8290000000, "investmentsInPropertyPlantAndEquipment": -747000000, "acquisitionsNet": 12000000, "purchasesOfInvestments": -6579000000, "salesMaturitiesOfInvestments": 4356000000, "otherInvestingActivities": 251000000, "netCashProvidedByInvestingActivities": -2719000000, "netDebtIssuance": 654000000, "longTermNetDebtIssuance": 1000000, "shortTermNetDebtIssuance": 653000000, "netStockIssuance": -391000000, "netCommonStockIssuance": -391000000, "commonStockIssuance": 0, "commonStockRepurchased": -391000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2791000000, "commonDividendsPaid": -2791000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 321000000, "netCashProvidedByFinancingActivities": -2207000000, "effectOfForexChangesOnCash": -92000000, "netChangeInCash": 3272000000, "cashAtEndOfPeriod": 17604000000, "cashAtBeginningOfPeriod": 14332000000, "operatingCashFlow": 8290000000, "capitalExpenditure": -747000000, "freeCashFlow": 7543000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-07-04", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2021-07-04", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-07-29", "acceptedDate": "2021-07-29 16:07:51", "fiscalYear": "2021", "period": "Q2", "netIncome": 6278000000, "depreciationAndAmortization": 1839000000, "deferredIncomeTax": 45000000, "stockBasedCompensation": 354000000, "changeInWorkingCapital": -3154000000, "accountsReceivables": 38000000, "inventory": -123000000, "accountsPayables": -18117000000, "otherWorkingCapital": 15048000000, "otherNonCashItems": -48000000, "netCashProvidedByOperatingActivities": 5314000000, "investmentsInPropertyPlantAndEquipment": -813000000, "acquisitionsNet": 0, "purchasesOfInvestments": -6270000000, "salesMaturitiesOfInvestments": 7661000000, "otherInvestingActivities": -997000000, "netCashProvidedByInvestingActivities": -419000000, "netDebtIssuance": -189000000, "longTermNetDebtIssuance": -450000000, "shortTermNetDebtIssuance": 261000000, "netStockIssuance": -631000000, "netCommonStockIssuance": -631000000, "commonStockIssuance": 0, "commonStockRepurchased": -631000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -2791000000, "commonDividendsPaid": -2791000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 332000000, "netCashProvidedByFinancingActivities": -3279000000, "effectOfForexChangesOnCash": 45000000, "netChangeInCash": 1661000000, "cashAtEndOfPeriod": 14332000000, "cashAtBeginningOfPeriod": 12671000000, "operatingCashFlow": 5314000000, "capitalExpenditure": -813000000, "freeCashFlow": 4501000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-04-04", "symbol": "JNJ", "type": "cash_flow_quarter", "result": {"date": "2021-04-04", "symbol": "JNJ", "reportedCurrency": "USD", "cik": "0000200406", "filingDate": "2021-04-30", "acceptedDate": "2021-04-30 16:04:02", "fiscalYear": "2021", "period": "Q1", "netIncome": 6197000000, "depreciationAndAmortization": 1894000000, "deferredIncomeTax": -730000000, "stockBasedCompensation": 307000000, "changeInWorkingCapital": -3015000000, "accountsReceivables": -1604000000, "inventory": -695000000, "accountsPayables": -2336000000, "otherWorkingCapital": 1620000000, "otherNonCashItems": -579000000, "netCashProvidedByOperatingActivities": 4074000000, "investmentsInPropertyPlantAndEquipment": -677000000, "acquisitionsNet": 0, "purchasesOfInvestments": -5994000000, "salesMaturitiesOfInvestments": 5233000000, "otherInvestingActivities": 1253000000, "netCashProvidedByInvestingActivities": -185000000, "netDebtIssuance": -1452000000, "longTermNetDebtIssuance": -1000000000, "shortTermNetDebtIssuance": -452000000, "netStockIssuance": -1202000000, "netCommonStockIssuance": -1438000000, "commonStockIssuance": 0, "commonStockRepurchased": -1438000000, "netPreferredStockIssuance": 236000000, "netDividendsPaid": -2659000000, "commonDividendsPaid": -2659000000, "preferredDividendsPaid": 0, "otherFinancingActivities": 188000000, "netCashProvidedByFinancingActivities": -5125000000, "effectOfForexChangesOnCash": -78000000, "netChangeInCash": -1314000000, "cashAtEndOfPeriod": 12671000000, "cashAtBeginningOfPeriod": 13985000000, "operatingCashFlow": 4074000000, "capitalExpenditure": -677000000, "freeCashFlow": 3397000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-09-28", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2025-09-28", "fiscalYear": "2025", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.6956195557037469, "ebitMargin": 0.31304963947818115, "ebitdaMargin": 0.38711290793148, "operatingProfitMargin": 0.29575292793731506, "pretaxProfitMargin": 0.31229942066436045, "continuousOperationsProfitMargin": 0.2147292960446797, "netProfitMargin": 0.2147292960446797, "bottomLineProfitMargin": 0.2147292960446797, "receivablesTurnover": 1.3623871443983873, "payablesTurnover": 0.7587532467532467, "inventoryTurnover": 0.5162590131485932, "fixedAssetTurnover": 0.4495175644028103, "assetTurnover": 0.12443469421624762, "currentRatio": 1.073561501110696, "quickRatio": 0.7954746505730406, "solvencyRatio": 0.06102748835202001, "cashRatio": 0.3583911616111974, "priceToEarningsRatio": 21.40345166925466, "priceToEarningsGrowthRatio": -2.8831708425054825, "forwardPriceToEarningsGrowthRatio": -2.8831708425054825, "priceToBookRatio": 5.563812101870656, "priceToSalesRatio": 18.38379243946151, "priceToFreeCashFlowRatio": 52.62884285884739, "priceToOperatingCashFlowRatio": 48.10582746210056, "debtToAssetsRatio": 0.03312484441125218, "debtToEquityRatio": 0.08056561171588228, "debtToCapitalRatio": 0.0745587411281285, "longTermDebtToCapitalRatio": 0, "financialLeverageRatio": 2.4321808342898947, "workingCapitalTurnoverRatio": 11.8192118226601, "operatingCashFlowRatio": 0.18024730189309796, "operatingCashFlowSalesRatio": 0.3821531279956654, "freeCashFlowOperatingCashFlowRatio": 0.9140582397207984, "debtServiceCoverageRatio": 1.0846213895394223, "interestCoverageRatio": 394.22222222222223, "shortTermOperatingCashFlowCoverageRatio": 1.435572256145295, "operatingCashFlowCoverageRatio": 1.435572256145295, "capitalExpenditureCoverageRatio": 11.635786802030458, "dividendPaidAndCapexCoverageRatio": 2.339030612244898, "dividendPayoutRatio": 0.6079192546583851, "dividendYield": 0.007100715156280618, "dividendYieldPercentage": 0.7100715156280618, "revenuePerShare": 9.879354360536935, "netIncomePerShare": 2.1213868072140327, "interestDebtPerShare": 2.637321913859837, "cashPerShare": 7.643086551922918, "bookValuePerShare": 32.64308655192292, "tangibleBookValuePerShare": -7.209091657745203, "shareholdersEquityPerShare": 32.64308655192292, "operatingCashFlowPerShare": 3.7754261714568065, "capexPerShare": 0.32446677097916493, "freeCashFlowPerShare": 3.4509594004776414, "netIncomePerEBT": 0.6875750700653944, "ebtPerEbit": 1.0559470124013528, "priceToFairValue": 5.563812101870656, "debtToMarketCap": 0.014480289815825132, "effectiveTaxRate": 0.31242492993460563, "enterpriseValueMultiple": 46.21429069767442, "dividendPerShare": 1.289631886683686}}
{"date": "2025-06-29", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2025-06-29", "fiscalYear": "2025", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.6787263614539022, "ebitMargin": 0.28635808448805966, "ebitdaMargin": 0.3681927304889862, "operatingProfitMargin": 0.28682137893273807, "pretaxProfitMargin": 0.27338584003706357, "continuousOperationsProfitMargin": 0.23320557638040687, "netProfitMargin": 0.23320557638040687, "bottomLineProfitMargin": 0.23320557638040687, "receivablesTurnover": 1.330438193432702, "payablesTurnover": 0.8060016906170753, "inventoryTurnover": 0.5687444079928422, "fixedAssetTurnover": 1.0817349309763542, "assetTurnover": 0.12277327045488627, "currentRatio": 1.0058693244739756, "quickRatio": 0.7583241048357328, "solvencyRatio": 0.06509102300811027, "cashRatio": 0.34287559985234406, "priceToEarningsRatio": 16.684013229185478, "priceToEarningsGrowthRatio": -0.3344120195499019, "forwardPriceToEarningsGrowthRatio": -0.3344120195499019, "priceToBookRatio": 4.7088492220254095, "priceToSalesRatio": 15.563219685802132, "priceToFreeCashFlowRatio": 148.99900201612903, "priceToOperatingCashFlowRatio": 95.28559179989685, "debtToAssetsRatio": 0.26248132003371444, "debtToEquityRatio": 0.6468594293578683, "debtToCapitalRatio": 0.3927836327901326, "longTermDebtToCapitalRatio": 0.33332483773405375, "financialLeverageRatio": 2.46440176876123, "workingCapitalTurnoverRatio": 3.172925297340639, "operatingCashFlowRatio": 0.07157622739018088, "operatingCashFlowSalesRatio": 0.16333235058754159, "freeCashFlowOperatingCashFlowRatio": 0.6395048994326973, "debtServiceCoverageRatio": 0.6581037688017577, "interestCoverageRatio": 22.11038961038961, "shortTermOperatingCashFlowCoverageRatio": 0.3364567065764359, "operatingCashFlowCoverageRatio": 0.07639723409704301, "capitalExpenditureCoverageRatio": 2.7739628040057225, "dividendPaidAndCapexCoverageRatio": 0.8566379500773139, "dividendPayoutRatio": 0.5651074589127687, "dividendYield": 0.008467798651768952, "dividendYieldPercentage": 0.8467798651768952, "revenuePerShare": 9.814807159687486, "netIncomePerShare": 2.2888677607374643, "interestDebtPerShare": 21.11074366499938, "cashPerShare": 7.8045554131701875, "bookValuePerShare": 32.438923566615685, "tangibleBookValuePerShare": -8.052168161713034, "shareholdersEquityPerShare": 32.438923566615685, "operatingCashFlowPerShare": 1.60307552395519, "capexPerShare": 0.5779008722252077, "freeCashFlowPerShare": 1.0251746517299822, "netIncomePerEBT": 0.8530272685256509, "ebtPerEbit": 0.9531571218795888, "priceToFairValue": 4.7088492220254095, "debtToMarketCap": 0.13737102184801656, "effectiveTaxRate": 0.1469727314743491, "enterpriseValueMultiple": 45.95075783573553, "dividendPerShare": 1.2934562440577073}}
{"date": "2025-03-30", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2025-03-30", "fiscalYear": "2025", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6639565157813, "ebitMargin": 0.6319371488603663, "ebitdaMargin": 0.7128762618188462, "operatingProfitMargin": 0.287717535285251, "pretaxProfitMargin": 0.6226191019960718, "continuousOperationsProfitMargin": 0.5023980267665464, "netProfitMargin": 0.5023980267665464, "bottomLineProfitMargin": 0.5023980267665464, "receivablesTurnover": 1.3666042446941324, "payablesTurnover": 0.7707700366684128, "inventoryTurnover": 0.5811675487795245, "fixedAssetTurnover": 1.0489674668199895, "assetTurnover": 0.11304222108627518, "currentRatio": 1.2574205226437973, "quickRatio": 1.0349542203398767, "solvencyRatio": 0.11051210605562382, "cashRatio": 0.6761330685552607, "priceToEarningsRatio": 9.067843667606146, "priceToEarningsGrowthRatio": 0.041296230715531165, "forwardPriceToEarningsGrowthRatio": 0.041296230715531165, "priceToBookRatio": 5.10759131470125, "priceToSalesRatio": 18.222667062531404, "priceToFreeCashFlowRatio": 118.55835066864785, "priceToOperatingCashFlowRatio": 95.57950407283181, "debtToAssetsRatio": 0.2697977497921733, "debtToEquityRatio": 0.6689626035412053, "debtToCapitalRatio": 0.4008254002347328, "longTermDebtToCapitalRatio": 0.3293292347849979, "financialLeverageRatio": 2.479496600903865, "workingCapitalTurnoverRatio": 2.165479723046489, "operatingCashFlowRatio": 0.07335289879268228, "operatingCashFlowSalesRatio": 0.19065454711551638, "freeCashFlowOperatingCashFlowRatio": 0.8061811212266411, "debtServiceCoverageRatio": 0.920147507268988, "interestCoverageRatio": 30.877450980392158, "shortTermOperatingCashFlowCoverageRatio": 0.3003525940850543, "operatingCashFlowCoverageRatio": 0.07988210977570237, "capitalExpenditureCoverageRatio": 5.159456118665019, "dividendPaidAndCapexCoverageRatio": 1.0989994734070563, "dividendPayoutRatio": 0.2717519774524957, "dividendYield": 0.0074921885349462725, "dividendYieldPercentage": 0.7492188534946272, "revenuePerShare": 9.100753442452586, "netIncomePerShare": 4.572200571577033, "interestDebtPerShare": 21.805559885684595, "cashPerShare": 16.120966484801247, "bookValuePerShare": 32.46931670563783, "tangibleBookValuePerShare": -1.2944660950896336, "shareholdersEquityPerShare": 32.46931670563783, "operatingCashFlowPerShare": 1.7351000259807743, "capexPerShare": 0.33629514159521956, "freeCashFlowPerShare": 1.3988048843855547, "netIncomePerEBT": 0.8069107182158316, "ebtPerEbit": 2.1639942848071123, "priceToFairValue": 5.10759131470125, "debtToMarketCap": 0.1309741837832093, "effectiveTaxRate": 0.19308928178416843, "enterpriseValueMultiple": 26.444983020439548, "dividendPerShare": 1.2425045466354898}}
{"date": "2024-12-31", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2024-12-31", "fiscalYear": "2024", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.68348134991119, "ebitMargin": 0.17868561278863232, "ebitdaMargin": 0.26287744227353466, "operatingProfitMargin": 0.1705595026642984, "pretaxProfitMargin": 0.17260213143872113, "continuousOperationsProfitMargin": 0.15235346358792184, "netProfitMargin": 0.15235346358792184, "bottomLineProfitMargin": 0.15235346358792184, "receivablesTurnover": 1.1898346277804195, "payablesTurnover": 0.6913005528076811, "inventoryTurnover": 0.5728061716489875, "fixedAssetTurnover": 1.0975728628521297, "assetTurnover": 0.12503886643272777, "currentRatio": 1.1107291190556627, "quickRatio": 0.863436736153892, "solvencyRatio": 0.04904524278638113, "cashRatio": 0.47902466167206537, "priceToEarningsRatio": 25.363528099679396, "priceToEarningsGrowthRatio": 0.916359724891643, "forwardPriceToEarningsGrowthRatio": 0.916359724891643, "priceToBookRatio": 4.869059443838299, "priceToSalesRatio": 15.456885419182948, "priceToFreeCashFlowRatio": 71.94895817279868, "priceToOperatingCashFlowRatio": 49.848068113991125, "debtToAssetsRatio": 0.20340469950695153, "debtToEquityRatio": 0.512435305637152, "debtToCapitalRatio": 0.3388146942399467, "longTermDebtToCapitalRatio": 0.3000851763738362, "financialLeverageRatio": 2.5192894111064486, "workingCapitalTurnoverRatio": 6.37779665817049, "operatingCashFlowRatio": 0.13876910236283063, "operatingCashFlowSalesRatio": 0.3100799289520426, "freeCashFlowOperatingCashFlowRatio": 0.6928254331949019, "debtServiceCoverageRatio": 0.8928104575163399, "interestCoverageRatio": 28.036496350364963, "shortTermOperatingCashFlowCoverageRatio": 1.1671402306535184, "operatingCashFlowCoverageRatio": 0.19061527542719878, "capitalExpenditureCoverageRatio": 3.2554778554778556, "dividendPaidAndCapexCoverageRatio": 1.3614739715344122, "dividendPayoutRatio": 0.8697172835907898, "dividendYield": 0.008572518777482139, "dividendYieldPercentage": 0.8572518777482139, "revenuePerShare": 9.3563480661193, "netIncomePerShare": 1.4254720344074299, "interestDebtPerShare": 15.277188043484584, "cashPerShare": 10.188115776082482, "bookValuePerShare": 29.701834957676237, "tangibleBookValuePerShare": -4.290957496753115, "shareholdersEquityPerShare": 29.701834957676237, "operatingCashFlowPerShare": 2.901215743592854, "capexPerShare": 0.8911796892462656, "freeCashFlowPerShare": 2.0100360543465885, "netIncomePerEBT": 0.8826858759969128, "ebtPerEbit": 1.0119760479041917, "priceToFairValue": 4.869059443838299, "debtToMarketCap": 0.10524318126483936, "effectiveTaxRate": 0.11731412400308722, "enterpriseValueMultiple": 60.91521277702703, "dividendPerShare": 1.2397576655994669}}
{"date": "2024-09-29", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2024-09-29", "fiscalYear": "2024", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.6901339504249923, "ebitMargin": 0.1571358640024921, "ebitdaMargin": 0.23928619109073918, "operatingProfitMargin": 0.23488051266076276, "pretaxProfitMargin": 0.14854701615415425, "continuousOperationsProfitMargin": 0.11988785545814605, "netProfitMargin": 0.11988785545814605, "bottomLineProfitMargin": 0.11988785545814605, "receivablesTurnover": 1.3893285519970322, "payablesTurnover": 0.7776412776412777, "inventoryTurnover": 0.552487502975482, "fixedAssetTurnover": 1.0972703745300063, "assetTurnover": 0.12603835389007612, "currentRatio": 1.0287872640506965, "quickRatio": 0.7852933789292683, "solvencyRatio": 0.041986886034273876, "cashRatio": 0.38601982263954093, "priceToEarningsRatio": 36.203295645879734, "priceToEarningsGrowthRatio": -0.8505593555357289, "forwardPriceToEarningsGrowthRatio": -0.8505593555357289, "priceToBookRatio": 5.560687503634654, "priceToSalesRatio": 17.36134190200703, "priceToFreeCashFlowRatio": 68.27558870843542, "priceToOperatingCashFlowRatio": 48.808546713374206, "debtToAssetsRatio": 0.2005249962139696, "debtToEquityRatio": 0.5095783802274866, "debtToCapitalRatio": 0.3375633798827295, "longTermDebtToCapitalRatio": 0.30842706043549833, "financialLeverageRatio": 2.5412212434790047, "workingCapitalTurnoverRatio": 8.362858206177894, "operatingCashFlowRatio": 0.1544272493672598, "operatingCashFlowSalesRatio": 0.3557029059676917, "freeCashFlowOperatingCashFlowRatio": 0.714875516076567, "debtServiceCoverageRatio": 1.0167561761546724, "interestCoverageRatio": 27.34715025906736, "shortTermOperatingCashFlowCoverageRatio": 1.791349170775437, "operatingCashFlowCoverageRatio": 0.2235741657576012, "capitalExpenditureCoverageRatio": 3.507240017551558, "dividendPaidAndCapexCoverageRatio": 1.5184270516717324, "dividendPayoutRatio": 1.1080178173719377, "dividendYield": 0.00765136017042443, "dividendYieldPercentage": 0.765136017042443, "revenuePerShare": 9.334531910880996, "netIncomePerShare": 1.1190970125011528, "interestDebtPerShare": 14.931263183868387, "cashPerShare": 8.43144471519521, "bookValuePerShare": 29.1438783233318, "tangibleBookValuePerShare": -5.870066771957606, "shareholdersEquityPerShare": 29.1438783233318, "operatingCashFlowPerShare": 3.3203201265485203, "capexPerShare": 0.9467045625427346, "freeCashFlowPerShare": 2.3736155640057857, "netIncomePerEBT": 0.8070701018573997, "ebtPerEbit": 0.6324365289882531, "priceToFairValue": 5.560687503634654, "debtToMarketCap": 0.09163945643311351, "effectiveTaxRate": 0.19292989814260036, "enterpriseValueMultiple": 75.48776527431653, "dividendPerShare": 1.2399794292189832}}
{"date": "2024-06-30", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2024-06-30", "fiscalYear": "2024", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.6939902882345079, "ebitMargin": 0.2680981868401123, "ebitdaMargin": 0.3474851873301555, "operatingProfitMargin": 0.2965652425713904, "pretaxProfitMargin": 0.25606985343252997, "continuousOperationsProfitMargin": 0.20875840869603957, "netProfitMargin": 0.20875840869603957, "bottomLineProfitMargin": 0.20875840869603957, "receivablesTurnover": 1.4212359123717868, "payablesTurnover": 0.7763336347197106, "inventoryTurnover": 0.5644670885035746, "fixedAssetTurnover": 1.1366720680575249, "assetTurnover": 0.12395630853507687, "currentRatio": 1.0720152782155639, "quickRatio": 0.8463834757940407, "solvencyRatio": 0.05904153354632588, "cashRatio": 0.4612760276639534, "priceToEarningsRatio": 18.80344600938967, "priceToEarningsGrowthRatio": 0.4230775352112676, "forwardPriceToEarningsGrowthRatio": 0.4230775352112676, "priceToBookRatio": 4.926777265229668, "priceToSalesRatio": 15.701509867688333, "priceToFreeCashFlowRatio": 75.68215417650848, "priceToOperatingCashFlowRatio": 62.56910917805787, "debtToAssetsRatio": 0.22912064852447428, "debtToEquityRatio": 0.5799854622717996, "debtToCapitalRatio": 0.3670827840642667, "longTermDebtToCapitalRatio": 0.30662763874619575, "financialLeverageRatio": 2.53135396572451, "workingCapitalTurnoverRatio": 3.691637200888085, "operatingCashFlowRatio": 0.10444440324105835, "operatingCashFlowSalesRatio": 0.2509466743885597, "freeCashFlowOperatingCashFlowRatio": 0.8267353097816439, "debtServiceCoverageRatio": 0.6654814814814815, "interestCoverageRatio": 24.655555555555555, "shortTermOperatingCashFlowCoverageRatio": 0.5715880263825469, "operatingCashFlowCoverageRatio": 0.13576438263719842, "capitalExpenditureCoverageRatio": 5.771516393442623, "dividendPaidAndCapexCoverageRatio": 1.4221156273668265, "dividendPayoutRatio": 0.6370038412291933, "dividendYield": 0.008469243362507858, "dividendYieldPercentage": 0.8469243362507859, "revenuePerShare": 9.32649160711318, "netIncomePerShare": 1.946983546617916, "interestDebtPerShare": 17.351254778128634, "cashPerShare": 10.584593651321256, "bookValuePerShare": 29.723284028585674, "tangibleBookValuePerShare": -5.167442246966927, "shareholdersEquityPerShare": 29.723284028585674, "operatingCashFlowPerShare": 2.340452052517866, "capexPerShare": 0.4055176998504238, "freeCashFlowPerShare": 1.9349343526674423, "netIncomePerEBT": 0.8152400835073069, "ebtPerEbit": 0.8634520054078414, "priceToFairValue": 4.926777265229668, "debtToMarketCap": 0.11772106410513015, "effectiveTaxRate": 0.1847599164926931, "enterpriseValueMultiple": 47.315998974358976, "dividendPerShare": 1.2402359980056508}}
{"date": "2024-03-31", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2024-03-31", "fiscalYear": "2024", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6955057756161437, "ebitMargin": 0.18093812841977272, "ebitdaMargin": 0.2658186409764766, "operatingProfitMargin": 0.29336388720011225, "pretaxProfitMargin": 0.17368937941355284, "continuousOperationsProfitMargin": 0.15222372913061777, "netProfitMargin": 0.15222372913061777, "bottomLineProfitMargin": 0.15222372913061777, "receivablesTurnover": 1.4306837949953164, "payablesTurnover": 0.7965500367017372, "inventoryTurnover": 0.5719933233769656, "fixedAssetTurnover": 1.0891911165444172, "assetTurnover": 0.12434434713838782, "currentRatio": 1.169871729091842, "quickRatio": 0.9362544894817856, "solvencyRatio": 0.04973221117061974, "cashRatio": 0.5227911749615187, "priceToEarningsRatio": 29.183240860215054, "priceToEarningsGrowthRatio": -1.485692261974585, "forwardPriceToEarningsGrowthRatio": -1.485692261974585, "priceToBookRatio": 5.4265323621822334, "priceToSalesRatio": 17.769527007435812, "priceToFreeCashFlowRatio": 133.32133192982457, "priceToOperatingCashFlowRatio": 103.90095597484277, "debtToAssetsRatio": 0.1955735436074573, "debtToEquityRatio": 0.48031990859754353, "debtToCapitalRatio": 0.32447034307104544, "longTermDebtToCapitalRatio": 0.26373788143256716, "financialLeverageRatio": 2.455955441302485, "workingCapitalTurnoverRatio": 2.7608779857972885, "operatingCashFlowRatio": 0.07505387378142638, "operatingCashFlowSalesRatio": 0.17102371042416872, "freeCashFlowOperatingCashFlowRatio": 0.7793273174733388, "debtServiceCoverageRatio": 0.6002297530155083, "interestCoverageRatio": 40.47096774193548, "shortTermOperatingCashFlowCoverageRatio": 0.42771929824561405, "operatingCashFlowCoverageRatio": 0.10873572787821123, "capitalExpenditureCoverageRatio": 4.5315985130111525, "dividendPaidAndCapexCoverageRatio": 0.9948313384113167, "dividendPayoutRatio": 0.8814132104454685, "dividendYield": 0.007550679640648496, "dividendYieldPercentage": 0.7550679640648496, "revenuePerShare": 8.879245909808155, "netIncomePerShare": 1.3516319242587824, "interestDebtPerShare": 14.029980898596461, "cashPerShare": 10.88696952080392, "bookValuePerShare": 29.075658167926253, "tangibleBookValuePerShare": -0.36624865044431526, "shareholdersEquityPerShare": 29.075658167926253, "operatingCashFlowPerShare": 1.5185615812640145, "capexPerShare": 0.33510505771945853, "freeCashFlowPerShare": 1.183456523544556, "netIncomePerEBT": 0.8764135702746365, "ebtPerEbit": 0.5920612147297943, "priceToFairValue": 5.4265323621822334, "debtToMarketCap": 0.08851323028033818, "effectiveTaxRate": 0.12358642972536349, "enterpriseValueMultiple": 68.28374313863476, "dividendPerShare": 1.1913462337015197}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2023-12-31", "fiscalYear": "2023", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.6822622107969152, "ebitMargin": 0.23262444496377657, "ebitdaMargin": 0.31876606683804626, "operatingProfitMargin": 0.2153306847394251, "pretaxProfitMargin": 0.22556672119654125, "continuousOperationsProfitMargin": 0.19312923580275765, "netProfitMargin": 0.18924982472540314, "bottomLineProfitMargin": 0.18924982472540314, "receivablesTurnover": 1.1035745602723475, "payablesTurnover": 0.7057724252491694, "inventoryTurnover": 0.6079957070029515, "fixedAssetTurnover": 1.0752336918283245, "assetTurnover": 0.12768712923286266, "currentRatio": 1.1558489261483946, "quickRatio": 0.9142647249470637, "solvencyRatio": 0.05964528668610301, "cashRatio": 0.4723002463160624, "priceToEarningsRatio": 23.2961551000247, "priceToEarningsGrowthRatio": -0.2782596303614061, "forwardPriceToEarningsGrowthRatio": -0.2782596303614061, "priceToBookRatio": 5.4861506964841364, "priceToSalesRatio": 17.63517307782192, "priceToFreeCashFlowRatio": 60.13779534587185, "priceToOperatingCashFlowRatio": 47.98480579931324, "debtToAssetsRatio": 0.1750558015731866, "debtToEquityRatio": 0.4264983860179719, "debtToCapitalRatio": 0.2989827329623061, "longTermDebtToCapitalRatio": 0.27342454175690667, "financialLeverageRatio": 2.4363567627301017, "workingCapitalTurnoverRatio": 2.5861235343889764, "operatingCashFlowRatio": 0.16989326303962662, "operatingCashFlowSalesRatio": 0.36751577471371816, "freeCashFlowOperatingCashFlowRatio": 0.7979142820806308, "debtServiceCoverageRatio": 1.7007218212104387, "interestCoverageRatio": 30.509933774834437, "shortTermOperatingCashFlowCoverageRatio": 2.2784700086931324, "operatingCashFlowCoverageRatio": 0.2680690031365062, "capitalExpenditureCoverageRatio": 4.948395217117684, "dividendPaidAndCapexCoverageRatio": 1.7653794342164346, "dividendPayoutRatio": 0.7075821190417387, "dividendYield": 0.007593335853101663, "dividendYieldPercentage": 0.7593335853101663, "revenuePerShare": 8.887919574609505, "netIncomePerShare": 1.6820372216683284, "interestDebtPerShare": 12.247839813891659, "cashPerShare": 9.524343635759388, "bookValuePerShare": 28.570122964440014, "tangibleBookValuePerShare": -0.8138085742771685, "shareholdersEquityPerShare": 28.570122964440014, "operatingCashFlowPerShare": 3.2664506480558324, "capexPerShare": 0.6601030242605517, "freeCashFlowPerShare": 2.6063476237952807, "netIncomePerEBT": 0.8389970990468296, "ebtPerEbit": 1.0475363577165184, "priceToFairValue": 5.4861506964841364, "debtToMarketCap": 0.07774091701332564, "effectiveTaxRate": 0.14380439287194363, "enterpriseValueMultiple": 56.41899237536657, "dividendPerShare": 1.1901794616151546}}
{"date": "2023-10-01", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2023-10-01", "fiscalYear": "2023", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.6905999718982717, "ebitMargin": 0.25333708023043416, "ebitdaMargin": 0.33900051519835134, "operatingProfitMargin": 0.2902908528874526, "pretaxProfitMargin": 0.2443445271884221, "continuousOperationsProfitMargin": 0.2018172450939066, "netProfitMargin": 1.2190529717577632, "bottomLineProfitMargin": 1.2190529717577632, "receivablesTurnover": 1.4428301121773213, "payablesTurnover": 0.7906642728904847, "inventoryTurnover": 0.5899267726379711, "fixedAssetTurnover": 1.1344243132670953, "assetTurnover": 0.128573235136486, "currentRatio": 1.210344827586207, "quickRatio": 0.9579670948839306, "solvencyRatio": 0.29374795693482225, "cashRatio": 0.44462474645030425, "priceToEarningsRatio": 3.7596812567235283, "priceToEarningsGrowthRatio": 0.008925861976393988, "forwardPriceToEarningsGrowthRatio": 0.008925861976393988, "priceToBookRatio": 5.495422235637671, "priceToSalesRatio": 18.333002435483117, "priceToFreeCashFlowRatio": 60.01654937135848, "priceToOperatingCashFlowRatio": 52.26704967285352, "debtToAssetsRatio": 0.18018077694341236, "debtToEquityRatio": 0.42007356657494244, "debtToCapitalRatio": 0.2958111301149789, "longTermDebtToCapitalRatio": 0.2677967495554025, "financialLeverageRatio": 2.331400572808446, "workingCapitalTurnoverRatio": 2.7146853146853145, "operatingCashFlowRatio": 0.1687852152355195, "operatingCashFlowSalesRatio": 0.35075640485223175, "freeCashFlowOperatingCashFlowRatio": 0.8708772866871411, "debtServiceCoverageRatio": 1.5583456425406204, "interestCoverageRatio": 32.28125, "shortTermOperatingCashFlowCoverageRatio": 1.935142118863049, "operatingCashFlowCoverageRatio": 0.2502924367501086, "capitalExpenditureCoverageRatio": 7.7445708376421925, "dividendPaidAndCapexCoverageRatio": 1.9512767066180303, "dividendPayoutRatio": 0.1103042876901798, "dividendYield": 0.007334683458399564, "dividendYieldPercentage": 0.7334683458399563, "revenuePerShare": 8.462880019025725, "netIncomePerShare": 10.316699036822705, "interestDebtPerShare": 11.935867454120258, "cashPerShare": 9.319037615442546, "bookValuePerShare": 28.232589480359902, "tangibleBookValuePerShare": 0.032898648380831584, "shareholdersEquityPerShare": 28.232589480359902, "operatingCashFlowPerShare": 2.9684093701692498, "capexPerShare": 0.383289072099568, "freeCashFlowPerShare": 2.5851202980696817, "netIncomePerEBT": 4.989074180563542, "ebtPerEbit": 0.8417231364956438, "priceToFairValue": 5.495422235637671, "debtToMarketCap": 0.07644063523468247, "effectiveTaxRate": 0.17404638681234427, "enterpriseValueMultiple": 55.48783296490743, "dividendPerShare": 1.1379761385706924}}
{"date": "2023-07-02", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2023-07-02", "fiscalYear": "2023", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.6997072354663321, "ebitMargin": 0.3031274687485478, "ebitdaMargin": 0.3930015335285097, "operatingProfitMargin": 0.29545982620010225, "pretaxProfitMargin": 0.2930433570333194, "continuousOperationsProfitMargin": 0.24982573539662623, "netProfitMargin": 0.23904456526790277, "bottomLineProfitMargin": 0.23904456526790277, "receivablesTurnover": 1.282648864516898, "payablesTurnover": 0.6187877046825625, "inventoryTurnover": 0.5013966480446927, "fixedAssetTurnover": 1.0458300933125972, "assetTurnover": 0.11226171968740545, "currentRatio": 1.1180911943880376, "quickRatio": 0.8801735277829057, "solvencyRatio": 0.06139993233689287, "cashRatio": 0.39104670481816506, "priceToEarningsRatio": 20.628335925349923, "priceToEarningsGrowthRatio": -0.0030788561082611826, "forwardPriceToEarningsGrowthRatio": -0.0030788561082611826, "priceToBookRatio": 5.648094319285685, "priceToSalesRatio": 19.724366373902132, "priceToFreeCashFlowRatio": 138.79942446043165, "priceToOperatingCashFlowRatio": 101.49417503586801, "debtToAssetsRatio": 0.2378994814436109, "debtToEquityRatio": 0.6068211153841035, "debtToCapitalRatio": 0.37765318713716656, "longTermDebtToCapitalRatio": 0.3108757450710683, "financialLeverageRatio": 2.550745851574871, "workingCapitalTurnoverRatio": 4.133499807913945, "operatingCashFlowRatio": 0.0772014029905852, "operatingCashFlowSalesRatio": 0.1943398856824202, "freeCashFlowOperatingCashFlowRatio": 0.7312290769966523, "debtServiceCoverageRatio": 0.6315656989427756, "interestCoverageRatio": 29.29953917050691, "shortTermOperatingCashFlowCoverageRatio": 0.35740534997008805, "operatingCashFlowCoverageRatio": 0.09170650410069733, "capitalExpenditureCoverageRatio": 3.7206405693950177, "dividendPaidAndCapexCoverageRatio": 0.9919354838709677, "dividendPayoutRatio": 0.6010886469673405, "dividendYield": 0.007284744745559793, "dividendYieldPercentage": 0.7284744745559794, "revenuePerShare": 8.281634852216749, "netIncomePerShare": 1.979679802955665, "interestDebtPerShare": 17.633543719211822, "cashPerShare": 10.970212438423646, "bookValuePerShare": 29.40617302955665, "tangibleBookValuePerShare": -5.879387315270936, "shareholdersEquityPerShare": 28.921259236453203, "operatingCashFlowPerShare": 1.6094519704433496, "capexPerShare": 0.43257389162561577, "freeCashFlowPerShare": 1.176878078817734, "netIncomePerEBT": 0.8157310497938471, "ebtPerEbit": 0.9918213274614659, "priceToFairValue": 5.648094319285685, "debtToMarketCap": 0.10743820500873792, "effectiveTaxRate": 0.14747859181731685, "enterpriseValueMultiple": 53.07646210240038, "dividendPerShare": 1.1899630541871922}}
{"date": "2023-04-02", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2023-04-02", "fiscalYear": "2023", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6799559682205418, "ebitMargin": -0.05145017708433043, "ebitdaMargin": 0.03852780702594046, "operatingProfitMargin": 0.29893749401742126, "pretaxProfitMargin": -0.06159663061165885, "continuousOperationsProfitMargin": -0.023499569254331387, "netProfitMargin": -0.0032545228295204364, "bottomLineProfitMargin": -0.0032545228295204364, "receivablesTurnover": 1.277920489296636, "payablesTurnover": 0.6748410535876476, "inventoryTurnover": 0.5220548052150832, "fixedAssetTurnover": 1.0356895013383562, "assetTurnover": 0.10661890401032817, "currentRatio": 1.0665032382025077, "quickRatio": 0.8543388600864625, "solvencyRatio": 0.01448441247002398, "cashRatio": 0.3175260464114753, "priceToEarningsRatio": -1502.473069852941, "priceToEarningsGrowthRatio": 14.6981061181266, "forwardPriceToEarningsGrowthRatio": 14.6981061181266, "priceToBookRatio": 5.76659293908479, "priceToSalesRatio": 19.559331626304203, "priceToFreeCashFlowRatio": 170.70704887218045, "priceToOperatingCashFlowRatio": 125.47518421860607, "debtToAssetsRatio": 0.26997637381422573, "debtToEquityRatio": 0.7465464448489466, "debtToCapitalRatio": 0.42744150723888313, "longTermDebtToCapitalRatio": 0.3301416864372336, "financialLeverageRatio": 2.7652288024383016, "workingCapitalTurnoverRatio": 11.91559737667522, "operatingCashFlowRatio": 0.053947956868136415, "operatingCashFlowSalesRatio": 0.15588207140805974, "freeCashFlowOperatingCashFlowRatio": 0.7350322382560639, "debtServiceCoverageRatio": 0.0880105546698917, "interestCoverageRatio": 29.462264150943398, "shortTermOperatingCashFlowCoverageRatio": 0.18115579286945882, "operatingCashFlowCoverageRatio": 0.06156085206116393, "capitalExpenditureCoverageRatio": 3.7740440324449596, "dividendPaidAndCapexCoverageRatio": 0.8559789750328515, "dividendPayoutRatio": -43.26470588235294, "dividendYield": 0.007198915366680682, "dividendYieldPercentage": 0.7198915366680682, "revenuePerShare": 8.01919017463059, "netIncomePerShare": -0.02609863749760123, "interestDebtPerShare": 20.387257724045288, "cashPerShare": 9.44655536365381, "bookValuePerShare": 27.199769717904434, "tangibleBookValuePerShare": -8.502782575321435, "shareholdersEquityPerShare": 27.199769717904434, "operatingCashFlowPerShare": 1.2500479754365765, "capexPerShare": 0.3312224141239685, "freeCashFlowPerShare": 0.918825561312608, "netIncomePerEBT": 0.05283605283605284, "ebtPerEbit": -0.20605187319884727, "priceToFairValue": 5.76659293908479, "debtToMarketCap": 0.12946057624234358, "effectiveTaxRate": 0.6184926184926185, "enterpriseValueMultiple": 549.5772360248448, "dividendPerShare": 1.129149875263865}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2022-12-31", "fiscalYear": "2022", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.6724457943136759, "ebitMargin": 0.18467898422340337, "ebitdaMargin": 0.2594279929131865, "operatingProfitMargin": 0.164726229646503, "pretaxProfitMargin": 0.1772125200371214, "continuousOperationsProfitMargin": 0.1484856154560027, "netProfitMargin": 0.1484856154560027, "bottomLineProfitMargin": 0.1484856154560027, "receivablesTurnover": 1.4014779781259237, "payablesTurnover": 0.7852158964506016, "inventoryTurnover": 0.7562329567588625, "fixedAssetTurnover": 1.3183183183183182, "assetTurnover": 0.1265143186500016, "currentRatio": 0.9908963836421634, "quickRatio": 0.8068886419841583, "solvencyRatio": 0.04785935210809051, "cashRatio": 0.23097738432314255, "priceToEarningsRatio": 32.79061861150568, "priceToEarningsGrowthRatio": -1.5926871897017048, "forwardPriceToEarningsGrowthRatio": -1.5926871897017048, "priceToBookRatio": 6.011300323550857, "priceToSalesRatio": 19.47574074284991, "priceToFreeCashFlowRatio": 122.69250865001328, "priceToOperatingCashFlowRatio": 86.29755328037383, "debtToAssetsRatio": 0.21156165611758052, "debtToEquityRatio": 0.51614499244831, "debtToCapitalRatio": 0.3404324751386909, "longTermDebtToCapitalRatio": 0.25929212074452695, "financialLeverageRatio": 2.439690641112442, "workingCapitalTurnoverRatio": 2.47130570758405, "operatingCashFlowRatio": 0.09587469983154726, "operatingCashFlowSalesRatio": 0.22568126212773137, "freeCashFlowOperatingCashFlowRatio": 0.7033644859813084, "debtServiceCoverageRatio": 0.4228717234980283, "interestCoverageRatio": 22.062146892655367, "shortTermOperatingCashFlowCoverageRatio": 0.4194104735026654, "operatingCashFlowCoverageRatio": 0.13495787296301903, "capitalExpenditureCoverageRatio": 3.3711405166981727, "dividendPaidAndCapexCoverageRatio": 1.1781545914996696, "dividendPayoutRatio": 0.8392045454545455, "dividendYield": 0.006398206110390996, "dividendYieldPercentage": 0.6398206110390995, "revenuePerShare": 9.070258345108293, "netIncomePerShare": 1.3468028927183495, "interestDebtPerShare": 15.23532510941817, "cashPerShare": 8.525032742232257, "bookValuePerShare": 29.386320844414804, "tangibleBookValuePerShare": 0.8677695911037547, "shareholdersEquityPerShare": 29.386320844414804, "operatingCashFlowPerShare": 2.0469873511486276, "capexPerShare": 0.6072091450977332, "freeCashFlowPerShare": 1.4397782060508946, "netIncomePerEBT": 0.8378957391097358, "ebtPerEbit": 1.0758002560819462, "priceToFairValue": 6.011300323550857, "debtToMarketCap": 0.08586245315779277, "effectiveTaxRate": 0.16210426089026422, "enterpriseValueMultiple": 79.42193659349593, "dividendPerShare": 1.1302431094005694}}
{"date": "2022-10-02", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2022-10-02", "fiscalYear": "2022", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.6913382676535307, "ebitMargin": 0.2612022404480896, "ebitdaMargin": 0.34546909381876373, "operatingProfitMargin": 0.28325665133026606, "pretaxProfitMargin": 0.2586517303460692, "continuousOperationsProfitMargin": 0.21554310862172435, "netProfitMargin": 0.22294458891778357, "bottomLineProfitMargin": 0.22294458891778357, "receivablesTurnover": 1.2584015103838893, "payablesTurnover": 0.6078991431104107, "inventoryTurnover": 0.5286509635974304, "fixedAssetTurnover": 1.1015866020273248, "assetTurnover": 0.1141819510746671, "currentRatio": 1.4324045407636739, "quickRatio": 1.1760534000834377, "solvencyRatio": 0.06110917682168615, "cashRatio": 0.249324813912127, "priceToEarningsRatio": 23.94992947510094, "priceToEarningsGrowthRatio": -3.3714131491872825, "forwardPriceToEarningsGrowthRatio": -3.3714131491872825, "priceToBookRatio": 5.724944602474563, "priceToSalesRatio": 21.35802872574515, "priceToFreeCashFlowRatio": 80.09661335333834, "priceToOperatingCashFlowRatio": 67.96230782940802, "debtToAssetsRatio": 0.18288184372216257, "debtToEquityRatio": 0.4293221088754541, "debtToCapitalRatio": 0.3003676401628121, "longTermDebtToCapitalRatio": 0.2700827772450637, "financialLeverageRatio": 2.347538170752959, "workingCapitalTurnoverRatio": 1.0328779152354142, "operatingCashFlowRatio": 0.1379794919087456, "operatingCashFlowSalesRatio": 0.3142628525705141, "freeCashFlowOperatingCashFlowRatio": 0.8485041374920432, "debtServiceCoverageRatio": 1.3510614525139666, "interestCoverageRatio": 111.05882352941177, "shortTermOperatingCashFlowCoverageRatio": 1.4204339963833634, "operatingCashFlowCoverageRatio": 0.19620944827801542, "capitalExpenditureCoverageRatio": 6.600840336134453, "dividendPaidAndCapexCoverageRatio": 1.6022437531871494, "dividendPayoutRatio": 0.6662180349932705, "dividendYield": 0.006954279715999692, "dividendYieldPercentage": 0.6954279715999692, "revenuePerShare": 7.641154626001478, "netIncomePerShare": 1.7035540769511197, "interestDebtPerShare": 12.25809952454868, "cashPerShare": 13.022749974970212, "bookValuePerShare": 28.506826062466708, "tangibleBookValuePerShare": 0.3362780591558962, "shareholdersEquityPerShare": 28.506826062466708, "operatingCashFlowPerShare": 2.4013310496996043, "capexPerShare": 0.36379171854137865, "freeCashFlowPerShare": 2.0375393311582255, "netIncomePerEBT": 0.8619489559164734, "ebtPerEbit": 0.913135593220339, "priceToFairValue": 5.724944602474563, "debtToMarketCap": 0.07499148702502428, "effectiveTaxRate": 0.16666666666666666, "enterpriseValueMultiple": 64.81574151708165, "dividendPerShare": 1.1349384496511497}}
{"date": "2022-07-03", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2022-07-03", "fiscalYear": "2022", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.6703164029975021, "ebitMargin": 0.2447127393838468, "ebitdaMargin": 0.3173189009159034, "operatingProfitMargin": 0.2694421315570358, "pretaxProfitMargin": 0.24313072439633637, "continuousOperationsProfitMargin": 0.20041631973355536, "netProfitMargin": 0.20041631973355536, "bottomLineProfitMargin": 0.20041631973355536, "receivablesTurnover": 1.488320218105211, "payablesTurnover": 0.8109575012800819, "inventoryTurnover": 0.6924018536329457, "fixedAssetTurnover": 1.3087065489811485, "assetTurnover": 0.13515338389862933, "currentRatio": 1.4244885210057785, "quickRatio": 1.1693179536378038, "solvencyRatio": 0.06469561099766197, "cashRatio": 0.2450413868499141, "priceToEarningsRatio": 24.509961811383466, "priceToEarningsGrowthRatio": -3.695348088485512, "forwardPriceToEarningsGrowthRatio": -3.695348088485512, "priceToBookRatio": 6.181015815707793, "priceToSalesRatio": 19.648785372189842, "priceToFreeCashFlowRatio": 100.03472332344214, "priceToOperatingCashFlowRatio": 84.56617535208746, "debtToAssetsRatio": 0.18341360761630393, "debtToEquityRatio": 0.426902576057205, "debtToCapitalRatio": 0.29918130587220293, "longTermDebtToCapitalRatio": 0.27035136503932194, "financialLeverageRatio": 2.3275403695797374, "workingCapitalTurnoverRatio": 1.3322240709927897, "operatingCashFlowRatio": 0.12451752526717387, "operatingCashFlowSalesRatio": 0.23234804329725228, "freeCashFlowOperatingCashFlowRatio": 0.8453682135817954, "debtServiceCoverageRatio": 1.5187658300713793, "interestCoverageRatio": 170.31578947368422, "shortTermOperatingCashFlowCoverageRatio": 1.2963995354239257, "operatingCashFlowCoverageRatio": 0.17121207473080344, "capitalExpenditureCoverageRatio": 6.466975666280417, "dividendPaidAndCapexCoverageRatio": 1.4556598852373501, "dividendPayoutRatio": 0.6171582883257166, "dividendYield": 0.0062949739893013845, "dividendYieldPercentage": 0.6294973989301385, "revenuePerShare": 9.136442614620133, "netIncomePerShare": 1.8310922042789894, "interestDebtPerShare": 12.413314101920403, "cashPerShare": 12.387829436842154, "bookValuePerShare": 29.043769722087827, "tangibleBookValuePerShare": -0.08253988540268814, "shareholdersEquityPerShare": 29.043769722087827, "operatingCashFlowPerShare": 2.1228345642046196, "capexPerShare": 0.3282577009332713, "freeCashFlowPerShare": 1.7945768632713486, "netIncomePerEBT": 0.8243150684931507, "ebtPerEbit": 0.9023485784919654, "priceToFairValue": 6.181015815707793, "debtToMarketCap": 0.06906673413977019, "effectiveTaxRate": 0.17568493150684933, "enterpriseValueMultiple": 64.75699614799265, "dividendPerShare": 1.1300737305593846}}
{"date": "2022-04-03", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2022-04-03", "fiscalYear": "2022", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6756595236062495, "ebitMargin": 0.2506616579868522, "ebitdaMargin": 0.3261760437121147, "operatingProfitMargin": 0.2611628105523777, "pretaxProfitMargin": 0.2502347818663024, "continuousOperationsProfitMargin": 0.2197985144711005, "netProfitMargin": 0.2197985144711005, "bottomLineProfitMargin": 0.2197985144711005, "receivablesTurnover": 1.5022444529947416, "payablesTurnover": 0.8161993769470405, "inventoryTurnover": 0.6913557779799818, "fixedAssetTurnover": 1.2526602855462274, "assetTurnover": 0.13134478988534104, "currentRatio": 1.3925789352385343, "quickRatio": 1.139294768379811, "solvencyRatio": 0.06674642533238137, "cashRatio": 0.24113851117769072, "priceToEarningsRatio": 22.52900536414838, "priceToEarningsGrowthRatio": 2.5345131034666957, "forwardPriceToEarningsGrowthRatio": 2.5345131034666957, "priceToBookRatio": 6.210863409763214, "priceToSalesRatio": 19.807367646205073, "priceToFreeCashFlowRatio": 137.60598887307236, "priceToOperatingCashFlowRatio": 116.6140725006283, "debtToAssetsRatio": 0.18585405511479913, "debtToEquityRatio": 0.44369486942670894, "debtToCapitalRatio": 0.3073328573945131, "longTermDebtToCapitalRatio": 0.2785921205098494, "financialLeverageRatio": 2.3873295051466354, "workingCapitalTurnoverRatio": 1.428980998566505, "operatingCashFlowRatio": 0.09170315740954137, "operatingCashFlowSalesRatio": 0.16985400836677197, "freeCashFlowOperatingCashFlowRatio": 0.8474491078160342, "debtServiceCoverageRatio": 1.6085442303227304, "interestCoverageRatio": 611.8, "shortTermOperatingCashFlowCoverageRatio": 0.9259948801489412, "operatingCashFlowCoverageRatio": 0.12003740798841558, "capitalExpenditureCoverageRatio": 6.555189456342669, "dividendPaidAndCapexCoverageRatio": 1.172362993517973, "dividendPayoutRatio": 0.5412701495436008, "dividendYield": 0.006006369797454008, "dividendYieldPercentage": 0.6006369797454009, "revenuePerShare": 8.909311078184091, "netIncomePerShare": 1.958253339945782, "interestDebtPerShare": 12.610558214395462, "cashPerShare": 11.557079528893459, "bookValuePerShare": 28.4131188141405, "tangibleBookValuePerShare": -1.7669537808094975, "shareholdersEquityPerShare": 28.4131188141405, "operatingCashFlowPerShare": 1.513282198416055, "capexPerShare": 0.23085254949448236, "freeCashFlowPerShare": 1.2824296489215725, "netIncomePerEBT": 0.8783691572842034, "ebtPerEbit": 0.9581562602157568, "priceToFairValue": 6.210863409763214, "debtToMarketCap": 0.07143851670111427, "effectiveTaxRate": 0.12163084271579666, "enterpriseValueMultiple": 63.69485597173145, "dividendPerShare": 1.0599440781567089}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2021-12-31", "fiscalYear": "2021", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.6792855990969199, "ebitMargin": 0.19738751814223512, "ebitdaMargin": 0.2716900499919368, "operatingProfitMargin": 0.18041444928237382, "pretaxProfitMargin": 0.1949685534591195, "continuousOperationsProfitMargin": 0.1909369456539268, "netProfitMargin": 0.1909369456539268, "bottomLineProfitMargin": 0.1909369456539268, "receivablesTurnover": 1.306573957016435, "payablesTurnover": 0.7195838986883764, "inventoryTurnover": 0.7658611726196207, "fixedAssetTurnover": 1.308089863938403, "assetTurnover": 0.13627223681174389, "currentRatio": 1.3483173395834254, "quickRatio": 1.1186485649847433, "solvencyRatio": 0.06091948701328765, "cashRatio": 0.32032459204882147, "priceToEarningsRatio": 23.740342195418073, "priceToEarningsGrowthRatio": 0.8048555036983196, "forwardPriceToEarningsGrowthRatio": 0.8048555036983196, "priceToBookRatio": 6.075639227672481, "priceToSalesRatio": 18.131633710288664, "priceToFreeCashFlowRatio": 104.17814281908733, "priceToOperatingCashFlowRatio": 78.46075410851361, "debtToAssetsRatio": 0.18542671603907307, "debtToEquityRatio": 0.45595287951042246, "debtToCapitalRatio": 0.31316458515040735, "longTermDebtToCapitalRatio": 0.28829513114375815, "financialLeverageRatio": 2.4589384380530377, "workingCapitalTurnoverRatio": 1.5960876419677617, "operatingCashFlowRatio": 0.12674125503029232, "operatingCashFlowSalesRatio": 0.23109175939364618, "freeCashFlowOperatingCashFlowRatio": 0.7531402651779484, "debtServiceCoverageRatio": 1.7352326189231573, "interestCoverageRatio": 74.58333333333333, "shortTermOperatingCashFlowCoverageRatio": 1.522039298990972, "operatingCashFlowCoverageRatio": 0.1698320049776303, "capitalExpenditureCoverageRatio": 4.050883392226148, "dividendPaidAndCapexCoverageRatio": 1.3628150261531147, "dividendPayoutRatio": 0.5893158783783784, "dividendYield": 0.006205848609167451, "dividendYieldPercentage": 0.6205848609167451, "revenuePerShare": 9.434891677903662, "netIncomePerShare": 1.8014693995545776, "interestDebtPerShare": 12.860954786389321, "cashPerShare": 12.022982428446175, "bookValuePerShare": 28.156708058114123, "tangibleBookValuePerShare": -2.8965771701030634, "shareholdersEquityPerShare": 28.156708058114123, "operatingCashFlowPerShare": 2.1803257175352275, "capexPerShare": 0.5382346284564458, "freeCashFlowPerShare": 1.6420910890787819, "netIncomePerEBT": 0.9793217535153019, "ebtPerEbit": 1.0806703910614526, "priceToFairValue": 6.075639227672481, "debtToMarketCap": 0.07504607538803677, "effectiveTaxRate": 0.0206782464846981, "enterpriseValueMultiple": 69.59505008903398, "dividendPerShare": 1.0616345215702758}}
{"date": "2021-10-03", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2021-10-03", "fiscalYear": "2021", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.6893478447167709, "ebitMargin": 0.16578112948838802, "ebitdaMargin": 0.24350844116890907, "operatingProfitMargin": 0.29419830319650353, "pretaxProfitMargin": 0.16492415802553775, "continuousOperationsProfitMargin": 0.15712571771360015, "netProfitMargin": 0.15712571771360015, "bottomLineProfitMargin": 0.15712571771360015, "receivablesTurnover": 1.5651532425725974, "payablesTurnover": 0.8090614886731392, "inventoryTurnover": 0.6979878694521998, "fixedAssetTurnover": 1.2630154778655698, "assetTurnover": 0.1302140290579597, "currentRatio": 1.3439779179102802, "quickRatio": 1.110881712708422, "solvencyRatio": 0.05030471015822901, "cashRatio": 0.39505397096115435, "priceToEarningsRatio": 28.576668393782384, "priceToEarningsGrowthRatio": -0.6869946543151726, "forwardPriceToEarningsGrowthRatio": -0.6869946543151726, "priceToBookRatio": 5.9648590050091075, "priceToSalesRatio": 17.96051812494644, "priceToFreeCashFlowRatio": 55.56974307304786, "priceToOperatingCashFlowRatio": 50.56243329312425, "debtToAssetsRatio": 0.18930077889615463, "debtToEquityRatio": 0.4828096539162113, "debtToCapitalRatio": 0.3256046065259117, "longTermDebtToCapitalRatio": 0.30009362363299535, "financialLeverageRatio": 2.5504895264116576, "workingCapitalTurnoverRatio": 1.5366078483012906, "operatingCashFlowRatio": 0.18603711765893943, "operatingCashFlowSalesRatio": 0.355214671351444, "freeCashFlowOperatingCashFlowRatio": 0.909891435464415, "debtServiceCoverageRatio": 1.4408067050811943, "interestCoverageRatio": 343.3, "shortTermOperatingCashFlowCoverageRatio": 2.1827277514481307, "operatingCashFlowCoverageRatio": 0.24434095732138647, "capitalExpenditureCoverageRatio": 11.09772423025435, "dividendPaidAndCapexCoverageRatio": 2.3431317128321085, "dividendPayoutRatio": 0.7611126261248977, "dividendYield": 0.006658514348461437, "dividendYieldPercentage": 0.6658514348461436, "revenuePerShare": 8.865000379852617, "netIncomePerShare": 1.3929195472156803, "interestDebtPerShare": 12.895236648180505, "cashPerShare": 11.775810985337689, "bookValuePerShare": 26.693003114791463, "tangibleBookValuePerShare": -4.965813264453392, "shareholdersEquityPerShare": 26.693003114791463, "operatingCashFlowPerShare": 3.1489781964597734, "capexPerShare": 0.2837499050368457, "freeCashFlowPerShare": 2.865228291422928, "netIncomePerEBT": 0.9527149909067291, "ebtPerEbit": 0.5605884066414215, "priceToFairValue": 5.9648590050091075, "debtToMarketCap": 0.08094234138824781, "effectiveTaxRate": 0.04728500909327098, "enterpriseValueMultiple": 76.62969769487947, "dividendPerShare": 1.06016865456203}}
{"date": "2021-07-04", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2021-07-04", "fiscalYear": "2021", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.6745452985586822, "ebitMargin": 0.2874914207275223, "ebitdaMargin": 0.3663778311599176, "operatingProfitMargin": 0.2727350720658888, "pretaxProfitMargin": 0.2857755662319835, "continuousOperationsProfitMargin": 0.26930336307481123, "netProfitMargin": 0.26930336307481123, "bottomLineProfitMargin": 0.26930336307481123, "receivablesTurnover": 1.5676148207921459, "payablesTurnover": 0.8716681985294118, "inventoryTurnover": 0.7511881188118812, "fixedAssetTurnover": 1.2511807642765136, "assetTurnover": 0.132124234867377, "currentRatio": 1.3886263267994112, "quickRatio": 1.1277859559412204, "solvencyRatio": 0.07595919895189968, "cashRatio": 0.3701350688257018, "priceToEarningsRatio": 17.71079568413507, "priceToEarningsGrowthRatio": 13.87345661923924, "forwardPriceToEarningsGrowthRatio": 13.87345661923924, "priceToBookRatio": 6.391973285714285, "priceToSalesRatio": 19.078307361873712, "priceToFreeCashFlowRatio": 98.812153125972, "priceToOperatingCashFlowRatio": 83.69467467444485, "debtToAssetsRatio": 0.1897698934481977, "debtToEquityRatio": 0.4812158666283415, "debtToCapitalRatio": 0.3248789575308307, "longTermDebtToCapitalRatio": 0.30343377715487035, "financialLeverageRatio": 2.535786145444093, "workingCapitalTurnoverRatio": 1.7495590828924161, "operatingCashFlowRatio": 0.13723819116241834, "operatingCashFlowSalesRatio": 0.2279512697323267, "freeCashFlowOperatingCashFlowRatio": 0.8470079036507339, "debtServiceCoverageRatio": 2.53874883286648, "interestCoverageRatio": 158.95, "shortTermOperatingCashFlowCoverageRatio": 1.6747557516545855, "operatingCashFlowCoverageRatio": 0.1587074037571305, "capitalExpenditureCoverageRatio": 6.536285362853628, "dividendPaidAndCapexCoverageRatio": 1.474472807991121, "dividendPayoutRatio": 0.444568333864288, "dividendYield": 0.006275386236070157, "dividendYieldPercentage": 0.6275386236070157, "revenuePerShare": 8.857179874231997, "netIncomePerShare": 2.385268327489211, "interestDebtPerShare": 12.736755358779995, "cashPerShare": 9.614781824696076, "bookValuePerShare": 26.436280698741523, "tangibleBookValuePerShare": -6.262564167251459, "shareholdersEquityPerShare": 26.436280698741523, "operatingCashFlowPerShare": 2.0190053985787935, "capexPerShare": 0.30889186846905514, "freeCashFlowPerShare": 1.7101135301097383, "netIncomePerEBT": 0.9423596517562294, "ebtPerEbit": 1.0478137779175842, "priceToFairValue": 6.391973285714285, "debtToMarketCap": 0.07528439890445614, "effectiveTaxRate": 0.05764034824377064, "enterpriseValueMultiple": 54.31501009483667, "dividendPerShare": 1.0604147661711352}}
{"date": "2021-04-04", "symbol": "JNJ", "type": "ratios_quarter", "result": {"symbol": "JNJ", "date": "2021-04-04", "fiscalYear": "2021", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.6835715245732719, "ebitMargin": 0.3356480444424533, "ebitdaMargin": 0.42050087361677346, "operatingProfitMargin": 0.3067962904887774, "pretaxProfitMargin": 0.33282559025133285, "continuousOperationsProfitMargin": 0.2776309305138659, "netProfitMargin": 0.2776309305138659, "bottomLineProfitMargin": 0.2776309305138659, "receivablesTurnover": 1.4942428705315303, "payablesTurnover": 0.8306480065859109, "inventoryTurnover": 0.7097065916398714, "fixedAssetTurnover": 1.2152773996842163, "assetTurnover": 0.12935435827002092, "currentRatio": 1.2834212840809147, "quickRatio": 1.0402863285449038, "solvencyRatio": 0.07581308621384332, "cashRatio": 0.3095622007231506, "priceToEarningsRatio": 17.357692748910765, "priceToEarningsGrowthRatio": 0.06778743913775802, "forwardPriceToEarningsGrowthRatio": 0.06778743913775802, "priceToBookRatio": 6.535566544034998, "priceToSalesRatio": 19.27612955781551, "priceToFreeCashFlowRatio": 126.6595489726229, "priceToOperatingCashFlowRatio": 105.61180359842906, "debtToAssetsRatio": 0.19479360443215865, "debtToEquityRatio": 0.5105720448400523, "debtToCapitalRatio": 0.33799913521775415, "longTermDebtToCapitalRatio": 0.31492138152075505, "financialLeverageRatio": 2.6210924446334722, "workingCapitalTurnoverRatio": 2.1942492012779553, "operatingCashFlowRatio": 0.09953092934623278, "operatingCashFlowSalesRatio": 0.1825187043591237, "freeCashFlowOperatingCashFlowRatio": 0.8338242513500246, "debtServiceCoverageRatio": 2.3891004980955173, "interestCoverageRatio": 108.6984126984127, "shortTermOperatingCashFlowCoverageRatio": 1.2161194029850746, "operatingCashFlowCoverageRatio": 0.12120310594115372, "capitalExpenditureCoverageRatio": 6.017725258493353, "dividendPaidAndCapexCoverageRatio": 1.2212230215827338, "dividendPayoutRatio": 0.4290785864127804, "dividendYield": 0.00617994846175201, "dividendYieldPercentage": 0.617994846175201, "revenuePerShare": 8.478361774329187, "netIncomePerShare": 2.353855468640203, "interestDebtPerShare": 12.79142113311723, "cashPerShare": 9.351229269396992, "bookValuePerShare": 25.006248333461212, "tangibleBookValuePerShare": -7.962921743516737, "shareholdersEquityPerShare": 25.006248333461212, "operatingCashFlowPerShare": 1.5474596061384844, "capexPerShare": 0.25715025855565876, "freeCashFlowPerShare": 1.2903093475828256, "netIncomePerEBT": 0.8341634136492125, "ebtPerEbit": 1.0848422897196262, "priceToFairValue": 6.535566544034998, "debtToMarketCap": 0.07812207884350143, "effectiveTaxRate": 0.16583658635078746, "enterpriseValueMultiple": 48.07207413807799, "dividendPerShare": 1.009988977104131}}
{"date": "2024-12-29", "symbol": "JNJ", "type": "ratios_annual", "result": {"symbol": "JNJ", "date": "2024-12-29", "fiscalYear": "2024", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.6907150336069173, "ebitMargin": 0.19637247948120376, "ebitdaMargin": 0.2789993357426735, "operatingProfitMargin": 0.24936670382004256, "pretaxProfitMargin": 0.18787223742133055, "continuousOperationsProfitMargin": 0.1583634500850024, "netProfitMargin": 0.1583634500850024, "bottomLineProfitMargin": 0.1583634500850024, "receivablesTurnover": 4.69281978126486, "payablesTurnover": 2.6642420715740474, "inventoryTurnover": 2.207569913211186, "fixedAssetTurnover": 4.328930694999513, "assetTurnover": 0.49316506018744727, "currentRatio": 1.1107291190556627, "quickRatio": 0.863436736153892, "solvencyRatio": 0.1970740420203657, "cashRatio": 0.47902466167206537, "priceToEarningsRatio": 24.531663728138774, "priceToEarningsGrowthRatio": -0.42350683152557983, "forwardPriceToEarningsGrowthRatio": -0.42350683152557983, "priceToBookRatio": 4.826722366764582, "priceToSalesRatio": 3.884918904313169, "priceToFreeCashFlowRatio": 17.390504082249773, "priceToOperatingCashFlowRatio": 14.219994313030579, "debtToAssetsRatio": 0.21006751654599565, "debtToEquityRatio": 0.5292208700517554, "debtToCapitalRatio": 0.34607222567780177, "longTermDebtToCapitalRatio": 0.3000851763738362, "financialLeverageRatio": 2.5192894111064486, "workingCapitalTurnoverRatio": 13.894563942119671, "operatingCashFlowRatio": 0.48222412114226665, "operatingCashFlowSalesRatio": 0.273201157383952, "freeCashFlowOperatingCashFlowRatio": 0.8176872991016236, "debtServiceCoverageRatio": 3.288809735826655, "interestCoverageRatio": 29.336423841059602, "shortTermOperatingCashFlowCoverageRatio": 4.0558248370382755, "operatingCashFlowCoverageRatio": 0.6413807686208173, "capitalExpenditureCoverageRatio": 5.48508137432188, "dividendPaidAndCapexCoverageRatio": 1.4935680433310765, "dividendPayoutRatio": 0.8405374662306271, "dividendYield": 0.034263369804246005, "dividendYieldPercentage": 3.4263369804246, "revenuePerShare": 36.896523075644915, "netIncomePerShare": 5.8430606904000335, "interestDebtPerShare": 16.029992107340174, "cashPerShare": 10.186516013791385, "bookValuePerShare": 29.697171104556972, "tangibleBookValuePerShare": -4.2902837203506, "shareholdersEquityPerShare": 29.697171104556972, "operatingCashFlowPerShare": 10.080172807709882, "capexPerShare": 1.8377435300959581, "freeCashFlowPerShare": 8.242429277613924, "netIncomePerEBT": 0.8429316234194283, "ebtPerEbit": 0.7533974445798908, "priceToFairValue": 4.826722366764582, "debtToMarketCap": 0.10616631053106218, "effectiveTaxRate": 0.1570683765805717, "enterpriseValueMultiple": 14.47848682458335, "dividendPerShare": 4.911311427740622}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "ratios_annual", "result": {"symbol": "JNJ", "date": "2023-12-31", "fiscalYear": "2023", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.6881950234267664, "ebitMargin": 0.18593454596695594, "ebitdaMargin": 0.2738406979884686, "operatingProfitMargin": 0.2748858018530044, "pretaxProfitMargin": 0.1768691506476121, "continuousOperationsProfitMargin": 0.1564837539191395, "netProfitMargin": 0.41279254101151963, "bottomLineProfitMargin": 0.41279254101151963, "receivablesTurnover": 5.725744637934512, "payablesTurnover": 2.7567483388704317, "inventoryTurnover": 2.3748323048027906, "fixedAssetTurnover": 4.27977686199618, "assetTurnover": 0.5082359541173802, "currentRatio": 1.1558489261483946, "quickRatio": 0.9142647249470637, "solvencyRatio": 0.4316387269193392, "cashRatio": 0.4723002463160624, "priceToEarningsRatio": 11.29635564532188, "priceToEarningsGrowthRatio": 0.1094384525638985, "forwardPriceToEarningsGrowthRatio": 0.1094384525638985, "priceToBookRatio": 5.773995841451712, "priceToSalesRatio": 4.663051351002243, "priceToFreeCashFlowRatio": 21.761332200789127, "priceToOperatingCashFlowRatio": 17.423579044359617, "debtToAssetsRatio": 0.1750558015731866, "debtToEquityRatio": 0.4264983860179719, "debtToCapitalRatio": 0.2989827329623061, "longTermDebtToCapitalRatio": 0.27342454175690667, "financialLeverageRatio": 2.4363567627301017, "workingCapitalTurnoverRatio": 25.40164056674124, "operatingCashFlowRatio": 0.4924376647508751, "operatingCashFlowSalesRatio": 0.26762878850150895, "freeCashFlowOperatingCashFlowRatio": 0.8006669299284805, "debtServiceCoverageRatio": 5.111058489225669, "interestCoverageRatio": 30.322538860103627, "shortTermOperatingCashFlowCoverageRatio": 6.604172703564184, "operatingCashFlowCoverageRatio": 0.777001227328515, "capitalExpenditureCoverageRatio": 5.016729033678186, "dividendPaidAndCapexCoverageRatio": 1.3971066020964875, "dividendPayoutRatio": 0.3348220635507638, "dividendYield": 0.029639830230506464, "dividendYieldPercentage": 2.9639830230506465, "revenuePerShare": 33.61318334320111, "netIncomePerShare": 13.875271363726071, "interestDebtPerShare": 11.882376159463194, "cashPerShare": 9.049536214722716, "bookValuePerShare": 27.145845668048153, "tangibleBookValuePerShare": -0.7732386027235051, "shareholdersEquityPerShare": 27.145845668048153, "operatingCashFlowPerShare": 8.995855535820011, "capexPerShare": 1.7931715018748766, "freeCashFlowPerShare": 7.202684033945135, "netIncomePerEBT": 2.333886602044881, "ebtPerEbit": 0.6434277414669571, "priceToFairValue": 5.773995841451712, "debtToMarketCap": 0.07386537810715511, "effectiveTaxRate": 0.11525693798964282, "enterpriseValueMultiple": 17.348790308747855, "dividendPerShare": 4.645746990329584}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "ratios_annual", "result": {"symbol": "JNJ", "date": "2022-12-31", "fiscalYear": "2022", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.6925115639454932, "ebitMargin": 0.24546818352294036, "ebitdaMargin": 0.33260407550943866, "operatingProfitMargin": 0.26269533691711466, "pretaxProfitMargin": 0.24201775221902738, "continuousOperationsProfitMargin": 0.20465058132266534, "netProfitMargin": 0.22429053631703963, "bottomLineProfitMargin": 0.22429053631703963, "receivablesTurnover": 4.728938811705587, "payablesTurnover": 2.4872080088987762, "inventoryTurnover": 2.395403194390339, "fixedAssetTurnover": 4.448337226115004, "assetTurnover": 0.42689109714053947, "currentRatio": 0.9908963836421634, "quickRatio": 0.8068886419841583, "solvencyRatio": 0.22528804239694683, "cashRatio": 0.23097738432314255, "priceToEarningsRatio": 25.73390056574327, "priceToEarningsGrowthRatio": -1.8551802862394933, "forwardPriceToEarningsGrowthRatio": -1.8551802862394933, "priceToBookRatio": 6.011300323550857, "priceToSalesRatio": 5.771870359419927, "priceToFreeCashFlowRatio": 26.865982545824846, "priceToOperatingCashFlowRatio": 21.784085592620553, "debtToAssetsRatio": 0.21156165611758052, "debtToEquityRatio": 0.51614499244831, "debtToCapitalRatio": 0.3404324751386909, "longTermDebtToCapitalRatio": 0.25929212074452695, "financialLeverageRatio": 2.439690641112442, "workingCapitalTurnoverRatio": 10.493932436864545, "operatingCashFlowRatio": 0.3798071753700584, "operatingCashFlowSalesRatio": 0.26495811976497063, "freeCashFlowOperatingCashFlowRatio": 0.8108426913277342, "debtServiceCoverageRatio": 1.8121546961325967, "interestCoverageRatio": 76.1340579710145, "shortTermOperatingCashFlowCoverageRatio": 1.6614926309187834, "operatingCashFlowCoverageRatio": 0.5346349830987337, "capitalExpenditureCoverageRatio": 5.286605138438514, "dividendPaidAndCapexCoverageRatio": 1.3507105984322223, "dividendPayoutRatio": 0.65113427345187, "dividendYield": 0.025302587603787275, "dividendYieldPercentage": 2.5302587603787274, "revenuePerShare": 30.605330508108175, "netIncomePerShare": 6.864485993823838, "interestDebtPerShare": 15.273203940775874, "cashPerShare": 8.525032742232257, "bookValuePerShare": 29.386320844414804, "tangibleBookValuePerShare": 0.8677695911037547, "shareholdersEquityPerShare": 29.386320844414804, "operatingCashFlowPerShare": 8.109130826213836, "capexPerShare": 1.5339013627579157, "freeCashFlowPerShare": 6.575229463455919, "netIncomePerEBT": 0.9267524148974637, "ebtPerEbit": 0.9212868224432494, "priceToFairValue": 6.011300323550857, "debtToMarketCap": 0.08586245315779277, "effectiveTaxRate": 0.15439847099540266, "enterpriseValueMultiple": 18.359139637286223, "dividendPerShare": 4.469702100209022}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "ratios_annual", "result": {"symbol": "JNJ", "date": "2021-12-31", "fiscalYear": "2021", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.7027940055880112, "ebitMargin": 0.24588519177038354, "ebitdaMargin": 0.33973837947675894, "operatingProfitMargin": 0.26597663195326393, "pretaxProfitMargin": 0.24356108712217425, "continuousOperationsProfitMargin": 0.2260731521463043, "netProfitMargin": 0.2651511303022606, "bottomLineProfitMargin": 0.2651511303022606, "receivablesTurnover": 4.147703329119258, "payablesTurnover": 2.116870194482135, "inventoryTurnover": 2.2530085684028114, "fixedAssetTurnover": 4.152515557430651, "assetTurnover": 0.4325945785581646, "currentRatio": 1.3483173395834254, "quickRatio": 1.1186485649847433, "solvencyRatio": 0.26175285892865413, "cashRatio": 0.32032459204882147, "priceToEarningsRatio": 21.541193723057763, "priceToEarningsGrowthRatio": 0.5145951833841576, "forwardPriceToEarningsGrowthRatio": 0.5145951833841576, "priceToBookRatio": 6.075639227672481, "priceToSalesRatio": 5.711671863728728, "priceToFreeCashFlowRatio": 22.762275663022574, "priceToOperatingCashFlowRatio": 19.21132176633917, "debtToAssetsRatio": 0.18542671603907307, "debtToEquityRatio": 0.45595287951042246, "debtToCapitalRatio": 0.31316458515040735, "longTermDebtToCapitalRatio": 0.28829513114375815, "financialLeverageRatio": 2.4589384380530377, "workingCapitalTurnoverRatio": 6.4285422704821, "operatingCashFlowRatio": 0.5176226064653076, "operatingCashFlowSalesRatio": 0.29730759461518924, "freeCashFlowOperatingCashFlowRatio": 0.8439982913284921, "debtServiceCoverageRatio": 6.425424158014687, "interestCoverageRatio": 114.44262295081967, "shortTermOperatingCashFlowCoverageRatio": 6.216144450345194, "operatingCashFlowCoverageRatio": 0.6936090782495333, "capitalExpenditureCoverageRatio": 6.410186199342826, "dividendPaidAndCapexCoverageRatio": 1.594252247344048, "dividendPayoutRatio": 0.5284031037455695, "dividendYield": 0.02452988959381416, "dividendYieldPercentage": 2.452988959381416, "revenuePerShare": 29.950950278912043, "netIncomePerShare": 7.9415283200803355, "interestDebtPerShare": 12.907741259392955, "cashPerShare": 12.022982428446175, "bookValuePerShare": 28.156708058114123, "tangibleBookValuePerShare": -2.8965771701030634, "shareholdersEquityPerShare": 28.156708058114123, "operatingCashFlowPerShare": 8.90464498386247, "capexPerShare": 1.3891398325957174, "freeCashFlowPerShare": 7.515505151266753, "netIncomePerEBT": 1.0886432370424444, "ebtPerEbit": 0.9157236308074297, "priceToFairValue": 6.075639227672481, "debtToMarketCap": 0.07504607538803677, "effectiveTaxRate": 0.07180102200438002, "enterpriseValueMultiple": 17.53209384882808, "dividendPerShare": 4.196328212813788}}
{"date": "2025-09-28", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2025-09-28", "fiscalYear": "2025", "period": "Q3", "reportedCurrency": "USD", "marketCap": 441082332000, "enterpriseValue": 429238332000, "evToSales": 17.89014845996749, "evToOperatingCashFlow": 46.81408354237103, "evToFreeCashFlow": 51.215646342918504, "evToEBITDA": 46.21429069767442, "netDebtToEBITDA": -1.2751937984496124, "currentRatio": 1.073561501110696, "incomeQuality": 1.7796972049689441, "grahamNumber": 39.472696842943094, "grahamNetNet": -30.756711685744875, "taxBurden": 0.6875750700653944, "interestBurden": 0.9976035148448942, "workingCapital": 3742000000, "investedCapital": 153902000000, "returnOnAssets": 0.026719774292589826, "operatingReturnOnAssets": 0.03674732331274841, "returnOnTangibleAssets": 0.05364934239985005, "returnOnEquity": 0.06498732293098881, "returnOnInvestedCapital": 0.032892207431769106, "returnOnCapitalEmployed": 0.049990489408018486, "earningsYield": 0.011680359031020993, "freeCashFlowYield": 0.01900098777930647, "capexToOperatingCashFlow": 0.08594176027920165, "capexToDepreciation": 0.4434440067529544, "capexToRevenue": 0.03284291251615054, "salesGeneralAndAdministrativeToRevenue": 0.24682198974700956, "researchAndDevelopementToRevenue": 0.15304463801942234, "stockBasedCompensationToRevenue": 0.01446255157754345, "intangiblesToTotalAssets": 0.50195523193096, "averageReceivables": 17728500000, "averagePayables": 9544500000, "averageInventory": 13779000000, "daysOfSalesOutstanding": 66.06051765098154, "daysOfPayablesOutstanding": 118.61563740928385, "daysOfInventoryOutstanding": 174.33109680953032, "operatingCycle": 240.39161446051185, "cashConversionCycle": 121.775977051228, "freeCashFlowToEquity": 19856000000, "freeCashFlowToFirm": 2360376351.261177, "tangibleAssetValue": -17508000000, "netCurrentAssetValue": -58928000000}}
{"date": "2025-06-29", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2025-06-29", "fiscalYear": "2025", "period": "Q2", "reportedCurrency": "USD", "marketCap": 369517525000, "enterpriseValue": 401701525000, "evToSales": 16.918734995577644, "evToOperatingCashFlow": 103.58471505930892, "evToFreeCashFlow": 161.97642137096773, "evToEBITDA": 45.95075783573553, "netDebtToEBITDA": 3.681537405628003, "currentRatio": 1.0058693244739756, "incomeQuality": 0.7003792667509482, "grahamNumber": 40.87284113876477, "grahamNetNet": -31.394113513290065, "taxBurden": 0.8530272685256509, "interestBurden": 0.954699220473599, "workingCapital": 318000000, "investedCapital": 120219000000, "returnOnAssets": 0.02863141130053933, "operatingReturnOnAssets": 0.035188342892574796, "returnOnTangibleAssets": 0.05801733080461456, "returnOnEquity": 0.07055930065117938, "returnOnInvestedCapital": 0.038538598856666884, "returnOnCapitalEmployed": 0.04891925091050148, "earningsYield": 0.014984404325613515, "freeCashFlowYield": 0.006711454348477789, "capexToOperatingCashFlow": 0.3604951005673027, "capexToDepreciation": 0.7195059186824498, "capexToRevenue": 0.058880512150949756, "salesGeneralAndAdministrativeToRevenue": 0.24381923093122185, "researchAndDevelopementToRevenue": 0.1480857515899423, "stockBasedCompensationToRevenue": 0.01726824748346881, "intangiblesToTotalAssets": 0.5065024380911014, "averageReceivables": 16933000000, "averagePayables": 9504500000, "averageInventory": 13035500000, "daysOfSalesOutstanding": 67.64688539780146, "daysOfPayablesOutstanding": 111.66229680125852, "daysOfInventoryOutstanding": 158.24331410592555, "operatingCycle": 225.890199503727, "cashConversionCycle": 114.22790270246847, "freeCashFlowToEquity": -29349000000, "freeCashFlowToFirm": 21029732398.705902, "tangibleAssetValue": -19479000000, "netCurrentAssetValue": -60418000000}}
{"date": "2025-03-30", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2025-03-30", "fiscalYear": "2025", "period": "Q1", "reportedCurrency": "USD", "marketCap": 398948850000, "enterpriseValue": 412726850000, "evToSales": 18.852000639473804, "evToOperatingCashFlow": 98.88041447053186, "evToFreeCashFlow": 122.65285289747399, "evToEBITDA": 26.444983020439548, "netDebtToEBITDA": 0.8828089959633498, "currentRatio": 1.2574205226437973, "incomeQuality": 0.37948904445858717, "grahamNumber": 57.79502694008579, "grahamNetNet": -24.291608209924657, "taxBurden": 0.8069107182158316, "interestBurden": 0.9852547885796892, "workingCapital": 14648000000, "investedCapital": 116742000000, "returnOnAssets": 0.05679218881505233, "operatingReturnOnAssets": 0.033704768911778475, "returnOnTangibleAssets": 0.09781410073989755, "returnOnEquity": 0.14081603912481278, "returnOnInvestedCapital": 0.03373531088203314, "returnOnCapitalEmployed": 0.046056094992980814, "earningsYield": 0.027569950383363684, "freeCashFlowYield": 0.008434665245933157, "capexToOperatingCashFlow": 0.19381887877335888, "capexToDepreciation": 0.45654627539503384, "capexToRevenue": 0.036952450554971907, "salesGeneralAndAdministrativeToRevenue": 0.22893162197962819, "researchAndDevelopementToRevenue": 0.14730735851642077, "stockBasedCompensationToRevenue": 0.013154889690768739, "intangiblesToTotalAssets": 0.41938648532821127, "averageReceivables": 17473500000, "averagePayables": 9928000000, "averageInventory": 12551500000, "daysOfSalesOutstanding": 65.856666514411, "daysOfPayablesOutstanding": 116.76634497757237, "daysOfInventoryOutstanding": 154.8606769063477, "operatingCycle": 220.7173434207587, "cashConversionCycle": 103.95099844318634, "freeCashFlowToEquity": -10399000000, "freeCashFlowToFirm": 3064609786.5160294, "tangibleAssetValue": -3114000000, "netCurrentAssetValue": -44011000000}}
{"date": "2024-12-31", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2024-12-31", "fiscalYear": "2024", "period": "Q4", "reportedCurrency": "USD", "marketCap": 348089059640, "enterpriseValue": 360618059640, "evToSales": 16.013235330373004, "evToOperatingCashFlow": 51.64228263497064, "evToFreeCashFlow": 74.53866466308392, "evToEBITDA": 60.91521277702703, "netDebtToEBITDA": 2.1163851351351353, "currentRatio": 1.1107291190556627, "incomeQuality": 2.035266686097348, "grahamNumber": 30.86471350607244, "grahamNetNet": -26.454845649339696, "taxBurden": 0.8826858759969128, "interestBurden": 0.9659542743538767, "workingCapital": 5572000000, "investedCapital": 107908000000, "returnOnAssets": 0.019050104384133612, "operatingReturnOnAssets": 0.02143469004522993, "returnOnTangibleAssets": 0.03490832875485827, "returnOnEquity": 0.04799272625542034, "returnOnInvestedCapital": 0.02497235279601772, "returnOnCapitalEmployed": 0.029595555658291146, "earningsYield": 0.009856672897299334, "freeCashFlowYield": 0.01389874190531454, "capexToOperatingCashFlow": 0.3071745668050981, "capexToDepreciation": 1.1313291139240507, "capexToRevenue": 0.09524866785079929, "salesGeneralAndAdministrativeToRevenue": 0.277664298401421, "researchAndDevelopementToRevenue": 0.2352575488454707, "stockBasedCompensationToRevenue": 0.010568383658969805, "intangiblesToTotalAssets": 0.45428197041709234, "averageReceivables": 17550500000, "averagePayables": 9632500000, "averageInventory": 12523500000, "daysOfSalesOutstanding": 75.64076376554175, "daysOfPayablesOutstanding": 130.18939393939394, "daysOfInventoryOutstanding": 157.12121212121212, "operatingCycle": 232.76197588675387, "cashConversionCycle": 102.57258194735994, "freeCashFlowToEquity": -7158000000, "freeCashFlowToFirm": -246072034.9884224, "tangibleAssetValue": -10328000000, "netCurrentAssetValue": -52721000000}}
{"date": "2024-09-29", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2024-09-29", "fiscalYear": "2024", "period": "Q3", "reportedCurrency": "USD", "marketCap": 390126713880, "enterpriseValue": 405897713880, "evToSales": 18.063179826442973, "evToOperatingCashFlow": 50.78164817715501, "evToFreeCashFlow": 71.03565171158557, "evToEBITDA": 75.48776527431653, "netDebtToEBITDA": 2.933048168123489, "currentRatio": 1.0287872640506965, "incomeQuality": 2.9669636228656273, "grahamNumber": 27.089363432860484, "grahamNetNet": -28.829002474974015, "taxBurden": 0.8070701018573997, "interestBurden": 0.9453412630982725, "workingCapital": 1490000000, "investedCapital": 106258000000, "returnOnAssets": 0.015110467953356105, "operatingReturnOnAssets": 0.029373217391304347, "returnOnTangibleAssets": 0.02866018425923956, "returnOnEquity": 0.03839904216197725, "returnOnInvestedCapital": 0.03251939840906447, "returnOnCapitalEmployed": 0.041714087000505815, "earningsYield": 0.006905448676423256, "freeCashFlowYield": 0.014646523287706934, "capexToOperatingCashFlow": 0.285124483923433, "capexToDepreciation": 1.2345612134344528, "capexToRevenue": 0.10141960749410352, "salesGeneralAndAdministrativeToRevenue": 0.23488051266076276, "researchAndDevelopementToRevenue": 0.22037292510346668, "stockBasedCompensationToRevenue": 0.013128031685283254, "intangiblesToTotalAssets": 0.47277143033423635, "averageReceivables": 15984000000, "averagePayables": 8901000000, "averageInventory": 12386000000, "daysOfSalesOutstanding": 64.77949356948956, "daysOfPayablesOutstanding": 115.7345971563981, "daysOfInventoryOutstanding": 162.89961223610513, "operatingCycle": 227.6791058055947, "cashConversionCycle": 111.9445086491966, "freeCashFlowToEquity": -9614000000, "freeCashFlowToFirm": 5253764529.658478, "tangibleAssetValue": -14131000000, "netCurrentAssetValue": -54880000000}}
{"date": "2024-06-30", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2024-06-30", "fiscalYear": "2024", "period": "Q2", "reportedCurrency": "USD", "marketCap": 352451792000, "enterpriseValue": 369064792000, "evToSales": 16.441608767318574, "evToOperatingCashFlow": 65.51833694301438, "evToFreeCashFlow": 79.24947219239854, "evToEBITDA": 47.315998974358976, "netDebtToEBITDA": 2.1298717948717947, "currentRatio": 1.0720152782155639, "incomeQuality": 1.2020913358941527, "grahamNumber": 36.08450860812596, "grahamNetNet": -27.482549443244142, "taxBurden": 0.8152400835073069, "interestBurden": 0.9551345962113659, "workingCapital": 3884000000, "investedCapital": 107607000000, "returnOnAssets": 0.025876921717617955, "operatingReturnOnAssets": 0.0377109450678933, "returnOnTangibleAssets": 0.04825306601587841, "returnOnEquity": 0.06550364841063491, "returnOnInvestedCapital": 0.039610635982104535, "returnOnCapitalEmployed": 0.05235342691990091, "earningsYield": 0.01329543530878118, "freeCashFlowYield": 0.013213154552495509, "capexToOperatingCashFlow": 0.1732646902183561, "capexToDepreciation": 0.547699214365881, "capexToRevenue": 0.04348019779926048, "salesGeneralAndAdministrativeToRevenue": 0.2441751681739208, "researchAndDevelopementToRevenue": 0.15324987748919677, "stockBasedCompensationToRevenue": 0.01519133959994654, "intangiblesToTotalAssets": 0.4637248188725923, "averageReceivables": 15370000000, "averagePayables": 8511000000, "averageInventory": 11776000000, "daysOfSalesOutstanding": 63.32516594645164, "daysOfPayablesOutstanding": 115.9295385063328, "daysOfInventoryOutstanding": 159.4424224777988, "operatingCycle": 222.76758842425045, "cashConversionCycle": 106.83804991791764, "freeCashFlowToEquity": -11956000000, "freeCashFlowToFirm": 10105114822.546974, "tangibleAssetValue": -12437000000, "netCurrentAssetValue": -51733000000}}
{"date": "2024-03-31", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2024-03-31", "fiscalYear": "2024", "period": "Q1", "reportedCurrency": "USD", "marketCap": 379965796000, "enterpriseValue": 388124796000, "evToSales": 18.151091801898705, "evToOperatingCashFlow": 106.13201968826907, "evToFreeCashFlow": 136.1841389473684, "evToEBITDA": 68.28374313863476, "netDebtToEBITDA": 1.435432793807178, "currentRatio": 1.169871729091842, "incomeQuality": 1.1235023041474654, "grahamNumber": 29.736185455915606, "grahamNetNet": -24.42778838966863, "taxBurden": 0.8764135702746365, "interestBurden": 0.9599379684673042, "workingCapital": 8277000000, "investedCapital": 98811000000, "returnOnAssets": 0.018928160217717455, "operatingReturnOnAssets": 0.03695173242539555, "returnOnTangibleAssets": 0.03220731417715507, "returnOnEquity": 0.04648671808054841, "returnOnInvestedCapital": 0.04171561279854311, "returnOnCapitalEmployed": 0.05090026857945002, "earningsYield": 0.00856656055430842, "freeCashFlowYield": 0.00750067513971705, "capexToOperatingCashFlow": 0.2206726825266612, "capexToDepreciation": 0.4446280991735537, "capexToRevenue": 0.03774026095496422, "salesGeneralAndAdministrativeToRevenue": 0.23649628209325166, "researchAndDevelopementToRevenue": 0.16564560632277978, "stockBasedCompensationToRevenue": 0.0141233690314736, "intangiblesToTotalAssets": 0.4123024318760685, "averageReceivables": 17166500000, "averagePayables": 8903000000, "averageInventory": 11282000000, "daysOfSalesOutstanding": 62.90698218210728, "daysOfPayablesOutstanding": 112.98725234219013, "daysOfInventoryOutstanding": 157.34449393334356, "operatingCycle": 220.25147611545083, "cashConversionCycle": 107.2642237732607, "freeCashFlowToEquity": -5309000000, "freeCashFlowToFirm": 3334844103.3925686, "tangibleAssetValue": -882000000, "netCurrentAssetValue": -44944000000}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2023-12-31", "fiscalYear": "2023", "period": "Q4", "reportedCurrency": "USD", "marketCap": 377304528000, "enterpriseValue": 384777528000, "evToSales": 17.98446029446132, "evToOperatingCashFlow": 48.93520640976726, "evToFreeCashFlow": 61.32890149824673, "evToEBITDA": 56.41899237536657, "netDebtToEBITDA": 1.0957478005865102, "currentRatio": 1.1558489261483946, "incomeQuality": 1.9029525653436592, "grahamNumber": 32.88252165985992, "grahamNetNet": -23.149821369225656, "taxBurden": 0.8389970990468296, "interestBurden": 0.9696604380148683, "workingCapital": 7213000000, "investedCapital": 97844000000, "returnOnAssets": 0.024164766827009156, "operatingReturnOnAssets": 0.02761833109025565, "returnOnTangibleAssets": 0.04181771236767364, "returnOnEquity": 0.058873993078779774, "returnOnInvestedCapital": 0.031625014327603125, "returnOnCapitalEmployed": 0.037987730466044395, "earningsYield": 0.010731384596582419, "freeCashFlowYield": 0.016628477885640428, "capexToOperatingCashFlow": 0.2020857179193692, "capexToDepreciation": 0.8621812262615302, "capexToRevenue": 0.07426968917971488, "salesGeneralAndAdministrativeToRevenue": 0.25753680766534237, "researchAndDevelopementToRevenue": 0.2093947183921477, "stockBasedCompensationToRevenue": 0.008319700864688011, "intangiblesToTotalAssets": 0.42214039317728785, "averageReceivables": 17092500000, "averagePayables": 8993500000, "averageInventory": 11189500000, "daysOfSalesOutstanding": 81.55316662771676, "daysOfPayablesOutstanding": 127.51985878199471, "daysOfInventoryOutstanding": 148.02736098852606, "operatingCycle": 229.58052761624282, "cashConversionCycle": 102.0606688342481, "freeCashFlowToEquity": -1199000000, "freeCashFlowToFirm": 6635285536.676336, "tangibleAssetValue": -1959000000, "netCurrentAssetValue": -45289000000}}
{"date": "2023-10-01", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2023-10-01", "fiscalYear": "2023", "period": "Q3", "reportedCurrency": "USD", "marketCap": 391427935000, "enterpriseValue": 401620935000, "evToSales": 18.810403962343685, "evToOperatingCashFlow": 53.62811256509547, "evToFreeCashFlow": 61.57941352345906, "evToEBITDA": 55.48783296490743, "netDebtToEBITDA": 1.4082619508151424, "currentRatio": 1.210344827586207, "incomeQuality": 1.7379902529589233, "grahamNumber": 80.95375467344549, "grahamNetNet": -21.651472511791987, "taxBurden": 4.989074180563542, "interestBurden": 0.9645036051026068, "workingCapital": 9333000000, "investedCapital": 99299000000, "returnOnAssets": 0.1567375843816429, "operatingReturnOnAssets": 0.03465018574579242, "returnOnTangibleAssets": 0.2742214168317249, "returnOnEquity": 0.36541809400797437, "returnOnInvestedCapital": 0.04077110324493346, "returnOnCapitalEmployed": 0.05093227929756514, "earningsYield": 0.0664949986259923, "freeCashFlowYield": 0.016662070886688248, "capexToOperatingCashFlow": 0.12912271331285885, "capexToDepreciation": 0.5287042099507928, "capexToRevenue": 0.045290618706383776, "salesGeneralAndAdministrativeToRevenue": 0.23886469017844597, "researchAndDevelopementToRevenue": 0.1614444288323732, "stockBasedCompensationToRevenue": 0.013863519273101962, "intangiblesToTotalAssets": 0.4284269033668351, "averageReceivables": 15787500000, "averagePayables": 9399000000, "averageInventory": 12043000000, "daysOfSalesOutstanding": 62.377406210481944, "daysOfPayablesOutstanding": 113.8283378746594, "daysOfInventoryOutstanding": 152.56130790190736, "operatingCycle": 214.9387141123893, "cashConversionCycle": 101.11037623772991, "freeCashFlowToEquity": -3671000000, "freeCashFlowToFirm": 2393583093.73203, "tangibleAssetValue": 83000000, "netCurrentAssetValue": -41130000000}}
{"date": "2023-07-02", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2023-07-02", "fiscalYear": "2023", "period": "Q2", "reportedCurrency": "USD", "marketCap": 424448640000, "enterpriseValue": 448867640000, "evToSales": 20.859131000511177, "evToOperatingCashFlow": 107.33324725011956, "evToFreeCashFlow": 146.78470896010464, "evToEBITDA": 53.07646210240038, "netDebtToEBITDA": 2.8874305309211303, "currentRatio": 1.1180911943880376, "incomeQuality": 0.8129860031104199, "grahamNumber": 35.89197316525181, "grahamNetNet": -26.07190963669951, "taxBurden": 0.8157310497938471, "interestBurden": 0.9667330982676683, "workingCapital": 6397000000, "investedCapital": 118659000000, "returnOnAssets": 0.026835553978903, "operatingReturnOnAssets": 0.032802362925797426, "returnOnTangibleAssets": 0.05144, "returnOnEquity": 0.06845067798640035, "returnOnInvestedCapital": 0.036325158080014346, "returnOnCapitalEmployed": 0.04623461997149422, "earningsYield": 0.012119251931164157, "freeCashFlowYield": 0.00720464082533048, "capexToOperatingCashFlow": 0.2687709230033477, "capexToDepreciation": 0.5811789038262668, "capexToRevenue": 0.052232910451229145, "salesGeneralAndAdministrativeToRevenue": 0.2321669222547516, "researchAndDevelopementToRevenue": 0.17208048701147824, "stockBasedCompensationToRevenue": 0.017751754263673963, "intangiblesToTotalAssets": 0.4783134918564736, "averageReceivables": 16563500000, "averagePayables": 10176000000, "averageInventory": 12848500000, "daysOfSalesOutstanding": 70.16729401923881, "daysOfPayablesOutstanding": 145.44568245125348, "daysOfInventoryOutstanding": 179.49860724233983, "operatingCycle": 249.66590126157865, "cashConversionCycle": 104.22021881032518, "freeCashFlowToEquity": -21361000000, "freeCashFlowToFirm": 3988997145.5756426, "tangibleAssetValue": -15277000000, "netCurrentAssetValue": -54710000000}}
{"date": "2023-04-02", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2023-04-02", "fiscalYear": "2023", "period": "Q1", "reportedCurrency": "USD", "marketCap": 408672675000, "enterpriseValue": 442409675000, "evToSales": 21.17400569541495, "evToOperatingCashFlow": 135.83348940743016, "evToFreeCashFlow": 184.79936299081035, "evToEBITDA": 549.5772360248448, "netDebtToEBITDA": 41.90931677018634, "currentRatio": 1.0665032382025077, "incomeQuality": -47.89705882352941, "grahamNumber": null, "grahamNetNet": -31.402801765496065, "taxBurden": 0.05283605283605284, "interestBurden": 1.1972093023255814, "workingCapital": 4015000000, "investedCapital": 117212000000, "returnOnAssets": -0.00034699365716006104, "operatingReturnOnAssets": 0.0325866643015336, "returnOnTangibleAssets": -0.0006605404775319099, "returnOnEquity": -0.0009595168550424022, "returnOnInvestedCapital": 0.015516165423376884, "returnOnCapitalEmployed": 0.046063305702233104, "earningsYield": -0.00016639233342429855, "freeCashFlowYield": 0.005857988914967216, "capexToOperatingCashFlow": 0.26496776174393616, "capexToDepreciation": 0.45904255319148934, "capexToRevenue": 0.04130372355700201, "salesGeneralAndAdministrativeToRevenue": 0.21565999808557482, "researchAndDevelopementToRevenue": 0.1653584761175457, "stockBasedCompensationToRevenue": 0.014645352732841965, "intangiblesToTotalAssets": 0.47468222014706407, "averageReceivables": 16632500000, "averagePayables": 9899000000, "averageInventory": 11538500000, "daysOfSalesOutstanding": 70.42691681822532, "daysOfPayablesOutstanding": 133.36473755047106, "daysOfInventoryOutstanding": 172.3956931359354, "operatingCycle": 242.82260995416073, "cashConversionCycle": 109.45787240368966, "freeCashFlowToEquity": -31343000000, "freeCashFlowToFirm": -3916120435.120435, "tangibleAssetValue": -22154000000, "netCurrentAssetValue": -60712000000}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2022-12-31", "fiscalYear": "2022", "period": "Q4", "reportedCurrency": "USD", "marketCap": 461691910050, "enterpriseValue": 488444910050, "evToSales": 20.604273603729013, "evToOperatingCashFlow": 91.29811402803739, "evToFreeCashFlow": 129.80199576136062, "evToEBITDA": 79.42193659349593, "netDebtToEBITDA": 4.350081300813008, "currentRatio": 0.9908963836421634, "incomeQuality": 1.5198863636363635, "grahamNumber": 29.84117278511631, "grahamNetNet": -26.963893056198028, "taxBurden": 0.8378957391097358, "interestBurden": 0.9595705801735952, "workingCapital": -508000000, "investedCapital": 92010000000, "returnOnAssets": 0.018785556468742328, "operatingReturnOnAssets": 0.02154470871884845, "returnOnTangibleAssets": 0.031194058949681858, "returnOnEquity": 0.04583094630487995, "returnOnInvestedCapital": 0.02266983663514341, "returnOnCapitalEmployed": 0.029678664802091567, "earningsYield": 0.007624131858014999, "freeCashFlowYield": 0.008150456869804102, "capexToOperatingCashFlow": 0.2966355140186916, "capexToDepreciation": 0.8955981941309256, "capexToRevenue": 0.06694507719564667, "salesGeneralAndAdministrativeToRevenue": 0.31266346072724205, "researchAndDevelopementToRevenue": 0.1950561039399308, "stockBasedCompensationToRevenue": 0.008985067071627436, "intangiblesToTotalAssets": 0.3977841582256188, "averageReceivables": 16402500000, "averagePayables": 10021000000, "averageInventory": 10971500000, "daysOfSalesOutstanding": 64.21791951404708, "daysOfPayablesOutstanding": 114.61815840309079, "daysOfInventoryOutstanding": 119.01094655505473, "operatingCycle": 183.2288660691018, "cashConversionCycle": 68.61070766601101, "freeCashFlowToEquity": -22990000000, "freeCashFlowToFirm": 24054307545.822426, "tangibleAssetValue": 2268000000, "netCurrentAssetValue": -55280000000}}
{"date": "2022-10-02", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2022-10-02", "fiscalYear": "2022", "period": "Q3", "reportedCurrency": "USD", "marketCap": 427075142400, "enterpriseValue": 447747142400, "evToSales": 22.39183548709742, "evToOperatingCashFlow": 71.25193227243794, "evToFreeCashFlow": 83.9735825956489, "evToEBITDA": 64.81574151708165, "netDebtToEBITDA": 2.992472495657209, "currentRatio": 1.4324045407636739, "incomeQuality": 1.4096007178106775, "grahamNumber": 33.05549416650976, "grahamNetNet": -18.606494293590618, "taxBurden": 0.8619489559164734, "interestBurden": 0.9902354968408961, "workingCapital": 19693000000, "investedCapital": 111564000000, "returnOnAssets": 0.02545624814417213, "operatingReturnOnAssets": 0.03210447558155353, "returnOnTangibleAssets": 0.04396232927370445, "returnOnEquity": 0.05975951420260325, "returnOnInvestedCapital": 0.035222566322152156, "returnOnCapitalEmployed": 0.043710111821949206, "earningsYield": 0.010438444098965195, "freeCashFlowYield": 0.01248492237229305, "capexToOperatingCashFlow": 0.1514958625079567, "capexToDepreciation": 0.5649851632047478, "capexToRevenue": 0.04760952190438088, "salesGeneralAndAdministrativeToRevenue": 0.2337967593518704, "researchAndDevelopementToRevenue": 0.1742848569713943, "stockBasedCompensationToRevenue": 0.014052810562112423, "intangiblesToTotalAssets": 0.42095315319430804, "averageReceivables": 16014500000, "averagePayables": 9959000000, "averageInventory": 11556000000, "daysOfSalesOutstanding": 71.51930386077215, "daysOfPayablesOutstanding": 148.050874918989, "daysOfInventoryOutstanding": 170.2446532728451, "operatingCycle": 241.76395713361728, "cashConversionCycle": 93.71308221462829, "freeCashFlowToEquity": -15340000000, "freeCashFlowToFirm": 4418500000, "tangibleAssetValue": 880000000, "netCurrentAssetValue": -35289000000}}
{"date": "2022-07-03", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2022-07-03", "fiscalYear": "2022", "period": "Q2", "reportedCurrency": "USD", "marketCap": 471963824640, "enterpriseValue": 493577824640, "evToSales": 20.54861884429642, "evToOperatingCashFlow": 88.43895800752553, "evToFreeCashFlow": 104.6159017888936, "evToEBITDA": 64.75699614799265, "netDebtToEBITDA": 2.835738651272632, "currentRatio": 1.4244885210057785, "incomeQuality": 1.1593269630245118, "grahamNumber": 34.59177586106641, "grahamNetNet": -19.389741167091156, "taxBurden": 0.8243150684931507, "interestBurden": 0.9935352160598843, "workingCapital": 19026000000, "investedCapital": 113954000000, "returnOnAssets": 0.02708694380049965, "operatingReturnOnAssets": 0.03635148379994327, "returnOnTangibleAssets": 0.04759268413247652, "returnOnEquity": 0.06304595518420053, "returnOnInvestedCapital": 0.03888233283254381, "returnOnCapitalEmployed": 0.04869717011655117, "earningsYield": 0.010199934292997936, "freeCashFlowYield": 0.009996528872946461, "capexToOperatingCashFlow": 0.15463178641820463, "capexToDepreciation": 0.4948394495412844, "capexToRevenue": 0.03592839300582848, "salesGeneralAndAdministrativeToRevenue": 0.24671107410491258, "researchAndDevelopementToRevenue": 0.1541631973355537, "stockBasedCompensationToRevenue": 0.01523730224812656, "intangiblesToTotalAssets": 0.43085908487317415, "averageReceivables": 15866500000, "averagePayables": 9537000000, "averageInventory": 11213500000, "daysOfSalesOutstanding": 60.470857618651124, "daysOfPayablesOutstanding": 110.97992170728627, "daysOfInventoryOutstanding": 129.98232100012626, "operatingCycle": 190.45317861877737, "cashConversionCycle": 79.4732569114911, "freeCashFlowToEquity": -16896000000, "freeCashFlowToFirm": 3734323972.6027403, "tangibleAssetValue": -217000000, "netCurrentAssetValue": -37520000000}}
{"date": "2022-04-03", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2022-04-03", "fiscalYear": "2022", "period": "Q1", "reportedCurrency": "USD", "marketCap": 464007394480, "enterpriseValue": 486692394480, "evToSales": 20.77573612567233, "evToOperatingCashFlow": 122.31525370193516, "evToFreeCashFlow": 144.3334503202847, "evToEBITDA": 63.69485597173145, "netDebtToEBITDA": 2.968852244470619, "currentRatio": 1.3925789352385343, "incomeQuality": 0.7727714119246456, "grahamNumber": 35.382225881952465, "grahamNetNet": -21.323435451041004, "taxBurden": 0.8783691572842034, "interestBurden": 0.9982970027247956, "workingCapital": 17034000000, "investedCapital": 115090000000, "returnOnAssets": 0.028869389700316783, "operatingReturnOnAssets": 0.03395370907365424, "returnOnTangibleAssets": 0.05201010101010101, "returnOnEquity": 0.06892074582714265, "returnOnInvestedCapital": 0.03858814683305393, "returnOnCapitalEmployed": 0.045330270810950986, "earningsYield": 0.011096805915712485, "freeCashFlowYield": 0.007267125567640803, "capexToOperatingCashFlow": 0.1525508921839658, "capexToDepreciation": 0.3431317128321085, "capexToRevenue": 0.025911380517373857, "salesGeneralAndAdministrativeToRevenue": 0.2406727567659865, "researchAndDevelopementToRevenue": 0.17382395628788525, "stockBasedCompensationToRevenue": 0.011867156151284896, "intangiblesToTotalAssets": 0.444927251829217, "averageReceivables": 17289000000, "averagePayables": 10182000000, "averageInventory": 10688500000, "daysOfSalesOutstanding": 59.91035601468454, "daysOfPayablesOutstanding": 110.26717557251908, "daysOfInventoryOutstanding": 130.17899447222953, "operatingCycle": 190.08935048691407, "cashConversionCycle": 79.82217491439499, "freeCashFlowToEquity": -19313000000, "freeCashFlowToFirm": 5038783691.572843, "tangibleAssetValue": -4646000000, "netCurrentAssetValue": -43222000000}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2021-12-31", "fiscalYear": "2021", "period": "Q4", "reportedCurrency": "USD", "marketCap": 449737042550, "enterpriseValue": 469001042550, "evToSales": 18.908282637880987, "evToOperatingCashFlow": 81.82153568562457, "evToFreeCashFlow": 108.64050093815149, "evToEBITDA": 69.59505008903398, "netDebtToEBITDA": 2.8585843596972844, "currentRatio": 1.3483173395834254, "incomeQuality": 1.210304054054054, "grahamNumber": 33.7828000478779, "grahamNetNet": -21.664609456573213, "taxBurden": 0.9793217535153019, "interestBurden": 0.9877450980392157, "workingCapital": 15753000000, "investedCapital": 116353000000, "returnOnAssets": 0.026019404674262985, "operatingReturnOnAssets": 0.024775360834445224, "returnOnTangibleAssets": 0.0471807132894999, "returnOnEquity": 0.06398011428880213, "returnOnInvestedCapital": 0.031179049552362555, "returnOnCapitalEmployed": 0.03271390139774256, "earningsYield": 0.010530597998214635, "freeCashFlowYield": 0.009598942474301642, "capexToOperatingCashFlow": 0.24685973482205165, "capexToDepreciation": 0.7677699403147042, "capexToRevenue": 0.05704725044347686, "salesGeneralAndAdministrativeToRevenue": 0.3085792614094501, "researchAndDevelopementToRevenue": 0.19029188840509595, "stockBasedCompensationToRevenue": 0.008667956781164329, "intangiblesToTotalAssets": 0.4485160808271709, "averageReceivables": 16947500000, "averagePayables": 10008000000, "averageInventory": 10387000000, "daysOfSalesOutstanding": 68.88243831640058, "daysOfPayablesOutstanding": 125.07228158390949, "daysOfInventoryOutstanding": 117.51477058453801, "operatingCycle": 186.3972089009386, "cashConversionCycle": 61.32492731702912, "freeCashFlowToEquity": -14947000000, "freeCashFlowToFirm": 4797759305.210918, "tangibleAssetValue": -7615000000, "netCurrentAssetValue": -47016000000}}
{"date": "2021-10-03", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2021-10-03", "fiscalYear": "2021", "period": "Q3", "reportedCurrency": "USD", "marketCap": 419162572000, "enterpriseValue": 435486572000, "evToSales": 18.659978232924843, "evToOperatingCashFlow": 52.53155271411339, "evToFreeCashFlow": 57.73386875248575, "evToEBITDA": 76.62969769487947, "netDebtToEBITDA": 2.8724265352806615, "currentRatio": 1.3439779179102802, "incomeQuality": 2.260703572402509, "grahamNumber": 28.92364311045285, "grahamNetNet": -23.390659424143433, "taxBurden": 0.9527149909067291, "interestBurden": 0.9948307056086844, "workingCapital": 15328000000, "investedCapital": 117151000000, "returnOnAssets": 0.0204599727721115, "operatingReturnOnAssets": 0.03860903989113443, "returnOnTangibleAssets": 0.03824452718417238, "returnOnEquity": 0.05218294626593807, "returnOnInvestedCapital": 0.04724183820868524, "returnOnCapitalEmployed": 0.0509850223143012, "earningsYield": 0.008748395598641379, "freeCashFlowYield": 0.01799540441793071, "capexToOperatingCashFlow": 0.09010856453558504, "capexToDepreciation": 0.4117971334068357, "capexToRevenue": 0.032007884137458226, "salesGeneralAndAdministrativeToRevenue": 0.24852172422658325, "researchAndDevelopementToRevenue": 0.14662781729368413, "stockBasedCompensationToRevenue": 0.011097780443911218, "intangiblesToTotalAssets": 0.4650222063516861, "averageReceivables": 14891000000, "averagePayables": 8832500000, "averageInventory": 10243500000, "daysOfSalesOutstanding": 57.50235667152284, "daysOfPayablesOutstanding": 111.24000000000001, "daysOfInventoryOutstanding": 128.94206896551725, "operatingCycle": 186.4444256370401, "cashConversionCycle": 75.20442563704009, "freeCashFlowToEquity": -8781000000, "freeCashFlowToFirm": 4473054299.818134, "tangibleAssetValue": -13073000000, "netCurrentAssetValue": -49067000000}}
{"date": "2021-07-04", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2021-07-04", "fiscalYear": "2021", "period": "Q2", "reportedCurrency": "USD", "marketCap": 444753501220, "enterpriseValue": 463904501220, "evToSales": 19.89981559797529, "evToOperatingCashFlow": 87.29855122694768, "evToFreeCashFlow": 103.06698538546989, "evToEBITDA": 54.31501009483667, "netDebtToEBITDA": 2.2422432970378177, "currentRatio": 1.3886263267994112, "incomeQuality": 0.8464479133482, "grahamNumber": 37.66691543735372, "grahamNetNet": -24.829416080386356, "taxBurden": 0.9423596517562294, "interestBurden": 0.9940316323485526, "workingCapital": 15048000000, "investedCapital": 119743000000, "returnOnAssets": 0.03558150079347087, "operatingReturnOnAssets": 0.03643584328805119, "returnOnTangibleAssets": 0.06946457616428958, "returnOnEquity": 0.09022707674619143, "returnOnInvestedCapital": 0.04252564138394022, "returnOnCapitalEmployed": 0.04616646940509298, "earningsYield": 0.014115684267305072, "freeCashFlowYield": 0.010120212629362873, "capexToOperatingCashFlow": 0.15299209634926608, "capexToDepreciation": 0.44208809135399674, "capexToRevenue": 0.03487474262182567, "salesGeneralAndAdministrativeToRevenue": 0.25621997254632806, "researchAndDevelopementToRevenue": 0.14559025394646535, "stockBasedCompensationToRevenue": 0.015185312285518188, "intangiblesToTotalAssets": 0.4877748809793698, "averageReceivables": 14904500000, "averagePayables": 8603500000, "averageInventory": 10026000000, "daysOfSalesOutstanding": 57.41206245710364, "daysOfPayablesOutstanding": 103.2502965599051, "daysOfInventoryOutstanding": 119.81020166073547, "operatingCycle": 177.2222641178391, "cashConversionCycle": 73.97196755793401, "freeCashFlowToEquity": -14650000000, "freeCashFlowToFirm": 3894694386.0702496, "tangibleAssetValue": -16483000000, "netCurrentAssetValue": -53091000000}}
{"date": "2021-04-04", "symbol": "JNJ", "type": "key_metrics_quarter", "result": {"symbol": "JNJ", "date": "2021-04-04", "fiscalYear": "2021", "period": "Q1", "reportedCurrency": "USD", "marketCap": 430262487860, "enterpriseValue": 451204487860, "evToSales": 20.214349171632094, "evToOperatingCashFlow": 110.75220615120276, "evToFreeCashFlow": 132.82440031204004, "evToEBITDA": 48.07207413807799, "netDebtToEBITDA": 2.2311953974003838, "currentRatio": 1.2834212840809147, "incomeQuality": 0.657414878166855, "grahamNumber": 36.39195822943009, "grahamNetNet": -25.040623663445388, "taxBurden": 0.8341634136492125, "interestBurden": 0.9915910304324613, "workingCapital": 11601000000, "investedCapital": 116766000000, "returnOnAssets": 0.03591277085252989, "operatingReturnOnAssets": 0.03941850793349278, "returnOnTangibleAssets": 0.07226063736750661, "returnOnEquity": 0.09413069234741926, "returnOnInvestedCapital": 0.04232154885474945, "returnOnCapitalEmployed": 0.05202659069325736, "earningsYield": 0.014402835884722529, "freeCashFlowYield": 0.007895180490624888, "capexToOperatingCashFlow": 0.16617574864997545, "capexToDepreciation": 0.35744456177402323, "capexToRevenue": 0.030330182339500918, "salesGeneralAndAdministrativeToRevenue": 0.23439810044352852, "researchAndDevelopementToRevenue": 0.1423771336409659, "stockBasedCompensationToRevenue": 0.013753864074190224, "intangiblesToTotalAssets": 0.5030105993961416, "averageReceivables": 14257000000, "averagePayables": 9004000000, "averageInventory": 9648000000, "daysOfSalesOutstanding": 60.23117243851082, "daysOfPayablesOutstanding": 108.34914342347444, "daysOfInventoryOutstanding": 126.8129689933456, "operatingCycle": 187.04414143185642, "cashConversionCycle": 78.69499800838197, "freeCashFlowToEquity": -17545000000, "freeCashFlowToFirm": 4609552295.0599, "tangibleAssetValue": -20964000000, "netCurrentAssetValue": -54190000000}}
{"date": "2024-12-29", "symbol": "JNJ", "type": "key_metrics_annual", "result": {"symbol": "JNJ", "date": "2024-12-29", "fiscalYear": "2024", "period": "FY", "reportedCurrency": "USD", "marketCap": 345062382000, "enterpriseValue": 358791382000, "evToSales": 4.039488206617804, "evToOperatingCashFlow": 14.785765350696447, "evToFreeCashFlow": 18.082420219735912, "evToEBITDA": 14.47848682458335, "netDebtToEBITDA": 0.5540131552399016, "currentRatio": 1.1107291190556627, "incomeQuality": 1.7251528508460117, "grahamNumber": 62.48402511590633, "grahamNetNet": -26.450691646242678, "taxBurden": 0.8429316234194283, "interestBurden": 0.9567136796238963, "workingCapital": 5572000000, "investedCapital": 107908000000, "returnOnAssets": 0.07809932039266201, "operatingReturnOnAssets": 0.12741685890318757, "returnOnTangibleAssets": 0.14311295606698818, "returnOnEquity": 0.19675479087984332, "returnOnInvestedCapital": 0.13751670173030742, "returnOnCapitalEmployed": 0.17066179699960704, "earningsYield": 0.04076364371703665, "freeCashFlowYield": 0.05750264599981809, "capexToOperatingCashFlow": 0.18231270089837634, "capexToDepreciation": 0.6028069219239679, "capexToRevenue": 0.04980804089123068, "salesGeneralAndAdministrativeToRevenue": 0.24734015604417875, "researchAndDevelopementToRevenue": 0.194008173742696, "stockBasedCompensationToRevenue": 0.013240112135643597, "intangiblesToTotalAssets": 0.45428197041709234, "averageReceivables": 16900000000, "averagePayables": 9971500000, "averageInventory": 11812500000, "daysOfSalesOutstanding": 77.77839700070929, "daysOfPayablesOutstanding": 136.99956317571255, "daysOfInventoryOutstanding": 165.34017691383642, "operatingCycle": 243.11857391454572, "cashConversionCycle": 106.11901073883317, "freeCashFlowToEquity": 6113000000, "freeCashFlowToFirm": 19258413375.681667, "tangibleAssetValue": -10328000000, "netCurrentAssetValue": -52721000000}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "key_metrics_annual", "result": {"symbol": "JNJ", "date": "2023-12-31", "fiscalYear": "2023", "period": "FY", "reportedCurrency": "USD", "marketCap": 397100790000, "enterpriseValue": 404573790000, "evToSales": 4.750804847403093, "evToOperatingCashFlow": 17.751471633539555, "evToFreeCashFlow": 22.17085653222271, "evToEBITDA": 17.348790308747855, "netDebtToEBITDA": 0.32045454545454544, "currentRatio": 1.1558489261483946, "incomeQuality": 1.710265646105358, "grahamNumber": 92.05845663731773, "grahamNetNet": -23.33205052299191, "taxBurden": 2.333886602044881, "interestBurden": 0.9512441581407098, "workingCapital": 7213000000, "investedCapital": 97844000000, "returnOnAssets": 0.20979601093352748, "operatingReturnOnAssets": 0.13190547028196634, "returnOnTangibleAssets": 0.3630570617092693, "returnOnEquity": 0.511137930031698, "returnOnInvestedCapital": 0.16605025646893173, "returnOnCapitalEmployed": 0.19302252712820345, "earningsYield": 0.08852412507162224, "freeCashFlowYield": 0.04595306899288717, "capexToOperatingCashFlow": 0.19933307007151946, "capexToDepreciation": 0.606866150146941, "capexToRevenue": 0.05334726805152714, "salesGeneralAndAdministrativeToRevenue": 0.23616998790497776, "researchAndDevelopementToRevenue": 0.17713923366878429, "stockBasedCompensationToRevenue": 0.013645063939219578, "intangiblesToTotalAssets": 0.42214039317728785, "averageReceivables": 15894000000, "averagePayables": 9760500000, "averageInventory": 10724500000, "daysOfSalesOutstanding": 63.747167063962706, "daysOfPayablesOutstanding": 132.40236508115842, "daysOfInventoryOutstanding": 153.6950627047791, "operatingCycle": 217.4422297687418, "cashConversionCycle": 85.03986468758339, "freeCashFlowToEquity": 10775000000, "freeCashFlowToFirm": 9231021643.871994, "tangibleAssetValue": -1959000000, "netCurrentAssetValue": -45289000000}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "key_metrics_annual", "result": {"symbol": "JNJ", "date": "2022-12-31", "fiscalYear": "2022", "period": "FY", "reportedCurrency": "USD", "marketCap": 461691910050, "enterpriseValue": 488444910050, "evToSales": 6.106324666208276, "evToOperatingCashFlow": 23.04637680711522, "evToFreeCashFlow": 28.422747166133256, "evToEBITDA": 18.359139637286223, "netDebtToEBITDA": 1.005562864123285, "currentRatio": 0.9908963836421634, "incomeQuality": 1.1813165375397134, "grahamNumber": 67.37020651999092, "grahamNetNet": -26.963893056198028, "taxBurden": 0.9267524148974637, "interestBurden": 0.9859434682964094, "workingCapital": -508000000, "investedCapital": 92010000000, "returnOnAssets": 0.09574763312662106, "operatingReturnOnAssets": 0.11376950481326273, "returnOnTangibleAssets": 0.1589922192091597, "returnOnEquity": 0.233594604447685, "returnOnInvestedCapital": 0.12310939312816009, "returnOnCapitalEmployed": 0.15970237733325227, "earningsYield": 0.03885924706382019, "freeCashFlowYield": 0.037221791471587426, "capexToOperatingCashFlow": 0.18915730867226574, "capexToDepreciation": 0.5751793400286944, "capexToRevenue": 0.0501187648456057, "salesGeneralAndAdministrativeToRevenue": 0.25310663832979124, "researchAndDevelopementToRevenue": 0.17670958869858733, "stockBasedCompensationToRevenue": 0.014226778347293412, "intangiblesToTotalAssets": 0.3977841582256188, "averageReceivables": 17949500000, "averagePayables": 10472000000, "averageInventory": 10327500000, "daysOfSalesOutstanding": 77.18433554194274, "daysOfPayablesOutstanding": 146.7508944543828, "daysOfInventoryOutstanding": 152.3751829565783, "operatingCycle": 229.55951849852104, "cashConversionCycle": 82.80862404413824, "freeCashFlowToEquity": -9568000000, "freeCashFlowToFirm": 35825386022.00527, "tangibleAssetValue": 2268000000, "netCurrentAssetValue": -55280000000}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "key_metrics_annual", "result": {"symbol": "JNJ", "date": "2021-12-31", "fiscalYear": "2021", "period": "FY", "reportedCurrency": "USD", "marketCap": 449737042550, "enterpriseValue": 469001042550, "evToSales": 5.956325153035306, "evToOperatingCashFlow": 20.034217964545068, "evToFreeCashFlow": 23.737273132402066, "evToEBITDA": 17.53209384882808, "netDebtToEBITDA": 0.7201226122387948, "currentRatio": 1.3483173395834254, "incomeQuality": 1.121275984289683, "grahamNumber": 70.93069945365207, "grahamNetNet": -21.664609456573213, "taxBurden": 1.0886432370424444, "interestBurden": 0.9905480088838386, "workingCapital": 15753000000, "investedCapital": 116353000000, "returnOnAssets": 0.1147029414673274, "operatingReturnOnAssets": 0.11735665934460035, "returnOnTangibleAssets": 0.2079896393703925, "returnOnEquity": 0.28204747173175904, "returnOnInvestedCapital": 0.13830070999987384, "returnOnCapitalEmployed": 0.15310105854143516, "earningsYield": 0.04642268264500109, "freeCashFlowYield": 0.04393233852380168, "capexToOperatingCashFlow": 0.1560017086715079, "capexToDepreciation": 0.4941813261163735, "capexToRevenue": 0.04638049276098552, "salesGeneralAndAdministrativeToRevenue": 0.255499110998222, "researchAndDevelopementToRevenue": 0.18131826263652528, "stockBasedCompensationToRevenue": 0.014414528829057659, "intangiblesToTotalAssets": 0.4485160808271709, "averageReceivables": 16280000000, "averagePayables": 10280000000, "averageInventory": 9865500000, "daysOfSalesOutstanding": 88.000508001016, "daysOfPayablesOutstanding": 172.4243654388514, "daysOfInventoryOutstanding": 162.0055978121528, "operatingCycle": 250.0061058131688, "cashConversionCycle": 77.5817403743174, "freeCashFlowToEquity": 494000000, "freeCashFlowToFirm": 14699860412.973198, "tangibleAssetValue": -7615000000, "netCurrentAssetValue": -47016000000}}
{"date": "2025-12-23", "symbol": "JNJ", "type": "ratios_ttm", "result": [{"symbol": "JNJ", "grossProfitMarginTTM": 0.6807778706225787, "ebitMarginTTM": 0.3490976570554211, "ebitdaMarginTTM": 0.4292721570499951, "operatingProfitMarginTTM": 0.2609469446222965, "pretaxProfitMarginTTM": 0.34185937991730786, "continuousOperationsProfitMarginTTM": 0.27259112958360915, "netProfitMarginTTM": 0.27259112958360915, "bottomLineProfitMarginTTM": 0.27259112958360915, "receivablesTurnoverTTM": 5.232468343648856, "payablesTurnoverTTM": 3.0562077922077924, "inventoryTurnoverTTM": 2.07945709034356, "fixedAssetTurnoverTTM": 1.7264449648711944, "assetTurnoverTTM": 0.4779115841009045, "currentRatioTTM": 1.073561501110696, "quickRatioTTM": 0.7954746505730406, "solvencyRatioTTM": 0.28630690775856754, "cashRatioTTM": 0.3583911616111974, "priceToEarningsRatioTTM": 20.0154772084876, "priceToEarningsGrowthRatioTTM": 1.8834564053186833, "forwardPriceToEarningsGrowthRatioTTM": 3.2545228225481626, "priceToBookRatioTTM": 6.341924795337866, "priceToSalesRatioTTM": 5.412671676415371, "priceToFreeCashFlowRatioTTM": 26.16304460291649, "priceToOperatingCashFlowRatioTTM": 20.772135680052884, "debtToAssetsRatioTTM": 0.03312484441125218, "debtToEquityRatioTTM": 0.08056561171588228, "debtToCapitalRatioTTM": 0.0745587411281285, "longTermDebtToCapitalRatioTTM": 0, "financialLeverageRatioTTM": 2.4321808342898947, "workingCapitalTurnoverRatioTTM": 45.3935960591133, "operatingCashFlowRatioTTM": 0.47581041498751697, "operatingCashFlowSalesRatioTTM": 0.26266155899684207, "freeCashFlowOperatingCashFlowRatioTTM": 0.7876384068748967, "debtServiceCoverageRatioTTM": 4.702863623476042, "interestCoverageRatioTTM": 36.05097451274363, "shortTermOperatingCashFlowCoverageRatioTTM": 3.789572569281353, "operatingCashFlowCoverageRatioTTM": 3.789572569281353, "capitalExpenditureCoverageRatioTTM": 4.708949416342413, "dividendPaidAndCapexCoverageRatioTTM": 1.3931161505698169, "dividendPayoutRatioTTM": 0.4870416815956049, "dividendYieldTTM": 0.02482852, "enterpriseValueTTM": 486928282310, "revenuePerShareTTM": 37.94325949106481, "netIncomePerShareTTM": 10.342995964753356, "interestDebtPerShareTTM": 2.9045540640698344, "cashPerShareTTM": 7.643086551922918, "bookValuePerShareTTM": 32.64308655192292, "tangibleBookValuePerShareTTM": -7.209091657745203, "shareholdersEquityPerShareTTM": 32.64308655192292, "operatingCashFlowPerShareTTM": 9.966235691344808, "capexPerShareTTM": 2.1164456888742484, "freeCashFlowPerShareTTM": 7.849790002470559, "netIncomePerEBTTTM": 0.7973779442575074, "ebtPerEbitTTM": 1.310072361307494, "priceToFairValueTTM": 6.341924795337866, "debtToMarketCapTTM": 0.012805442937645666, "effectiveTaxRateTTM": 0.20262205574249254, "enterpriseValueMultipleTTM": 12.309535159643046, "dividendPerShareTTM": 5.14}]}
{"date": "2025-12-23", "symbol": "JNJ", "type": "key_metrics_ttm", "result": [{"symbol": "JNJ", "marketCap": 498772282310, "enterpriseValueTTM": 486928282310, "evToSalesTTM": 5.284140710262727, "evToOperatingCashFlowTTM": 20.11767816517931, "evToFreeCashFlowTTM": 25.54176890002098, "evToEBITDATTM": 12.309535159643046, "netDebtToEBITDATTM": -0.2994160325606087, "currentRatioTTM": 1.073561501110696, "incomeQualityTTM": 0.9635733906604562, "grahamNumberTTM": 87.15855971091852, "grahamNetNetTTM": -30.756711685744875, "taxBurdenTTM": 0.7973779442575074, "interestBurdenTTM": 0.9792657527433243, "workingCapitalTTM": 3742000000, "investedCapitalTTM": 153902000000, "returnOnAssetsTTM": 0.13027445855115757, "operatingReturnOnAssetsTTM": 0.12452454007586644, "returnOnTangibleAssetsTTM": 0.2615717841113807, "returnOnEquityTTM": 0.3269117517870564, "returnOnInvestedCapitalTTM": 0.12926065532929756, "returnOnCapitalEmployedTTM": 0.16940125539814155, "earningsYieldTTM": 0.04996133689862504, "freeCashFlowYieldTTM": 0.03822185128593659, "capexToOperatingCashFlowTTM": 0.21236159312510328, "capexToDepreciationTTM": 0.6957227937195453, "capexToRevenueTTM": 0.05577922712129269, "salesGeneralAndAdministrativeToRevenueTTM": 0.2493353156301208, "researchAndDevelopementToRevenueTTM": 0.17049561037016137, "stockBasedCompensationToRevenueTTM": 0.013923102800898545, "intangiblesToTotalAssetsTTM": 0.50195523193096, "averageReceivablesTTM": 17728500000, "averagePayablesTTM": 9544500000, "averageInventoryTTM": 13779000000, "daysOfSalesOutstandingTTM": 69.75675265059849, "daysOfPayablesOutstandingTTM": 119.42905221648084, "daysOfInventoryOutstandingTTM": 175.52658417187925, "operatingCycleTTM": 245.28333682247774, "cashConversionCycleTTM": 125.8542846059969, "freeCashFlowToEquityTTM": 31441000000, "freeCashFlowToFirmTTM": 25007851088.819756, "tangibleAssetValueTTM": -17508000000, "netCurrentAssetValueTTM": -58928000000}]}
{"date": "2025-09-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2025-09-28", "stockPrice": 181.62, "numberOfShares": 2428600000, "marketCapitalization": 441082332000, "minusCashAndCashEquivalents": 18231000000, "addTotalDebt": 6387000000, "enterpriseValue": 429238332000}}
{"date": "2025-06-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2025-06-29", "stockPrice": 152.75, "numberOfShares": 2419100000, "marketCapitalization": 369517525000, "minusCashAndCashEquivalents": 18577000000, "addTotalDebt": 50761000000, "enterpriseValue": 401701525000}}
{"date": "2025-03-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2025-03-30", "stockPrice": 165.84, "numberOfShares": 2405625000, "marketCapitalization": 398948850000, "minusCashAndCashEquivalents": 38474000000, "addTotalDebt": 52252000000, "enterpriseValue": 412726850000}}
{"date": "2024-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2024-12-31", "stockPrice": 144.62, "numberOfShares": 2406922000, "marketCapitalization": 348089059640, "minusCashAndCashEquivalents": 24105000000, "addTotalDebt": 36634000000, "enterpriseValue": 360618059640}}
{"date": "2024-09-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2024-09-29", "stockPrice": 162.06, "numberOfShares": 2407298000, "marketCapitalization": 390126713880, "minusCashAndCashEquivalents": 19980000000, "addTotalDebt": 35751000000, "enterpriseValue": 405897713880}}
{"date": "2024-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2024-06-30", "stockPrice": 146.44, "numberOfShares": 2406800000, "marketCapitalization": 352451792000, "minusCashAndCashEquivalents": 24878000000, "addTotalDebt": 41491000000, "enterpriseValue": 369064792000}}
{"date": "2024-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2024-03-31", "stockPrice": 157.78, "numberOfShares": 2408200000, "marketCapitalization": 379965796000, "minusCashAndCashEquivalents": 25473000000, "addTotalDebt": 33632000000, "enterpriseValue": 388124796000}}
{"date": "2023-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2023-12-31", "stockPrice": 156.74, "numberOfShares": 2407200000, "marketCapitalization": 377304528000, "minusCashAndCashEquivalents": 21859000000, "addTotalDebt": 29332000000, "enterpriseValue": 384777528000}}
{"date": "2023-10-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2023-10-01", "stockPrice": 155.15, "numberOfShares": 2522900000, "marketCapitalization": 391427935000, "minusCashAndCashEquivalents": 19728000000, "addTotalDebt": 29921000000, "enterpriseValue": 401620935000}}
{"date": "2023-07-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2023-07-02", "stockPrice": 163.35, "numberOfShares": 2598400000, "marketCapitalization": 424448640000, "minusCashAndCashEquivalents": 21183000000, "addTotalDebt": 45602000000, "enterpriseValue": 448867640000}}
{"date": "2023-04-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2023-04-02", "stockPrice": 156.85, "numberOfShares": 2605500000, "marketCapitalization": 408672675000, "minusCashAndCashEquivalents": 19170000000, "addTotalDebt": 52907000000, "enterpriseValue": 442409675000}}
{"date": "2022-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2022-12-31", "stockPrice": 176.65, "numberOfShares": 2613597000, "marketCapitalization": 461691910050, "minusCashAndCashEquivalents": 12889000000, "addTotalDebt": 39642000000, "enterpriseValue": 488444910050}}
{"date": "2022-10-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2022-10-02", "stockPrice": 163.2, "numberOfShares": 2616882000, "marketCapitalization": 427075142400, "minusCashAndCashEquivalents": 11355000000, "addTotalDebt": 32027000000, "enterpriseValue": 447747142400}}
{"date": "2022-07-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2022-07-03", "stockPrice": 179.52, "numberOfShares": 2629032000, "marketCapitalization": 471963824640, "minusCashAndCashEquivalents": 10983000000, "addTotalDebt": 32597000000, "enterpriseValue": 493577824640}}
{"date": "2022-04-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2022-04-03", "stockPrice": 176.47, "numberOfShares": 2629384000, "marketCapitalization": 464007394480, "minusCashAndCashEquivalents": 10463000000, "addTotalDebt": 33148000000, "enterpriseValue": 486692394480}}
{"date": "2021-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2021-12-31", "stockPrice": 171.07, "numberOfShares": 2628965000, "marketCapitalization": 449737042550, "minusCashAndCashEquivalents": 14487000000, "addTotalDebt": 33751000000, "enterpriseValue": 469001042550}}
{"date": "2021-10-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2021-10-03", "stockPrice": 159.22, "numberOfShares": 2632600000, "marketCapitalization": 419162572000, "minusCashAndCashEquivalents": 17604000000, "addTotalDebt": 33928000000, "enterpriseValue": 435486572000}}
{"date": "2021-07-04", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2021-07-04", "stockPrice": 168.98, "numberOfShares": 2631989000, "marketCapitalization": 444753501220, "minusCashAndCashEquivalents": 14332000000, "addTotalDebt": 33483000000, "enterpriseValue": 463904501220}}
{"date": "2021-04-04", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2021-04-04", "stockPrice": 163.43, "numberOfShares": 2632702000, "marketCapitalization": 430262487860, "minusCashAndCashEquivalents": 12671000000, "addTotalDebt": 33613000000, "enterpriseValue": 451204487860}}
{"date": "2020-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2020-12-31", "stockPrice": 157.38, "numberOfShares": 2632512000, "marketCapitalization": 414304738560, "minusCashAndCashEquivalents": 13985000000, "addTotalDebt": 35266000000, "enterpriseValue": 435585738560}}
{"date": "2020-09-27", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2020-09-27", "stockPrice": 147.11, "numberOfShares": 2632167000, "marketCapitalization": 387218087370, "minusCashAndCashEquivalents": 18965000000, "addTotalDebt": 37758000000, "enterpriseValue": 406011087370}}
{"date": "2020-06-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2020-06-28", "stockPrice": 139.04, "numberOfShares": 2632377000, "marketCapitalization": 366005698080, "minusCashAndCashEquivalents": 11174000000, "addTotalDebt": 30394000000, "enterpriseValue": 385225698080}}
{"date": "2020-03-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2020-03-29", "stockPrice": 133.01, "numberOfShares": 2632392000, "marketCapitalization": 350134459920, "minusCashAndCashEquivalents": 15530000000, "addTotalDebt": 27583000000, "enterpriseValue": 362187459920}}
{"date": "2019-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2019-12-31", "stockPrice": 145.87, "numberOfShares": 2632507000, "marketCapitalization": 384003796090, "minusCashAndCashEquivalents": 17305000000, "addTotalDebt": 27696000000, "enterpriseValue": 394394796090}}
{"date": "2019-09-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2019-09-29", "stockPrice": 129.38, "numberOfShares": 2630961000, "marketCapitalization": 340393734180, "minusCashAndCashEquivalents": 16249000000, "addTotalDebt": 29218000000, "enterpriseValue": 353362734180}}
{"date": "2019-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2019-06-30", "stockPrice": 139.36, "numberOfShares": 2642065000, "marketCapitalization": 368198178400, "minusCashAndCashEquivalents": 14376000000, "addTotalDebt": 29418000000, "enterpriseValue": 383240178400}}
{"date": "2019-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2019-03-31", "stockPrice": 138.98, "numberOfShares": 2655636000, "marketCapitalization": 369080291280, "minusCashAndCashEquivalents": 14734000000, "addTotalDebt": 29368000000, "enterpriseValue": 383714291280}}
{"date": "2018-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2018-12-31", "stockPrice": 129.05, "numberOfShares": 2724000000, "marketCapitalization": 351532200000, "minusCashAndCashEquivalents": 18107000000, "addTotalDebt": 30480000000, "enterpriseValue": 363905200000}}
{"date": "2018-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2018-09-30", "stockPrice": 139.69, "numberOfShares": 2683155000, "marketCapitalization": 374809921950, "minusCashAndCashEquivalents": 16056000000, "addTotalDebt": 31253000000, "enterpriseValue": 390006921950}}
{"date": "2018-07-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2018-07-01", "stockPrice": 121.58, "numberOfShares": 2682301000, "marketCapitalization": 326114155580, "minusCashAndCashEquivalents": 17569000000, "addTotalDebt": 32083000000, "enterpriseValue": 340628155580}}
{"date": "2018-04-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2018-04-01", "stockPrice": 124.56, "numberOfShares": 2682189000, "marketCapitalization": 334093461840, "minusCashAndCashEquivalents": 14639000000, "addTotalDebt": 32533000000, "enterpriseValue": 351987461840}}
{"date": "2017-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2017-12-31", "stockPrice": 139.72, "numberOfShares": 2684900000, "marketCapitalization": 375134228000, "minusCashAndCashEquivalents": 17824000000, "addTotalDebt": 34581000000, "enterpriseValue": 391891228000}}
{"date": "2017-10-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2017-10-01", "stockPrice": 131.22, "numberOfShares": 2684982000, "marketCapitalization": 352323338040, "minusCashAndCashEquivalents": 15721000000, "addTotalDebt": 35166000000, "enterpriseValue": 371768338040}}
{"date": "2017-07-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2017-07-02", "stockPrice": 132.9, "numberOfShares": 2685190000, "marketCapitalization": 356861751000, "minusCashAndCashEquivalents": 12598000000, "addTotalDebt": 34572000000, "enterpriseValue": 378835751000}}
{"date": "2017-04-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2017-04-02", "stockPrice": 124.69, "numberOfShares": 2694909000, "marketCapitalization": 336028203210, "minusCashAndCashEquivalents": 20909000000, "addTotalDebt": 32370000000, "enterpriseValue": 347489203210}}
{"date": "2016-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2016-12-31", "stockPrice": 115.21, "numberOfShares": 2706511000, "marketCapitalization": 311817132310, "minusCashAndCashEquivalents": 18972000000, "addTotalDebt": 27126000000, "enterpriseValue": 319971132310}}
{"date": "2016-10-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2016-10-02", "stockPrice": 118.81, "numberOfShares": 2722584000, "marketCapitalization": 323470205040, "minusCashAndCashEquivalents": 18205000000, "addTotalDebt": 26989000000, "enterpriseValue": 332254205040}}
{"date": "2016-07-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2016-07-03", "stockPrice": 121.29, "numberOfShares": 2737654000, "marketCapitalization": 332050053660, "minusCashAndCashEquivalents": 18640000000, "addTotalDebt": 26243000000, "enterpriseValue": 339653053660}}
{"date": "2016-04-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2016-04-03", "stockPrice": 108.59, "numberOfShares": 2751705000, "marketCapitalization": 298807645950, "minusCashAndCashEquivalents": 13861000000, "addTotalDebt": 23349000000, "enterpriseValue": 308295645950}}
{"date": "2015-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2015-12-31", "stockPrice": 102.72, "numberOfShares": 2755162000, "marketCapitalization": 283010240640, "minusCashAndCashEquivalents": 13732000000, "addTotalDebt": 19861000000, "enterpriseValue": 289139240640}}
{"date": "2015-09-27", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2015-09-27", "stockPrice": 91.37, "numberOfShares": 2767281000, "marketCapitalization": 252846464970, "minusCashAndCashEquivalents": 13639000000, "addTotalDebt": 19750000000, "enterpriseValue": 258957464970}}
{"date": "2015-06-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2015-06-28", "stockPrice": 97.68, "numberOfShares": 2768975000, "marketCapitalization": 270473478000, "minusCashAndCashEquivalents": 10639000000, "addTotalDebt": 19307000000, "enterpriseValue": 279141478000}}
{"date": "2015-03-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2015-03-29", "stockPrice": 101.55, "numberOfShares": 2775874000, "marketCapitalization": 281890004700, "minusCashAndCashEquivalents": 11988000000, "addTotalDebt": 18983000000, "enterpriseValue": 288885004700}}
{"date": "2014-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2014-12-31", "stockPrice": 104.57, "numberOfShares": 2783223000, "marketCapitalization": 291041629110, "minusCashAndCashEquivalents": 14523000000, "addTotalDebt": 18760000000, "enterpriseValue": 295278629110}}
{"date": "2014-09-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2014-09-28", "stockPrice": 106.54, "numberOfShares": 2804056000, "marketCapitalization": 298744126240, "minusCashAndCashEquivalents": 13818000000, "addTotalDebt": 15267000000, "enterpriseValue": 300193126240}}
{"date": "2014-06-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2014-06-29", "stockPrice": 104.62, "numberOfShares": 2822579000, "marketCapitalization": 295298214980, "minusCashAndCashEquivalents": 14236000000, "addTotalDebt": 17122000000, "enterpriseValue": 298184214980}}
{"date": "2014-03-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2014-03-30", "stockPrice": 98.23, "numberOfShares": 2827641000, "marketCapitalization": 277759175430, "minusCashAndCashEquivalents": 19722000000, "addTotalDebt": 17292000000, "enterpriseValue": 275329175430}}
{"date": "2013-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2013-12-31", "stockPrice": 91.59, "numberOfShares": 2820628000, "marketCapitalization": 258341318520, "minusCashAndCashEquivalents": 20927000000, "addTotalDebt": 18180000000, "enterpriseValue": 255594318520}}
{"date": "2013-09-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2013-09-29", "stockPrice": 86.69, "numberOfShares": 2820659000, "marketCapitalization": 244522928710, "minusCashAndCashEquivalents": 17204000000, "addTotalDebt": 15107000000, "enterpriseValue": 242425928710}}
{"date": "2013-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2013-06-30", "stockPrice": 86.63, "numberOfShares": 2814188000, "marketCapitalization": 243793106440, "minusCashAndCashEquivalents": 17307000000, "addTotalDebt": 14982000000, "enterpriseValue": 241468106440}}
{"date": "2013-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2013-03-31", "stockPrice": 81.93, "numberOfShares": 2803164000, "marketCapitalization": 229663226520, "minusCashAndCashEquivalents": 14855000000, "addTotalDebt": 15892000000, "enterpriseValue": 230700226520}}
{"date": "2012-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2012-12-31", "stockPrice": 70.1, "numberOfShares": 2778489000, "marketCapitalization": 194772078899, "minusCashAndCashEquivalents": 14911000000, "addTotalDebt": 16165000000, "enterpriseValue": 196026078899}}
{"date": "2012-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2012-09-30", "stockPrice": 69.13, "numberOfShares": 2762558000, "marketCapitalization": 190975634540, "minusCashAndCashEquivalents": 15486000000, "addTotalDebt": 16851000000, "enterpriseValue": 192340634540}}
{"date": "2012-07-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2012-07-01", "stockPrice": 68, "numberOfShares": 2750559000, "marketCapitalization": 187038012000, "minusCashAndCashEquivalents": 14042000000, "addTotalDebt": 17565000000, "enterpriseValue": 190561012000}}
{"date": "2012-04-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2012-04-01", "stockPrice": 66.21, "numberOfShares": 2745721000, "marketCapitalization": 181794187409, "minusCashAndCashEquivalents": 30267000000, "addTotalDebt": 19449000000, "enterpriseValue": 170976187409}}
{"date": "2011-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2011-12-31", "stockPrice": 65.58, "numberOfShares": 2728500000, "marketCapitalization": 178935030000, "minusCashAndCashEquivalents": 24542000000, "addTotalDebt": 19627000000, "enterpriseValue": 174020030000}}
{"date": "2011-10-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2011-10-02", "stockPrice": 62.08, "numberOfShares": 2732251000, "marketCapitalization": 169618142080, "minusCashAndCashEquivalents": 15617000000, "addTotalDebt": 18357000000, "enterpriseValue": 172358142080}}
{"date": "2011-07-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2011-07-03", "stockPrice": 67.3, "numberOfShares": 2740580000, "marketCapitalization": 184441034000, "minusCashAndCashEquivalents": 14974000000, "addTotalDebt": 18726000000, "enterpriseValue": 188193034000}}
{"date": "2011-04-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2011-04-03", "stockPrice": 60.15, "numberOfShares": 2738454000, "marketCapitalization": 164718008100, "minusCashAndCashEquivalents": 22356000000, "addTotalDebt": 17830000000, "enterpriseValue": 160192008100}}
{"date": "2010-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2010-12-31", "stockPrice": 61.85, "numberOfShares": 2743000000, "marketCapitalization": 169654550000, "minusCashAndCashEquivalents": 19355000000, "addTotalDebt": 16773000000, "enterpriseValue": 167072550000}}
{"date": "2010-10-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2010-10-03", "stockPrice": 61.67, "numberOfShares": 2747711000, "marketCapitalization": 169451337370, "minusCashAndCashEquivalents": 14338000000, "addTotalDebt": 12025000000, "enterpriseValue": 167138337370}}
{"date": "2010-07-04", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2010-07-04", "stockPrice": 59.08, "numberOfShares": 2755400000, "marketCapitalization": 162789032000, "minusCashAndCashEquivalents": 12713000000, "addTotalDebt": 11652000000, "enterpriseValue": 161728032000}}
{"date": "2010-04-04", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2010-04-04", "stockPrice": 65.4, "numberOfShares": 2757834000, "marketCapitalization": 180362343600, "minusCashAndCashEquivalents": 13743000000, "addTotalDebt": 12103000000, "enterpriseValue": 178722343600}}
{"date": "2009-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2009-12-31", "stockPrice": 64.41, "numberOfShares": 2758000000, "marketCapitalization": 177642780000, "minusCashAndCashEquivalents": 15810000000, "addTotalDebt": 14541000000, "enterpriseValue": 176373780000}}
{"date": "2009-09-27", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2009-09-27", "stockPrice": 61.27, "numberOfShares": 2793000000, "marketCapitalization": 171127110000, "minusCashAndCashEquivalents": 11856000000, "addTotalDebt": 11600000000, "enterpriseValue": 170871110000}}
{"date": "2009-06-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2009-06-28", "stockPrice": 56.96, "numberOfShares": 2782000000, "marketCapitalization": 158462720000, "minusCashAndCashEquivalents": 11686000000, "addTotalDebt": 13614000000, "enterpriseValue": 160390720000}}
{"date": "2009-03-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2009-03-29", "stockPrice": 53.01, "numberOfShares": 2755565766, "marketCapitalization": 146072541255, "minusCashAndCashEquivalents": 12589000000, "addTotalDebt": 14074000000, "enterpriseValue": 147557541255}}
{"date": "2008-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2008-12-31", "stockPrice": 59.83, "numberOfShares": 2774300000, "marketCapitalization": 165986369000, "minusCashAndCashEquivalents": 10768000000, "addTotalDebt": 11852000000, "enterpriseValue": 167070369000}}
{"date": "2008-09-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2008-09-28", "stockPrice": 66.9, "numberOfShares": 2790900000, "marketCapitalization": 186711210000, "minusCashAndCashEquivalents": 14018000000, "addTotalDebt": 14640000000, "enterpriseValue": 187333210000}}
{"date": "2008-06-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2008-06-29", "stockPrice": 64.34, "numberOfShares": 2809800000, "marketCapitalization": 180782532000, "minusCashAndCashEquivalents": 12646000000, "addTotalDebt": 13926000000, "enterpriseValue": 182062532000}}
{"date": "2008-03-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2008-03-30", "stockPrice": 64.87, "numberOfShares": 2832300000, "marketCapitalization": 183731301000, "minusCashAndCashEquivalents": 10539000000, "addTotalDebt": 11416000000, "enterpriseValue": 184608301000}}
{"date": "2007-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2007-12-31", "stockPrice": 66.7, "numberOfShares": 2855600000, "marketCapitalization": 190468520000, "minusCashAndCashEquivalents": 7770000000, "addTotalDebt": 9537000000, "enterpriseValue": 192235520000}}
{"date": "2007-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2007-09-30", "stockPrice": 66.14, "numberOfShares": 2887700000, "marketCapitalization": 190992478000, "minusCashAndCashEquivalents": 6640000000, "addTotalDebt": 7897000000, "enterpriseValue": 192249478000}}
{"date": "2007-07-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2007-07-01", "stockPrice": 61.85, "numberOfShares": 2895100000, "marketCapitalization": 179061935000, "minusCashAndCashEquivalents": 5571000000, "addTotalDebt": 6483000000, "enterpriseValue": 179973935000}}
{"date": "2007-04-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2007-04-01", "stockPrice": 60.1, "numberOfShares": 2894200000, "marketCapitalization": 173941420000, "minusCashAndCashEquivalents": 5175000000, "addTotalDebt": 6694000000, "enterpriseValue": 175460420000}}
{"date": "2006-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2006-12-31", "stockPrice": 66.02, "numberOfShares": 2912410638, "marketCapitalization": 192277350320, "minusCashAndCashEquivalents": 4083000000, "addTotalDebt": 6593000000, "enterpriseValue": 194787350320}}
{"date": "2006-10-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2006-10-01", "stockPrice": 65.09, "numberOfShares": 2920000000, "marketCapitalization": 190062800000, "minusCashAndCashEquivalents": 14491000000, "addTotalDebt": 2369000000, "enterpriseValue": 177940800000}}
{"date": "2006-07-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2006-07-02", "stockPrice": 60.15, "numberOfShares": 2954000000, "marketCapitalization": 177683100000, "minusCashAndCashEquivalents": 14647000000, "addTotalDebt": 2635000000, "enterpriseValue": 165671100000}}
{"date": "2006-04-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2006-04-02", "stockPrice": 59.17, "numberOfShares": 2974500000, "marketCapitalization": 176001165000, "minusCashAndCashEquivalents": 16822000000, "addTotalDebt": 2808000000, "enterpriseValue": 161987165000}}
{"date": "2005-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2005-12-31", "stockPrice": 60.1, "numberOfShares": 2984825444, "marketCapitalization": 179388009184, "minusCashAndCashEquivalents": 16055000000, "addTotalDebt": 2685000000, "enterpriseValue": 166018009184}}
{"date": "2005-10-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2005-10-02", "stockPrice": 62.58, "numberOfShares": 2974600000, "marketCapitalization": 186150468000, "minusCashAndCashEquivalents": 14825000000, "addTotalDebt": 2417000000, "enterpriseValue": 173742468000}}
{"date": "2005-07-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2005-07-03", "stockPrice": 64.95, "numberOfShares": 2973700000, "marketCapitalization": 193141815000, "minusCashAndCashEquivalents": 12156000000, "addTotalDebt": 2633000000, "enterpriseValue": 183618815000}}
{"date": "2005-04-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2005-04-03", "stockPrice": 67.98, "numberOfShares": 2972100000, "marketCapitalization": 202043358000, "minusCashAndCashEquivalents": 8539000000, "addTotalDebt": 2778000000, "enterpriseValue": 196282358000}}
{"date": "2004-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2004-12-31", "stockPrice": 63.42, "numberOfShares": 2968100000, "marketCapitalization": 188236902000, "minusCashAndCashEquivalents": 9203000000, "addTotalDebt": 2845000000, "enterpriseValue": 181878902000}}
{"date": "2004-09-26", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2004-09-26", "stockPrice": 56.53, "numberOfShares": 2968100000, "marketCapitalization": 167786693000, "minusCashAndCashEquivalents": 7348000000, "addTotalDebt": 3415000000, "enterpriseValue": 163853693000}}
{"date": "2004-06-27", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2004-06-27", "stockPrice": 54.97, "numberOfShares": 2968200000, "marketCapitalization": 163161954000, "minusCashAndCashEquivalents": 5681000000, "addTotalDebt": 3453000000, "enterpriseValue": 160933954000}}
{"date": "2004-03-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2004-03-28", "stockPrice": 50.57, "numberOfShares": 2967800000, "marketCapitalization": 150081646000, "minusCashAndCashEquivalents": 5637000000, "addTotalDebt": 3555000000, "enterpriseValue": 147999646000}}
{"date": "2003-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2003-12-31", "stockPrice": 51.66, "numberOfShares": 2968000000, "marketCapitalization": 153326880000, "minusCashAndCashEquivalents": 5377000000, "addTotalDebt": 4094000000, "enterpriseValue": 152043880000}}
{"date": "2003-09-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2003-09-28", "stockPrice": 49.86, "numberOfShares": 2968000000, "marketCapitalization": 147984480000, "minusCashAndCashEquivalents": 3850000000, "addTotalDebt": 5173000000, "enterpriseValue": 149307480000}}
{"date": "2003-06-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2003-06-29", "stockPrice": 51.7, "numberOfShares": 2967700000, "marketCapitalization": 153430090000, "minusCashAndCashEquivalents": 2968000000, "addTotalDebt": 6418000000, "enterpriseValue": 156880090000}}
{"date": "2003-03-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2003-03-30", "stockPrice": 57.87, "numberOfShares": 2968400000, "marketCapitalization": 171781308000, "minusCashAndCashEquivalents": 3061000000, "addTotalDebt": 4107000000, "enterpriseValue": 172827308000}}
{"date": "2002-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2002-12-31", "stockPrice": 53.71, "numberOfShares": 2973845455, "marketCapitalization": 159725239388, "minusCashAndCashEquivalents": 2894000000, "addTotalDebt": 4139000000, "enterpriseValue": 160970239388}}
{"date": "2002-09-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2002-09-29", "stockPrice": 54.08, "numberOfShares": 2974400000, "marketCapitalization": 160855552000, "minusCashAndCashEquivalents": 3161000000, "addTotalDebt": 4483000000, "enterpriseValue": 162177552000}}
{"date": "2002-07-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2002-07-30", "stockPrice": 50.94, "numberOfShares": 3003400000, "marketCapitalization": 152993196000, "minusCashAndCashEquivalents": 2606000000, "addTotalDebt": 4669000000, "enterpriseValue": 155056196000}}
{"date": "2002-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2002-03-31", "stockPrice": 64.61, "numberOfShares": 3042000000, "marketCapitalization": 196543620000, "minusCashAndCashEquivalents": 3437000000, "addTotalDebt": 2894000000, "enterpriseValue": 196000620000}}
{"date": "2001-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2001-12-31", "stockPrice": 59.1, "numberOfShares": 3034964171, "marketCapitalization": 179366382506, "minusCashAndCashEquivalents": 3758000000, "addTotalDebt": 2782000000, "enterpriseValue": 178390382506}}
{"date": "2001-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2001-09-30", "stockPrice": 55.42, "numberOfShares": 3039200000, "marketCapitalization": 168432464000, "minusCashAndCashEquivalents": 5066000000, "addTotalDebt": 2826000000, "enterpriseValue": 166192464000}}
{"date": "2001-07-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2001-07-01", "stockPrice": 51.19, "numberOfShares": 3029300000, "marketCapitalization": 155069867000, "minusCashAndCashEquivalents": 4722000000, "addTotalDebt": 3415000000, "enterpriseValue": 153762867000}}
{"date": "2001-04-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2001-04-01", "stockPrice": 43.66, "numberOfShares": 3020400000, "marketCapitalization": 131870663999, "minusCashAndCashEquivalents": 3647000000, "addTotalDebt": 2472000000, "enterpriseValue": 130695663999}}
{"date": "2000-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2000-12-31", "stockPrice": 52.53, "numberOfShares": 3013900000, "marketCapitalization": 158320167000, "minusCashAndCashEquivalents": 4278000000, "addTotalDebt": 4652000000, "enterpriseValue": 158694167000}}
{"date": "2000-10-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2000-10-01", "stockPrice": 46.59, "numberOfShares": 2998400000, "marketCapitalization": 139695456000, "minusCashAndCashEquivalents": 3550000000, "addTotalDebt": 3312000000, "enterpriseValue": 139457456000}}
{"date": "2000-06-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2000-06-02", "stockPrice": 42.25, "numberOfShares": 2983000000, "marketCapitalization": 126031750000, "minusCashAndCashEquivalents": 2937000000, "addTotalDebt": 3304000000, "enterpriseValue": 126398750000}}
{"date": "2000-04-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "2000-04-02", "stockPrice": 36.13, "numberOfShares": 2779400000, "marketCapitalization": 100419722000, "minusCashAndCashEquivalents": 2663000000, "addTotalDebt": 3660000000, "enterpriseValue": 101416722000}}
{"date": "1999-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1999-12-31", "stockPrice": 46.63, "numberOfShares": 3611847552, "marketCapitalization": 168420451349, "minusCashAndCashEquivalents": 2363000000, "addTotalDebt": 4256000000, "enterpriseValue": 170313451349}}
{"date": "1999-10-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1999-10-03", "stockPrice": 47.25, "numberOfShares": 2779800000, "marketCapitalization": 131345550000, "minusCashAndCashEquivalents": 2617000000, "addTotalDebt": 3448000000, "enterpriseValue": 132176550000}}
{"date": "1999-07-04", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1999-07-04", "stockPrice": 48.72, "numberOfShares": 2780200000, "marketCapitalization": 135451344000, "minusCashAndCashEquivalents": 2024000000, "addTotalDebt": 3776000000, "enterpriseValue": 137203344000}}
{"date": "1999-04-04", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1999-04-04", "stockPrice": 47.44, "numberOfShares": 2780400000, "marketCapitalization": 131902176000, "minusCashAndCashEquivalents": 1780000000, "addTotalDebt": 3835000000, "enterpriseValue": 133957176000}}
{"date": "1998-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1998-12-31", "stockPrice": 41.94, "numberOfShares": 3042584213, "marketCapitalization": 127605981893, "minusCashAndCashEquivalents": 1994000000, "addTotalDebt": 4482000000, "enterpriseValue": 130093981893}}
{"date": "1998-09-27", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1998-09-27", "stockPrice": 40, "numberOfShares": 2707042254, "marketCapitalization": 108281690160, "minusCashAndCashEquivalents": 3742000000, "addTotalDebt": 1692000000, "enterpriseValue": 106231690160}}
{"date": "1998-06-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1998-06-28", "stockPrice": 38.5, "numberOfShares": 2680000000, "marketCapitalization": 103180000000, "minusCashAndCashEquivalents": 3114000000, "addTotalDebt": 1677000000, "enterpriseValue": 101743000000}}
{"date": "1998-03-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1998-03-29", "stockPrice": 35.84, "numberOfShares": 2679487855, "marketCapitalization": 96032844723, "minusCashAndCashEquivalents": 2893000000, "addTotalDebt": 1694000000, "enterpriseValue": 94833844723}}
{"date": "1997-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1997-12-31", "stockPrice": 32.94, "numberOfShares": 2678975709, "marketCapitalization": 88245459854, "minusCashAndCashEquivalents": 2753000000, "addTotalDebt": 1840000000, "enterpriseValue": 87332459854}}
{"date": "1997-09-28", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1997-09-28", "stockPrice": 29, "numberOfShares": 2671875000, "marketCapitalization": 77484375000, "minusCashAndCashEquivalents": 2994000000, "addTotalDebt": 2096000000, "enterpriseValue": 76586375000}}
{"date": "1997-06-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1997-06-29", "stockPrice": 32.19, "numberOfShares": 2673529412, "marketCapitalization": 86060911772, "minusCashAndCashEquivalents": 2237000000, "addTotalDebt": 2069000000, "enterpriseValue": 85892911772}}
{"date": "1997-03-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1997-03-30", "stockPrice": 26.44, "numberOfShares": 2673529412, "marketCapitalization": 70688117653, "minusCashAndCashEquivalents": 2190000000, "addTotalDebt": 2202000000, "enterpriseValue": 70700117653}}
{"date": "1996-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1996-12-31", "stockPrice": 24.88, "numberOfShares": 2651317972, "marketCapitalization": 65964791143, "minusCashAndCashEquivalents": 2011000000, "addTotalDebt": 2282000000, "enterpriseValue": 66235791143}}
{"date": "1996-09-29", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1996-09-29", "stockPrice": 25.63, "numberOfShares": 2678571429, "marketCapitalization": 68651785725, "minusCashAndCashEquivalents": 2088000000, "addTotalDebt": 2220000000, "enterpriseValue": 68783785725}}
{"date": "1996-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1996-06-30", "stockPrice": 24.81, "numberOfShares": 2636666667, "marketCapitalization": 65415700008, "minusCashAndCashEquivalents": 1860000000, "addTotalDebt": 2361000000, "enterpriseValue": 65916700008}}
{"date": "1996-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1996-03-31", "stockPrice": 23.31, "numberOfShares": 2677966102, "marketCapitalization": 62423389837, "minusCashAndCashEquivalents": 1724000000, "addTotalDebt": 2378000000, "enterpriseValue": 63077389837}}
{"date": "1995-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1995-12-31", "stockPrice": 21.38, "numberOfShares": 2583483871, "marketCapitalization": 55234885161, "minusCashAndCashEquivalents": 1201000000, "addTotalDebt": 2428000000, "enterpriseValue": 56461885161}}
{"date": "1995-10-01", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1995-10-01", "stockPrice": 18.38, "numberOfShares": 2595833333, "marketCapitalization": 47711416660, "minusCashAndCashEquivalents": 1293000000, "addTotalDebt": 2517000000, "enterpriseValue": 48935416660}}
{"date": "1995-07-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1995-07-02", "stockPrice": 16.92, "numberOfShares": 2592156863, "marketCapitalization": 43859294121, "minusCashAndCashEquivalents": 1041000000, "addTotalDebt": 2787000000, "enterpriseValue": 45605294121}}
{"date": "1995-04-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1995-04-02", "stockPrice": 14.88, "numberOfShares": 2572400000, "marketCapitalization": 38277312000, "minusCashAndCashEquivalents": 460000000, "addTotalDebt": 2736000000, "enterpriseValue": 40553312000}}
{"date": "1994-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1994-12-31", "stockPrice": 13.69, "numberOfShares": 2568779487, "marketCapitalization": 35166591177, "minusCashAndCashEquivalents": 636000000, "addTotalDebt": 3098000000, "enterpriseValue": 37628591177}}
{"date": "1994-10-02", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1994-10-02", "stockPrice": 12.84, "numberOfShares": 2573200000, "marketCapitalization": 33039888000, "minusCashAndCashEquivalents": 866000000, "addTotalDebt": 2400000000, "enterpriseValue": 34573888000}}
{"date": "1994-07-03", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1994-07-03", "stockPrice": 10.72, "numberOfShares": 2573200000, "marketCapitalization": 27584704000, "minusCashAndCashEquivalents": 571000000, "addTotalDebt": 2095000000, "enterpriseValue": 29108704000}}
{"date": "1994-03-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1994-03-30", "stockPrice": 9.28, "numberOfShares": 2572400000, "marketCapitalization": 23871872000, "minusCashAndCashEquivalents": 334000000, "addTotalDebt": 2201000000, "enterpriseValue": 25738872000}}
{"date": "1993-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1993-12-31", "stockPrice": 11.22, "numberOfShares": 2586387848, "marketCapitalization": 29019271654, "minusCashAndCashEquivalents": 372000000, "addTotalDebt": 2408000000, "enterpriseValue": 31055271654}}
{"date": "1993-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1993-09-30", "stockPrice": 9.84, "numberOfShares": 2594285714, "marketCapitalization": 25527771425, "minusCashAndCashEquivalents": 644000000, "addTotalDebt": 2320000000, "enterpriseValue": 27203771425}}
{"date": "1993-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1993-06-30", "stockPrice": 10.38, "numberOfShares": 2605263158, "marketCapitalization": 27042631580, "minusCashAndCashEquivalents": 595000000, "addTotalDebt": 2233000000, "enterpriseValue": 28680631580}}
{"date": "1993-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1993-03-31", "stockPrice": 10.66, "numberOfShares": 2579487179, "marketCapitalization": 27497333328, "minusCashAndCashEquivalents": 488000000, "addTotalDebt": 2189000000, "enterpriseValue": 29198333328}}
{"date": "1992-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1992-12-31", "stockPrice": 12.63, "numberOfShares": 2627184466, "marketCapitalization": 33181339805, "minusCashAndCashEquivalents": 745000000, "addTotalDebt": 2397000000, "enterpriseValue": 34833339805}}
{"date": "1992-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1992-09-30", "stockPrice": 11.78, "numberOfShares": 2575757576, "marketCapitalization": 30342424245, "minusCashAndCashEquivalents": 681000000, "addTotalDebt": 2619000000, "enterpriseValue": 32280424245}}
{"date": "1992-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1992-06-30", "stockPrice": 11.19, "numberOfShares": 2651428571, "marketCapitalization": 29669485709, "minusCashAndCashEquivalents": 452000000, "addTotalDebt": 2527000000, "enterpriseValue": 31744485709}}
{"date": "1992-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1992-03-31", "stockPrice": 12.19, "numberOfShares": 2651428571, "marketCapitalization": 32320914280, "minusCashAndCashEquivalents": 394000000, "addTotalDebt": 1848000000, "enterpriseValue": 33774914280}}
{"date": "1991-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1991-12-31", "stockPrice": 14.31, "numberOfShares": 2623207354, "marketCapitalization": 37538097235, "minusCashAndCashEquivalents": 589000000, "addTotalDebt": 1980000000, "enterpriseValue": 38929097235}}
{"date": "1991-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1991-09-30", "stockPrice": 11.05, "numberOfShares": 2592857143, "marketCapitalization": 28651071430, "minusCashAndCashEquivalents": 579000000, "addTotalDebt": 1888000000, "enterpriseValue": 29960071430}}
{"date": "1991-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1991-06-30", "stockPrice": 10.56, "numberOfShares": 2619354839, "marketCapitalization": 27660387099, "minusCashAndCashEquivalents": 548000000, "addTotalDebt": 1904000000, "enterpriseValue": 29016387099}}
{"date": "1991-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1991-03-31", "stockPrice": 11.8, "numberOfShares": 2612500000, "marketCapitalization": 30827500000, "minusCashAndCashEquivalents": 440000000, "addTotalDebt": 1914000000, "enterpriseValue": 32301500000}}
{"date": "1990-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1990-12-31", "stockPrice": 8.97, "numberOfShares": 2710819009, "marketCapitalization": 24316046510, "minusCashAndCashEquivalents": 826000000, "addTotalDebt": 2192000000, "enterpriseValue": 25682046510}}
{"date": "1990-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1990-09-30", "stockPrice": 8.23, "numberOfShares": 2616666667, "marketCapitalization": 21535166669, "minusCashAndCashEquivalents": 845000000, "addTotalDebt": 2269000000, "enterpriseValue": 22959166669}}
{"date": "1990-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1990-06-30", "stockPrice": 8.47, "numberOfShares": 2614814815, "marketCapitalization": 22147481483, "minusCashAndCashEquivalents": 636000000, "addTotalDebt": 2280000000, "enterpriseValue": 23791481483}}
{"date": "1990-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1990-03-31", "stockPrice": 7.02, "numberOfShares": 2568421053, "marketCapitalization": 18030315792, "minusCashAndCashEquivalents": 549000000, "addTotalDebt": 2050000000, "enterpriseValue": 19531315792}}
{"date": "1989-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1989-12-31", "stockPrice": 7.42, "numberOfShares": 2695510662, "marketCapitalization": 20000689112, "minusCashAndCashEquivalents": 452000000, "addTotalDebt": 1740000000, "enterpriseValue": 21288689112}}
{"date": "1989-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1989-09-30", "stockPrice": 6.84, "numberOfShares": 2650000000, "marketCapitalization": 18126000000, "minusCashAndCashEquivalents": 442000000, "addTotalDebt": 1584000000, "enterpriseValue": 19268000000}}
{"date": "1989-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1989-06-30", "stockPrice": 5.98, "numberOfShares": 2641666667, "marketCapitalization": 15797166668, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 15797166668}}
{"date": "1989-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1989-03-31", "stockPrice": 5.67, "numberOfShares": 2641666667, "marketCapitalization": 14978250001, "minusCashAndCashEquivalents": 410000000, "addTotalDebt": 1680000000, "enterpriseValue": 16248250001}}
{"date": "1988-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1988-12-31", "stockPrice": 5.32, "numberOfShares": 2664560000, "marketCapitalization": 14175459200, "minusCashAndCashEquivalents": 660000000, "addTotalDebt": 1688000000, "enterpriseValue": 15203459200}}
{"date": "1988-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1988-09-30", "stockPrice": 5.37, "numberOfShares": 2737168000, "marketCapitalization": 14698592160, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 14698592160}}
{"date": "1988-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1988-06-30", "stockPrice": 4.96, "numberOfShares": 2753536000, "marketCapitalization": 13657538560, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 13657538560}}
{"date": "1988-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1988-03-31", "stockPrice": 4.96, "numberOfShares": 2761872000, "marketCapitalization": 13698885120, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 13698885120}}
{"date": "1987-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1987-12-31", "stockPrice": 4.68, "numberOfShares": 2753536000, "marketCapitalization": 12886548480, "minusCashAndCashEquivalents": 741000000, "addTotalDebt": 1089000000, "enterpriseValue": 13234548480}}
{"date": "1987-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1987-09-30", "stockPrice": 5.97, "numberOfShares": 2762976000, "marketCapitalization": 16494966720, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 16494966720}}
{"date": "1987-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1987-06-30", "stockPrice": 5.74, "numberOfShares": 2765600000, "marketCapitalization": 15874544000, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 15874544000}}
{"date": "1987-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1987-03-31", "stockPrice": 5.53, "numberOfShares": 2765600000, "marketCapitalization": 15293768000, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 15293768000}}
{"date": "1986-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1986-12-31", "stockPrice": 4.1, "numberOfShares": 2765600000, "marketCapitalization": 11338959999, "minusCashAndCashEquivalents": 952500000, "addTotalDebt": 1252200000, "enterpriseValue": 11638659999}}
{"date": "1986-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1986-09-30", "stockPrice": 4, "numberOfShares": 2844992000, "marketCapitalization": 11379968000, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 11379968000}}
{"date": "1986-06-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1986-06-30", "stockPrice": 4.54, "numberOfShares": 2903552000, "marketCapitalization": 13182126080, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 13182126080}}
{"date": "1986-03-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1986-03-31", "stockPrice": 3.59, "numberOfShares": 2925632000, "marketCapitalization": 10503018880, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 10503018880}}
{"date": "1985-12-31", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1985-12-31", "stockPrice": 3.29, "numberOfShares": 2925632000, "marketCapitalization": 9625329280, "minusCashAndCashEquivalents": 735600000, "addTotalDebt": 414600000, "enterpriseValue": 9304329280}}
{"date": "1985-09-30", "symbol": "JNJ", "type": "enterprise_values", "result": {"symbol": "JNJ", "date": "1985-09-30", "stockPrice": 2.77, "numberOfShares": 2926912000, "marketCapitalization": 8107546240, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 8107546240}}
{"date": "2029-12-29", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2029-12-29", "revenueLow": 114419421895, "revenueHigh": 117091584523, "revenueAvg": 116142101902, "ebitdaLow": 34667619163, "ebitdaHigh": 35477250210, "ebitdaAvg": 35189569139, "ebitLow": 24619730681, "ebitHigh": 25194702335, "ebitAvg": 24990401299, "netIncomeLow": 34859120498, "netIncomeHigh": 35922250232, "netIncomeAvg": 35544502826, "sgaExpenseLow": 28822903814, "sgaExpenseHigh": 29496036793, "sgaExpenseAvg": 29256856715, "epsAvg": 14.63098, "epsHigh": 14.78647, "epsLow": 14.34886, "numAnalystsRevenue": 10, "numAnalystsEps": 2}}
{"date": "2028-12-29", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2028-12-29", "revenueLow": 108012048437, "revenueHigh": 110534572624, "revenueAvg": 109638260082, "ebitdaLow": 32726267082, "ebitdaHigh": 33490559598, "ebitdaAvg": 33218988379, "ebitLow": 23241050328, "ebitHigh": 23783824143, "ebitAvg": 23590963761, "netIncomeLow": 32508530233, "netIncomeHigh": 33499992667, "netIncomeAvg": 33147705373, "sgaExpenseLow": 27208849960, "sgaExpenseHigh": 27844288164, "sgaExpenseAvg": 27618501932, "epsAvg": 13.6444, "epsHigh": 13.78941, "epsLow": 13.3813, "numAnalystsRevenue": 16, "numAnalystsEps": 5}}
{"date": "2027-12-29", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2027-12-29", "revenueLow": 103593452436, "revenueHigh": 104134469349, "revenueAvg": 103863960893, "ebitdaLow": 31387489094, "ebitdaHigh": 31551410288, "ebitdaAvg": 31469449691, "ebitLow": 22290297023, "ebitHigh": 22406708123, "ebitAvg": 22348502573, "netIncomeLow": 22889490987, "netIncomeHigh": 34127239454, "netIncomeAvg": 23370730000, "sgaExpenseLow": 26095780470, "sgaExpenseHigh": 26232065711, "sgaExpenseAvg": 26163923090, "epsAvg": 12.41573, "epsHigh": 14.0476, "epsLow": 9.42187, "numAnalystsRevenue": 21, "numAnalystsEps": 6}}
{"date": "2026-12-29", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2026-12-29", "revenueLow": 98183350849, "revenueHigh": 99107523990, "revenueAvg": 98806163184, "ebitdaLow": 29748297615, "ebitdaHigh": 30028310238, "ebitdaAvg": 29937001774, "ebitLow": 21126200563, "ebitHigh": 21325055735, "ebitAvg": 21260211657, "netIncomeLow": 27857103815, "netIncomeHigh": 28540129625, "netIncomeAvg": 28198616720, "sgaExpenseLow": 24732945078, "sgaExpenseHigh": 24965749554, "sgaExpenseAvg": 24889835051, "epsAvg": 11.53695, "epsHigh": 11.74781, "epsLow": 11.46666, "numAnalystsRevenue": 18, "numAnalystsEps": 14}}
{"date": "2025-12-29", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2025-12-29", "revenueLow": 93495753445, "revenueHigh": 93986045816, "revenueAvg": 93755908581, "ebitdaLow": 28328015647, "ebitdaHigh": 28476567955, "ebitdaAvg": 28406839321, "ebitLow": 20117565982, "ebitHigh": 20223062636, "ebitAvg": 20173543798, "netIncomeLow": 26331124792, "netIncomeHigh": 26501158498, "netIncomeAvg": 26416141645, "sgaExpenseLow": 23552112604, "sgaExpenseHigh": 23675620043, "sgaExpenseAvg": 23617647164, "epsAvg": 10.86853, "epsHigh": 10.90852, "epsLow": 10.83853, "numAnalystsRevenue": 17, "numAnalystsEps": 13}}
{"date": "2024-12-29", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2024-12-29", "revenueLow": 88577028708, "revenueHigh": 89206794289, "revenueAvg": 88776954290, "ebitdaLow": 26837705059, "ebitdaHigh": 27028515963, "ebitdaAvg": 26898279950, "ebitLow": 19059199524, "ebitHigh": 19194706754, "ebitAvg": 19102217692, "netIncomeLow": 24050112543, "netIncomeHigh": 24511674250, "netIncomeAvg": 24280893396.5, "sgaExpenseLow": 22313057838, "sgaExpenseHigh": 22471699373, "sgaExpenseAvg": 22363420230, "epsAvg": 9.94961, "epsHigh": 10.0896, "epsLow": 9.89961, "numAnalystsRevenue": 13, "numAnalystsEps": 15}}
{"date": "2023-12-29", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2023-12-29", "revenueLow": 83959891437, "revenueHigh": 85018547139, "revenueAvg": 84746751631, "ebitdaLow": 26214971715, "ebitdaHigh": 39322457580, "ebitdaAvg": 32768714648, "ebitLow": 19706453467, "ebitHigh": 29559680208, "ebitAvg": 24633066838, "netIncomeLow": 13105599997, "netIncomeHigh": 19658400002, "netIncomeAvg": 16382000000, "sgaExpenseLow": 21599051329, "sgaExpenseHigh": 32398576998, "sgaExpenseAvg": 26998814164, "epsAvg": 9.91821, "epsHigh": 10.02362, "epsLow": 9.72696, "numAnalystsRevenue": 17, "numAnalystsEps": 18}}
{"date": "2022-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2022-12-28", "revenueLow": 93621367550, "revenueHigh": 95807810336, "revenueAvg": 95018825749, "ebitdaLow": 23831792469, "ebitdaHigh": 35747688710, "ebitdaAvg": 29789740590, "ebitLow": 17914957699, "ebitHigh": 26872436553, "ebitAvg": 22393697127, "netIncomeLow": 15186154564, "netIncomeHigh": 22779231851, "netIncomeAvg": 18982693208, "sgaExpenseLow": 19635501209, "sgaExpenseHigh": 29453251816, "sgaExpenseAvg": 24544376513, "epsAvg": 10.04625, "epsHigh": 10.15469, "epsLow": 9.85417, "numAnalystsRevenue": 8, "numAnalystsEps": 6}}
{"date": "2021-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2021-12-28", "revenueLow": 93060106527, "revenueHigh": 95233441567, "revenueAvg": 94449186951, "ebitdaLow": 21665265882, "ebitdaHigh": 32497898828, "ebitdaAvg": 27081582355, "ebitLow": 16286325182, "ebitHigh": 24429487777, "ebitAvg": 20357906480, "netIncomeLow": 13805595059, "netIncomeHigh": 20708392593, "netIncomeAvg": 17256993826, "sgaExpenseLow": 17850455646, "sgaExpenseHigh": 26775683471, "sgaExpenseAvg": 22313069559, "epsAvg": 9.83192, "epsHigh": 9.93805, "epsLow": 9.64394, "numAnalystsRevenue": 9, "numAnalystsEps": 5}}
{"date": "2020-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2020-12-28", "revenueLow": 80592486391, "revenueHigh": 82474651383, "revenueAvg": 81795466372, "ebitdaLow": 19695696258, "ebitdaHigh": 29543544390, "ebitdaAvg": 24619620324, "ebitLow": 14805750167, "ebitHigh": 22208625252, "ebitAvg": 18507187710, "netIncomeLow": 12550540964, "netIncomeHigh": 18825811449, "netIncomeAvg": 15688176207, "sgaExpenseLow": 16227686952, "sgaExpenseHigh": 24341530429, "sgaExpenseAvg": 20284608691, "epsAvg": 7.99572, "epsHigh": 8.08203, "epsLow": 7.84285, "numAnalystsRevenue": 9, "numAnalystsEps": 8}}
{"date": "2019-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2019-12-28", "revenueLow": 80920563669, "revenueHigh": 82810390610, "revenueAvg": 82128440761, "ebitdaLow": 19055574858, "ebitdaHigh": 28583362287, "ebitdaAvg": 23819468573, "ebitLow": 16163087544, "ebitHigh": 24244631319, "ebitAvg": 20203859432, "netIncomeLow": 11694275138, "netIncomeHigh": 17541412707, "netIncomeAvg": 14617843923, "sgaExpenseLow": 17142055834, "sgaExpenseHigh": 25713083752, "sgaExpenseAvg": 21427569793, "epsAvg": 8.66903, "epsHigh": 8.76261, "epsLow": 8.50328, "numAnalystsRevenue": 8, "numAnalystsEps": 6}}
{"date": "2018-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2018-12-28", "revenueLow": 80201893145, "revenueHigh": 82074936183, "revenueAvg": 81399042857, "ebitdaLow": 24300146266, "ebitdaHigh": 24867654314, "ebitdaAvg": 24662867294, "ebitLow": 17257114016, "ebitHigh": 17660138384, "ebitAvg": 17514705804, "netIncomeLow": 19453371920, "netIncomeHigh": 20046631400, "netIncomeAvg": 19832552672, "sgaExpenseLow": 20203313506, "sgaExpenseHigh": 20675143712, "sgaExpenseAvg": 20504882335, "epsAvg": 8.16356, "epsHigh": 8.25168, "epsLow": 8.00748, "numAnalystsRevenue": 18, "numAnalystsEps": 17}}
{"date": "2017-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2017-12-28", "revenueLow": 75138548372, "revenueHigh": 76893341549, "revenueAvg": 76260119048, "ebitdaLow": 22766017659, "ebitdaHigh": 23297697514, "ebitdaAvg": 23105839207, "ebitLow": 16167629534, "ebitHigh": 16545209971, "ebitAvg": 16408958912, "netIncomeLow": 17342320495, "netIncomeHigh": 17871200875, "netIncomeAvg": 17680347211, "sgaExpenseLow": 18927828130, "sgaExpenseHigh": 19369870522, "sgaExpenseAvg": 19210358169, "epsAvg": 7.27766, "epsHigh": 7.35622, "epsLow": 7.13852, "numAnalystsRevenue": 12, "numAnalystsEps": 11}}
{"date": "2016-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2016-12-28", "revenueLow": 70963119701, "revenueHigh": 72620399499, "revenueAvg": 72022365000, "ebitdaLow": 21500916258, "ebitdaHigh": 22003050807, "ebitdaAvg": 21821854015, "ebitLow": 15269198763, "ebitHigh": 15625797159, "ebitAvg": 15497117534, "netIncomeLow": 15980423148, "netIncomeHigh": 16467785082, "netIncomeAvg": 16291920816, "sgaExpenseLow": 17876013876, "sgaExpenseHigh": 18293492092, "sgaExpenseAvg": 18142843797, "epsAvg": 6.70615, "epsHigh": 6.77854, "epsLow": 6.57793, "numAnalystsRevenue": 8, "numAnalystsEps": 9}}
{"date": "2015-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2015-12-28", "revenueLow": 69077977861, "revenueHigh": 70691231868, "revenueAvg": 70109084211, "ebitdaLow": 20929742428, "ebitdaHigh": 21418537727, "ebitdaAvg": 21242154444, "ebitLow": 14863571085, "ebitHigh": 15210696412, "ebitAvg": 15085435173, "netIncomeLow": 14731590078, "netIncomeHigh": 15180859020, "netIncomeAvg": 15018745158, "sgaExpenseLow": 17401135913, "sgaExpenseHigh": 17807523783, "sgaExpenseAvg": 17660877473, "epsAvg": 6.18208, "epsHigh": 6.24881, "epsLow": 6.06388, "numAnalystsRevenue": 9, "numAnalystsEps": 8}}
{"date": "2014-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2014-12-28", "revenueLow": 57144281755, "revenueHigh": 85716422633, "revenueAvg": 71430352194, "ebitdaLow": 19132479754, "ebitdaHigh": 28698719632, "ebitdaAvg": 23915599693, "ebitLow": 16183213074, "ebitHigh": 24274819611, "ebitAvg": 20229016343, "netIncomeLow": 12496211032, "netIncomeHigh": 18744316550, "netIncomeAvg": 15620263791, "sgaExpenseLow": 16858560367, "sgaExpenseHigh": 25287840552, "sgaExpenseAvg": 21073200460, "epsAvg": 5.49, "epsHigh": 6.59, "epsLow": 4.39, "numAnalystsRevenue": 19, "numAnalystsEps": 19}}
{"date": "2013-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2013-12-28", "revenueLow": 54903701276, "revenueHigh": 82355551914, "revenueAvg": 68629626595, "ebitdaLow": 15394608896, "ebitdaHigh": 23091913346, "ebitdaAvg": 19243261121, "ebitLow": 14563414288, "ebitHigh": 21845121433, "ebitAvg": 18204267861, "netIncomeLow": 10620193776, "netIncomeHigh": 15930290665, "netIncomeAvg": 13275242221, "sgaExpenseLow": 16779537167, "sgaExpenseHigh": 25169305752, "sgaExpenseAvg": 20974421460, "epsAvg": 5.1, "epsHigh": 6.12, "epsLow": 4.08, "numAnalystsRevenue": 14, "numAnalystsEps": 14}}
{"date": "2008-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2008-12-28", "revenueLow": 48799946918, "revenueHigh": 73199920378, "revenueAvg": 60999933648, "ebitdaLow": 15083184246, "ebitdaHigh": 22624776370, "ebitdaAvg": 18853980308, "ebitLow": 12331560213, "ebitHigh": 18497340321, "ebitAvg": 15414450267, "netIncomeLow": 9882359149, "netIncomeHigh": 14823538725, "netIncomeAvg": 12352948937, "sgaExpenseLow": 16427895325, "sgaExpenseHigh": 24641842989, "sgaExpenseAvg": 20534869157, "epsAvg": 4.15, "epsHigh": 4.98, "epsLow": 3.32, "numAnalystsRevenue": 10, "numAnalystsEps": 10}}
{"date": "2003-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2003-12-28", "revenueLow": 32970496089, "revenueHigh": 49455744132, "revenueAvg": 41213120111, "ebitdaLow": 9591462841, "ebitdaHigh": 14387194262, "ebitdaAvg": 11989328552, "ebitLow": 8563844511, "ebitHigh": 12845766769, "ebitAvg": 10704805641, "netIncomeLow": 5668484458, "netIncomeHigh": 8502726688, "netIncomeAvg": 7085605573, "sgaExpenseLow": 11128911799, "sgaExpenseHigh": 16693367700, "sgaExpenseAvg": 13911139750, "epsAvg": 2.57, "epsHigh": 3.08, "epsLow": 2.06, "numAnalystsRevenue": 14, "numAnalystsEps": 14}}
{"date": "2002-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "2002-12-28", "revenueLow": 29092804364, "revenueHigh": 43639206549, "revenueAvg": 36366005457, "ebitdaLow": 8756957949, "ebitdaHigh": 13135436925, "ebitdaAvg": 10946197437, "ebitLow": 7738596922, "ebitHigh": 11607895383, "ebitAvg": 9673246153, "netIncomeLow": 5277012968, "netIncomeHigh": 7915519453, "netIncomeAvg": 6596266211, "sgaExpenseLow": 9788898539, "sgaExpenseHigh": 14683347810, "sgaExpenseAvg": 12236123175, "epsAvg": 2.22, "epsHigh": 2.66, "epsLow": 1.78, "numAnalystsRevenue": 17, "numAnalystsEps": 17}}
{"date": "1997-12-28", "symbol": "JNJ", "type": "analyst_estimates_annual", "result": {"symbol": "JNJ", "date": "1997-12-28", "revenueLow": 18458608695, "revenueHigh": 27687913042, "revenueAvg": 23073260869, "ebitdaLow": 4300973913, "ebitdaHigh": 6451460869, "ebitdaAvg": 5376217391, "ebitLow": 3668486956, "ebitHigh": 5502730434, "ebitAvg": 4585608695, "netIncomeLow": 2406608695, "netIncomeHigh": 3609913043, "netIncomeAvg": 3008260869, "sgaExpenseLow": 6892486956, "sgaExpenseHigh": 10338730434, "sgaExpenseAvg": 8615608695, "epsAvg": 1.22, "epsHigh": 1.46, "epsLow": 0.98, "numAnalystsRevenue": 13, "numAnalystsEps": 13}}
{"date": "2025-12-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-12-11 00:00:00", "acceptedDate": "2025-12-11 17:02:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000217/0000200406-25-000217-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000217/xslF345X05/wk-form4_1765490532.xml"}}
{"date": "2025-12-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-12-11 00:00:00", "acceptedDate": "2025-12-11 16:59:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000215/0000200406-25-000215-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000215/xslF345X05/wk-form4_1765490380.xml"}}
{"date": "2025-12-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-12-11 00:00:00", "acceptedDate": "2025-12-11 16:58:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000213/0000200406-25-000213-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000213/xslF345X05/wk-form4_1765490317.xml"}}
{"date": "2025-12-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-12-01 00:00:00", "acceptedDate": "2025-12-01 16:15:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000211/0000200406-25-000211-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000211/xslF345X05/wk-form4_1764623736.xml"}}
{"date": "2025-12-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-12-01 00:00:00", "acceptedDate": "2025-12-01 16:07:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525303876/0001193125-25-303876-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525303876/xslF345X05/ownership.xml"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-11-25 00:00:00", "acceptedDate": "2025-11-25 12:54:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525296047/0001193125-25-296047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525296047/xslF345X05/ownership.xml"}}
{"date": "2025-11-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-11-14 00:00:00", "acceptedDate": "2025-11-14 15:07:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525282669/0001193125-25-282669-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525282669/xslF345X05/ownership.xml"}}
{"date": "2025-11-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-11-13 00:00:00", "acceptedDate": "2025-11-13 15:25:42", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000587/0000904454-25-000587-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000587/infotable.xml"}}
{"date": "2025-11-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-11-10 00:00:00", "acceptedDate": "2025-11-10 15:28:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/0001193125-25-274067-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/xslF345X05/ownership.xml"}}
{"date": "2025-10-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-10-22 00:00:00", "acceptedDate": "2025-10-22 17:09:06", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000502/0000904454-25-000502-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000502/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-10-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-10-22 00:00:00", "acceptedDate": "2025-10-22 16:04:17", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"}}
{"date": "2025-10-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-10-20 00:00:00", "acceptedDate": "2025-10-20 19:13:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/0000200406-25-000204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-10-14 00:00:00", "acceptedDate": "2025-10-14 07:22:58", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/0000200406-25-000201-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/a2025q3exhibit992.htm"}}
{"date": "2025-09-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-09-15 00:00:00", "acceptedDate": "2025-09-15 16:36:54", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000199/0000200406-25-000199-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000199/xslF345X02/wk-form3_1757968612.xml"}}
{"date": "2025-09-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-09-11 00:00:00", "acceptedDate": "2025-09-11 17:52:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/0000200406-25-000196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"}}
{"date": "2025-09-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-09-11 00:00:00", "acceptedDate": "2025-09-11 17:48:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/0000200406-25-000194-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"}}
{"date": "2025-09-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-09-11 00:00:00", "acceptedDate": "2025-09-11 17:46:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/0000200406-25-000192-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"}}
{"date": "2025-09-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-09-09 00:00:00", "acceptedDate": "2025-09-08 19:55:25", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/0000200406-25-000190-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"}}
{"date": "2025-09-05", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-09-05 00:00:00", "acceptedDate": "2025-09-05 18:00:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/0000200406-25-000186-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"}}
{"date": "2025-09-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-09-03 00:00:00", "acceptedDate": "2025-09-03 17:13:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000184/0000200406-25-000184-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000184/xslF345X05/wk-form4_1756934034.xml"}}
{"date": "2025-08-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-08-26 00:00:00", "acceptedDate": "2025-08-26 16:27:56", "formType": "N-PX", "link": "https://www.sec.gov/Archives/edgar/data/200406/000102140825003516/0001021408-25-003516-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000102140825003516/xslN-PX_X01/primary_doc.xml"}}
{"date": "2025-08-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-08-25 00:00:00", "acceptedDate": "2025-08-25 19:12:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000182/0000200406-25-000182-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000182/xslF345X05/wk-form4_1756163533.xml"}}
{"date": "2025-08-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-08-18 00:00:00", "acceptedDate": "2025-08-18 18:19:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000180/0000200406-25-000180-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000180/xslF345X05/wk-form4_1755555550.xml"}}
{"date": "2025-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-07-24 00:00:00", "acceptedDate": "2025-07-24 16:04:24", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/0000200406-25-000178-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"}}
{"date": "2025-07-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-07-22 00:00:00", "acceptedDate": "2025-07-22 12:33:19", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/0000904454-25-000367-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/infotable.xml"}}
{"date": "2025-07-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-07-18 00:00:00", "acceptedDate": "2025-07-18 16:12:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/0000200406-25-000172-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"}}
{"date": "2025-07-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-07-16 00:00:00", "acceptedDate": "2025-07-16 08:06:45", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/0000200406-25-000170-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/a2025q2exhibit992.htm"}}
{"date": "2025-07-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-07-08 00:00:00", "acceptedDate": "2025-07-08 17:31:26", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000167/0000200406-25-000167-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000167/xslF345X02/wk-form3_1752010278.xml"}}
{"date": "2025-06-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-06-24 00:00:00", "acceptedDate": "2025-06-23 21:42:57", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000160/0000200406-25-000160-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000160/a2024form11-kxjjretirement.htm"}}
{"date": "2025-06-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-06-24 00:00:00", "acceptedDate": "2025-06-23 21:41:23", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000159/0000200406-25-000159-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000159/a2024form11-kxjjsavingsplan.htm"}}
{"date": "2025-06-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-06-12 00:00:00", "acceptedDate": "2025-06-12 16:32:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/0000200406-25-000156-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"}}
{"date": "2025-06-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-06-12 00:00:00", "acceptedDate": "2025-06-12 16:30:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/0000200406-25-000154-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/xslF345X05/wk-form4_1749760229.xml"}}
{"date": "2025-06-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-06-10 00:00:00", "acceptedDate": "2025-06-10 17:06:51", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/0000200406-25-000152-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/ex991-pressrelease.htm"}}
{"date": "2025-05-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-05-28 00:00:00", "acceptedDate": "2025-05-28 16:05:16", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000149/0000200406-25-000149-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000149/coverformsd2024.htm"}}
{"date": "2025-05-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-05-07 00:00:00", "acceptedDate": "2025-05-07 16:47:35", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/0000904454-25-000238-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/infotable.xml"}}
{"date": "2025-05-05", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-05-05 00:00:00", "acceptedDate": "2025-05-05 17:10:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/0000200406-25-000143-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"}}
{"date": "2025-04-30", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-30 00:00:00", "acceptedDate": "2025-04-30 16:30:48", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/0000200406-25-000141-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:57:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/0000200406-25-000138-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:54:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/0000200406-25-000135-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:52:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000133/0000200406-25-000133-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000133/xslF345X05/wk-form4_1745877141.xml"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:50:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000131/0000200406-25-000131-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000131/xslF345X05/wk-form4_1745877052.xml"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:48:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000129/0000200406-25-000129-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000129/xslF345X05/wk-form4_1745876902.xml"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:45:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000127/0000200406-25-000127-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000127/xslF345X05/wk-form4_1745876716.xml"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:41:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000125/0000200406-25-000125-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000125/xslF345X05/wk-form4_1745876478.xml"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:39:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000123/0000200406-25-000123-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000123/xslF345X05/wk-form4_1745876377.xml"}}
{"date": "2025-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-28 00:00:00", "acceptedDate": "2025-04-28 17:38:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000122/0000200406-25-000122-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000122/xslF345X05/wk-form4_1745876302.xml"}}
{"date": "2025-04-23", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-23 00:00:00", "acceptedDate": "2025-04-23 16:04:45", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/0000200406-25-000119-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/jnj-20250330.htm"}}
{"date": "2025-04-23", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-23 00:00:00", "acceptedDate": "2025-04-23 13:41:11", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000109690625000570/0001096906-25-000570-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000109690625000570/bowy_px14a6g.htm"}}
{"date": "2025-04-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-15 00:00:00", "acceptedDate": "2025-04-15 08:14:19", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000110/0000200406-25-000110-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000110/jnj-20250415.htm"}}
{"date": "2025-04-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-04-03 00:00:00", "acceptedDate": "2025-04-03 16:43:02", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000106/0000200406-25-000106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000106/jnj-20250331.htm"}}
{"date": "2025-03-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-03-20 00:00:00", "acceptedDate": "2025-03-20 14:00:33", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465925004577/0001214659-25-004577-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465925004577/y320251px14a6g.htm"}}
{"date": "2025-03-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-03-19 00:00:00", "acceptedDate": "2025-03-19 20:07:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000103/0000200406-25-000103-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000103/xslF345X05/wk-form4_1742429234.xml"}}
{"date": "2025-03-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-03-12 00:00:00", "acceptedDate": "2025-03-12 06:48:37", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000101/0000200406-25-000101-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000101/a2025jnjdefa14a-additional.htm"}}
{"date": "2025-03-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-03-12 00:00:00", "acceptedDate": "2025-03-12 06:44:24", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/200406/000130817925000085/0001308179-25-000085-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000130817925000085/jnj013333-ars.pdf"}}
{"date": "2025-03-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-03-12 00:00:00", "acceptedDate": "2025-03-12 06:40:55", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000099/0000200406-25-000099-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000099/jnj-20250311.htm"}}
{"date": "2025-03-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-03-07 00:00:00", "acceptedDate": "2025-03-07 17:01:04", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525049944/0001193125-25-049944-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525049944/d866658ddfan14a.htm"}}
{"date": "2025-03-06", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-03-06 00:00:00", "acceptedDate": "2025-03-06 16:42:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000095/0000200406-25-000095-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000095/xslF345X05/wk-form4_1741297319.xml"}}
{"date": "2025-03-06", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-03-06 00:00:00", "acceptedDate": "2025-03-06 16:38:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000093/0000200406-25-000093-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000093/xslF345X05/wk-form4_1741297124.xml"}}
{"date": "2025-02-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-28 00:00:00", "acceptedDate": "2025-02-28 19:05:42", "formType": "5", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000091/0000200406-25-000091-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000091/xslF345X05/wk-form5_1740787536.xml"}}
{"date": "2025-02-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-28 00:00:00", "acceptedDate": "2025-02-28 11:43:33", "formType": "CERT", "link": "https://www.sec.gov/Archives/edgar/data/200406/000087666125000141/0000876661-25-000141-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000087666125000141/JNJ2933374555.pdf"}}
{"date": "2025-02-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-26 00:00:00", "acceptedDate": "2025-02-26 18:42:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000086/0000200406-25-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000086/xslF345X05/wk-form4_1740613359.xml"}}
{"date": "2025-02-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-26 00:00:00", "acceptedDate": "2025-02-26 17:22:10", "formType": "8-A12B", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036928/0001193125-25-036928-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036928/d843802d8a12b.htm"}}
{"date": "2025-02-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-26 00:00:00", "acceptedDate": "2025-02-26 16:23:21", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036773/0001193125-25-036773-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036773/d863514dex11.htm"}}
{"date": "2025-02-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-25 00:00:00", "acceptedDate": "2025-02-25 17:21:26", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525035283/0001193125-25-035283-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525035283/d925868ddfan14a.htm"}}
{"date": "2025-02-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-21 00:00:00", "acceptedDate": "2025-02-21 16:28:29", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525032025/0001193125-25-032025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525032025/d867955d424b2.htm"}}
{"date": "2025-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-20 00:00:00", "acceptedDate": "2025-02-20 17:26:35", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525030851/0001193125-25-030851-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525030851/d866332dex11.htm"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:44:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000084/0000200406-25-000084-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000084/xslF345X05/wk-form4_1740005083.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:37:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000082/0000200406-25-000082-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000082/xslF345X05/wk-form4_1740004664.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:35:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000080/0000200406-25-000080-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000080/xslF345X05/wk-form4_1740004513.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:33:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000078/0000200406-25-000078-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000078/xslF345X05/wk-form4_1740004392.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:31:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000076/0000200406-25-000076-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000076/xslF345X05/wk-form4_1740004292.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:29:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000074/0000200406-25-000074-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000074/xslF345X05/wk-form4_1740004157.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:27:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000072/0000200406-25-000072-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000072/xslF345X05/wk-form4_1740004038.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:25:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000070/0000200406-25-000070-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000070/xslF345X05/wk-form4_1740003921.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:22:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000068/0000200406-25-000068-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000068/xslF345X05/wk-form4_1740003766.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:18:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000066/0000200406-25-000066-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000066/xslF345X05/wk-form4_1740003520.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:16:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000064/0000200406-25-000064-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000064/xslF345X05/wk-form4_1740003385.xml"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:11:23", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525029695/0001193125-25-029695-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525029695/d877773d424b2.htm"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 17:07:07", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525029688/0001193125-25-029688-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525029688/d900883dfwp.htm"}}
{"date": "2025-02-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 06:04:08", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525029057/0001193125-25-029057-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525029057/d867955d424b5.htm"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:46:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000062/0000200406-25-000062-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000062/xslF345X05/wk-form4_1739933175.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:33:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000060/0000200406-25-000060-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000060/xslF345X05/wk-form4_1739932395.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:16:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000058/0000200406-25-000058-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000058/xslF345X05/wk-form4_1739931408.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:13:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000056/0000200406-25-000056-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000056/xslF345X05/wk-form4_1739931179.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:11:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000054/0000200406-25-000054-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000054/xslF345X05/wk-form4_1739931099.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:08:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/0000200406-25-000052-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000052/xslF345X05/wk-form4_1739930875.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:06:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000050/0000200406-25-000050-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000050/xslF345X05/wk-form4_1739930786.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:05:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000048/0000200406-25-000048-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000048/xslF345X05/wk-form4_1739930704.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:03:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000046/0000200406-25-000046-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000046/xslF345X05/wk-form4_1739930611.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:02:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000044/0000200406-25-000044-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000044/xslF345X05/wk-form4_1739930549.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 21:01:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000042/0000200406-25-000042-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000042/xslF345X05/wk-form4_1739930459.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 20:58:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000040/0000200406-25-000040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000040/xslF345X05/wk-form4_1739930299.xml"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 17:24:15", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525028745/0001193125-25-028745-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525028745/d897119dfwp.htm"}}
{"date": "2025-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-18 00:00:00", "acceptedDate": "2025-02-18 08:09:35", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525028185/0001193125-25-028185-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525028185/d877773d424b5.htm"}}
{"date": "2025-02-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-13 00:00:00", "acceptedDate": "2025-02-13 16:07:39", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm"}}
{"date": "2025-02-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-13 00:00:00", "acceptedDate": "2025-02-13 15:10:50", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000124/0000904454-25-000124-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000124/infotable.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 18:38:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000035/0000200406-25-000035-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000035/xslF345X05/wk-form4_1739403530.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 18:37:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000033/0000200406-25-000033-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000033/xslF345X05/wk-form4_1739403421.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 18:35:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000031/0000200406-25-000031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000031/xslF345X05/wk-form4_1739403336.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 18:32:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000029/0000200406-25-000029-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000029/xslF345X05/wk-form4_1739403114.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 18:21:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000027/0000200406-25-000027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000027/xslF345X05/wk-form4_1739402472.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 18:18:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000025/0000200406-25-000025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000025/xslF345X05/wk-form4_1739402273.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 18:10:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000023/0000200406-25-000023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000023/xslF345X05/wk-form4_1739401822.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 18:07:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000021/0000200406-25-000021-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000021/xslF345X05/wk-form4_1739401614.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 17:53:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000019/0000200406-25-000019-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000019/xslF345X05/wk-form4_1739400827.xml"}}
{"date": "2025-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 17:38:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000017/0000200406-25-000017-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000017/xslF345X05/wk-form4_1739399922.xml"}}
{"date": "2025-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-11 00:00:00", "acceptedDate": "2025-02-11 19:43:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000015/0000200406-25-000015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000015/xslF345X05/wk-form4_1739320983.xml"}}
{"date": "2025-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-11 00:00:00", "acceptedDate": "2025-02-11 19:42:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000014/0000200406-25-000014-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000014/xslF345X05/wk-form4_1739320931.xml"}}
{"date": "2025-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-11 00:00:00", "acceptedDate": "2025-02-11 19:41:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000013/0000200406-25-000013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000013/xslF345X05/wk-form4_1739320870.xml"}}
{"date": "2025-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-02-11 00:00:00", "acceptedDate": "2025-02-11 19:40:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000012/0000200406-25-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000012/xslF345X05/wk-form4_1739320809.xml"}}
{"date": "2025-01-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-01-22 00:00:00", "acceptedDate": "2025-01-22 17:25:03", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525010511/0001193125-25-010511-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525010511/d859518ddfan14a.htm"}}
{"date": "2025-01-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-01-22 00:00:00", "acceptedDate": "2025-01-22 16:55:07", "formType": "8-K/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000007/0000200406-25-000007-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000007/jnj-20250122.htm"}}
{"date": "2025-01-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-01-22 00:00:00", "acceptedDate": "2025-01-22 06:35:57", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000003/0000200406-25-000003-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000003/a2024q4exhibit991.htm"}}
{"date": "2025-01-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2025-01-13 00:00:00", "acceptedDate": "2025-01-13 17:27:51", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312525005390/0001193125-25-005390-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312525005390/d866658ddfan14a.htm"}}
{"date": "2024-12-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-12-12 00:00:00", "acceptedDate": "2024-12-12 17:27:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/0000200406-24-000106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"}}
{"date": "2024-12-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-12-12 00:00:00", "acceptedDate": "2024-12-12 17:16:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/0000200406-24-000104-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"}}
{"date": "2024-12-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-12-12 00:00:00", "acceptedDate": "2024-12-12 17:09:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/0000200406-24-000102-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"}}
{"date": "2024-11-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-11-13 00:00:00", "acceptedDate": "2024-11-13 16:45:43", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/0000904454-24-000604-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/infotable.xml"}}
{"date": "2024-11-06", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-11-06 00:00:00", "acceptedDate": "2024-11-06 09:23:39", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/200406/000087666124001042/0000876661-24-001042-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000087666124001042/xslF25X02/primary_doc.xml"}}
{"date": "2024-11-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-11-01 00:00:00", "acceptedDate": "2024-11-01 11:05:15", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000574/0000904454-24-000574-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000574/s13ga_093024-cvrx.htm"}}
{"date": "2024-10-31", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-10-31 00:00:00", "acceptedDate": "2024-10-31 17:57:46", "formType": "4/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000098/0000200406-24-000098-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000098/xslF345X05/wk-form4a_1730411857.xml"}}
{"date": "2024-10-23", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-10-23 00:00:00", "acceptedDate": "2024-10-23 16:02:27", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/0000200406-24-000096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/jnj-20240929.htm"}}
{"date": "2024-10-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-10-21 00:00:00", "acceptedDate": "2024-10-21 18:18:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000090/0000200406-24-000090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000090/xslF345X05/wk-form4_1729549096.xml"}}
{"date": "2024-10-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-10-18 00:00:00", "acceptedDate": "2024-10-18 17:23:54", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000538/0000904454-24-000538-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000538/s13g_093024-rapportthera.htm"}}
{"date": "2024-10-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-10-18 00:00:00", "acceptedDate": "2024-10-18 16:47:58", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000536/0000904454-24-000536-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000536/s13g_101524-meiragtx.htm"}}
{"date": "2024-10-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-10-15 00:00:00", "acceptedDate": "2024-10-15 16:39:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824009300/0001225208-24-009300-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824009300/xslF345X05/doc4.xml"}}
{"date": "2024-10-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-10-15 00:00:00", "acceptedDate": "2024-10-15 07:37:20", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000088/0000200406-24-000088-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000088/a2024q3exhibit991.htm"}}
{"date": "2024-10-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-10-09 00:00:00", "acceptedDate": "2024-10-09 17:07:15", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000086/0000200406-24-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000086/xslF345X02/wk-form3_1728508028.xml"}}
{"date": "2024-09-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-09-20 00:00:00", "acceptedDate": "2024-09-20 16:19:26", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000083/0000200406-24-000083-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000083/a2024q3exhibit991talc1.htm"}}
{"date": "2024-09-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-09-12 00:00:00", "acceptedDate": "2024-09-12 16:44:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824008647/0001225208-24-008647-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824008647/xslF345X05/doc4.xml"}}
{"date": "2024-09-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-09-12 00:00:00", "acceptedDate": "2024-09-12 16:43:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824008646/0001225208-24-008646-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824008646/xslF345X05/doc4.xml"}}
{"date": "2024-09-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-09-10 00:00:00", "acceptedDate": "2024-09-10 16:26:10", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000081/0000200406-24-000081-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000081/0000200406-24-000081.txt"}}
{"date": "2024-09-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-09-03 00:00:00", "acceptedDate": "2024-09-03 16:48:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824008326/0001225208-24-008326-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824008326/xslF345X05/doc4.xml"}}
{"date": "2024-08-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-08-29 00:00:00", "acceptedDate": "2024-08-29 14:05:30", "formType": "N-PX", "link": "https://www.sec.gov/Archives/edgar/data/200406/000102140824005775/0001021408-24-005775-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000102140824005775/xslN-PX_X01/primary_doc.xml"}}
{"date": "2024-08-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-08-26 00:00:00", "acceptedDate": "2024-08-26 16:26:20", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000079/0000200406-24-000079-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000079/exhibit991-pressreleasefas.htm"}}
{"date": "2024-08-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-08-09 00:00:00", "acceptedDate": "2024-08-09 16:35:52", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000451/0000904454-24-000451-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000451/infotable.xml"}}
{"date": "2024-07-30", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-07-30 00:00:00", "acceptedDate": "2024-07-30 21:06:36", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000439/0000904454-24-000439-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000439/rallybiosch13gforjjdc.htm"}}
{"date": "2024-07-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-07-25 00:00:00", "acceptedDate": "2024-07-25 16:02:29", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/0000200406-24-000075-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/jnj-20240630.htm"}}
{"date": "2024-07-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-07-17 00:00:00", "acceptedDate": "2024-07-17 08:14:26", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000071/0000200406-24-000071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000071/a2024q2exhibit991.htm"}}
{"date": "2024-07-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-07-09 00:00:00", "acceptedDate": "2024-07-09 17:48:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824007379/0001225208-24-007379-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824007379/xslF345X05/doc4.xml"}}
{"date": "2024-06-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-06-25 00:00:00", "acceptedDate": "2024-06-25 16:18:30", "formType": "11-K/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000067/0000200406-24-000067-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000067/amendment2023form11-kaxjjs.htm"}}
{"date": "2024-06-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-06-24 00:00:00", "acceptedDate": "2024-06-24 16:43:49", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000065/0000200406-24-000065-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000065/a2023form11-kxjjretirement.htm"}}
{"date": "2024-06-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-06-24 00:00:00", "acceptedDate": "2024-06-24 16:42:41", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000063/0000200406-24-000063-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000063/a2023form11-kxjjsavingsplan.htm"}}
{"date": "2024-06-06", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-06-06 00:00:00", "acceptedDate": "2024-06-06 17:07:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824006708/0001225208-24-006708-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824006708/xslF345X05/doc4.xml"}}
{"date": "2024-06-06", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-06-06 00:00:00", "acceptedDate": "2024-06-06 17:07:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824006707/0001225208-24-006707-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824006707/xslF345X05/doc4.xml"}}
{"date": "2024-05-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-28 00:00:00", "acceptedDate": "2024-05-28 16:10:27", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000059/0000200406-24-000059-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000059/coverformsd2023.htm"}}
{"date": "2024-05-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-21 00:00:00", "acceptedDate": "2024-05-21 10:43:01", "formType": "CERT", "link": "https://www.sec.gov/Archives/edgar/data/200406/000087666124000375/0000876661-24-000375-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000087666124000375/JNJ3236A44052124.pdf"}}
{"date": "2024-05-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-20 00:00:00", "acceptedDate": "2024-05-20 17:17:51", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000345/0000904454-24-000345-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000345/s13ga_051724-kenvue.htm"}}
{"date": "2024-05-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-20 00:00:00", "acceptedDate": "2024-05-20 16:34:50", "formType": "8-A12B", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524142900/0001193125-24-142900-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524142900/d799580d8a12b.htm"}}
{"date": "2024-05-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-20 00:00:00", "acceptedDate": "2024-05-20 16:01:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524142828/0001193125-24-142828-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524142828/d746288dex11.htm"}}
{"date": "2024-05-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-20 00:00:00", "acceptedDate": "2024-05-20 09:31:36", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/200406/000087666124000368/0000876661-24-000368-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000087666124000368/xslF25X02/primary_doc.xml"}}
{"date": "2024-05-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-17 00:00:00", "acceptedDate": "2024-05-17 11:21:36", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000053/0000200406-24-000053-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000053/0000200406-24-000053.txt"}}
{"date": "2024-05-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-16 00:00:00", "acceptedDate": "2024-05-16 16:16:35", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524140574/0001193125-24-140574-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524140574/d838744d424b2.htm"}}
{"date": "2024-05-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-15 00:00:00", "acceptedDate": "2024-05-15 16:09:24", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524139370/0001193125-24-139370-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524139370/d811802d424b2.htm"}}
{"date": "2024-05-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-14 00:00:00", "acceptedDate": "2024-05-14 17:01:04", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524138346/0001193125-24-138346-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524138346/d838744dfwp.htm"}}
{"date": "2024-05-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-14 00:00:00", "acceptedDate": "2024-05-14 06:05:42", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524137660/0001193125-24-137660-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524137660/d838744d424b5.htm"}}
{"date": "2024-05-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-14 00:00:00", "acceptedDate": "2024-05-13 18:06:56", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524137391/0001193125-24-137391-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524137391/d811802dfwp.htm"}}
{"date": "2024-05-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-13 00:00:00", "acceptedDate": "2024-05-13 08:36:43", "formType": "424B5", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524136756/0001193125-24-136756-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524136756/d811802d424b5.htm"}}
{"date": "2024-05-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-10 00:00:00", "acceptedDate": "2024-05-10 17:14:19", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000285/0000904454-24-000285-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000285/infotable.xml"}}
{"date": "2024-05-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-03 00:00:00", "acceptedDate": "2024-05-03 16:31:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005567/0001225208-24-005567-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005567/xslF345X05/doc4.xml"}}
{"date": "2024-05-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-01 00:00:00", "acceptedDate": "2024-05-01 07:09:36", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/0000200406-24-000049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/jnj-20240331.htm"}}
{"date": "2024-05-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-05-01 00:00:00", "acceptedDate": "2024-05-01 07:00:25", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000048/0000200406-24-000048-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000048/a2024q1exhibit9912.htm"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:06:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005338/0001225208-24-005338-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005338/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:06:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005337/0001225208-24-005337-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005337/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:06:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005334/0001225208-24-005334-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005334/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:06:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005336/0001225208-24-005336-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005336/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:06:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005335/0001225208-24-005335-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005335/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:06:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005332/0001225208-24-005332-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005332/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:06:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005333/0001225208-24-005333-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005333/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:06:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005331/0001225208-24-005331-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005331/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:05:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005330/0001225208-24-005330-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005330/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:05:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005329/0001225208-24-005329-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005329/xslF345X05/doc4.xml"}}
{"date": "2024-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-29 00:00:00", "acceptedDate": "2024-04-29 17:05:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005328/0001225208-24-005328-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824005328/xslF345X05/doc4.xml"}}
{"date": "2024-04-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-16 00:00:00", "acceptedDate": "2024-04-16 12:16:27", "formType": "8-K/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000036/0000200406-24-000036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000036/jnj-20240416.htm"}}
{"date": "2024-04-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-16 00:00:00", "acceptedDate": "2024-04-16 07:06:41", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000031/0000200406-24-000031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000031/a2024q1exhibit991.htm"}}
{"date": "2024-04-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-10 00:00:00", "acceptedDate": "2024-04-10 17:12:55", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000255/0000904454-24-000255-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000255/s13g_040924-contineum.htm"}}
{"date": "2024-04-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-10 00:00:00", "acceptedDate": "2024-04-10 17:05:42", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000253/0000904454-24-000253-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000253/xslF345X02/ownership.xml"}}
{"date": "2024-04-05", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-04-05 00:00:00", "acceptedDate": "2024-04-05 17:29:30", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524088685/0001193125-24-088685-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524088685/d810145ddfan14a.htm"}}
{"date": "2024-03-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-27 00:00:00", "acceptedDate": "2024-03-27 09:48:39", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000109690624000603/0001096906-24-000603-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000109690624000603/nlpc_px14a6g.htm"}}
{"date": "2024-03-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-13 00:00:00", "acceptedDate": "2024-03-13 16:36:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824004185/0001225208-24-004185-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824004185/xslF345X05/doc4.xml"}}
{"date": "2024-03-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-13 00:00:00", "acceptedDate": "2024-03-13 07:42:43", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/200406/000130817924000109/0001308179-24-000109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000130817924000109/jnj4244661-ars.pdf"}}
{"date": "2024-03-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-13 00:00:00", "acceptedDate": "2024-03-13 07:39:15", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000028/0000200406-24-000028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000028/a2024jnjdefa14a-additional.htm"}}
{"date": "2024-03-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-13 00:00:00", "acceptedDate": "2024-03-13 07:37:32", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000026/0000200406-24-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000026/a2024jnjdefa14a-amendmentf.htm"}}
{"date": "2024-03-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-13 00:00:00", "acceptedDate": "2024-03-13 07:35:57", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000024/0000200406-24-000024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000024/jnj-20240311.htm"}}
{"date": "2024-03-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-07 00:00:00", "acceptedDate": "2024-03-07 16:58:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824003853/0001225208-24-003853-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824003853/xslF345X05/doc4.xml"}}
{"date": "2024-03-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-07 00:00:00", "acceptedDate": "2024-03-07 16:58:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824003852/0001225208-24-003852-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824003852/xslF345X05/doc4.xml"}}
{"date": "2024-03-06", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-03-06 00:00:00", "acceptedDate": "2024-03-06 15:42:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/0000950170-24-027095-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000095017024027095/xslF345X05/ownership.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:58:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002536/0001225208-24-002536-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002536/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:56:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002537/0001225208-24-002537-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002537/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:56:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002535/0001225208-24-002535-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002535/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:55:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002532/0001225208-24-002532-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002532/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:55:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002533/0001225208-24-002533-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002533/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:55:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002534/0001225208-24-002534-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002534/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:55:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002538/0001225208-24-002538-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002538/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:55:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002531/0001225208-24-002531-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002531/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:54:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002529/0001225208-24-002529-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002529/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:54:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002528/0001225208-24-002528-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002528/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:54:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002530/0001225208-24-002530-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002530/xslF345X05/doc4.xml"}}
{"date": "2024-02-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 17:54:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002527/0001225208-24-002527-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002527/xslF345X05/doc4.xml"}}
{"date": "2024-02-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-16 00:00:00", "acceptedDate": "2024-02-16 16:12:22", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/jnj-20231231.htm"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 17:23:00", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524037665/0001193125-24-037665-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524037665/d773015ddfan14a.htm"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002183/0001225208-24-002183-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002183/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002182/0001225208-24-002182-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002182/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002181/0001225208-24-002181-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002181/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002180/0001225208-24-002180-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002180/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002179/0001225208-24-002179-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002179/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002176/0001225208-24-002176-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002176/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002178/0001225208-24-002178-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002178/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002175/0001225208-24-002175-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002175/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002174/0001225208-24-002174-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002174/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002177/0001225208-24-002177-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002177/xslF345X05/doc4.xml"}}
{"date": "2024-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-15 00:00:00", "acceptedDate": "2024-02-15 16:53:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002173/0001225208-24-002173-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002173/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002105/0001225208-24-002105-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002105/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002100/0001225208-24-002100-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002100/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002104/0001225208-24-002104-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002104/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002099/0001225208-24-002099-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002099/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002103/0001225208-24-002103-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002103/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002098/0001225208-24-002098-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002098/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002102/0001225208-24-002102-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002102/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002097/0001225208-24-002097-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002097/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002101/0001225208-24-002101-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002101/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002096/0001225208-24-002096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002096/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 18:36:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002095/0001225208-24-002095-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824002095/xslF345X05/doc4.xml"}}
{"date": "2024-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-13 17:46:56", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000151/0000904454-24-000151-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000151/infotable.xml"}}
{"date": "2024-02-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-13 00:00:00", "acceptedDate": "2024-02-13 17:18:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001953/0001225208-24-001953-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001953/xslF345X05/doc4.xml"}}
{"date": "2024-02-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-13 00:00:00", "acceptedDate": "2024-02-13 17:18:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001952/0001225208-24-001952-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001952/xslF345X05/doc4.xml"}}
{"date": "2024-02-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-13 00:00:00", "acceptedDate": "2024-02-13 17:07:58", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000110465924021263/0001104659-24-021263-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465924021263/tv01257-johnsonjohnson.htm"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:25:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001900/0001225208-24-001900-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001900/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:25:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001896/0001225208-24-001896-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001896/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:25:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001899/0001225208-24-001899-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001899/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:25:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001898/0001225208-24-001898-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001898/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:24:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001895/0001225208-24-001895-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001895/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:24:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001897/0001225208-24-001897-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001897/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:24:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001894/0001225208-24-001894-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001894/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:24:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001893/0001225208-24-001893-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001893/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:24:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001892/0001225208-24-001892-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001892/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:24:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001891/0001225208-24-001891-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001891/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 19:24:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001890/0001225208-24-001890-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520824001890/xslF345X05/doc4.xml"}}
{"date": "2024-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 16:19:15", "formType": "3/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000120919124003091/0001209191-24-003091-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000120919124003091/xslF345X02/doc3a.xml"}}
{"date": "2024-02-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 17:07:42", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000096/0000904454-24-000096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000096/s13ga_012224-biomxinc.htm"}}
{"date": "2024-02-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:52:17", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000094/0000904454-24-000094-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000094/s13ga_123123-cvrx.htm"}}
{"date": "2024-02-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:32:27", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000092/0000904454-24-000092-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000092/s13ga_011924-nanobiotix.htm"}}
{"date": "2024-01-30", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-01-30 00:00:00", "acceptedDate": "2024-01-30 12:46:49", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000009375124000440/0000093751-24-000440-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/93751/000009375124000440/Johnson_and_Johnson.txt"}}
{"date": "2024-01-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-01-29 00:00:00", "acceptedDate": "2024-01-29 16:50:59", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524018226/0001193125-24-018226-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524018226/d747059ddfan14a.htm"}}
{"date": "2024-01-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-01-26 00:00:00", "acceptedDate": "2024-01-26 11:49:38", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000108636424004277/0001086364-24-004277-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000108636424004277/us4781601046_012624.txt"}}
{"date": "2024-01-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-01-24 00:00:00", "acceptedDate": "2024-01-24 12:51:33", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000049/0000904454-24-000049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000049/s13g_011924-kenvue.htm"}}
{"date": "2024-01-23", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-01-23 00:00:00", "acceptedDate": "2024-01-23 07:45:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000004/0000200406-24-000004-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000004/a2023q4exhibit991.htm"}}
{"date": "2024-01-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-01-09 00:00:00", "acceptedDate": "2024-01-09 17:08:26", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524005285/0001193125-24-005285-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524005285/d706492ddfan14a.htm"}}
{"date": "2024-01-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-01-08 00:00:00", "acceptedDate": "2024-01-08 17:22:27", "formType": "DFAN14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524004564/0001193125-24-004564-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524004564/d871430ddfan14a.htm"}}
{"date": "2024-01-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2024-01-08 00:00:00", "acceptedDate": "2024-01-08 08:22:25", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312524003957/0001193125-24-003957-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312524003957/d653837ddefa14a.htm"}}
{"date": "2023-12-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-12-08 00:00:00", "acceptedDate": "2023-12-08 16:33:16", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823010901/0001225208-23-010901-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823010901/xslF345X02/doc3.xml"}}
{"date": "2023-12-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-12-07 00:00:00", "acceptedDate": "2023-12-07 17:17:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823010867/0001225208-23-010867-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823010867/xslF345X05/doc4.xml"}}
{"date": "2023-12-05", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-12-05 00:00:00", "acceptedDate": "2023-12-05 16:42:08", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000115/0000200406-23-000115-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000115/pressrelease_ewoodsxfinal.htm"}}
{"date": "2023-12-05", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-12-05 00:00:00", "acceptedDate": "2023-12-05 07:52:19", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000112/0000200406-23-000112-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000112/ebrpressrelease.htm"}}
{"date": "2023-11-30", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-11-30 00:00:00", "acceptedDate": "2023-11-30 16:30:38", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000109/0000200406-23-000109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000109/exhibit991-pressrelease.htm"}}
{"date": "2023-11-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-11-27 00:00:00", "acceptedDate": "2023-11-27 16:56:47", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000105/0000200406-23-000105-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000105/exh101jjdeferredcompensati.htm"}}
{"date": "2023-11-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-11-09 00:00:00", "acceptedDate": "2023-11-09 16:40:00", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000600/0000904454-23-000600-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000600/infotable.xml"}}
{"date": "2023-11-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-11-02 00:00:00", "acceptedDate": "2023-11-02 16:36:47", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823009908/0001225208-23-009908-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823009908/xslF345X02/doc3.xml"}}
{"date": "2023-10-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-10-27 00:00:00", "acceptedDate": "2023-10-27 16:11:34", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/0000200406-23-000102-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/jnj-20231001.htm"}}
{"date": "2023-10-23", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-10-23 00:00:00", "acceptedDate": "2023-10-23 16:48:39", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000096/0000200406-23-000096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000096/a1023238-kexhibit991.htm"}}
{"date": "2023-10-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-10-17 00:00:00", "acceptedDate": "2023-10-17 07:33:25", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000094/0000200406-23-000094-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000094/a2023q3exhibit991.htm"}}
{"date": "2023-09-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-09-11 00:00:00", "acceptedDate": "2023-09-11 16:36:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008842/0001225208-23-008842-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008842/xslF345X05/doc4.xml"}}
{"date": "2023-08-30", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-30 00:00:00", "acceptedDate": "2023-08-30 07:46:49", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000091/0000200406-23-000091-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000091/post-splitguidanceex991.htm"}}
{"date": "2023-08-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-25 00:00:00", "acceptedDate": "2023-08-25 17:02:47", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000086/0000200406-23-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000086/0000200406-23-000086.txt"}}
{"date": "2023-08-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-25 00:00:00", "acceptedDate": "2023-08-25 16:53:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030660/0001628280-23-030660-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030660/xslF345X05/wk-form4_1692996787.xml"}}
{"date": "2023-08-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-25 00:00:00", "acceptedDate": "2023-08-25 16:07:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008460/0001225208-23-008460-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008460/xslF345X05/doc4.xml"}}
{"date": "2023-08-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-25 00:00:00", "acceptedDate": "2023-08-25 16:07:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008459/0001225208-23-008459-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008459/xslF345X05/doc4.xml"}}
{"date": "2023-08-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-25 00:00:00", "acceptedDate": "2023-08-25 16:07:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008462/0001225208-23-008462-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008462/xslF345X05/doc4.xml"}}
{"date": "2023-08-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-25 00:00:00", "acceptedDate": "2023-08-25 16:07:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008461/0001225208-23-008461-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008461/xslF345X05/doc4.xml"}}
{"date": "2023-08-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-25 00:00:00", "acceptedDate": "2023-08-25 16:07:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008458/0001225208-23-008458-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823008458/xslF345X05/doc4.xml"}}
{"date": "2023-08-23", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-23 00:00:00", "acceptedDate": "2023-08-23 07:04:15", "formType": "SC TO-I/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030300/0001628280-23-030300-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030300/jjscto-ia4.htm"}}
{"date": "2023-08-23", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-23 00:00:00", "acceptedDate": "2023-08-23 06:37:44", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030298/0001628280-23-030298-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030298/a425-pressrelease08232023.htm"}}
{"date": "2023-08-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-21 00:00:00", "acceptedDate": "2023-08-21 06:52:24", "formType": "SC TO-I/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030044/0001628280-23-030044-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030044/jjscto-ia3.htm"}}
{"date": "2023-08-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-21 00:00:00", "acceptedDate": "2023-08-21 06:38:36", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030039/0001628280-23-030039-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030039/pre-marketpressrelease425x.htm"}}
{"date": "2023-08-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-18 00:00:00", "acceptedDate": "2023-08-18 17:11:19", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030009/0001628280-23-030009-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023030009/vwapday20.htm"}}
{"date": "2023-08-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-17 00:00:00", "acceptedDate": "2023-08-17 16:53:29", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029851/0001628280-23-029851-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029851/vwapday19.htm"}}
{"date": "2023-08-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-17 00:00:00", "acceptedDate": "2023-08-17 06:23:24", "formType": "SC TO-I/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029731/0001628280-23-029731-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029731/jjscto-ia2.htm"}}
{"date": "2023-08-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-17 00:00:00", "acceptedDate": "2023-08-16 21:22:22", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029728/0001628280-23-029728-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029728/vwapday18-2.htm"}}
{"date": "2023-08-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-17 00:00:00", "acceptedDate": "2023-08-16 19:08:28", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029703/0001628280-23-029703-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029703/jj425pressrelease8162023.htm"}}
{"date": "2023-08-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-16 00:00:00", "acceptedDate": "2023-08-16 16:43:46", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029676/0001628280-23-029676-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029676/vwapday18.htm"}}
{"date": "2023-08-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-15 00:00:00", "acceptedDate": "2023-08-15 16:43:02", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029573/0001628280-23-029573-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029573/vwapday17.htm"}}
{"date": "2023-08-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-14 00:00:00", "acceptedDate": "2023-08-14 16:44:47", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029421/0001628280-23-029421-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029421/vwapday16.htm"}}
{"date": "2023-08-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-11 00:00:00", "acceptedDate": "2023-08-11 16:51:06", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029104/0001628280-23-029104-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023029104/vwapday15.htm"}}
{"date": "2023-08-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-10 00:00:00", "acceptedDate": "2023-08-10 16:47:54", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023028908/0001628280-23-028908-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023028908/vwapday14.htm"}}
{"date": "2023-08-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-09 00:00:00", "acceptedDate": "2023-08-09 16:38:27", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023028617/0001628280-23-028617-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023028617/vwapday13.htm"}}
{"date": "2023-08-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-08 00:00:00", "acceptedDate": "2023-08-08 16:45:12", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023028238/0001628280-23-028238-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023028238/vwapday12.htm"}}
{"date": "2023-08-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-07 00:00:00", "acceptedDate": "2023-08-07 16:43:04", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027810/0001628280-23-027810-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027810/vwapday11.htm"}}
{"date": "2023-08-04", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-04 00:00:00", "acceptedDate": "2023-08-04 16:32:03", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027551/0001628280-23-027551-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027551/vwapday10.htm"}}
{"date": "2023-08-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-03 00:00:00", "acceptedDate": "2023-08-03 16:39:24", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027300/0001628280-23-027300-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027300/vwapday9.htm"}}
{"date": "2023-08-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-03 00:00:00", "acceptedDate": "2023-08-03 16:16:27", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027240/0001628280-23-027240-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027240/jj-425informationagenttalk.htm"}}
{"date": "2023-08-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-03 00:00:00", "acceptedDate": "2023-08-03 08:03:51", "formType": "SC TO-I/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027025/0001628280-23-027025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023027025/jjscto-ia.htm"}}
{"date": "2023-08-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-02 00:00:00", "acceptedDate": "2023-08-02 16:41:55", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026804/0001628280-23-026804-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026804/vwapday8.htm"}}
{"date": "2023-08-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-02 00:00:00", "acceptedDate": "2023-08-02 14:57:03", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000459/0000904454-23-000459-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000459/infotable.xml"}}
{"date": "2023-08-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-08-01 00:00:00", "acceptedDate": "2023-08-01 16:39:03", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026471/0001628280-23-026471-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026471/vwapday7.htm"}}
{"date": "2023-07-31", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-31 00:00:00", "acceptedDate": "2023-07-31 16:38:18", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026255/0001628280-23-026255-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026255/vwapday6.htm"}}
{"date": "2023-07-31", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-31 00:00:00", "acceptedDate": "2023-07-31 16:06:04", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/0000200406-23-000082-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/jnj-20230702.htm"}}
{"date": "2023-07-31", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-31 00:00:00", "acceptedDate": "2023-07-28 20:59:40", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026169/0001628280-23-026169-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026169/jj425-shareholderfaqrefi.htm"}}
{"date": "2023-07-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-28 00:00:00", "acceptedDate": "2023-07-28 16:40:09", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026111/0001628280-23-026111-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026111/vwapday5.htm"}}
{"date": "2023-07-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-28 00:00:00", "acceptedDate": "2023-07-28 16:12:33", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026100/0001628280-23-026100-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026100/jj425-kenvuesavingsplans.htm"}}
{"date": "2023-07-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-28 00:00:00", "acceptedDate": "2023-07-28 16:10:24", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026098/0001628280-23-026098-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026098/jj425-retireeportalposting.htm"}}
{"date": "2023-07-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-28 00:00:00", "acceptedDate": "2023-07-28 16:09:34", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026096/0001628280-23-026096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026096/jj8-k07282023.htm"}}
{"date": "2023-07-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-28 00:00:00", "acceptedDate": "2023-07-28 16:08:43", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026095/0001628280-23-026095-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026095/exhibit991-8xk072823.htm"}}
{"date": "2023-07-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-27 00:00:00", "acceptedDate": "2023-07-27 17:52:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823007708/0001225208-23-007708-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823007708/xslF345X05/doc4.xml"}}
{"date": "2023-07-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-27 00:00:00", "acceptedDate": "2023-07-27 17:52:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823007707/0001225208-23-007707-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823007707/xslF345X05/doc4.xml"}}
{"date": "2023-07-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-27 00:00:00", "acceptedDate": "2023-07-27 16:42:00", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025948/0001628280-23-025948-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025948/vwapday4.htm"}}
{"date": "2023-07-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-27 00:00:00", "acceptedDate": "2023-07-27 16:22:05", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025933/0001628280-23-025933-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025933/jj-425finalseparationleade.htm"}}
{"date": "2023-07-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-26 00:00:00", "acceptedDate": "2023-07-26 16:41:55", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025738/0001628280-23-025738-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025738/vwapday3.htm"}}
{"date": "2023-07-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-26 00:00:00", "acceptedDate": "2023-07-26 16:05:52", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025706/0001628280-23-025706-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025706/jj-425updatedfaq.htm"}}
{"date": "2023-07-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-25 00:00:00", "acceptedDate": "2023-07-25 17:02:35", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025598/0001628280-23-025598-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025598/vwapday2.htm"}}
{"date": "2023-07-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-25 00:00:00", "acceptedDate": "2023-07-25 16:10:38", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025580/0001628280-23-025580-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025580/kenvue425-kenvuesavingsp.htm"}}
{"date": "2023-07-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-25 00:00:00", "acceptedDate": "2023-07-25 16:09:39", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025578/0001628280-23-025578-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025578/kenvue425-roadshowpresen.htm"}}
{"date": "2023-07-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-25 00:00:00", "acceptedDate": "2023-07-25 16:08:25", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025576/0001628280-23-025576-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025576/kenvue425-day2postxroadsho.htm"}}
{"date": "2023-07-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-25 00:00:00", "acceptedDate": "2023-07-25 16:07:10", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025575/0001628280-23-025575-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025575/jj425-day2xsavingsplans.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:51:49", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025480/0001628280-23-025480-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025480/vwapday1.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:07:44", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025460/0001628280-23-025460-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025460/jj425-day1xmessageonfory.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:05:56", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025458/0001628280-23-025458-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025458/jjltiwithpsuupdate.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:05:50", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025457/0001628280-23-025457-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025457/jj425-day1xbenefitservic.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:05:37", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025456/0001628280-23-025456-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025456/kenvue425-kenvuebenefits.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:05:25", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025455/0001628280-23-025455-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025455/jj425-day1xlticonversion.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:05:19", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025454/0001628280-23-025454-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025454/jj425day1-shareholderfaq.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:04:54", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025453/0001628280-23-025453-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025453/jj425-day1xltifinalsepar.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:04:47", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025451/0001628280-23-025451-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025451/jj425-day1xltionexpagerw.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:04:37", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025449/0001628280-23-025449-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025449/kenvue425-messageonforyo.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:04:29", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025448/0001628280-23-025448-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025448/jjltinopsueml.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 16:04:16", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025447/0001628280-23-025447-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025447/jj425-day1xltionepagerwp.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 08:41:00", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025399/0001628280-23-025399-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025399/jj425-day1prexallemploye.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 08:40:09", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025398/0001628280-23-025398-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025398/jj425-prehomearticleunde.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 08:28:10", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025397/0001628280-23-025397-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025397/kenvue425-day1prextop500.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 08:27:30", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025396/0001628280-23-025396-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025396/kenvue425-day1prexallken.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 08:27:03", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025395/0001628280-23-025395-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025395/kenvue425-day1prexvueart.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 07:09:28", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025394/0001628280-23-025394-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025394/kenvue425-prepressrelease.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 07:01:35", "formType": "SC TO-I", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025393/0001628280-23-025393-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025393/scheduleto.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 06:23:49", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025389/0001628280-23-025389-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025389/jj425-prepressrelease.htm"}}
{"date": "2023-07-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 06:20:54", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025388/0001628280-23-025388-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025388/exhibit991-8xk.htm"}}
{"date": "2023-07-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-20 00:00:00", "acceptedDate": "2023-07-20 17:05:04", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025263/0001628280-23-025263-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025263/kenvue425filing.htm"}}
{"date": "2023-07-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-20 00:00:00", "acceptedDate": "2023-07-20 17:02:34", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025261/0001628280-23-025261-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025261/jj-425xlinkedinpost.htm"}}
{"date": "2023-07-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-20 00:00:00", "acceptedDate": "2023-07-20 17:01:58", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025259/0001628280-23-025259-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025259/jj-425xbeyondthenumbers.htm"}}
{"date": "2023-07-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-20 00:00:00", "acceptedDate": "2023-07-20 17:01:39", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025258/0001628280-23-025258-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025258/jj-425xearningsscript.htm"}}
{"date": "2023-07-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-20 00:00:00", "acceptedDate": "2023-07-20 17:01:13", "formType": "425", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025257/0001628280-23-025257-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025257/jj-425xearningsrelease.htm"}}
{"date": "2023-07-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-07-20 00:00:00", "acceptedDate": "2023-07-20 07:15:55", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000073/0000200406-23-000073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000073/a2023q2exhibit991.htm"}}
{"date": "2023-06-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-06-26 00:00:00", "acceptedDate": "2023-06-26 16:39:14", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000071/0000200406-23-000071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000071/a2022form11-kxjjretirement.htm"}}
{"date": "2023-06-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-06-26 00:00:00", "acceptedDate": "2023-06-26 16:38:36", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000070/0000200406-23-000070-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000070/a2022form11-kxjjsavingsplan.htm"}}
{"date": "2023-06-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-06-14 00:00:00", "acceptedDate": "2023-06-14 16:19:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823006820/0001225208-23-006820-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823006820/xslF345X04/doc4.xml"}}
{"date": "2023-06-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-06-12 00:00:00", "acceptedDate": "2023-06-12 10:21:26", "formType": "144", "link": "https://www.sec.gov/Archives/edgar/data/200406/000195917323001782/0001959173-23-001782-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000195917323001782/primary_doc.xml"}}
{"date": "2023-06-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-06-08 00:00:00", "acceptedDate": "2023-06-08 16:10:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823006636/0001225208-23-006636-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823006636/xslF345X04/doc4.xml"}}
{"date": "2023-05-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-25 00:00:00", "acceptedDate": "2023-05-25 16:52:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823006233/0001225208-23-006233-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823006233/xslF345X04/doc4.xml"}}
{"date": "2023-05-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-24 00:00:00", "acceptedDate": "2023-05-24 15:59:42", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000063/0000200406-23-000063-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000063/coverformsd2022.htm"}}
{"date": "2023-05-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-11 00:00:00", "acceptedDate": "2023-05-11 10:58:57", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000307/0000904454-23-000307-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000307/infotable.xml"}}
{"date": "2023-05-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-10 00:00:00", "acceptedDate": "2023-05-10 16:18:57", "formType": "3/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005666/0001225208-23-005666-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005666/xslF345X02/doc3a.xml"}}
{"date": "2023-05-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-08 00:00:00", "acceptedDate": "2023-05-08 16:23:05", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312523138287/0001193125-23-138287-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312523138287/d301195dex101.htm"}}
{"date": "2023-05-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 16:16:46", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000162828023015225/0001628280-23-015225-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000162828023015225/xslF345X02/wf-form3_168314498390839.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005258/0001225208-23-005258-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005258/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005257/0001225208-23-005257-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005257/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005256/0001225208-23-005256-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005256/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005255/0001225208-23-005255-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005255/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005252/0001225208-23-005252-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005252/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005251/0001225208-23-005251-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005251/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005254/0001225208-23-005254-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005254/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005253/0001225208-23-005253-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005253/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005250/0001225208-23-005250-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005250/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:21:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005249/0001225208-23-005249-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005249/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:20:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005248/0001225208-23-005248-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005248/xslF345X04/doc4.xml"}}
{"date": "2023-05-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-02 00:00:00", "acceptedDate": "2023-05-02 17:20:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005247/0001225208-23-005247-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823005247/xslF345X04/doc4.xml"}}
{"date": "2023-05-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-05-01 00:00:00", "acceptedDate": "2023-04-28 18:14:54", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000059/0000200406-23-000059-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000059/jnj-20230427.htm"}}
{"date": "2023-04-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-28 00:00:00", "acceptedDate": "2023-04-28 16:07:02", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/0000200406-23-000056-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/jnj-20230402.htm"}}
{"date": "2023-04-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 17:20:36", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000047/0000200406-23-000047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000047/defa14a-removalofshproposa.htm"}}
{"date": "2023-04-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-18 00:00:00", "acceptedDate": "2023-04-18 07:29:50", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000043/0000200406-23-000043-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000043/a2023q1exhibit991.htm"}}
{"date": "2023-04-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-13 00:00:00", "acceptedDate": "2023-04-13 17:10:32", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823004834/0001225208-23-004834-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823004834/xslF345X02/doc3.xml"}}
{"date": "2023-04-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-13 00:00:00", "acceptedDate": "2023-04-12 18:15:04", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000039/0000200406-23-000039-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000039/a2023jnjdefa14aletterfroma.htm"}}
{"date": "2023-04-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-12 00:00:00", "acceptedDate": "2023-04-12 09:01:57", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465923005237/0001214659-23-005237-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465923005237/d412230px14a6g.htm"}}
{"date": "2023-04-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-10 00:00:00", "acceptedDate": "2023-04-10 06:00:55", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465923005116/0001214659-23-005116-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465923005116/j47231px14a6g.htm"}}
{"date": "2023-04-04", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-04 00:00:00", "acceptedDate": "2023-04-04 16:12:15", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000037/0000200406-23-000037-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000037/a44238-kexhibit991.htm"}}
{"date": "2023-04-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-03-31 19:29:04", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000032/0000200406-23-000032-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000032/0000200406-23-000032.txt"}}
{"date": "2023-03-28", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-28 00:00:00", "acceptedDate": "2023-03-28 16:35:56", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000028/0000200406-23-000028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000028/a20230317defa14asupplement.htm"}}
{"date": "2023-03-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-21 18:22:13", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465923004067/0001214659-23-004067-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465923004067/b321231px14a6g.htm"}}
{"date": "2023-03-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-16 00:00:00", "acceptedDate": "2023-03-16 16:31:53", "formType": "ARS", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312523072650/0001193125-23-072650-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312523072650/d398151dars.pdf"}}
{"date": "2023-03-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-15 00:00:00", "acceptedDate": "2023-03-15 07:54:24", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000025/0000200406-23-000025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000025/a20230315defa14asupplement.htm"}}
{"date": "2023-03-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-15 00:00:00", "acceptedDate": "2023-03-15 07:53:34", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000024/0000200406-23-000024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000024/a2023jnjdefa14a.htm"}}
{"date": "2023-03-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-15 00:00:00", "acceptedDate": "2023-03-15 07:52:35", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000023/0000200406-23-000023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000023/jnj-20230313.htm"}}
{"date": "2023-03-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-09 00:00:00", "acceptedDate": "2023-03-09 17:41:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823003667/0001225208-23-003667-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823003667/xslF345X03/doc4.xml"}}
{"date": "2023-03-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-09 00:00:00", "acceptedDate": "2023-03-09 17:41:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823003666/0001225208-23-003666-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823003666/xslF345X03/doc4.xml"}}
{"date": "2023-03-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-03-08 00:00:00", "acceptedDate": "2023-03-08 16:16:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823003576/0001225208-23-003576-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823003576/xslF345X03/doc4.xml"}}
{"date": "2023-02-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 12:59:07", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002488/0001225208-23-002488-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002488/xslF345X02/doc3.xml"}}
{"date": "2023-02-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-16 00:00:00", "acceptedDate": "2023-02-16 17:05:32", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312523041171/0001193125-23-041171-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312523041171/d408374ds3asr.htm"}}
{"date": "2023-02-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-16 00:00:00", "acceptedDate": "2023-02-16 16:01:53", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000016/0000200406-23-000016-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000016/jnj-20230101.htm"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:25:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002067/0001225208-23-002067-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002067/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:25:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002066/0001225208-23-002066-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002066/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:25:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002065/0001225208-23-002065-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002065/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:25:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002064/0001225208-23-002064-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002064/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:25:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002063/0001225208-23-002063-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002063/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:24:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002062/0001225208-23-002062-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002062/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:24:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002061/0001225208-23-002061-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002061/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:24:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002060/0001225208-23-002060-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002060/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:24:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002059/0001225208-23-002059-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002059/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:24:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002058/0001225208-23-002058-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002058/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:24:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002057/0001225208-23-002057-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002057/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-15 19:24:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002056/0001225208-23-002056-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823002056/xslF345X03/doc4.xml"}}
{"date": "2023-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-15 00:00:00", "acceptedDate": "2023-02-14 17:55:02", "formType": "8-K/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000011/0000200406-23-000011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000011/jnj-20230214.htm"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:37:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001910/0001225208-23-001910-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001910/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:37:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001909/0001225208-23-001909-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001909/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:36:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001908/0001225208-23-001908-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001908/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:36:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001907/0001225208-23-001907-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001907/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:36:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001906/0001225208-23-001906-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001906/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:35:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001903/0001225208-23-001903-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001903/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:35:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001905/0001225208-23-001905-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001905/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:35:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001904/0001225208-23-001904-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001904/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:35:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001902/0001225208-23-001902-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001902/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:35:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001901/0001225208-23-001901-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001901/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:35:04", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000008/0000200406-23-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000008/pressrelease.htm"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:35:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001900/0001225208-23-001900-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001900/xslF345X03/doc4.xml"}}
{"date": "2023-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:34:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001899/0001225208-23-001899-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823001899/xslF345X03/doc4.xml"}}
{"date": "2023-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-10 00:00:00", "acceptedDate": "2023-02-10 07:53:36", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000009375123000419/0000093751-23-000419-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/93751/000009375123000419/Johnson_and_Johnson.txt"}}
{"date": "2023-02-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-09 00:00:00", "acceptedDate": "2023-02-09 13:18:43", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761923002139/0001567619-23-002139-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761923002139/form13fInfoTable.xml"}}
{"date": "2023-02-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-02-09 00:00:00", "acceptedDate": "2023-02-09 11:25:08", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000110465923016270/0001104659-23-016270-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465923016270/tv01216-johnsonjohnson.htm"}}
{"date": "2023-01-31", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-01-31 00:00:00", "acceptedDate": "2023-01-31 13:58:01", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000130655023005043/0001306550-23-005043-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000130655023005043/us4781601046_013123.txt"}}
{"date": "2023-01-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-01-27 00:00:00", "acceptedDate": "2023-01-27 11:12:26", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000061/0000904454-23-000061-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000061/s13ga_123122-fusion.htm"}}
{"date": "2023-01-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-01-24 00:00:00", "acceptedDate": "2023-01-24 07:44:10", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000005/0000200406-23-000005-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000005/a2022q4exhibit991.htm"}}
{"date": "2023-01-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-01-18 00:00:00", "acceptedDate": "2023-01-18 16:39:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823000735/0001225208-23-000735-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823000735/xslF345X03/doc4.xml"}}
{"date": "2023-01-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-01-18 00:00:00", "acceptedDate": "2023-01-18 16:39:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520823000734/0001225208-23-000734-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520823000734/xslF345X03/doc4.xml"}}
{"date": "2023-01-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2023-01-11 00:00:00", "acceptedDate": "2023-01-11 13:00:18", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000019/0000904454-23-000019-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445423000019/s13ga_123122-protagonthera.htm"}}
{"date": "2022-12-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-22 00:00:00", "acceptedDate": "2022-12-22 16:31:43", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522311072/0001193125-22-311072-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522311072/d428734dex101.htm"}}
{"date": "2022-12-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-22 00:00:00", "acceptedDate": "2022-12-22 09:14:37", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522310626/0001193125-22-310626-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522310626/d434768dsctota.htm"}}
{"date": "2022-12-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-19 00:00:00", "acceptedDate": "2022-12-19 07:33:38", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522307881/0001193125-22-307881-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522307881/d411208dsctota.htm"}}
{"date": "2022-12-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-15 00:00:00", "acceptedDate": "2022-12-15 17:11:34", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522306007/0001193125-22-306007-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522306007/d395835dsctota.htm"}}
{"date": "2022-12-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-15 00:00:00", "acceptedDate": "2022-12-15 16:34:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012842/0001225208-22-012842-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012842/xslF345X03/doc4.xml"}}
{"date": "2022-12-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-14 00:00:00", "acceptedDate": "2022-12-14 07:35:08", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522304358/0001193125-22-304358-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522304358/d411806dsctota.htm"}}
{"date": "2022-12-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-08 00:00:00", "acceptedDate": "2022-12-08 16:45:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012447/0001225208-22-012447-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012447/xslF345X03/doc4.xml"}}
{"date": "2022-12-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-08 00:00:00", "acceptedDate": "2022-12-08 16:45:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012446/0001225208-22-012446-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012446/xslF345X03/doc4.xml"}}
{"date": "2022-12-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-08 00:00:00", "acceptedDate": "2022-12-08 16:45:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012445/0001225208-22-012445-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012445/xslF345X03/doc4.xml"}}
{"date": "2022-12-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-08 00:00:00", "acceptedDate": "2022-12-08 08:03:46", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522300528/0001193125-22-300528-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522300528/d383562dsctota.htm"}}
{"date": "2022-12-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-02 00:00:00", "acceptedDate": "2022-12-02 16:32:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012182/0001225208-22-012182-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822012182/xslF345X03/doc4.xml"}}
{"date": "2022-12-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-12-01 00:00:00", "acceptedDate": "2022-11-30 17:38:34", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000089/0000200406-22-000089-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000089/pressrelease.htm"}}
{"date": "2022-11-23", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-23 00:00:00", "acceptedDate": "2022-11-23 16:44:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011890/0001225208-22-011890-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011890/xslF345X03/doc4.xml"}}
{"date": "2022-11-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-21 00:00:00", "acceptedDate": "2022-11-21 16:33:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011805/0001225208-22-011805-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011805/xslF345X03/doc4.xml"}}
{"date": "2022-11-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-15 00:00:00", "acceptedDate": "2022-11-15 06:38:09", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522285216/0001193125-22-285216-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522285216/d411777dsctot.htm"}}
{"date": "2022-11-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-14 00:00:00", "acceptedDate": "2022-11-14 14:44:59", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000089924322035681/0000899243-22-035681-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000089924322035681/xslF345X02/doc3.xml"}}
{"date": "2022-11-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-14 00:00:00", "acceptedDate": "2022-11-14 14:40:18", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522284369/0001193125-22-284369-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522284369/d381043dsc13ga.htm"}}
{"date": "2022-11-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-10 00:00:00", "acceptedDate": "2022-11-10 16:47:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011585/0001225208-22-011585-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011585/xslF345X03/doc4.xml"}}
{"date": "2022-11-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-10 00:00:00", "acceptedDate": "2022-11-10 16:42:57", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761922019556/0001567619-22-019556-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761922019556/form13fInfoTable.xml"}}
{"date": "2022-11-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-09 00:00:00", "acceptedDate": "2022-11-09 17:01:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011500/0001225208-22-011500-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011500/xslF345X03/doc4.xml"}}
{"date": "2022-11-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-08 00:00:00", "acceptedDate": "2022-11-08 16:59:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011458/0001225208-22-011458-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011458/xslF345X03/doc4.xml"}}
{"date": "2022-11-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-07 00:00:00", "acceptedDate": "2022-11-07 16:49:57", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522279173/0001193125-22-279173-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522279173/d258081dsctoc.htm"}}
{"date": "2022-11-04", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-04 00:00:00", "acceptedDate": "2022-11-04 16:30:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000120919122055807/0001209191-22-055807-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000120919122055807/xslF345X03/doc4.xml"}}
{"date": "2022-11-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-03 00:00:00", "acceptedDate": "2022-11-03 17:00:03", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522276998/0001193125-22-276998-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522276998/d419455dsctoc.htm"}}
{"date": "2022-11-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 17:25:17", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522275080/0001193125-22-275080-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522275080/d377633dsctoc.htm"}}
{"date": "2022-11-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 07:34:02", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522274493/0001193125-22-274493-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522274493/d395813dsctoc.htm"}}
{"date": "2022-11-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 07:30:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522274491/0001193125-22-274491-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522274491/d395813dex21.htm"}}
{"date": "2022-10-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-27 00:00:00", "acceptedDate": "2022-10-27 16:02:59", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/0000200406-22-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/jnj-20221002.htm"}}
{"date": "2022-10-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-26 00:00:00", "acceptedDate": "2022-10-26 19:21:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011145/0001225208-22-011145-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011145/xslF345X03/doc4.xml"}}
{"date": "2022-10-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-26 00:00:00", "acceptedDate": "2022-10-26 19:21:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011144/0001225208-22-011144-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011144/xslF345X03/doc4.xml"}}
{"date": "2022-10-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-26 00:00:00", "acceptedDate": "2022-10-26 19:20:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011143/0001225208-22-011143-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011143/xslF345X03/doc4.xml"}}
{"date": "2022-10-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-26 00:00:00", "acceptedDate": "2022-10-26 19:20:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011142/0001225208-22-011142-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011142/xslF345X03/doc4.xml"}}
{"date": "2022-10-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-26 00:00:00", "acceptedDate": "2022-10-26 19:20:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011141/0001225208-22-011141-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011141/xslF345X03/doc4.xml"}}
{"date": "2022-10-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-26 00:00:00", "acceptedDate": "2022-10-26 19:20:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011140/0001225208-22-011140-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011140/xslF345X03/doc4.xml"}}
{"date": "2022-10-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-26 00:00:00", "acceptedDate": "2022-10-26 16:51:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011139/0001225208-22-011139-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011139/xslF345X03/doc4.xml"}}
{"date": "2022-10-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-26 00:00:00", "acceptedDate": "2022-10-26 16:47:36", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011138/0001225208-22-011138-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011138/xslF345X02/doc3.xml"}}
{"date": "2022-10-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-21 00:00:00", "acceptedDate": "2022-10-21 16:31:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011073/0001225208-22-011073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011073/xslF345X03/doc4.xml"}}
{"date": "2022-10-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-21 00:00:00", "acceptedDate": "2022-10-21 16:31:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011072/0001225208-22-011072-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011072/xslF345X03/doc4.xml"}}
{"date": "2022-10-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-21 00:00:00", "acceptedDate": "2022-10-21 16:31:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011071/0001225208-22-011071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011071/xslF345X03/doc4.xml"}}
{"date": "2022-10-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-21 00:00:00", "acceptedDate": "2022-10-21 16:31:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011070/0001225208-22-011070-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822011070/xslF345X03/doc4.xml"}}
{"date": "2022-10-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-10-18 00:00:00", "acceptedDate": "2022-10-18 07:54:56", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000081/0000200406-22-000081-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000081/jnj-20221018.htm"}}
{"date": "2022-09-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-09-14 00:00:00", "acceptedDate": "2022-09-14 07:10:20", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000076/0000200406-22-000076-index.htm", "finalLink": ""}}
{"date": "2022-09-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-09-08 00:00:00", "acceptedDate": "2022-09-08 16:32:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822010161/0001225208-22-010161-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822010161/xslF345X03/doc4.xml"}}
{"date": "2022-09-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-09-08 00:00:00", "acceptedDate": "2022-09-08 16:31:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822010160/0001225208-22-010160-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822010160/xslF345X03/doc4.xml"}}
{"date": "2022-09-08", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-09-08 00:00:00", "acceptedDate": "2022-09-08 16:31:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822010159/0001225208-22-010159-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822010159/xslF345X03/doc4.xml"}}
{"date": "2022-08-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-08-10 00:00:00", "acceptedDate": "2022-08-10 11:53:38", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761922015421/0001567619-22-015421-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761922015421/form13fInfoTable.xml"}}
{"date": "2022-07-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-07-29 00:00:00", "acceptedDate": "2022-07-29 16:14:39", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/0000200406-22-000071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/jnj-20220703.htm"}}
{"date": "2022-07-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-07-19 00:00:00", "acceptedDate": "2022-07-19 07:59:43", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000063/0000200406-22-000063-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000063/jnj-20220719.htm"}}
{"date": "2022-06-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-06-16 00:00:00", "acceptedDate": "2022-06-16 16:33:24", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000058/0000200406-22-000058-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000058/a2021form11-kxjjretirement.htm"}}
{"date": "2022-06-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-06-16 00:00:00", "acceptedDate": "2022-06-16 16:31:19", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000057/0000200406-22-000057-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000057/a2021form11-kxjjsavingsplan.htm"}}
{"date": "2022-06-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-06-14 00:00:00", "acceptedDate": "2022-06-14 18:28:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822008089/0001225208-22-008089-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822008089/xslF345X03/doc4.xml"}}
{"date": "2022-06-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-06-09 00:00:00", "acceptedDate": "2022-06-09 16:32:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822007895/0001225208-22-007895-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822007895/xslF345X03/doc4.xml"}}
{"date": "2022-06-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-06-09 00:00:00", "acceptedDate": "2022-06-09 16:32:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822007894/0001225208-22-007894-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822007894/xslF345X03/doc4.xml"}}
{"date": "2022-06-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-06-09 00:00:00", "acceptedDate": "2022-06-09 16:32:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822007893/0001225208-22-007893-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822007893/xslF345X03/doc4.xml"}}
{"date": "2022-05-31", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-05-31 00:00:00", "acceptedDate": "2022-05-31 17:21:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822007461/0001225208-22-007461-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822007461/xslF345X03/doc4.xml"}}
{"date": "2022-05-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-05-26 00:00:00", "acceptedDate": "2022-05-26 16:04:46", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000052/0000200406-22-000052-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000052/coverformsd2021.htm"}}
{"date": "2022-05-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-05-09 00:00:00", "acceptedDate": "2022-05-09 17:10:21", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761922009807/0001567619-22-009807-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761922009807/form13fInfoTable.xml"}}
{"date": "2022-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-04-29 00:00:00", "acceptedDate": "2022-04-29 17:22:07", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/200406/000119312522134336/0001193125-22-134336-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000119312522134336/d280310ds8.htm"}}
{"date": "2022-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-04-29 00:00:00", "acceptedDate": "2022-04-29 16:08:24", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/0000200406-22-000048-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/jnj-20220403.htm"}}
{"date": "2022-04-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-04-29 00:00:00", "acceptedDate": "2022-04-29 16:03:29", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000047/0000200406-22-000047-index.htm", "finalLink": ""}}
{"date": "2022-04-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-04-25 00:00:00", "acceptedDate": "2022-04-25 16:33:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822006073/0001225208-22-006073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822006073/xslF345X03/doc4.xml"}}
{"date": "2022-04-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-04-19 00:00:00", "acceptedDate": "2022-04-19 07:56:38", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000038/0000200406-22-000038-index.htm", "finalLink": ""}}
{"date": "2022-04-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-04-01 00:00:00", "acceptedDate": "2022-03-31 19:05:35", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004616/0001214659-22-004616-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004616/b331229px14a6g.htm"}}
{"date": "2022-03-31", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-31 00:00:00", "acceptedDate": "2022-03-31 12:15:28", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004547/0001214659-22-004547-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004547/g331221px14a6g.htm"}}
{"date": "2022-03-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-29 00:00:00", "acceptedDate": "2022-03-28 19:16:56", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004403/0001214659-22-004403-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004403/j328222px14a6g.htm"}}
{"date": "2022-03-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 15:28:01", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004208/0001214659-22-004208-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004208/b322224px14a6g.htm"}}
{"date": "2022-03-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-21 00:00:00", "acceptedDate": "2022-03-21 16:38:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004925/0001225208-22-004925-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004925/xslF345X03/doc4.xml"}}
{"date": "2022-03-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-21 00:00:00", "acceptedDate": "2022-03-21 16:38:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004924/0001225208-22-004924-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004924/xslF345X03/doc4.xml"}}
{"date": "2022-03-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-17 00:00:00", "acceptedDate": "2022-03-17 16:32:02", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000029/0000200406-22-000029-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000029/a20220317defa14asupplement.htm"}}
{"date": "2022-03-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-17 00:00:00", "acceptedDate": "2022-03-17 16:30:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004862/0001225208-22-004862-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004862/xslF345X03/doc4.xml"}}
{"date": "2022-03-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-17 00:00:00", "acceptedDate": "2022-03-16 20:01:40", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004017/0001214659-22-004017-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465922004017/s316211px14a6g.htm"}}
{"date": "2022-03-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-16 00:00:00", "acceptedDate": "2022-03-16 08:13:01", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000027/0000200406-22-000027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000027/jnjdefa14a2022.htm"}}
{"date": "2022-03-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-16 00:00:00", "acceptedDate": "2022-03-16 08:10:56", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000026/0000200406-22-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000026/a2022jnjproxy.htm"}}
{"date": "2022-03-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-09 00:00:00", "acceptedDate": "2022-03-09 17:50:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004418/0001225208-22-004418-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004418/xslF345X03/doc4.xml"}}
{"date": "2022-03-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-09 00:00:00", "acceptedDate": "2022-03-09 17:50:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004417/0001225208-22-004417-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004417/xslF345X03/doc4.xml"}}
{"date": "2022-03-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-03-09 00:00:00", "acceptedDate": "2022-03-09 17:50:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004416/0001225208-22-004416-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822004416/xslF345X03/doc4.xml"}}
{"date": "2022-02-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-25 00:00:00", "acceptedDate": "2022-02-25 16:36:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822003428/0001225208-22-003428-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822003428/xslF345X03/doc4.xml"}}
{"date": "2022-02-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-25 00:00:00", "acceptedDate": "2022-02-25 16:33:03", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822003426/0001225208-22-003426-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822003426/xslF345X02/doc3.xml"}}
{"date": "2022-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-18 00:00:00", "acceptedDate": "2022-02-18 19:15:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002823/0001225208-22-002823-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002823/xslF345X03/doc4.xml"}}
{"date": "2022-02-18", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-18 00:00:00", "acceptedDate": "2022-02-18 13:59:15", "formType": "3/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002736/0001225208-22-002736-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002736/xslF345X02/doc3a.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:47:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002585/0001225208-22-002585-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002585/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:47:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002584/0001225208-22-002584-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002584/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:47:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002588/0001225208-22-002588-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002588/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:47:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002587/0001225208-22-002587-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002587/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:47:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002583/0001225208-22-002583-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002583/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:47:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002586/0001225208-22-002586-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002586/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:47:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002582/0001225208-22-002582-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002582/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:46:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002581/0001225208-22-002581-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002581/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:46:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002580/0001225208-22-002580-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002580/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:46:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002577/0001225208-22-002577-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002577/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:46:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002579/0001225208-22-002579-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002579/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:46:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002578/0001225208-22-002578-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002578/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:46:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002576/0001225208-22-002576-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002576/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:06:50", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/0000200406-22-000022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/jnj-20220102.htm"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:01:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002378/0001225208-22-002378-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002378/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:01:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002377/0001225208-22-002377-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002377/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:01:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002376/0001225208-22-002376-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002376/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:01:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002375/0001225208-22-002375-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002375/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:01:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002374/0001225208-22-002374-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002374/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:01:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002373/0001225208-22-002373-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002373/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:00:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002372/0001225208-22-002372-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002372/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:00:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002371/0001225208-22-002371-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002371/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:00:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002368/0001225208-22-002368-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002368/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:00:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002370/0001225208-22-002370-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002370/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:00:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002369/0001225208-22-002369-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002369/xslF345X03/doc4.xml"}}
{"date": "2022-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 06:00:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002367/0001225208-22-002367-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002367/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:04:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002223/0001225208-22-002223-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002223/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:04:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002222/0001225208-22-002222-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002222/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:04:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002221/0001225208-22-002221-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002221/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:04:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002218/0001225208-22-002218-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002218/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:03:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002220/0001225208-22-002220-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002220/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:03:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002217/0001225208-22-002217-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002217/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:03:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002219/0001225208-22-002219-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002219/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:03:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002216/0001225208-22-002216-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002216/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:03:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002215/0001225208-22-002215-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002215/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:03:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002214/0001225208-22-002214-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002214/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:02:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002213/0001225208-22-002213-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002213/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:02:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002212/0001225208-22-002212-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002212/xslF345X03/doc4.xml"}}
{"date": "2022-02-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-15 00:00:00", "acceptedDate": "2022-02-15 20:02:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002211/0001225208-22-002211-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822002211/xslF345X03/doc4.xml"}}
{"date": "2022-02-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-16 00:00:00", "acceptedDate": "2022-02-15 18:07:09", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000017/0000200406-22-000017-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000017/jnj-20220215.htm"}}
{"date": "2022-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-14 00:00:00", "acceptedDate": "2022-02-14 15:26:55", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761922004279/0001567619-22-004279-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761922004279/form13fInfoTable.xml"}}
{"date": "2022-02-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-14 00:00:00", "acceptedDate": "2022-02-14 12:37:22", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000009375122000400/0000093751-22-000400-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/93751/000009375122000400/JOHNSON_JOHNSON.txt"}}
{"date": "2022-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-10 00:00:00", "acceptedDate": "2022-02-10 08:22:08", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000110465922017888/0001104659-22-017888-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465922017888/tv01228-johnsonjohnson.htm"}}
{"date": "2022-02-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-07 00:00:00", "acceptedDate": "2022-02-07 13:32:36", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445422000106/0000904454-22-000106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445422000106/s13g_123121-cvrx.htm"}}
{"date": "2022-02-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-02 00:00:00", "acceptedDate": "2022-02-02 16:35:08", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000015/0000200406-22-000015-index.htm", "finalLink": ""}}
{"date": "2022-02-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-01 00:00:00", "acceptedDate": "2022-02-01 14:42:27", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445422000079/0000904454-22-000079-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445422000079/s13ga_phasebio-020122.htm"}}
{"date": "2022-02-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-02-01 00:00:00", "acceptedDate": "2022-01-31 17:49:47", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000083423722003836/0000834237-22-003836-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000083423722003836/us4781601046_013122.txt"}}
{"date": "2022-01-25", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-25 00:00:00", "acceptedDate": "2022-01-25 08:00:34", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000012/0000200406-22-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000012/jnj-20220125.htm"}}
{"date": "2022-01-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-20 00:00:00", "acceptedDate": "2022-01-20 14:45:22", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/200406/000087666122000070/0000876661-22-000070-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000087666122000070/xslF25X02/primary_doc.xml"}}
{"date": "2022-01-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-19 00:00:00", "acceptedDate": "2022-01-19 20:54:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000906/0001225208-22-000906-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000906/xslF345X03/doc4.xml"}}
{"date": "2022-01-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-19 00:00:00", "acceptedDate": "2022-01-19 20:54:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000905/0001225208-22-000905-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000905/xslF345X03/doc4.xml"}}
{"date": "2022-01-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-13 00:00:00", "acceptedDate": "2022-01-13 17:51:19", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000737/0001225208-22-000737-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000737/xslF345X02/doc3.xml"}}
{"date": "2022-01-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-13 00:00:00", "acceptedDate": "2022-01-13 17:37:34", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000735/0001225208-22-000735-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000735/xslF345X02/doc3.xml"}}
{"date": "2022-01-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-13 00:00:00", "acceptedDate": "2022-01-13 17:34:20", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000734/0001225208-22-000734-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000734/xslF345X02/doc3.xml"}}
{"date": "2022-01-13", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-13 00:00:00", "acceptedDate": "2022-01-13 16:43:13", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000731/0001225208-22-000731-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520822000731/xslF345X02/doc3.xml"}}
{"date": "2022-01-06", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2022-01-06 00:00:00", "acceptedDate": "2022-01-06 16:51:56", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/0000200406-22-000004-index.htm", "finalLink": ""}}
{"date": "2021-12-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-12-09 00:00:00", "acceptedDate": "2021-12-09 16:43:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821014718/0001225208-21-014718-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821014718/xslF345X03/doc4.xml"}}
{"date": "2021-12-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-12-09 00:00:00", "acceptedDate": "2021-12-09 16:43:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821014717/0001225208-21-014717-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821014717/xslF345X03/doc4.xml"}}
{"date": "2021-12-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-12-09 00:00:00", "acceptedDate": "2021-12-09 16:43:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821014716/0001225208-21-014716-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821014716/xslF345X03/doc4.xml"}}
{"date": "2021-12-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-12-09 00:00:00", "acceptedDate": "2021-12-09 16:43:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821014714/0001225208-21-014714-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821014714/xslF345X03/doc4.xml"}}
{"date": "2021-11-16", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-11-16 00:00:00", "acceptedDate": "2021-11-16 14:21:44", "formType": "13F-HR/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761921020557/0001567619-21-020557-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761921020557/form13fInfoTable.xml"}}
{"date": "2021-11-15", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-11-15 00:00:00", "acceptedDate": "2021-11-15 16:57:48", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000072/0000200406-21-000072-index.htm", "finalLink": ""}}
{"date": "2021-11-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-11-12 00:00:00", "acceptedDate": "2021-11-12 17:18:42", "formType": "13F-HR", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761921020090/0001567619-21-020090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761921020090/form13fInfoTable.xml"}}
{"date": "2021-10-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-10-29 00:00:00", "acceptedDate": "2021-10-29 16:05:20", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/0000200406-21-000070-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/jnj-20211003.htm"}}
{"date": "2021-10-19", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-10-19 00:00:00", "acceptedDate": "2021-10-19 08:01:28", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000067/0000200406-21-000067-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000067/jnj-20211019.htm"}}
{"date": "2021-10-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-10-12 00:00:00", "acceptedDate": "2021-10-12 16:50:04", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000063/0000200406-21-000063-index.htm", "finalLink": ""}}
{"date": "2021-09-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-09-09 00:00:00", "acceptedDate": "2021-09-09 16:37:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821012179/0001225208-21-012179-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821012179/xslF345X03/doc4.xml"}}
{"date": "2021-09-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-09-09 00:00:00", "acceptedDate": "2021-09-09 16:37:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821012178/0001225208-21-012178-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821012178/xslF345X03/doc4.xml"}}
{"date": "2021-09-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-09-09 00:00:00", "acceptedDate": "2021-09-09 16:37:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821012177/0001225208-21-012177-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821012177/xslF345X03/doc4.xml"}}
{"date": "2021-08-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-08-20 00:00:00", "acceptedDate": "2021-08-20 16:31:14", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000061/0000200406-21-000061-index.htm", "finalLink": ""}}
{"date": "2021-08-03", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-08-03 00:00:00", "acceptedDate": "2021-08-03 13:05:59", "formType": "13F-NT", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761921014325/0001567619-21-014325-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761921014325/xslForm13F_X01/primary_doc.xml"}}
{"date": "2021-07-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-07-29 00:00:00", "acceptedDate": "2021-07-29 16:07:51", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/0000200406-21-000057-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/jnj-20210704.htm"}}
{"date": "2021-07-21", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-07-21 00:00:00", "acceptedDate": "2021-07-21 08:00:52", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000053/0000200406-21-000053-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000053/jnj-20210721.htm"}}
{"date": "2021-07-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-07-02 00:00:00", "acceptedDate": "2021-07-02 16:59:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445421000576/0000904454-21-000576-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445421000576/xslF345X03/edgar.xml"}}
{"date": "2021-06-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-06-29 00:00:00", "acceptedDate": "2021-06-29 21:45:00", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445421000561/0000904454-21-000561-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445421000561/xslF345X02/edgar.xml"}}
{"date": "2021-06-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-06-17 00:00:00", "acceptedDate": "2021-06-17 16:48:01", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000048/0000200406-21-000048-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000048/a2020form11-kxjjretirement.htm"}}
{"date": "2021-06-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-06-17 00:00:00", "acceptedDate": "2021-06-17 16:40:44", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000046/0000200406-21-000046-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000046/a2020form11-kxjjsavingsplan.htm"}}
{"date": "2021-06-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-06-10 00:00:00", "acceptedDate": "2021-06-10 16:50:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821009208/0001225208-21-009208-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821009208/xslF345X03/doc4.xml"}}
{"date": "2021-06-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-06-10 00:00:00", "acceptedDate": "2021-06-10 16:50:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821009207/0001225208-21-009207-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821009207/xslF345X03/doc4.xml"}}
{"date": "2021-06-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-06-10 00:00:00", "acceptedDate": "2021-06-10 16:49:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821009206/0001225208-21-009206-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821009206/xslF345X03/doc4.xml"}}
{"date": "2021-06-01", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-06-01 00:00:00", "acceptedDate": "2021-06-01 17:16:39", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000040/0000200406-21-000040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000040/jnj-20210601.htm"}}
{"date": "2021-05-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-05-27 00:00:00", "acceptedDate": "2021-05-27 16:12:10", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000038/0000200406-21-000038-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000038/formsd2020.htm"}}
{"date": "2021-05-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-05-27 00:00:00", "acceptedDate": "2021-05-27 14:30:05", "formType": "UPLOAD", "link": "https://www.sec.gov/Archives/edgar/data/200406/000000000021006671/0000000000-21-006671-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000000000021006671/filename1.pdf"}}
{"date": "2021-05-07", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-05-07 00:00:00", "acceptedDate": "2021-05-06 17:43:37", "formType": "13F-NT", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761921009229/0001567619-21-009229-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761921009229/xslForm13F_X01/primary_doc.xml"}}
{"date": "2021-05-04", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-05-04 00:00:00", "acceptedDate": "2021-05-04 15:31:32", "formType": "CORRESP", "link": "https://www.sec.gov/Archives/edgar/data/200406/000134100421000177/0001341004-21-000177-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000134100421000177/filename1.htm"}}
{"date": "2021-04-30", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-04-30 00:00:00", "acceptedDate": "2021-04-30 16:04:02", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/0000200406-21-000036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/jnj-20210404.htm"}}
{"date": "2021-04-27", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-04-27 00:00:00", "acceptedDate": "2021-04-27 15:30:04", "formType": "UPLOAD", "link": "https://www.sec.gov/Archives/edgar/data/200406/000000000021005337/0000000000-21-005337-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000000000021005337/filename1.pdf"}}
{"date": "2021-04-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-04-26 00:00:00", "acceptedDate": "2021-04-26 16:35:23", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000030/0000200406-21-000030-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000030/jnj-20210422.htm"}}
{"date": "2021-04-20", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-04-20 00:00:00", "acceptedDate": "2021-04-20 08:02:01", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000024/0000200406-21-000024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000024/jnj-20210420.htm"}}
{"date": "2021-04-14", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-04-14 00:00:00", "acceptedDate": "2021-04-14 13:33:03", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465921004175/0001214659-21-004175-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465921004175/s413210pc14a6g.htm"}}
{"date": "2021-04-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-04-12 00:00:00", "acceptedDate": "2021-04-09 19:02:10", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000014/0000200406-21-000014-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000014/a20210409supplementalproxy.htm"}}
{"date": "2021-03-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-29 00:00:00", "acceptedDate": "2021-03-29 13:02:12", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465921003524/0001214659-21-003524-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465921003524/s328211px14a6g.htm"}}
{"date": "2021-03-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-26 00:00:00", "acceptedDate": "2021-03-26 16:20:11", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465921003496/0001214659-21-003496-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465921003496/r326211px14a6g.htm"}}
{"date": "2021-03-24", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-24 00:00:00", "acceptedDate": "2021-03-24 09:19:10", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465921003366/0001214659-21-003366-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465921003366/d32421px14a6g.htm"}}
{"date": "2021-03-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-22 00:00:00", "acceptedDate": "2021-03-22 16:32:30", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000121465921003326/0001214659-21-003326-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000121465921003326/p322212px14a6g.htm"}}
{"date": "2021-03-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-11 00:00:00", "acceptedDate": "2021-03-11 17:07:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821005124/0001225208-21-005124-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821005124/xslF345X03/doc4.xml"}}
{"date": "2021-03-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-11 00:00:00", "acceptedDate": "2021-03-11 17:07:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821005123/0001225208-21-005123-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821005123/xslF345X03/doc4.xml"}}
{"date": "2021-03-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-11 00:00:00", "acceptedDate": "2021-03-11 17:07:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821005122/0001225208-21-005122-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821005122/xslF345X03/doc4.xml"}}
{"date": "2021-03-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-10 00:00:00", "acceptedDate": "2021-03-10 08:22:51", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000012/0000200406-21-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000012/jnjdefa14a2021.htm"}}
{"date": "2021-03-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-03-10 00:00:00", "acceptedDate": "2021-03-10 08:21:10", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000011/0000200406-21-000011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000011/jnjproxy2021.htm"}}
{"date": "2021-02-22", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-22 00:00:00", "acceptedDate": "2021-02-22 16:36:14", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000008/0000200406-21-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000008/jnj-20210103.htm"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002860/0001225208-21-002860-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002860/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002859/0001225208-21-002859-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002859/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002858/0001225208-21-002858-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002858/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002857/0001225208-21-002857-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002857/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002856/0001225208-21-002856-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002856/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002855/0001225208-21-002855-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002855/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002854/0001225208-21-002854-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002854/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002853/0001225208-21-002853-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002853/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002851/0001225208-21-002851-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002851/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002852/0001225208-21-002852-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002852/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002850/0001225208-21-002850-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002850/xslF345X03/doc4.xml"}}
{"date": "2021-02-17", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 19:09:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002849/0001225208-21-002849-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002849/xslF345X03/doc4.xml"}}
{"date": "2021-02-12", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-12 00:00:00", "acceptedDate": "2021-02-12 16:27:56", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/200406/000009375121000387/0000093751-21-000387-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/93751/000009375121000387/JOHNSON_JOHNSON.txt"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:34:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002226/0001225208-21-002226-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002226/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:34:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002229/0001225208-21-002229-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002229/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:34:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002227/0001225208-21-002227-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002227/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:34:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002228/0001225208-21-002228-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002228/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:34:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002225/0001225208-21-002225-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002225/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:34:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002224/0001225208-21-002224-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002224/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:34:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002222/0001225208-21-002222-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002222/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:33:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002223/0001225208-21-002223-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002223/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:33:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002221/0001225208-21-002221-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002221/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:33:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002220/0001225208-21-002220-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002220/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:33:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002218/0001225208-21-002218-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002218/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:33:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002217/0001225208-21-002217-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002217/xslF345X03/doc4.xml"}}
{"date": "2021-02-11", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-11 00:00:00", "acceptedDate": "2021-02-11 17:33:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002219/0001225208-21-002219-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002219/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 19:04:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002106/0001225208-21-002106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002106/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:47:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002098/0001225208-21-002098-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002098/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:47:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002097/0001225208-21-002097-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002097/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:47:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002096/0001225208-21-002096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002096/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:47:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002095/0001225208-21-002095-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002095/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:47:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002094/0001225208-21-002094-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002094/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:46:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002093/0001225208-21-002093-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002093/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:46:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002092/0001225208-21-002092-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002092/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:46:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002091/0001225208-21-002091-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002091/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:46:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002090/0001225208-21-002090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002090/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:46:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002089/0001225208-21-002089-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002089/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 18:46:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002088/0001225208-21-002088-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000122520821002088/xslF345X03/doc4.xml"}}
{"date": "2021-02-10", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 11:10:57", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000110465921018422/0001104659-21-018422-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/102909/000110465921018422/tv01198-johnsonjohnson.htm"}}
{"date": "2021-02-09", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-09 00:00:00", "acceptedDate": "2021-02-08 18:26:40", "formType": "13F-NT", "link": "https://www.sec.gov/Archives/edgar/data/200406/000156761921002492/0001567619-21-002492-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000156761921002492/xslForm13F_X01/primary_doc.xml"}}
{"date": "2021-02-02", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-02-02 00:00:00", "acceptedDate": "2021-02-01 17:41:10", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000090445421000100/0000904454-21-000100-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000090445421000100/s13g_123120-protagonistpharm.htm"}}
{"date": "2021-01-29", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-01-29 00:00:00", "acceptedDate": "2021-01-29 17:22:55", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/200406/000083423721004788/0000834237-21-004788-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000083423721004788/us4781601046_012921.txt"}}
{"date": "2021-01-26", "symbol": "JNJ", "type": "sec_filings", "result": {"symbol": "JNJ", "cik": "0000200406", "filingDate": "2021-01-26 00:00:00", "acceptedDate": "2021-01-26 08:06:06", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000006/0000200406-21-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000006/jnj-20210126.htm"}}
{"date": "2025-12-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-22 06:36:44", "publisher": "Defense World", "title": "Rydar Equities Inc. Sells 3,178 Shares of Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/rydar-equities-inc-sells-3178-shares-of-johnson-johnson-20251222.png", "site": "defenseworld.net", "text": "Rydar Equities Inc. cut its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 55.8% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,515 shares of the company's stock after selling 3,178 shares during the quarter. Rydar Equities", "url": "https://www.defenseworld.net/2025/12/22/rydar-equities-inc-sells-3178-shares-of-johnson-johnson-jnj.html"}}
{"date": "2025-12-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-22 05:56:46", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Purchased by Foster Victor Wealth Advisors LLC", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-purchased-by-foster-victor-wealth-20251222.png", "site": "defenseworld.net", "text": "Foster Victor Wealth Advisors LLC boosted its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 3.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 90,706 shares of the company's stock after buying an additional 2,997 shares", "url": "https://www.defenseworld.net/2025/12/22/johnson-johnson-jnj-shares-purchased-by-foster-victor-wealth-advisors-llc.html"}}
{"date": "2025-12-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-22 05:24:51", "publisher": "Defense World", "title": "Cyndeo Wealth Partners LLC Increases Stock Position in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/cyndeo-wealth-partners-llc-increases-stock-position-in-johnson-20251222.png", "site": "defenseworld.net", "text": "Cyndeo Wealth Partners LLC raised its stake in Johnson and Johnson (NYSE: JNJ) by 63.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,832 shares of the company's stock after acquiring an additional 40,238 shares during the period.", "url": "https://www.defenseworld.net/2025/12/22/cyndeo-wealth-partners-llc-increases-stock-position-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-22 05:24:51", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Acquired by Fairvoy Private Wealth LLC", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-acquired-by-fairvoy-private-wealth-20251222.png", "site": "defenseworld.net", "text": "Fairvoy Private Wealth LLC boosted its position in Johnson and Johnson (NYSE: JNJ) by 245.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,179 shares of the company's stock after purchasing an additional 3,680 shares during the quarter. Fairvoy Private Wealth LLC's", "url": "https://www.defenseworld.net/2025/12/22/johnson-johnson-jnj-shares-acquired-by-fairvoy-private-wealth-llc.html"}}
{"date": "2025-12-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-22 03:26:51", "publisher": "Defense World", "title": "Bartlett & CO. Wealth Management LLC Has $47.19 Million Stake in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/bartlett-co-wealth-management-llc-has-4719-million-stake-20251222.png", "site": "defenseworld.net", "text": "Bartlett and CO. Wealth Management LLC lessened its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 5.1% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 254,517 shares of the company's stock after selling 13,578 shares during the period.", "url": "https://www.defenseworld.net/2025/12/22/bartlett-co-wealth-management-llc-has-47-19-million-stake-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-21", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-21 05:08:42", "publisher": "Defense World", "title": "Brady Family Wealth LLC Sells 2,471 Shares of Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/brady-family-wealth-llc-sells-2471-shares-of-johnson-20251221.png", "site": "defenseworld.net", "text": "Brady Family Wealth LLC cut its stake in shares of Johnson and Johnson (NYSE: JNJ) by 7.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 29,349 shares of the company's stock after selling 2,471 shares during the period. Johnson", "url": "https://www.defenseworld.net/2025/12/21/brady-family-wealth-llc-sells-2471-shares-of-johnson-johnson-jnj.html"}}
{"date": "2025-12-21", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-21 03:44:42", "publisher": "Defense World", "title": "Astoria Portfolio Advisors LLC. Lowers Holdings in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/astoria-portfolio-advisors-llc-lowers-holdings-in-johnson-johnson-20251221.png", "site": "defenseworld.net", "text": "Astoria Portfolio Advisors LLC. lowered its position in Johnson and Johnson (NYSE: JNJ) by 43.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,801 shares of the company's stock after selling 3,652 shares during the quarter. Astoria Portfolio", "url": "https://www.defenseworld.net/2025/12/21/astoria-portfolio-advisors-llc-lowers-holdings-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-20", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-20 16:41:17", "publisher": "Benzinga", "title": "Why a Minnesota Jury Ordered Johnson & Johnson To Pay $65.5 Million in Damages", "image": "https://images.financialmodelingprep.com/news/why-a-minnesota-jury-ordered-johnson-johnson-to-pay-20251220.jpeg", "site": "feeds.benzinga.com", "text": "Johnson and Johnson has been directed to pay $65.6 million to a Minnesota woman who was diagnosed with cancer following the use of their talcum powder.", "url": "https://www.benzinga.com/news/legal/25/12/49526414/why-a-minnesota-jury-ordered-johnson-johnson-to-pay-65-5-million-in-damages"}}
{"date": "2025-12-20", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-20 10:31:56", "publisher": "247 Wallst", "title": "What Retirement Really Looks Like With $2.5 Million in Savings", "image": "https://images.financialmodelingprep.com/news/what-retirement-really-looks-like-with-25-million-in-20251220.jpg", "site": "247wallst.com", "text": "For as long as most of us can remember, the idea of retiring with $2.5 million in the \"bank,\" is something of a dream. The belief that this amount of money would guarantee decades of worry-free living feels like all of the stars aligning after decades of hard work, disciplined savings, and investing, and the... What Retirement Really Looks Like With $2.5 Million in Savings.", "url": "https://247wallst.com/personal-finance/2025/12/20/what-retirement-really-looks-like-with-2-5-million-in-savings/"}}
{"date": "2025-12-20", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-20 03:55:05", "publisher": "New York Post", "title": "Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder", "image": "https://images.financialmodelingprep.com/news/minnesota-jury-says-johnson-johnson-owes-655-million-to-20251220.jpg", "site": "nypost.com", "text": "A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made byJohnson & Johnsonexposed her to asbestos and contributed to her developing cancer in the lining of her lungs.", "url": "https://nypost.com/2025/12/20/business/johnson-and-johnson-owes-65-6-million-to-minnesota-woman-anna-jean-houghton-carley-with-cancer-after-using-talcum-powder/"}}
{"date": "2025-12-20", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-20 01:38:01", "publisher": "Benzinga", "title": "Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal", "image": "https://images.financialmodelingprep.com/news/trump-secures-drug-price-cuts-from-9-major-pharma-20251220.jpeg", "site": "feeds.benzinga.com", "text": "Trump and nine major pharmaceutical companies struck deals to lower drug prices for cash payers and Medicaid, with over $150 billion pledged for U.S. R&D and manufacturing.", "url": "https://www.benzinga.com/news/health-care/25/12/49525415/trump-secures-drug-price-cuts-from-9-major-pharma-firms-including-bristol-myers-gilead-merck-in-"}}
{"date": "2025-12-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-19 17:54:00", "publisher": "Business Wire", "title": "Minnesota Jury Delivers $65.5 Million History-Making Verdict Against Johnson & Johnson", "image": "https://images.financialmodelingprep.com/news/minnesota-jury-delivers-655-million-historymaking-verdict-against-johnson-20251219.jpg", "site": "businesswire.com", "text": "ST. PAUL, Minn.--(BUSINESS WIRE)--A Minnesota jury awarded $65.5 million to a 37-year-old mother of three minor children after finding in her favor in a lawsuit against Johnson & Johnson, concluding that the company's talc products exposed her to asbestos and contributed to her developing mesothelioma, a cancer of the lining of the lungs. The verdict follows a 13-day trial in Ramsey County District Court, where jurors heard evidence that Johnson & Johnson sold and marketed talc-based co.", "url": "https://www.businesswire.com/news/home/20251219314312/en/Minnesota-Jury-Delivers-65.5-Million-History-Making-Verdict-Against-Johnson-Johnson/"}}
{"date": "2025-12-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-19 07:37:00", "publisher": "GuruFocus", "title": "First Look: Oracle leads TikTok JV, CPI cools, Nike drops", "image": "https://images.financialmodelingprep.com/news/first-look-oracle-leads-tiktok-jv-cpi-cools-nike-20251219.png", "site": "gurufocus.com", "text": "Stock News TikTok inks U.S. spinoff deal: Oracle (ORCL) and partners Silver Lake and MGX will take major stakes in a new TikTok U.S. venture, with U.S. data hos", "url": "https://www.gurufocus.com/news/4077544/first-look-oracle-leads-tiktok-jv-cpi-cools-nike-drops"}}
{"date": "2025-12-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-19 05:28:53", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Bought by Czech National Bank", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-bought-by-czech-national-bank-20251219.png", "site": "defenseworld.net", "text": "Czech National Bank grew its stake in shares of Johnson and Johnson (NYSE: JNJ) by 4.0% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 611,668 shares of the company's stock after buying an additional 23,539 shares during the period. Johnson and Johnson", "url": "https://www.defenseworld.net/2025/12/19/johnson-johnson-jnj-shares-bought-by-czech-national-bank.html"}}
{"date": "2025-12-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-19 04:48:43", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Sold by Chesley Taft & Associates LLC", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-sold-by-chesley-taft-associates-20251219.png", "site": "defenseworld.net", "text": "Chesley Taft and Associates LLC lowered its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 2.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 198,127 shares of the company's stock after selling 5,244 shares during the period.", "url": "https://www.defenseworld.net/2025/12/19/johnson-johnson-jnj-shares-sold-by-chesley-taft-associates-llc.html"}}
{"date": "2025-12-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-18 17:35:00", "publisher": "GuruFocus", "title": "Market Today: CPI Cools; Micron Lifts AI Stocks (MU)", "image": "https://images.financialmodelingprep.com/news/market-today-cpi-cools-micron-lifts-ai-stocks-mu-20251218.png", "site": "gurufocus.com", "text": "Guru Stock PicksCI Select Canadian Equity Fund has made the following transactions:Reduce in TSX: ABX by 9.95%Sold out in TSX:DOLAdd in TSX: KEY by 27.62%New posi", "url": "https://www.gurufocus.com/news/4077010/market-today-cpi-cools-micron-lifts-ai-stocks-mu"}}
{"date": "2025-12-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-18 14:40:40", "publisher": "Benzinga", "title": "FDA Approves J&J's New 5-Minute Injection For Lung Cancer", "image": "https://images.financialmodelingprep.com/news/fda-approves-jjs-new-5minute-injection-for-lung-cancer-20251218.jpeg", "site": "feeds.benzinga.com", "text": "FDA approves Johnson and Johnson's Rybrevant Faspro for EGFR lung cancer and expands TRUFILL use for chronic subdural hematoma treatment.", "url": "https://www.benzinga.com/news/fda/25/12/49490895/fda-approves-jjs-new-5-minute-injection-for-lung-cancer"}}
{"date": "2025-12-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-18 13:51:04", "publisher": "Zacks Investment Research", "title": "J&J Wins FDA Nod for Subcutaneous Version of NSCLC Drug Rybrevant", "image": "https://images.financialmodelingprep.com/news/jj-wins-fda-nod-for-subcutaneous-version-of-nsclc-20251218.jpg", "site": "zacks.com", "text": "JNJ wins FDA approval for a subcutaneous version of Rybrevant, cutting treatment time to minutes and boosting convenience across NSCLC indications.", "url": "https://www.zacks.com/stock/news/2806390/j-j-wins-fda-nod-for-subcutaneous-version-of-nsclc-drug-rybrevant?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2806390"}}
{"date": "2025-12-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-18 11:40:45", "publisher": "Zacks Investment Research", "title": "3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment", "image": "https://images.financialmodelingprep.com/news/3-cancer-stocks-to-buy-amid-rapid-advances-in-20251218.jpg", "site": "zacks.com", "text": "J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.", "url": "https://www.zacks.com/stock/news/2806268/3-cancer-stocks-to-buy-amid-rapid-advances-in-cancer-treatment?cid=CS-STOCKNEWSAPI-FT-cancer-2806268"}}
{"date": "2025-12-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-18 09:03:18", "publisher": "247 Wallst", "title": "Retirees Banking on Quarterly Income Choose HDV Over Growth Funds for Its Defensive Holdings", "image": "https://images.financialmodelingprep.com/news/retirees-banking-on-quarterly-income-choose-hdv-over-growth-20251218.webp", "site": "247wallst.com", "text": "When income matters more than growth, retirees turn to funds that deliver quarterly checks without volatility. The iShares Core High Dividend ETF (NYSEARCA:HDV) yields 3.3%, triple the S&P 500's 1.03%. That difference translates to predictable cash flow for investors who need their portfolio to pay bills. Built for Income, Not Speculation HDV tracks 75 U.S.... Retirees Banking on Quarterly Income Choose HDV Over Growth Funds for Its Defensive Holdings.", "url": "https://247wallst.com/investing/2025/12/18/retirees-banking-on-quarterly-income-choose-hdv-over-growth-funds-for-its-defensive-holdings/"}}
{"date": "2025-12-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-18 08:00:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson Receives FDA Approval for TRUFILL nBCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-receives-fda-approval-for-trufill-nbca-liquid-20251218.jpg", "site": "prnewswire.com", "text": "-TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - Approval builds on a trusted solution in neurovascular embolization for over 25 years.", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-receives-fda-approval-for-trufill-nbca-liquid-embolic-system-for-the-treatment-of-symptomatic-chronic-subdural-hematoma-302645188.html"}}
{"date": "2025-12-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-18 07:19:33", "publisher": "247 Wallst", "title": "5 Dividends That Beat Social Securitys Unpredictable COLA Adjustments", "image": "https://images.financialmodelingprep.com/news/5-dividends-that-beat-social-securitys-unpredictable-cola-adjustments-20251218.jpg", "site": "247wallst.com", "text": "Social Security's cost-of-living adjustments swing wildly year to year. The 2025 COLA came in at 2.5%, down from 3.2% in 2024 and 8.7% in 2023. For retirees counting on predictable income growth, this volatility creates planning challenges. The solution lies in dividend stocks that deliver consistent income growth regardless of Social Security. These five stocks... 5 Dividends That Beat Social Security's Unpredictable COLA Adjustments.", "url": "https://247wallst.com/investing/2025/12/18/5-dividends-that-beat-social-securitys-unpredictable-cola-adjustments/"}}
{"date": "2025-12-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-18 02:09:06", "publisher": "Seeking Alpha", "title": "Johnson & Johnson: Valuation Premium Justified By Accelerating Growth And Mix Premiumization", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-valuation-premium-justified-by-accelerating-growth-and-20251218.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson is rated a buy, with accelerating revenue and earnings growth driven by TREMFYA, CARVYKTI, and robust MedTech innovation. JNJ's portfolio reshaping (divesting Orthopaedics and focusing on premium cardiovascular and vision franchises) should enhance margins and long-term growth prospects. TREMFYA's rapid adoption in IBD and the anticipated 2026 launch of icotrokinra position JNJ for continued immunology growth despite STELARA's LOE.", "url": "https://seekingalpha.com/article/4854252-johnson-and-johnson-valuation-premium-justified-by-accelerating-growth-and-mix-premiumization"}}
{"date": "2025-12-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-17 18:49:00", "publisher": "PRNewsWire", "title": "U.S. FDA Approval of RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE (lazertinib)", "image": "https://images.financialmodelingprep.com/news/us-fda-approval-of-rybrevant-faspro-amivantamab-and-hyaluronidaselpuj-20251217.jpg", "site": "prnewswire.com", "text": "RYBREVANT FASPRO, the first and only subcutaneous therapy for patients with EGFR-mutated NSCLC, reduces administration time from hours to minutes and significantly reduces administration-related reactions1-5 Approval builds on previously reported Phase 3 MARIPOSA data showing unmatched overall survival benefit of this chemotherapy-free regimen, projected to exceed four years6 HORSHAM, Pa. , Dec. 17, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj), the first and only subcutaneously (SC) administered therapy for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 RYBREVANT FASPRO is approved across all indications of RYBREVANT  (amivantamab-vmjw).", "url": "https://www.prnewswire.com/news-releases/us-fda-approval-of-rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-enables-the-simplest-shortest-administration-time-for-a-first-line-combination-regimen-when-combined-with-lazcluze-lazertinib-302645263.html"}}
{"date": "2025-12-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-17 10:01:15", "publisher": "Zacks Investment Research", "title": "Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?", "image": "https://images.financialmodelingprep.com/news/is-trending-stock-johnson-johnson-jnj-a-buy-now-20251217.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2805475/is-trending-stock-johnson-johnson-jnj-a-buy-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2805475"}}
{"date": "2025-12-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-16 08:05:00", "publisher": "The Motley Fool", "title": "2 Recession-Proof Stocks to Watch in December", "image": "https://images.financialmodelingprep.com/news/2-recessionproof-stocks-to-watch-in-december-20251216.jpg", "site": "fool.com", "text": "Walmart's low prices make it a go-to during recessions when people are cutting back on spending. Johnson & Johnson sells consumer health products that many people don't cut back on when adjusting their budgets.", "url": "https://www.fool.com/investing/2025/12/16/2-recession-proof-stocks-to-watch-in-december/"}}
{"date": "2025-12-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-16 06:46:42", "publisher": "Defense World", "title": "GAMMA Investing LLC Grows Stock Position in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/gamma-investing-llc-grows-stock-position-in-johnson-johnson-20251216.png", "site": "defenseworld.net", "text": "GAMMA Investing LLC lifted its stake in Johnson and Johnson (NYSE: JNJ) by 10.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 54,509 shares of the company's stock after purchasing an additional 5,142 shares during the quarter. Johnson and Johnson", "url": "https://www.defenseworld.net/2025/12/16/gamma-investing-llc-grows-stock-position-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-16 06:02:45", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Sold by Cullen Capital Management LLC", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-sold-by-cullen-capital-management-20251216.png", "site": "defenseworld.net", "text": "Cullen Capital Management LLC reduced its position in shares of Johnson and Johnson (NYSE: JNJ) by 1.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,211,617 shares of the company's stock after selling 23,269 shares during the", "url": "https://www.defenseworld.net/2025/12/16/johnson-johnson-jnj-shares-sold-by-cullen-capital-management-llc.html"}}
{"date": "2025-12-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-16 01:30:52", "publisher": "Defense World", "title": "Johnson & Johnson (NYSE:JNJ) Shares Up 1.3% After Analyst Upgrade", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-nysejnj-shares-up-13-after-analyst-upgrade-20251216.png", "site": "defenseworld.net", "text": "Johnson and Johnson (NYSE: JNJ - Get Free Report)'s stock price was up 1.3% on Monday after Bank of America raised their price target on the stock from $204.00 to $220.00. Bank of America currently has a neutral rating on the stock. Johnson and Johnson traded as high as $215.19 and last traded at $214.4110. Approximately", "url": "https://www.defenseworld.net/2025/12/16/johnson-johnson-nysejnj-shares-up-1-3-after-analyst-upgrade.html"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 18:22:55", "publisher": "CNBC Television", "title": "Final Trade: JNJ, NVO, UBER, BMY", "image": "https://images.financialmodelingprep.com/news/final-trade-jnj-nvo-uber-bmy-20251215.jpg", "site": "youtube.com", "text": "The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.", "url": "https://www.youtube.com/watch?v=RxnhmDKcuoU"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 16:27:00", "publisher": "Business Wire", "title": "Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-host-investor-conference-call-on-fourthquarter-20251215.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, January 21st to review fourth-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson &amp.", "url": "https://www.businesswire.com/news/home/20251215079601/en/Johnson-Johnson-to-Host-Investor-Conference-Call-on-Fourth-Quarter-Results/"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 13:08:06", "publisher": "Benzinga", "title": "Johnson & Johnson Gets Target Hike, But BofA Flags Modest Pipeline Impact", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-gets-target-hike-but-bofa-flags-modest-20251215.jpeg", "site": "feeds.benzinga.com", "text": "BofA raised Johnson and Johnson's price target to $220, citing steady growth, but sees limited upside from its pipeline through 2026.", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/25/12/49401381/johnson-johnson-gets-target-hike-but-bofa-flags-modest-pipeline-impact"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 12:56:06", "publisher": "Benzinga", "title": "Bristol Myers Trades At Trough Valuation  Analyst Says Pipeline Upside Is Being Ignored", "image": "https://images.financialmodelingprep.com/news/bristol-myers-trades-at-trough-valuation-analyst-says-pipeline-20251215.jpeg", "site": "feeds.benzinga.com", "text": "Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and improving risk-reward outlook.", "url": "https://www.benzinga.com/analyst-stock-ratings/upgrades/25/12/49400823/bristol-myers-trades-at-trough-valuation-analyst-says-pipeline-upside-is-being-ign"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 11:51:09", "publisher": "Zacks Investment Research", "title": "FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer", "image": "https://images.financialmodelingprep.com/news/fda-approves-jjs-akeega-for-expanded-use-in-prostate-20251215.jpg", "site": "zacks.com", "text": "JNJ secures FDA approval to expand Akeega into earlier-stage prostate cancer, backed by strong phase III data and a first-of-its-kind precision combo.", "url": "https://www.zacks.com/stock/news/2804520/fda-approves-j-j-s-akeega-for-expanded-use-in-prostate-cancer?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2804520"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 10:39:50", "publisher": "Reuters", "title": "US FDA grants priority voucher to J&J's blood cancer treatment", "image": "https://images.financialmodelingprep.com/news/us-fda-grants-priority-voucher-to-jjs-blood-cancer-20251215.jpg", "site": "reuters.com", "text": "The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson & Johnson's treatment for a type of blood cancer, bringing the total number of products receiving an award under the program to 16 this year.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-grants-priority-voucher-jjs-blood-cancer-treatment-2025-12-15/"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 10:31:18", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Is Considered a Good Investment by Brokers: Is That True?", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-considered-a-good-investment-by-20251215.jpg", "site": "zacks.com", "text": "Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?", "url": "https://www.zacks.com/stock/news/2804343/johnson-johnson-jnj-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|average_broker_rating-2804343"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 10:11:03", "publisher": "Zacks Investment Research", "title": "Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus", "image": "https://images.financialmodelingprep.com/news/take-the-zacks-approach-to-beat-the-markets-liquidia-20251215.jpg", "site": "zacks.com", "text": "Liquidia shares have surged 43.9% since an October upgrade, as Zacks highlights stock wins and portfolio results despite a volatile market.", "url": "https://www.zacks.com/stock/news/2804284/take-the-zacks-approach-to-beat-the-markets-liquidia-western-digital-johnson-johnson-in-focus?cid=CS-STOCKNEWSAPI-FT-analyst_blog|investment_ideas-2804284"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 05:34:54", "publisher": "Defense World", "title": "Hilltop Partners LLC Raises Stock Holdings in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/hilltop-partners-llc-raises-stock-holdings-in-johnson-johnson-20251215.png", "site": "defenseworld.net", "text": "Hilltop Partners LLC increased its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 24.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,419 shares of the company's stock after acquiring an additional 3,453 shares during the quarter. Johnson", "url": "https://www.defenseworld.net/2025/12/15/hilltop-partners-llc-raises-stock-holdings-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-15 04:09:04", "publisher": "Defense World", "title": "Geneos Wealth Management Inc. Lowers Stake in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/geneos-wealth-management-inc-lowers-stake-in-johnson-johnson-20251215.png", "site": "defenseworld.net", "text": "Geneos Wealth Management Inc. cut its position in shares of Johnson and Johnson (NYSE: JNJ) by 12.4% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 57,016 shares of the company's stock after selling 8,037 shares during the quarter. Geneos Wealth Management", "url": "https://www.defenseworld.net/2025/12/15/geneos-wealth-management-inc-lowers-stake-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-14 09:51:41", "publisher": "24/7 Wall Street", "title": "Forget the 2.8% Social Security Increase. These Aristocrats Pay You 4% to 7% More Annually", "image": "https://images.financialmodelingprep.com/news/forget-the-28-social-security-increase-these-aristocrats-pay-20251214.jpg", "site": "247wallst.com", "text": "The Social Security Administration announced in October that beneficiaries will receive a 2.8% cost-of-living adjustment (COLA) in 2026, following a 2.5% increase in 2025.", "url": "https://247wallst.com/investing/2025/12/14/forget-the-2-8-social-security-increase-these-aristocrats-pay-you-4-to-7-more-annually/"}}
{"date": "2025-12-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-14 09:00:00", "publisher": "Business Wire", "title": "California Jury Awards $40 Million in Landmark Talc Verdict Against Johnson & Johnson", "image": "https://images.financialmodelingprep.com/news/california-jury-awards-40-million-in-landmark-talc-verdict-20251214.jpg", "site": "businesswire.com", "text": "LOS ANGELES--(BUSINESS WIRE)--A Los Angeles Superior Court jury on Friday delivered a $40 million verdict against Johnson & Johnson. The trial involved two women who developed ovarian cancer after decades of using the company's talc-based baby powder products. The award to plaintiffs Monica Kent and Deborah Schultz, and her husband, Dr. Albert Schultz, totals $40 million in compensatory damages. The California trial is the first of 10 or more trials expected through the first half of 2026 i.", "url": "https://www.businesswire.com/news/home/20251214605129/en/California-Jury-Awards-40-Million-in-Landmark-Talc-Verdict-Against-Johnson-Johnson/"}}
{"date": "2025-12-13", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-13 12:26:47", "publisher": "24/7 Wall Street", "title": "5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine", "image": "https://images.financialmodelingprep.com/news/5-dividend-powerhouses-that-could-transform-your-portfolio-into-20251213.jpg", "site": "247wallst.com", "text": "Building wealth through dividends requires more than chasing high yields. The path to getting rich combines meaningful current income with consistent dividend growth, backed by sustainable business fundamentals.", "url": "https://247wallst.com/investing/2025/12/13/5-dividend-powerhouses-that-could-transform-your-portfolio-into-a-wealth-building-machine/"}}
{"date": "2025-12-13", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-13 08:16:42", "publisher": "Defense World", "title": "AQR Capital Management LLC Has $728.72 Million Stock Holdings in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/aqr-capital-management-llc-has-72872-million-stock-holdings-20251213.png", "site": "defenseworld.net", "text": "AQR Capital Management LLC trimmed its position in Johnson and Johnson (NYSE: JNJ) by 8.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,795,489 shares of the company's stock after selling 470,221 shares during the period. Johnson and Johnson makes", "url": "https://www.defenseworld.net/2025/12/13/aqr-capital-management-llc-has-728-72-million-stock-holdings-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-13", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-13 03:58:50", "publisher": "Defense World", "title": "Ameriprise Financial Inc. Cuts Stock Holdings in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/ameriprise-financial-inc-cuts-stock-holdings-in-johnson-johnson-20251213.png", "site": "defenseworld.net", "text": "Ameriprise Financial Inc. cut its position in shares of Johnson and Johnson (NYSE: JNJ) by 0.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,200,118 shares of the company's stock after selling 82,472 shares during the period. Johnson and Johnson accounts for", "url": "https://www.defenseworld.net/2025/12/13/ameriprise-financial-inc-cuts-stock-holdings-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-12 21:57:00", "publisher": "Business Wire", "title": "California Jury Awards $40 Million in Landmark Talc Verdict Against Johnson & Johnson", "image": "https://images.financialmodelingprep.com/news/california-jury-awards-40-million-in-landmark-talc-verdict-20251212.jpg", "site": "businesswire.com", "text": "LOS ANGELES--(BUSINESS WIRE)--A Los Angeles Superior Court jury today delivered a $40 million verdict against Johnson & Johnson. The trial featured two California women who developed ovarian cancer after decades of using the company's talc-based baby powder products. The award to plaintiffs Monica Kent and Deborah Schultz, and her husband, Dr. Albert Schultz, totals $40 million in compensatory damages. The verdict followed a four-week trial that featured testimony from former United States.", "url": "https://www.businesswire.com/news/home/20251212492794/en/California-Jury-Awards-40-Million-in-Landmark-Talc-Verdict-Against-Johnson-Johnson/"}}
{"date": "2025-12-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-12 21:08:51", "publisher": "Reuters", "title": "Jury orders Johnson & Johnson to pay $40 million to two women in latest talc trial", "image": "https://images.financialmodelingprep.com/news/jury-orders-johnson-johnson-to-pay-40-million-to-20251212.jpg", "site": "reuters.com", "text": "A California jury on Friday awarded $40 million to two women who said Johnson & Johnson's baby powder was to blame for their ovarian cancer.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jury-orders-johnson-johnson-pay-40-million-two-women-latest-talc-trial-2025-12-13/"}}
{"date": "2025-12-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-12 20:25:00", "publisher": "PRNewsWire", "title": "U.S. FDA approves AKEEGA as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*", "image": "https://images.financialmodelingprep.com/news/us-fda-approves-akeega-as-the-first-precision-therapy-20251212.jpg", "site": "prnewswire.com", "text": "Expanded indication for AKEEGA (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with BRCA2-mutated mCSPC HORSHAM, Pa. , Dec. 12, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approvedthe supplemental New Drug Application (sNDA) for AKEEGA (niraparib and abiraterone acetate dual-action tablet) plus prednisone for the treatment of patients with BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC).1 Patients with BRCA mutations often have more aggressive forms of prostate cancer leading to poor prognosis, representing a significant unmet need not addressed by previously available therapies.2 \"There remains an urgent need for novel therapies for patients with BRCA2-mutated mCSPC, who face significantly faster disease progression and often shorter survival compared to those without the mutation,\" said Bradley McGregor, M.D.", "url": "https://www.prnewswire.com/news-releases/us-fda-approves-akeega-as-the-first-precision-therapy-for-brca2-mutated-metastatic-castration-sensitive-prostate-cancer-with-54-reduction-in-disease-progression-vs-standard-of-care-302640552.html"}}
{"date": "2025-12-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-12 12:30:00", "publisher": "The Motley Fool", "title": "These Institutional Investors Are Raising Their Stakes in Johnson & Johnson Stock. Should You Do the Same?", "image": "https://images.financialmodelingprep.com/news/these-institutional-investors-are-raising-their-stakes-in-johnson-20251212.jpg", "site": "fool.com", "text": "A notable bank and a major investment management firm bought more shares of Johnson & Johnson. The healthcare giant has performed well this year despite some significant headwinds.", "url": "https://www.fool.com/investing/2025/12/12/these-institutional-investors-are-raising-their-st/"}}
{"date": "2025-12-11", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-11 19:05:02", "publisher": "Seeking Alpha", "title": "Johnson & Johnson: Reliable Cash Flows, Moderate Expectations", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reliable-cash-flows-moderate-expectations-20251211.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson has surged 14% since my last update, surpassing my $188 target, and now trades near $200. Top-line growth is accelerating, but revenue expansion remains below industry rates and is partially priced in after a strong rally. JNJ's capital structure remains leveraged, clouding its outlook despite progress in positioning for future success.", "url": "https://seekingalpha.com/article/4852732-johnson-and-johnson-reliable-cash-flows-moderate-expectations"}}
{"date": "2025-12-11", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-11 18:46:19", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-exceeds-market-returns-some-facts-to-20251211.jpg", "site": "zacks.com", "text": "In the most recent trading session, Johnson & Johnson (JNJ) closed at $210.01, indicating a +1.68% shift from the previous trading day.", "url": "https://www.zacks.com/stock/news/2803288/johnson-johnson-jnj-exceeds-market-returns-some-facts-to-consider?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2803288"}}
{"date": "2025-12-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-10 17:28:43", "publisher": "24/7 Wall Street", "title": "5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right Now", "image": "https://images.financialmodelingprep.com/news/5-dividend-powerhouses-that-belong-in-every-retirement-portfolio-20251210.jpg", "site": "247wallst.com", "text": "For investors approaching or in retirement, the right stock portfolio balances reliable income, low volatility, and consistent dividend growth.", "url": "https://247wallst.com/investing/2025/12/10/5-dividend-powerhouses-that-belong-in-every-retirement-portfolio-right-now/"}}
{"date": "2025-12-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-10 08:35:55", "publisher": "Zacks Investment Research", "title": "JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now?", "image": "https://images.financialmodelingprep.com/news/jnj-vs-pfe-which-bluechip-drug-stock-is-the-20251210.jpg", "site": "zacks.com", "text": "JNJ and PFE battle patent cliffs and policy headwinds, but rising estimates and stronger 2025 momentum push JNJ ahead in this blue-chip faceoff.", "url": "https://www.zacks.com/stock/news/2802052/jnj-vs-pfe-which-blue-chip-drug-stock-is-the-better-investment-now?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2802052"}}
{"date": "2025-12-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-10 07:37:00", "publisher": "GuruFocus", "title": "First Look: Fed Cut Looms; SpaceX IPO; J&J Myeloma Data; Google Probe", "image": "https://images.financialmodelingprep.com/news/first-look-fed-cut-looms-spacex-ipo-jj-myeloma-20251210.png", "site": "gurufocus.com", "text": "Stock News Fed set for a hawkish cut: The Federal Reserve is widely expected to deliver a third 25 bp rate cut amid sharp divisions over inflation vs. job", "url": "https://www.gurufocus.com/news/3240667/first-look-fed-cut-looms-spacex-ipo-jj-myeloma-data-google-probe"}}
{"date": "2025-12-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-09 21:50:00", "publisher": "Seeking Alpha", "title": "GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities", "image": "https://images.financialmodelingprep.com/news/gs-equity-income-fund-q3-2025-witnesses-fundamental-strength-20251209.jpg", "site": "seekingalpha.com", "text": "The US Equity Income Fund underperformed its benchmark, the Russell 1000 Value Index, net of fees during the third quarter. Enterprise software company, Oracle Corporation, was a top contributor to relative returns during the quarter. Our position in consumer healthcare company, Kenvue Inc., was a top detractor from relative performance during the month.", "url": "https://seekingalpha.com/article/4851854-q3-2025-witnesses-fundamental-strength-and-expansive-margin-opportunities"}}
{"date": "2025-12-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-09 12:18:24", "publisher": "Invezz", "title": "5 defensive stocks traders are buying before the Fed rate-cut decision", "image": "https://images.financialmodelingprep.com/news/5-defensive-stocks-traders-are-buying-before-the-fed-20251209.jpg", "site": "invezz.com", "text": "With the Federal Reserve set to announce its final policy decision of 2025 on Wednesday, investors are rotating into defensive positions. More than the rate-cut possibility (which is around 90% as per recent estimates), the traders are worried about whether the central bank will signal more easing ahead or take a harder stance.", "url": "https://invezz.com/news/2025/12/09/five-defensive-stocks-traders-are-buying-before-the-fed-rate-cut-decision/"}}
{"date": "2025-12-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-09 10:55:17", "publisher": "The Motley Fool", "title": "1 Major Factor Behind the Healthcare Sector's Recent Surge", "image": "https://images.financialmodelingprep.com/news/1-major-factor-behind-the-healthcare-sectors-recent-surge-20251209.jpg", "site": "fool.com", "text": "Eli Lilly's GLP-1 drug became the world's best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other companies are soaring on new drugs or the growth of existing ones.", "url": "https://www.fool.com/investing/2025/12/09/major-factor-behind-healthcare-sector-surge/"}}
{"date": "2025-12-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-09 09:18:53", "publisher": "24/7 Wall Street", "title": "The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026", "image": "https://images.financialmodelingprep.com/news/the-5-best-sp-500-dividend-aristocrat-stocks-to-20251209.jpg", "site": "247wallst.com", "text": "Investors love S&P 500 dividend stocks, especially those with dependable, high yields, because they provide a substantial passive income stream and offer significant total return potential.", "url": "https://247wallst.com/investing/2025/12/09/the-5-best-sp-500-dividend-aristocrat-stocks-to-buy-before-2026/"}}
{"date": "2025-12-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-09 07:50:02", "publisher": "24/7 Wall Street", "title": "3 Under-the-Radar Dividend Stocks Quietly Beating the Market", "image": "https://images.financialmodelingprep.com/news/3-undertheradar-dividend-stocks-quietly-beating-the-market-20251209.jpg", "site": "247wallst.com", "text": "For reasons that seem pretty obvious, dividend investors tend to chase the most familiar names like Pepsi (NYSE:PEP), Johnson and Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG), and they do so for a lot of the right reasons.", "url": "https://247wallst.com/investing/2025/12/09/3-under-the-radar-dividend-stocks-quietly-beating-the-market/"}}
{"date": "2025-12-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-09 07:44:00", "publisher": "PRNewsWire", "title": "Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI plus DARZALEX FASPRO as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma", "image": "https://images.financialmodelingprep.com/news/unprecedented-results-from-the-phase-3-majestec3-study-support-20251209.jpg", "site": "prnewswire.com", "text": "TECVAYLI and DARZALEX FASPRO combination led to a statistically significant progression-free survival and overall survival advantage compared to standard treatment after three years of follow-up Combination regimen granted Breakthrough Therapy Designation by U.S. FDA ORLANDO,Fla., Dec. 9, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI (teclistamab-cqyv) plus DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) as early as second line for patients with relapsed/refractory multiple myeloma (RRMM).", "url": "https://www.prnewswire.com/news-releases/unprecedented-results-from-the-phase-3-majestec-3-study-support-tecvayli-plus-darzalex-faspro-as-a-potential-standard-of-care-as-early-as-second-line-for-patients-with-relapsedrefractory-multiple-myeloma-302636559.html"}}
{"date": "2025-12-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-08 16:25:00", "publisher": "Business Wire", "title": "Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-44th-annual-jp-20251208.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026. Management will participate in a Fireside Chat at 11:15 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available.", "url": "https://www.businesswire.com/news/home/20251208077091/en/Johnson-Johnson-to-Participate-in-the-44th-Annual-J.P.-Morgan-Healthcare-Conference/"}}
{"date": "2025-12-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-08 13:10:37", "publisher": "247 Wallst", "title": "Why 2026 Could Be the Breakout Year for Dividend Growth Investors", "image": "https://images.financialmodelingprep.com/news/why-2026-could-be-the-breakout-year-for-dividend-20251208.jpg", "site": "247wallst.com", "text": "Dividend growth investing has always had an appeal to people who are looking to boost their income, find stability in another unstable market, and build long-term wealth. However, 2026 is shaping up to be something of a turning point as a breakout year for this growing investment philosophy. Between market conditions, earnings trends, and a... Why 2026 Could Be the Breakout Year for Dividend Growth Investors.", "url": "https://247wallst.com/investing/2025/12/08/why-2026-could-be-the-breakout-year-for-dividend-growth-investors/"}}
{"date": "2025-12-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-08 12:11:07", "publisher": "Zacks Investment Research", "title": "Can J&J Offset Stelara LOE, MedTech China and Legal Headwinds in 2026?", "image": "https://images.financialmodelingprep.com/news/can-jj-offset-stelara-loe-medtech-china-and-legal-20251208.jpg", "site": "zacks.com", "text": "J&J faces Stelara losses, Medicare shifts, talc suits and China pressure, banking on new products and expects segment growth to stay on track.", "url": "https://www.zacks.com/stock/news/2801106/can-j-j-offset-stelara-loe-medtech-china-and-legal-headwinds-in-2026?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2801106"}}
{"date": "2025-12-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-08 03:34:52", "publisher": "Defense World", "title": "Bank of Nova Scotia Raises Stake in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/bank-of-nova-scotia-raises-stake-in-johnson-johnson-20251208.png", "site": "defenseworld.net", "text": "Bank of Nova Scotia increased its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 29.0% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 778,643 shares of the company's stock after acquiring an additional 175,272 shares during", "url": "https://www.defenseworld.net/2025/12/08/bank-of-nova-scotia-raises-stake-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-07 07:30:00", "publisher": "Seeking Alpha", "title": "The Generational Shift I See Now - And My 33 Stocks For What's Coming", "image": "https://images.financialmodelingprep.com/news/the-generational-shift-i-see-now-and-my-33-20251207.jpg", "site": "seekingalpha.com", "text": "I see a generational opportunity in quality stocks, defined by high ROE, stable earnings growth, and low debt. Quality stocks have underperformed AI-driven leaders, creating rare relative value and attractive risk/reward for diversified, income-focused investors. My screen highlights 33 U.S. large caps with 25% ROE and 2% yield, many trading at compelling valuations.", "url": "https://seekingalpha.com/article/4850802-the-generational-shift-i-see-now-and-my-33-stocks-for-whats-coming"}}
{"date": "2025-12-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-07 05:46:43", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Bought by Cerity Partners LLC", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-bought-by-cerity-partners-llc-20251207.png", "site": "defenseworld.net", "text": "Cerity Partners LLC lifted its position in shares of Johnson and Johnson (NYSE: JNJ) by 2.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,811,564 shares of the company's stock after purchasing an additional 39,452 shares during the quarter. Cerity", "url": "https://www.defenseworld.net/2025/12/07/johnson-johnson-jnj-shares-bought-by-cerity-partners-llc.html"}}
{"date": "2025-12-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-06 09:30:00", "publisher": "PRNewsWire", "title": "Earlier use of CARVYKTI demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma", "image": "https://images.financialmodelingprep.com/news/earlier-use-of-carvykti-demonstrated-lasting-treatmentfree-remissions-at-20251206.jpg", "site": "prnewswire.com", "text": "Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single infusion as early as second line Data suggest stronger immune fitness in earlier lines may be associated with longer progression free survival ORLANDO, Fla. , Dec. 6, 2025 /PRNewswire/ -- Johnson & Johnson(NYSE: JNJ) announced today updated results from the Phase 3 CARTITUDE-4 study supporting durable treatment-free remissions as early as second line treatment withCARVYKTI (ciltacabtagene autoleucel; cilta-cel).", "url": "https://www.prnewswire.com/news-releases/earlier-use-of-carvykti-demonstrated-lasting-treatment-free-remissions-at-2-5-years-in-patients-with-relapsed-or-refractory-multiple-myeloma-302634479.html"}}
{"date": "2025-12-05", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-05 16:20:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson's INLEXZO (gemcitabine intravesical system) delivers 74 percent disease-free survival at one year in BCG-unresponsive, high-risk, papillary-only NMIBC", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-inlexzo-gemcitabine-intravesical-system-delivers-74-percent-20251205.jpg", "site": "prnewswire.com", "text": "New data from Cohort 4 of the SunRISe-1 study show more than 95 percent of patients remained progression free at one year, with more than 92 percent not undergoing bladder removal Patients with this type of bladder cancer have limited choices beyond radical cystectomy, highlighting the need for newer therapies for bladder preservation RARITAN, N.J. , Dec. 5, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) announced today that new data from the investigational Cohort 4 of the Phase 2b SunRISe-1 study show treatment with gemcitabine intravesical system resulted in high one-year disease-free survival (DFS), progression-free survival (PFS), and overall survival (OS) rates in patients with Bacillus Calmette-Gurin (BCG)-unresponsive, high-risk, papillary-only non-muscle invasive bladder cancer (NMIBC).1 These data were featured as a late-breaking oral presentation at the Society of Urologic Oncology (SUO) 2025 Annual Meeting and build upon data presentedat the 2025 American Urological Association (AUA) Annual Meeting.", "url": "https://www.prnewswire.com/news-releases/johnson--johnsons-inlexzo-gemcitabine-intravesical-system-delivers-74-percent-disease-free-survival-at-one-year-in-bcg-unresponsive-high-risk-papillary-only-nmibc-302634314.html"}}
{"date": "2025-12-05", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-05 05:56:44", "publisher": "Defense World", "title": "Beutel Goodman & Co Ltd. Reduces Stake in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/beutel-goodman-co-ltd-reduces-stake-in-johnson-johnson-20251205.png", "site": "defenseworld.net", "text": "Beutel Goodman and Co Ltd. lowered its holdings in Johnson and Johnson (NYSE: JNJ) by 5.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 42,781 shares of the company's stock after selling 2,495 shares during the quarter. Beutel Goodman and Co", "url": "https://www.defenseworld.net/2025/12/05/beutel-goodman-co-ltd-reduces-stake-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-04", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-04 18:46:08", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-stock-drops-despite-market-gains-important-20251204.jpg", "site": "zacks.com", "text": "The latest trading day saw Johnson & Johnson (JNJ) settling at $202.48, representing a -1.39% change from its previous close.", "url": "https://www.zacks.com/stock/news/2799951/johnson-johnson-jnj-stock-drops-despite-market-gains-important-facts-to-note?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2799951"}}
{"date": "2025-12-04", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-04 16:06:00", "publisher": "24/7 Wall Street", "title": "The Dividend Stocks That Keep Paying Even When Markets Stumble", "image": "https://images.financialmodelingprep.com/news/the-dividend-stocks-that-keep-paying-even-when-markets-20251204.jpg", "site": "247wallst.com", "text": "When it comes to weathering market volatility, there is no easy answer, and what's worse is that when investors, retail or otherwise, try to time the market, it usually ends in disaster.", "url": "https://247wallst.com/investing/2025/12/04/the-dividend-stocks-that-keep-paying-even-when-markets-stumble/"}}
{"date": "2025-12-04", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-04 10:31:38", "publisher": "Zacks Investment Research", "title": "3 Large Drug Stocks to Watch as the Industry Shows Some Recovery", "image": "https://images.financialmodelingprep.com/news/3-large-drug-stocks-to-watch-as-the-industry-20251204.jpg", "site": "zacks.com", "text": "In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.", "url": "https://www.zacks.com/commentary/2799269/3-large-drug-stocks-to-watch-as-the-industry-shows-some-recovery?cid=CS-STOCKNEWSAPI-FT-industry_outlook-2799269"}}
{"date": "2025-12-04", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-04 04:38:52", "publisher": "Defense World", "title": "Edgestream Partners L.P. Sells 63,615 Shares of Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/edgestream-partners-lp-sells-63615-shares-of-johnson-johnson-20251204.png", "site": "defenseworld.net", "text": "Edgestream Partners L.P. cut its stake in shares of Johnson and Johnson (NYSE: JNJ) by 70.7% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,411 shares of the company's stock after selling 63,615 shares during the period. Edgestream Partners L.P.'s holdings in", "url": "https://www.defenseworld.net/2025/12/04/edgestream-partners-l-p-sells-63615-shares-of-johnson-johnson-jnj.html"}}
{"date": "2025-12-03", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-03 14:13:25", "publisher": "Seeking Alpha", "title": "Johnson & Johnson (JNJ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-presents-at-citi-annual-global-healthcare-20251203.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson (JNJ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript", "url": "https://seekingalpha.com/article/4849878-johnson-and-johnson-jnj-presents-at-citi-annual-global-healthcare-conference-2025-transcript"}}
{"date": "2025-12-03", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-03 10:01:13", "publisher": "Zacks Investment Research", "title": "Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?", "image": "https://images.financialmodelingprep.com/news/is-mostwatched-stock-johnson-johnson-jnj-worth-betting-on-20251203.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "url": "https://www.zacks.com/stock/news/2798754/is-most-watched-stock-johnson-johnson-jnj-worth-betting-on-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2798754"}}
{"date": "2025-12-02", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-02 14:46:42", "publisher": "24/7 Wall Street", "title": "3 Dividend Stocks Wall Street is Piling Into Before 2026", "image": "https://images.financialmodelingprep.com/news/3-dividend-stocks-wall-street-is-piling-into-before-20251202.jpg", "site": "247wallst.com", "text": "There is an apparent shift in how Wall Street views the stock market, as retail investors are increasingly doubting the AI rally.", "url": "https://247wallst.com/investing/2025/12/02/3-dividend-stocks-wall-street-is-piling-into-before-2026/"}}
{"date": "2025-12-02", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-02 11:10:25", "publisher": "Zacks Investment Research", "title": "JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis", "image": "https://images.financialmodelingprep.com/news/jnj-gets-eu-nod-for-imaavy-in-generalized-myasthenia-20251202.jpg", "site": "zacks.com", "text": "J&J gains EU approval for Imaavy, the first FcRn blocker for adults and adolescents with generalized myasthenia gravis.", "url": "https://www.zacks.com/stock/news/2798360/jnj-gets-eu-nod-for-imaavy-in-generalized-myasthenia-gravis?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2798360"}}
{"date": "2025-12-02", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-02 04:36:48", "publisher": "Defense World", "title": "Brandes Investment Partners LP Purchases 8,502 Shares of Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/brandes-investment-partners-lp-purchases-8502-shares-of-johnson-20251202.png", "site": "defenseworld.net", "text": "Brandes Investment Partners LP lifted its position in shares of Johnson and Johnson (NYSE: JNJ) by 2.1% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 410,765 shares of the company's stock after buying an additional 8,502 shares during the quarter. Brandes Investment Partners LP's", "url": "https://www.defenseworld.net/2025/12/02/brandes-investment-partners-lp-purchases-8502-shares-of-johnson-johnson-jnj.html"}}
{"date": "2025-12-01", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-01 13:36:00", "publisher": "Seeking Alpha", "title": "American Century Value Fund Q3 2025 Contributors/Detractors And Notable Trades", "image": "https://images.financialmodelingprep.com/news/american-century-value-fund-q3-2025-contributorsdetractors-and-notable-20251201.jpg", "site": "seekingalpha.com", "text": "Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. We initiated a position in this customer relationship management software company because it enjoys a dominant market share and a wide competitive moat. We exited our position in nVent. It rallied on the prospect of increasing data center demand, pushing the stock above what we viewed as its fair value.", "url": "https://seekingalpha.com/article/4849016-american-century-value-fund-q3-2025-contributors-detractors-and-notable-trades"}}
{"date": "2025-12-01", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-01 13:16:21", "publisher": "24/7 Wall Street", "title": "Time to Shore Up Your Personal Portfolio With These 3 Bullet-Proof Blue-Chip Stocks", "image": "https://images.financialmodelingprep.com/news/time-to-shore-up-your-personal-portfolio-with-these-20251201.jpg", "site": "247wallst.com", "text": "There are a number of valid reasons why many investors may be souring on the ability of equity markets to continue to rise at a 20%+ rate in the years to come.", "url": "https://247wallst.com/investing/2025/12/01/time-to-shore-up-your-personal-portfolio-with-these-3-bullet-proof-blue-chip-stocks/"}}
{"date": "2025-12-01", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-01 08:49:53", "publisher": "24/7 Wall Street", "title": "20 Years on Wall Street Taught Me: 5 Large Cap High-Yield Dividend Giants You Never Sell", "image": "https://images.financialmodelingprep.com/news/20-years-on-wall-street-taught-me-5-large-20251201.jpg", "site": "247wallst.com", "text": "After a 35-year career in the finance industry, including two decades as an institutional stockbroker at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing.", "url": "https://247wallst.com/investing/2025/12/01/20-years-on-wall-street-taught-me-5-large-cap-high-yield-dividend-giants-you-never-sell/"}}
{"date": "2025-12-01", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-01 08:18:00", "publisher": "GlobeNewsWire", "title": "Johnson & Johnson receives European Commission approval of IMAAVY (nipocalimab), a new FcRn blocker offering sustained disease control in a broad population of people living with generalised myasthenia gravis (gMG)", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-receives-european-commission-approval-of-imaavy-nipocalimab-20251201.jpg", "site": "globenewswire.com", "text": "Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive", "url": "https://www.globenewswire.com/news-release/2025/12/01/3196985/0/en/Johnson-Johnson-receives-European-Commission-approval-of-IMAAVY-nipocalimab-a-new-FcRn-blocker-offering-sustained-disease-control-in-a-broad-population-of-people-living-with-genera.html"}}
{"date": "2025-12-01", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-01 04:16:44", "publisher": "Defense World", "title": "Brentview Investment Management LLC Has $3.20 Million Position in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/brentview-investment-management-llc-has-320-million-position-in-20251201.png", "site": "defenseworld.net", "text": "Brentview Investment Management LLC lessened its position in shares of Johnson and Johnson (NYSE: JNJ) by 2.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,929 shares of the company's stock after selling 427 shares during the period.", "url": "https://www.defenseworld.net/2025/12/01/brentview-investment-management-llc-has-3-20-million-position-in-johnson-johnson-jnj.html"}}
{"date": "2025-12-01", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-12-01 03:30:54", "publisher": "Defense World", "title": "Boston Family Office LLC Trims Stock Position in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/boston-family-office-llc-trims-stock-position-in-johnson-20251201.png", "site": "defenseworld.net", "text": "Boston Family Office LLC lessened its stake in Johnson and Johnson (NYSE: JNJ) by 9.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,497 shares of the company's stock after selling 7,722 shares during the period. Boston Family", "url": "https://www.defenseworld.net/2025/12/01/boston-family-office-llc-trims-stock-position-in-johnson-johnson-jnj.html"}}
{"date": "2025-11-30", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-30 06:30:00", "publisher": "The Motley Fool", "title": "3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio", "image": "https://images.financialmodelingprep.com/news/3-stocks-to-buy-and-hold-the-longterm-play-20251130.jpg", "site": "fool.com", "text": "Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-term investors.", "url": "https://www.fool.com/investing/2025/11/30/stocks-buy-and-hold-long-term-pfe-mdt-jnj/"}}
{"date": "2025-11-30", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-30 04:05:00", "publisher": "The Motley Fool", "title": "2 Top Dividend Stocks to Buy and Hold", "image": "https://images.financialmodelingprep.com/news/2-top-dividend-stocks-to-buy-and-hold-20251130.jpg", "site": "fool.com", "text": "Bristol Myers Squibb and Johnson & Johnson have had a tough past few years due to several factors. Both companies are looking to right the ship thanks to new product launches.", "url": "https://www.fool.com/investing/2025/11/30/2-top-dividend-stocks-to-buy-and-hold/"}}
{"date": "2025-11-29", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-29 03:27:02", "publisher": "Defense World", "title": "Berry Wealth Group LP Cuts Stock Holdings in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/berry-wealth-group-lp-cuts-stock-holdings-in-johnson-20251129.png", "site": "defenseworld.net", "text": "Berry Wealth Group LP lessened its holdings in Johnson and Johnson (NYSE: JNJ) by 1.4% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 18,336 shares of the company's stock after selling 258 shares during the period. Johnson and Johnson comprises 2.0% of Berry Wealth Group", "url": "https://www.defenseworld.net/2025/11/29/berry-wealth-group-lp-cuts-stock-holdings-in-johnson-johnson-jnj.html"}}
{"date": "2025-11-29", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-29 01:45:00", "publisher": "Seeking Alpha", "title": "Dogs Of The Dow Continue Outperforming Broader Market", "image": "https://images.financialmodelingprep.com/news/dogs-of-the-dow-continue-outperforming-broader-market-20251129.jpg", "site": "seekingalpha.com", "text": "Through the end of November, the year-to-date total return of the Dogs of the Dow equals 20.96%, outpacing the Dow Jones Industrial Average return of 13.86% and outpacing the broader S&P 500 Index return of 17.74%. In a sign the market seems to be broadening out, two of the top three performing Dow Dogs are health care stocks, Johnson & Johnson and Amgen. The Dogs of the Dow strategy is one where investors select the ten stocks that have the highest dividend yield from the stocks in the DJIA Index after the close of business on the last trading day of the year.", "url": "https://seekingalpha.com/article/4848687-dogs-of-dow-continue-outperforming-broader-market"}}
{"date": "2025-11-28", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-28 11:05:49", "publisher": "Zacks Investment Research", "title": "JNJ's Oncology Momentum Builds as It Chases $50B Goal by 2030", "image": "https://images.financialmodelingprep.com/news/jnjs-oncology-momentum-builds-as-it-chases-50b-goal-20251128.jpg", "site": "zacks.com", "text": "JNJ's oncology sales surge on strong drug launches and pipeline momentum, raising the stakes for its ambitious $50B 2030 goal.", "url": "https://www.zacks.com/stock/news/2797167/jnj-s-oncology-momentum-builds-as-it-chases-50b-goal-by-2030?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2797167"}}
{"date": "2025-11-28", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-28 07:50:00", "publisher": "Seeking Alpha", "title": "Wasatch Global Value Fund Q3 2025 Performance Review", "image": "https://images.financialmodelingprep.com/news/wasatch-global-value-fund-q3-2025-performance-review-20251128.jpg", "site": "seekingalpha.com", "text": "The Wasatch Global Value Fund - Investor Class gained 6.36% in the third quarter of 2025, outperforming the MSCI All Country World Value Index, which added 6.13%. Leading contributors to the Fund's performance included Chinese e-commerce giant Alibaba Group. Leading detractors from Fund performance for the quarter included Centene Corp.", "url": "https://seekingalpha.com/article/4848513-wasatch-global-value-fund-q3-2025-performance-review"}}
{"date": "2025-11-27", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-27 06:30:00", "publisher": "The Motley Fool", "title": "3 Superb Dividend Stocks to Hold for the Next 20 Years", "image": "https://images.financialmodelingprep.com/news/3-superb-dividend-stocks-to-hold-for-the-next-20251127.jpeg", "site": "fool.com", "text": "Johnson & Johnson is a financial fortress with a solid pipeline and portfolio. Coca-Cola has an asset-light model that drives its profitability.", "url": "https://www.fool.com/investing/2025/11/27/3-dividend-stocks-to-hold-for-the-next-20-years/"}}
{"date": "2025-11-27", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-27 04:01:00", "publisher": "The Motley Fool", "title": "Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years", "image": "https://images.financialmodelingprep.com/news/have-2000-to-invest-here-are-4-of-my-20251127.jpeg", "site": "fool.com", "text": "Pfizer and Johnson & Johnson are healthcare leaders and faithful dividend payers. Home Depot is facing a difficult operating environment, but its core business remains strong.", "url": "https://www.fool.com/investing/2025/11/27/4-of-my-favorite-dividend-stocks-for-next-5-years/"}}
{"date": "2025-11-27", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-27 02:06:55", "publisher": "Defense World", "title": "Rep. Lisa C. McClain Sells Off Shares of Johnson & Johnson (NYSE:JNJ)", "image": "https://images.financialmodelingprep.com/news/rep-lisa-c-mcclain-sells-off-shares-of-johnson-20251127.png", "site": "defenseworld.net", "text": "Representative Lisa C. McClain (R-Michigan) recently sold shares of Johnson and Johnson (NYSE: JNJ). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Johnson and Johnson stock on October 31st. The trade occurred in the Representative's \"CHARLES SCHWAB 401K > SCHWAB 893\" account. Representative Lisa C.", "url": "https://www.defenseworld.net/2025/11/27/rep-lisa-c-mcclain-sells-off-shares-of-johnson-johnson-nysejnj.html"}}
{"date": "2025-11-26", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-26 10:51:13", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-a-topranked-momentum-stock-should-20251126.jpg", "site": "zacks.com", "text": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.", "url": "https://www.zacks.com/stock/news/2796003/johnson-johnson-jnj-is-a-top-ranked-momentum-stock-should-you-buy?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_momentum_score-2796003"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-25 18:00:00", "publisher": "GuruFocus", "title": "Market Today: Stocks Rise on Fed Cut Bets; Alphabet, Apple Hit Records", "image": "https://images.financialmodelingprep.com/news/market-today-stocks-rise-on-fed-cut-bets-alphabet-20251125.png", "site": "gurufocus.com", "text": "Guru Stock PicksJefferies Group has made the following transactions:Reduce in CLDX by 12.28%Sold out in UNFIAdd in SMH by 25.28%New position in XNCRT Rowe Price", "url": "https://www.gurufocus.com/news/3224917/market-today-stocks-rise-on-fed-cut-bets-alphabet-apple-hit-records"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-25 08:26:04", "publisher": "Zacks Investment Research", "title": "J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?", "image": "https://images.financialmodelingprep.com/news/jj-up-around-17-in-3-months-should-you-20251125.jpg", "site": "zacks.com", "text": "J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.", "url": "https://www.zacks.com/stock/news/2795171/j-j-up-around-17-in-3-months-should-you-buy-sell-or-hold-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2795171"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-25 05:54:56", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Sold by Advisors Asset Management Inc.", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-sold-by-advisors-asset-management-20251125.png", "site": "defenseworld.net", "text": "Advisors Asset Management Inc. trimmed its position in shares of Johnson and Johnson (NYSE: JNJ) by 1.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 188,271 shares of the company's stock after selling 2,956 shares during the", "url": "https://www.defenseworld.net/2025/11/25/johnson-johnson-jnj-shares-sold-by-advisors-asset-management-inc.html"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-25 05:20:12", "publisher": "Forbes", "title": "JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?", "image": "https://images.financialmodelingprep.com/news/jnj-stock-vs-pfe-stock-which-pharmaceutical-giant-is-20251125.jpg", "site": "forbes.com", "text": "The pharmaceutical powerhouse Johnson & Johnson (NYSE: JNJ) has significantly outperformed its competitor Pfizer (NYSE: PFE) this year. JNJ's stock has risen by almost 45%, whereas PFE has declined by 6%, greatly exceeding the S&P 500's 13% increase.", "url": "https://www.forbes.com/sites/greatspeculations/2025/11/25/jnj-stock-vs-pfe-stock-which-pharmaceutical-giant-is-a-better-buy/"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-25 04:34:52", "publisher": "Defense World", "title": "Aviso Financial Inc. Sells 2,635 Shares of Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/aviso-financial-inc-sells-2635-shares-of-johnson-johnson-20251125.png", "site": "defenseworld.net", "text": "Aviso Financial Inc. reduced its stake in Johnson and Johnson (NYSE: JNJ) by 8.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,839 shares of the company's stock after selling 2,635 shares during the period. Aviso Financial Inc.'s holdings", "url": "https://www.defenseworld.net/2025/11/25/aviso-financial-inc-sells-2635-shares-of-johnson-johnson-jnj.html"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-25 04:34:51", "publisher": "Defense World", "title": "Armor Investment Advisors LLC Decreases Stake in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/armor-investment-advisors-llc-decreases-stake-in-johnson-johnson-20251125.png", "site": "defenseworld.net", "text": "Armor Investment Advisors LLC reduced its stake in shares of Johnson and Johnson (NYSE: JNJ) by 12.8% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,310 shares of the company's stock after selling 338 shares during the period. Armor Investment Advisors LLC's", "url": "https://www.defenseworld.net/2025/11/25/armor-investment-advisors-llc-decreases-stake-in-johnson-johnson-jnj.html"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-25 03:58:59", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Sold by Associated Banc Corp", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-sold-by-associated-banc-corp-20251125.png", "site": "defenseworld.net", "text": "Associated Banc Corp trimmed its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 2.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 145,603 shares of the company's stock after selling 3,508 shares during the period. Associated", "url": "https://www.defenseworld.net/2025/11/25/johnson-johnson-jnj-shares-sold-by-associated-banc-corp.html"}}
{"date": "2025-11-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-25 01:20:56", "publisher": "Defense World", "title": "Johnson & Johnson Target of Unusually High Options Trading (NYSE:JNJ)", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-target-of-unusually-high-options-trading-nysejnj-20251125.png", "site": "defenseworld.net", "text": "Johnson and Johnson (NYSE: JNJ - Get Free Report) saw unusually large options trading activity on Monday. Stock investors bought 201,479 call options on the stock. This represents an increase of 468% compared to the typical daily volume of 35,489 call options. Analyst Ratings Changes JNJ has been the subject of a number of research analyst", "url": "https://www.defenseworld.net/2025/11/25/johnson-johnson-target-of-unusually-high-options-trading-nysejnj.html"}}
{"date": "2025-11-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-22 05:52:43", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Bought by Bahl & Gaynor Inc.", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-bought-by-bahl-gaynor-inc-20251122.png", "site": "defenseworld.net", "text": "Bahl and Gaynor Inc. raised its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 15.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,526,930 shares of the company's stock after purchasing an additional 338,839 shares during", "url": "https://www.defenseworld.net/2025/11/22/johnson-johnson-jnj-shares-bought-by-bahl-gaynor-inc.html"}}
{"date": "2025-11-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-22 03:47:01", "publisher": "Defense World", "title": "AlphaCore Capital LLC Buys 5,686 Shares of Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/alphacore-capital-llc-buys-5686-shares-of-johnson-johnson-20251122.png", "site": "defenseworld.net", "text": "AlphaCore Capital LLC boosted its stake in Johnson and Johnson (NYSE: JNJ) by 27.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,505 shares of the company's stock after purchasing an additional 5,686 shares during the quarter. AlphaCore Capital LLC's holdings in", "url": "https://www.defenseworld.net/2025/11/22/alphacore-capital-llc-buys-5686-shares-of-johnson-johnson-jnj.html"}}
{"date": "2025-11-21", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-21 12:43:10", "publisher": "The Motley Fool", "title": "1 Reason Why Shares of Johnson & Johnson Are Surging This Month", "image": "https://images.financialmodelingprep.com/news/1-reason-why-shares-of-johnson-johnson-are-surging-20251121.jpg", "site": "fool.com", "text": "Last month, Johnson & Johnson surged following a well-received quarterly earnings release. Despite a sluggish start to November, a spate of positive news has since sent the healthcare stock's shares to new highs.", "url": "https://www.fool.com/investing/2025/11/21/reason-why-shares-jnj-are-surging-november/"}}
{"date": "2025-11-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-19 12:24:46", "publisher": "The Motley Fool", "title": "Why Johnson & Johnson's Share Price Is Popping This Month", "image": "https://images.financialmodelingprep.com/news/why-johnson-johnsons-share-price-is-popping-this-month-20251119.jpg", "site": "fool.com", "text": "J&J beat Wall Street estimates on sales and profits in the third quarter. The company recently announced the acquisition of a biotech with an innovative cancer treatment.", "url": "https://www.fool.com/investing/2025/11/19/why-johnson-johnson-share-price-popping-november/"}}
{"date": "2025-11-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-19 10:01:10", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-attracting-investor-attention-here-is-20251119.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "url": "https://www.zacks.com/stock/news/2792918/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2792918"}}
{"date": "2025-11-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-19 04:34:44", "publisher": "Defense World", "title": "Aspen Investment Management Inc Reduces Position in Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/aspen-investment-management-inc-reduces-position-in-johnson-johnson-jnj-20251119.png", "site": "defenseworld.net", "text": "Aspen Investment Management Inc decreased its stake in shares of Johnson and Johnson (NYSE: JNJ) by 5.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,314 shares of the company's stock after selling 491 shares during the quarter. Aspen Investment", "url": "https://www.defenseworld.net/2025/11/19/aspen-investment-management-inc-reduces-position-in-johnson-johnson-jnj.html"}}
{"date": "2025-11-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-19 03:56:52", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Acquired by ARS Investment Partners LLC", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-acquired-by-ars-investment-partners-20251119.png", "site": "defenseworld.net", "text": "ARS Investment Partners LLC boosted its holdings in Johnson and Johnson (NYSE: JNJ) by 2.6% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,420 shares of the company's stock after purchasing an additional 1,270 shares during the", "url": "https://www.defenseworld.net/2025/11/19/johnson-johnson-jnj-shares-acquired-by-ars-investment-partners-llc.html"}}
{"date": "2025-11-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-19 03:08:58", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Purchased by America First Investment Advisors LLC", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-purchased-by-america-first-investment-20251119.png", "site": "defenseworld.net", "text": "America First Investment Advisors LLC boosted its stake in shares of Johnson and Johnson (NYSE: JNJ) by 0.2% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 150,762 shares of the company's stock after buying an additional 254 shares during the", "url": "https://www.defenseworld.net/2025/11/19/johnson-johnson-jnj-shares-purchased-by-america-first-investment-advisors-llc.html"}}
{"date": "2025-11-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-18 12:06:04", "publisher": "Zacks Investment Research", "title": "J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B", "image": "https://images.financialmodelingprep.com/news/jj-joins-pharma-ma-bandwagon-to-buy-cancer-biotech-20251118.jpg", "site": "zacks.com", "text": "J&J's $3.05B move for Halda adds targeted oral cancer therapies and expands its prostate cancer pipeline amid rising pharma M&A.", "url": "https://www.zacks.com/stock/news/2792619/j-j-joins-pharma-m-a-bandwagon-to-buy-cancer-biotech-for-3-05b?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2792619"}}
{"date": "2025-11-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-18 10:07:17", "publisher": "MarketBeat", "title": "3 Smart Defensive Stocks for an Uneasy Market", "image": "https://images.financialmodelingprep.com/news/3-smart-defensive-stocks-for-an-uneasy-market-20251118.jpg", "site": "marketbeat.com", "text": "At one point in early November, the Dow Jones Industrial Average (DJIA) briefly topped 48,000 for the first time ever. At different times in 2025, the NASDAQ and S&P 500 have made new all-time highs (ATHs).", "url": "https://www.marketbeat.com/stock-ideas/3-smart-defensive-stocks-for-an-uneasy-market/"}}
{"date": "2025-11-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-18 01:16:00", "publisher": "GuruFocus", "title": "Johnson & Johnson Expands Oncology Pipeline with $3.05 Billion Halda Acquisition", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-expands-oncology-pipeline-with-305-billion-halda-20251118.png", "site": "gurufocus.com", "text": "Johnson and Johnson (JNJ, Financials) agreed to buy privately held Halda Therapeutics for $3.05 billion in cash, expanding its cancer portfolio with a focus on so", "url": "https://www.gurufocus.com/news/3212777/johnson-johnson-expands-oncology-pipeline-with-305-billion-halda-acquisition"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 18:07:00", "publisher": "Business Wire", "title": "Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy", "image": "https://images.financialmodelingprep.com/news/vida-ventures-marks-fourth-major-portfolio-acquisition-in-2025-20251117.jpg", "site": "businesswire.com", "text": "LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (Vida), a next-generation life sciences venture firm, today announced its fourth major Vida portfolio acquisition of 2025, capping an unprecedented year of strategic exits and reinforcing the firm's disciplined, science-first approach to company building and investing. Earlier today, Halda Therapeutics announced its acquisition by Johnson & Johnson (NYSE: JNJ) for $3.05 billion, marking a historic moment for the Vida III portfolio. Hald.", "url": "https://www.businesswire.com/news/home/20251117106656/en/Vida-Ventures-Marks-Fourth-Major-Portfolio-Acquisition-in-2025-Capping-a-Record-Setting-Year-for-Its-Science-Led-Discipline-Driven-Strategy/"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 13:17:08", "publisher": "Seeking Alpha", "title": "Johnson & Johnson (JNJ) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-presents-at-7th-annual-wolfe-research-20251117.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson ( JNJ ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 10:40 AM EST Company Participants Candice Long - Worldwide Vice President of Immunology David Lee - Global Therapeutic Area Head, Immunology for Janssen Pharmaceutical Conference Call Participants Alexandria Hammond - Wolfe Research, LLC Presentation Alexandria Hammond Wolfe Research, LLC Good morning, everybody. My name is Alex Hammond, and I'm the biopharma analyst here at Wolfe.", "url": "https://seekingalpha.com/article/4844700-johnson-and-johnson-jnj-presents-at-7th-annual-wolfe-research-healthcare-conference"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 11:51:23", "publisher": "Proactive Investors", "title": "Johnson & Johnson strengthens oncology portfolio with $3B Halda Therapeutics acquisition", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-strengthens-oncology-portfolio-with-3b-halda-therapeutics-20251117.jpg", "site": "proactiveinvestors.com", "text": "Johnson & Johnson (NYSE:JNJ) announced that it has entered into a definitive agreement to acquire Halda Therapeutics, a clinical-stage biotechnology company focused on developing targeted oral therapies for solid tumors, for $3.05 billion in cash. Halda's lead candidate, HLD-0915, is a once-daily oral therapy for prostate cancer that received FDA fast track designation in August 2025 following positive preliminary data from Phase 1/2 trials.", "url": "https://www.proactiveinvestors.com/companies/news/1082653"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 09:39:44", "publisher": "Investors Business Daily", "title": "Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-inks-a-305-billion-deal-in-cancer-20251117.jpg", "site": "investors.com", "text": "Johnson & Johnson said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics.", "url": "https://www.investors.com/news/technology/johnson-johnson-halda-therapeutics-acquisition/"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 08:29:00", "publisher": "WSJ", "title": "Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-buy-halda-therapeutics-for-305-billion-20251117.jpg", "site": "wsj.com", "text": "Johnson & Johnson has agreed to buy clinical-stage biotechnology company Halda Therapeutics for $3.05 billion in cash in a deal that bolsters the healthcare giant's oncology pipeline.", "url": "https://www.wsj.com/business/deals/johnson-johnson-to-buy-halda-therapeutics-for-3-05-billion-2e460ca1"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 08:15:00", "publisher": "GlobeNewsWire", "title": "Halda Therapeutics Announces Acquisition by Johnson & Johnson", "image": "https://images.financialmodelingprep.com/news/halda-therapeutics-announces-acquisition-by-johnson-johnson-20251117.jpg", "site": "globenewswire.com", "text": "NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics announced today that it has entered into a definitive agreement pursuant to which Johnson & Johnson will acquire Halda for $3.05 billion, payable in cash at closing, subject to customary adjustments.", "url": "https://www.globenewswire.com/news-release/2025/11/17/3189145/0/en/Halda-Therapeutics-Announces-Acquisition-by-Johnson-Johnson.html"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 08:11:03", "publisher": "Zacks Investment Research", "title": "Growth or Stability? A 2025 Investment Face-Off Between LLY and JNJ", "image": "https://images.financialmodelingprep.com/news/growth-or-stability-a-2025-investment-faceoff-between-lly-20251117.jpg", "site": "zacks.com", "text": "Eli Lilly's surging GLP-1 momentum and Johnson & Johnson's diversified strength set up a compelling 2025 showdown for investors weighing growth vs. stability.", "url": "https://www.zacks.com/stock/news/2791637/growth-or-stability-a-2025-investment-face-off-between-lly-and-jnj?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2791637"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 08:07:06", "publisher": "Reuters", "title": "J&J to buy cancer therapy developer Halda Therapeutics for $3.05 billion", "image": "https://images.financialmodelingprep.com/news/jj-to-buy-cancer-therapy-developer-halda-therapeutics-for-20251117.jpg", "site": "reuters.com", "text": "Johnson & Johnson said on Monday it would buy Halda Therapeutics for $3.05 billion in cash, expanding its presence in solid tumors and prostate cancer treatments.", "url": "https://www.reuters.com/legal/transactional/jj-buy-cancer-therapy-developer-halda-therapeutics-305-billion-2025-11-17/"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 08:05:00", "publisher": "PRNewsWire", "title": "New long-term data reinforces TREMFYA (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis", "image": "https://images.financialmodelingprep.com/news/new-longterm-data-reinforces-tremfya-guselkumab-as-the-only-20251117.jpg", "site": "prnewswire.com", "text": "First-line treatment with TREMFYA shows significant inhibition of radiographic progression at Week 24, which was sustained through Week 48, preserving joint health with a well-established safety profile More than half of TREMFYA-treated patients across both dose groups achieved a 50% improvement in signs and symptoms of psoriatic arthritis by Week 48 in the Phase 3b APEX study NEW YORK , Nov. 17, 2025 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ) today announced new data from the Phase 3b APEX study showing that TREMFYA continued to reduce both signs and symptoms of active psoriatic arthritis (PsA) and inhibit progression of structural damage at 48 weeks.1 These data were presented at the Inflammatory Skin Disease Summit (ISDS) 2025. At Week 24, TREMFYA  demonstrated two and a half times greater ability to inhibit joint structural damage versus placebo with results consistent for patients with active PsA receiving TREMFYAevery four weeks (Q4W)a or every eight weeks (Q8W), as assessed by the PsA-modified van der Heijde-Sharp (vdH-S) score.2 The inhibition of structural joint damage was sustained through Week 48.1The 24 Week data from the APEX study was recently published in the Annals of the Rheumatic Diseases .3 Additionally, for patients in the study's placebo group, who switched to TREMFYA at Week 24, the rate of radiographic progression from baseline to Week 24 (0.96) was reduced by 57% (to 0.41) from Week 24 through Week 48, as measured by mean change in the PsA-modified vdH-S score.b \"Psoriatic arthritis is a chronic condition where joint damage can begin early and progress quickly if left untreated,\" said Christopher Ritchlin, MD, MPH of the University of Rochester Medical Center and APEX study investigator.c \"The APEX study results show that guselkumab can inhibit this process, even once it has begun, making it a valuable treatment option for both initiating treatment early and for patients who already show signs of joint damage.", "url": "https://www.prnewswire.com/news-releases/new-long-term-data-reinforces-tremfya-guselkumab-as-the-only-il-23-inhibitor-proven-to-substantially-inhibit-structural-joint-damage-in-active-psoriatic-arthritis-302616074.html"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 08:00:00", "publisher": "Business Wire", "title": "Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-set-to-revolutionize-the-treatment-of-cancer-20251117.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today that it has entered into a definitive agreement to acquire Halda Therapeutics OpCo, Inc. (Halda), a clinical-stage biotechnology company with a proprietary Regulated Induced Proximity TArgeting Chimera (RIPTAC) platform to develop oral, targeted therapies for multiple types of solid tumors, including prostate cancer, for $3.05 billion in cash. The transaction is expected to close within the next few months,.", "url": "https://www.businesswire.com/news/home/20251117764257/en/Johnson-Johnson-Set-to-Revolutionize-the-Treatment-of-Cancer-With-the-Acquisition-of-Halda-Therapeutics/"}}
{"date": "2025-11-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-17 03:30:50", "publisher": "Defense World", "title": "Alberta Investment Management Corp Sells 109,135 Shares of Johnson & Johnson $JNJ", "image": "https://images.financialmodelingprep.com/news/alberta-investment-management-corp-sells-109135-shares-of-johnson-20251117.png", "site": "defenseworld.net", "text": "Alberta Investment Management Corp cut its position in Johnson and Johnson (NYSE: JNJ) by 85.4% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 18,700 shares of the company's stock after selling 109,135 shares during the period. Alberta Investment Management Corp's holdings in Johnson and Johnson", "url": "https://www.defenseworld.net/2025/11/17/alberta-investment-management-corp-sells-109135-shares-of-johnson-johnson-jnj.html"}}
{"date": "2025-11-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-16 04:34:44", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Bought by Avantax Advisory Services Inc.", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-bought-by-avantax-advisory-services-inc-20251116.png", "site": "defenseworld.net", "text": "Avantax Advisory Services Inc. lifted its stake in shares of Johnson and Johnson (NYSE: JNJ) by 1.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 216,409 shares of the company's stock after buying an additional 3,079 shares during the quarter. Avantax", "url": "https://www.defenseworld.net/2025/11/16/johnson-johnson-jnj-shares-bought-by-avantax-advisory-services-inc.html"}}
{"date": "2025-11-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-14 15:32:19", "publisher": "Investopedia", "title": "Dow Jones Today: Stock Indexes Mixed as Tech Shares Rebound; Dow Down for 2nd Straight Day; Bitcoin Drops to Lowest Level in 6 Months", "image": "https://images.financialmodelingprep.com/news/dow-jones-today-stock-indexes-mixed-as-tech-shares-20251114.jpg", "site": "investopedia.com", "text": "Major stock indexes were mixed Friday, with the Dow Jones Industrial Average declining for a second straight session but technology shares rebounding.", "url": "https://www.investopedia.com/dow-jones-today-11142025-11849502"}}
{"date": "2025-11-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-14 15:19:12", "publisher": "CNBC Television", "title": "Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman", "image": "https://images.financialmodelingprep.com/news/biopharma-companies-have-confidence-in-their-ability-to-do-20251114.jpg", "site": "youtube.com", "text": "Evan Seigerman, BMO Capital Markets head of health care research, joins 'Power Lunch' to discuss what's behind the recent move in health care stocks, the state of play with GLP-1s and much more.", "url": "https://www.youtube.com/watch?v=X24CQW_cpss"}}
{"date": "2025-11-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-14 08:03:52", "publisher": "Reuters", "title": "Bristol Myers, J&J halt heart drug trial after interim review", "image": "https://images.financialmodelingprep.com/news/bristol-myers-jj-halt-heart-drug-trial-after-interim-20251114.jpg", "site": "reuters.com", "text": "Bristol Myers Squibb and Johnson & Johnson said on Friday they would stop a late-stage trial of their experimental blood clot drug in heart attack patients, after an independent review found the study was unlikely to meet its main goal.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-jj-halt-heart-drug-trial-after-interim-review-2025-11-14/"}}
{"date": "2025-11-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-14 04:12:56", "publisher": "Defense World", "title": "Johnson & Johnson $JNJ Shares Sold by Arvest Bank Trust Division", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-shares-sold-by-arvest-bank-trust-20251114.png", "site": "defenseworld.net", "text": "Arvest Bank Trust Division reduced its holdings in Johnson and Johnson (NYSE: JNJ) by 4.5% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 81,570 shares of the company's stock after selling 3,860 shares during the quarter. Arvest Bank Trust Division's holdings in", "url": "https://www.defenseworld.net/2025/11/14/johnson-johnson-jnj-shares-sold-by-arvest-bank-trust-division.html"}}
{"date": "2025-11-13", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-13 12:31:08", "publisher": "Zacks Investment Research", "title": "Why Is Johnson & Johnson (JNJ) Up 1.7% Since Last Earnings Report?", "image": "https://images.financialmodelingprep.com/news/why-is-johnson-johnson-jnj-up-17-since-last-20251113.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/2790750/why-is-johnson-johnson-jnj-up-1-7-since-last-earnings-report?cid=CS-STOCKNEWSAPI-FT-realtime_blog-2790750"}}
{"date": "2025-11-13", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-13 05:04:00", "publisher": "The Motley Fool", "title": "2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon", "image": "https://images.financialmodelingprep.com/news/2-healthcare-stocks-for-beginner-investors-with-a-40year-20251113.jpg", "site": "fool.com", "text": "These companies are leaders in their respective industries and are both very profitable. Intuitive Surgical has been the dominant presence in the surgical robotics market for decades.", "url": "https://www.fool.com/investing/2025/11/13/healthcare-stocks-beginner-investor-long-term/"}}
{"date": "2025-11-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-12 11:01:00", "publisher": "The Motley Fool", "title": "Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.", "image": "https://images.financialmodelingprep.com/news/want-decades-of-passive-income-2-stocks-to-buy-20251112.jpg", "site": "fool.com", "text": "CVS Health is successfully navigating industrywide and company-specific headwinds while maintaining a solid dividend program. Johnson & Johnson's rock-solid balance sheet and ability to develop brand-new products make its 62-year dividend growth streak safe.", "url": "https://www.fool.com/investing/2025/11/12/want-decades-of-passive-income-2-stocks-to-buy-now/"}}
{"date": "2025-11-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-12 07:56:05", "publisher": "Zacks Investment Research", "title": "J&J's MedTech Unit Sales Improve: Will the Momentum Last?", "image": "https://images.financialmodelingprep.com/news/jjs-medtech-unit-sales-improve-will-the-momentum-last-20251112.jpg", "site": "zacks.com", "text": "J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.", "url": "https://www.zacks.com/stock/news/2789703/j-j-s-medtech-unit-sales-improve-will-the-momentum-last?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2789703"}}
{"date": "2025-11-11", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-11 13:41:36", "publisher": "Seeking Alpha", "title": "Johnson & Johnson (JNJ) Presents at UBS Global Healthcare Conference 2025 Transcript", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-presents-at-ubs-global-healthcare-conference-20251111.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson ( JNJ ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Menziuso Conference Call Participants Danielle Antalffy - UBS Investment Bank, Research Division Presentation Danielle Antalffy UBS Investment Bank, Research Division All right. Good morning, everyone.", "url": "https://seekingalpha.com/article/4842022-johnson-and-johnson-jnj-presents-at-ubs-global-healthcare-conference-2025-transcript"}}
{"date": "2025-11-11", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-11 12:51:36", "publisher": "Seeking Alpha", "title": "Johnson & Johnson (JNJ) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-presents-at-guggenheim-securities-2nd-annual-healthcare-20251111.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson ( JNJ ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 11, 2025 10:30 AM EST Company Participants Sarah Brennan Mark Wildgust Conference Call Participants Vamil Divan - Guggenheim Securities, LLC, Research Division Presentation Vamil Divan Guggenheim Securities, LLC, Research Division Okay. I think we're ready to get going here.", "url": "https://seekingalpha.com/article/4841954-johnson-and-johnson-jnj-presents-at-guggenheim-securities-2nd-annual-healthcare-innovation"}}
{"date": "2025-11-11", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-11 10:31:19", "publisher": "Zacks Investment Research", "title": "Wall Street Analysts See Johnson & Johnson (JNJ) as a Buy: Should You Invest?", "image": "https://images.financialmodelingprep.com/news/wall-street-analysts-see-johnson-johnson-jnj-as-a-20251111.jpg", "site": "zacks.com", "text": "Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?", "url": "https://www.zacks.com/stock/news/2789230/wall-street-analysts-see-johnson-johnson-jnj-as-a-buy-should-you-invest?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|average_broker_rating-2789230"}}
{"date": "2025-11-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-10 06:26:53", "publisher": "Seeking Alpha", "title": "Johnson & Johnson: 2 Recent FDA Wins And Earnings Beat Warrant 'Buy' Rating", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-2-recent-fda-wins-and-earnings-beat-20251110.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson remains a \"buy\" following strong Q3 2025 results, driven by robust sales growth and raised full-year 2025 revenue guidance. The company's acquisition of Intra-Cellular Therapies and FDA approval of CAPLYTA for major depressive disorder unlock a large, underserved market opportunity. Oncology portfolio strength is highlighted by DARZALEX FASPRO's expanded FDA indication and CARVYKTI's 83% year-over-year revenue growth.", "url": "https://seekingalpha.com/article/4841211-johnson-and-johnson-2-recent-fda-wins-earnings-beat-warrant-buy-rating"}}
{"date": "2025-11-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-10 04:15:00", "publisher": "The Motley Fool", "title": "Got $1,000? Here Are the Smartest Dividend Stocks to Start With.", "image": "https://images.financialmodelingprep.com/news/got-1000-here-are-the-smartest-dividend-stocks-to-20251110.jpg", "site": "fool.com", "text": "Dividend stocks perform well in market corrections. These stocks are in three defensive sectors.", "url": "https://www.fool.com/investing/2025/11/10/got-1000-here-are-the-smartest-dividend-stocks-to/"}}
{"date": "2025-11-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-07 12:57:40", "publisher": "Benzinga", "title": "FDA Clears Johnson & Johnson's Darzalex Faspro, Enabling Early Intervention In Myeloma Progression", "image": "https://images.financialmodelingprep.com/news/fda-clears-johnson-johnsons-darzalex-faspro-enabling-early-intervention-20251107.jpeg", "site": "benzinga.com", "text": "The U.S. Food and Drug Administration (FDA) approved on Thursday Johnson & Johnson's (NYSE:JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a type of blood cancer.", "url": "https://www.benzinga.com/news/fda/25/11/48728351/fda-clears-johnson-johnsons-darzalex-faspro-enabling-early-intervention-in-myeloma-progression"}}
{"date": "2025-11-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-07 08:48:59", "publisher": "24/7 Wall Street", "title": "Is a Market Correction Coming? Better Grab 5 of the Safest Dividend Kings Now", "image": "https://images.financialmodelingprep.com/news/is-a-market-correction-coming-better-grab-5-of-the-20251107.jpg", "site": "247wallst.com", "text": "At 24/7 Wall St., we have focused on dividend stocks for over 15 years because, despite the stock market's ups and downs, many people need solid passive income streams to supplement their income from employment or other sources.", "url": "https://247wallst.com/investing/2025/11/07/sp-500-to-7000-better-grab-the-5-safest-dividend-kings-now/"}}
{"date": "2025-11-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-07 05:40:41", "publisher": "Seeking Alpha", "title": "Johnson & Johnson: Dividends Don't Lie", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-dividends-dont-lie-20251107.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson's latest dividend declaration translates into an annual growth rate of 4.47%. This is the lowest level in at least 10 years, signaling ongoing growth pressures. Mixed Q3 earnings results and Q4 outlook suggest profit headwinds and rising payout ratios, further limiting room for future dividend increases.", "url": "https://seekingalpha.com/article/4840106-johnson-and-johnson-dividends-dont-lie"}}
{"date": "2025-11-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-06 17:07:00", "publisher": "PRNewsWire", "title": "DARZALEX FASPRO is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma", "image": "https://images.financialmodelingprep.com/news/darzalex-faspro-is-the-first-and-only-treatment-approved-20251106.jpg", "site": "prnewswire.com", "text": "Phase 3 AQUILA study showed DARZALEX FASPRO significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to active monitoring  Landmark approval supports earlier intervention and disease interception of multiple myeloma for the first time HORSHAM, Pa. , Nov. 6, 2025 /PRNewswire/ --Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO  (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients with high-risk smoldering multiple myeloma (HR-SMM).1DARZALEX FASPRO is the first and only approved treatment for HR-SMM, enabling earlier intervention before the disease progresses to active multiple myeloma.", "url": "https://www.prnewswire.com/news-releases/darzalex-faspro-is-the-first-and-only-treatment-approved-by-the-us-fda-for-patients-with-high-risk-smoldering-multiple-myeloma-302607893.html"}}
{"date": "2025-11-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-06 09:54:04", "publisher": "CNBC Television", "title": "Cramer's Mad Dash: Johnson & Johnson", "image": "https://images.financialmodelingprep.com/news/cramers-mad-dash-johnson-johnson-20251106.jpg", "site": "youtube.com", "text": "Jim Cramer breaks down why he's keeping an eye on shares of Johnson & Johnson.", "url": "https://www.youtube.com/watch?v=VjhIGqm5jRI"}}
{"date": "2025-11-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-06 07:34:40", "publisher": "Reuters", "title": "US FDA expands use of J&J's Caplyta as add-on depression drug", "image": "https://images.financialmodelingprep.com/news/us-fda-expands-use-of-jjs-caplyta-as-addon-20251106.jpg", "site": "reuters.com", "text": "The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on treatment for adults with major depressive disorder, the company said on Thursday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-expands-use-jjs-caplyta-add-on-depression-drug-2025-11-06/"}}
{"date": "2025-11-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-06 07:30:00", "publisher": "PRNewsWire", "title": "FDA approval of CAPLYTA (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder", "image": "https://images.financialmodelingprep.com/news/fda-approval-of-caplyta-lumateperone-has-the-potential-to-20251106.jpg", "site": "prnewswire.com", "text": "CAPLYTA, in combination with an oral antidepressant, demonstrated superior efficacy with a favorable safety and tolerability profile consistent with established indications1,2 In pivotal trials, CAPLYTA did not increase mean weight gain, metabolic changes, or reported sexual side effects1,2 In a six-month open-label extension safety study, safety profile was consistent with pivotal studies and 80% of MDD patients taking CAPLYTA achieved response, with 65% of patients reaching remission from depression3 CAPLYTA offers a new option for the 2 in 3 people who experience residual symptoms despite their current antidepressant treatment1,2,3 TITUSVILLE, N.J. , Nov. 6, 2025 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved CAPLYTA(lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.", "url": "https://www.prnewswire.com/news-releases/fda-approval-of-caplyta-lumateperone-has-the-potential-to-reset-treatment-expectations-offering-hope-for-remission-in-adults-with-major-depressive-disorder-302606717.html"}}
{"date": "2025-11-05", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-05 16:50:00", "publisher": "Business Wire", "title": "Johnson & Johnson to Participate in the Citi's 2025 Global Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-citis-2025-global-healthcare-20251105.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Citi's 2025 Global Healthcare Conference on Wednesday, December 3rd, 2025. Management will participate in a Fireside Chat at 11:15 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available a.", "url": "https://www.businesswire.com/news/home/20251105796413/en/Johnson-Johnson-to-Participate-in-the-Citi%E2%80%99s-2025-Global-Healthcare-Conference/"}}
{"date": "2025-11-05", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-05 10:01:12", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-a-trending-stock-facts-to-20251105.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2785521/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2785521"}}
{"date": "2025-11-03", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-03 06:15:00", "publisher": "The Motley Fool", "title": "Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks?", "image": "https://images.financialmodelingprep.com/news/will-president-trumps-tylenol-claims-hurt-these-2-leading-20251103.jpg", "site": "fool.com", "text": "There were rumors that the FDA was going to warn pregnant women against using Tylenol. When the news finally hit, Tylenol maker Kenvue's stock had already fallen a great deal.", "url": "https://www.fool.com/investing/2025/11/03/will-president-trumps-tylenol-claims-hurt-these-2/"}}
{"date": "2025-11-01", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-11-01 10:25:22", "publisher": "Seeking Alpha", "title": "Best Dividend Aristocrats For November 2025", "image": "https://images.financialmodelingprep.com/news/best-dividend-aristocrats-for-november-2025-20251101.jpg", "site": "seekingalpha.com", "text": "The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW, and IBM have delivered strong double-digit returns this year. Dividend growth for the Aristocrats in 2025 averages 5.27%, with most constituents raising payouts, though growth may not exceed 2024's rate.", "url": "https://seekingalpha.com/article/4836679-best-dividend-aristocrats-for-november-2025"}}
{"date": "2025-10-30", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-30 10:42:02", "publisher": "Zacks Investment Research", "title": "Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-johnson-johnson-jnj-is-a-strong-value-20251030.jpg", "site": "zacks.com", "text": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.", "url": "https://www.zacks.com/stock/news/2781456/here-s-why-johnson-johnson-jnj-is-a-strong-value-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_value_score-2781456"}}
{"date": "2025-10-29", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-29 08:05:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson announces first head-to-head study comparing IMAAVY with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-first-headtohead-study-comparing-imaavy-with-an-20251029.jpg", "site": "prnewswire.com", "text": "The EPIC study will evaluate treatment with IMAAVY versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG study in which pediatric patients receiving treatment with IMAAVY demonstrated 72 weeks of sustained reduction in immunoglobulin G (IgG), sustained disease control and no new safety concerns IMAAVY is the only FcRn blocker for anti-AChR and anti-MuSK antibody positive adult and pediatric gMG patients aged 12 and older that has demonstrated sustained disease control SPRING HOUSE, Pa. , Oct. 29, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis (gMG), which aims to affirm IMAAVY (nipocalimab-aahu) as the FcRn blocker of choice for appropriate gMG patients.", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-announces-first-head-to-head-study-comparing-imaavy-with-an-alternative-fcrn-blocker-in-generalized-myasthenia-gravis-gmg-at-aanem-annual-meeting-302597514.html"}}
{"date": "2025-10-28", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-28 18:15:00", "publisher": "GlobeNewsWire", "title": "Levin Papantonio Announces Jury Awards $20 Million Verdict in Talc Mesothelioma Case Casaretto Estate v. Johnson & Johnson", "image": "https://images.financialmodelingprep.com/news/levin-papantonio-announces-jury-awards-20-million-verdict-in-20251028.jpg", "site": "globenewswire.com", "text": "FORT LAUDERDALE, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- A jury today awarded $20 million to the family of Dr. Alberto A.", "url": "https://www.globenewswire.com/news-release/2025/10/28/3176059/7663/en/Levin-Papantonio-Announces-Jury-Awards-20-Million-Verdict-in-Talc-Mesothelioma-Case-Casaretto-Estate-v-Johnson-Johnson.html"}}
{"date": "2025-10-28", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-28 09:25:03", "publisher": "Forbes", "title": "J&J Stock Can Fall", "image": "https://images.financialmodelingprep.com/news/jj-stock-can-fall-20251028.jpg", "site": "forbes.com", "text": "Johnson & Johnson (JNJ) is currently encountering challenges. Even the largest corporations are not invulnerable.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/28/jj-stock-can-fall/"}}
{"date": "2025-10-28", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-28 09:13:00", "publisher": "Reuters", "title": "Texas sues J&J and Kenvue, claiming they hid Tylenol's autism risks", "image": "https://images.financialmodelingprep.com/news/texas-sues-jj-and-kenvue-claiming-they-hid-tylenols-20251028.jpg", "site": "reuters.com", "text": "The makers of Tylenol, Johnson & Johnson and Kenvue , were sued on Tuesday by Texas Attorney General Ken Paxton, who accused them of knowingly hiding the drug's links to autism and attention deficit hyperactivity disorder.", "url": "https://www.reuters.com/world/texas-sues-jj-kenvue-claiming-they-hid-tylenols-autism-risks-2025-10-28/"}}
{"date": "2025-10-27", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-27 10:50:25", "publisher": "Zacks Investment Research", "title": "Here's Why Johnson & Johnson (JNJ) is a Strong Momentum Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-johnson-johnson-jnj-is-a-strong-momentum-20251027.jpg", "site": "zacks.com", "text": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.", "url": "https://www.zacks.com/stock/news/2777834/here-s-why-johnson-johnson-jnj-is-a-strong-momentum-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_momentum_score-2777834"}}
{"date": "2025-10-27", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-27 10:21:11", "publisher": "Zacks Investment Research", "title": "JNJ vs. MRK: Which Blue-Chip Pharma Stock Should Be in Your Portfolio?", "image": "https://images.financialmodelingprep.com/news/jnj-vs-mrk-which-bluechip-pharma-stock-should-be-in-20251027.jpg", "site": "zacks.com", "text": "J&J's diversified growth, strong pipeline, and robust balance sheet position it as a steadier long-term pick over Merck's Keytruda-dependent outlook.", "url": "https://www.zacks.com/stock/news/2777669/jnj-vs-mrk-which-blue-chip-pharma-stock-should-be-in-your-portfolio?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2777669"}}
{"date": "2025-10-27", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-27 08:00:00", "publisher": "PRNewsWire", "title": "New study reveals substantial unmet need in psoriasis, shows strong patient and provider preference for highly effective oral treatments with favorable safety profile", "image": "https://images.financialmodelingprep.com/news/new-study-reveals-substantial-unmet-need-in-psoriasis-shows-strong-20251027.jpg", "site": "prnewswire.com", "text": "Findings highlight opportunity for shared decision-making to improve treatment planning, with more than 90% of patients currently on injectables willing to switch to a new oral therapy with equivalent efficacy and a favorable safety profile Results show 50.5% of adult psoriasis patients eligible for systemic therapy and 47.5% of dermatology providerswould prefer oral treatment over topicals or injectables SPRING HOUSE, Pa. , Oct. 27, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced findings from the U.S. dataset from the global ENCOMPASS study evaluating patient and healthcare provider (HCP) perspectives on barriers and unmet needs in psoriasis care.", "url": "https://www.prnewswire.com/news-releases/new-study-reveals-substantial-unmet-need-in-psoriasis-shows-strong-patient-and-provider-preference-for-highly-effective-oral-treatments-with-favorable-safety-profile-302594112.html"}}
{"date": "2025-10-27", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-27 07:30:00", "publisher": "PRNewsWire", "title": "TREMFYA (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn's disease at two years", "image": "https://images.financialmodelingprep.com/news/tremfya-guselkumab-the-first-and-only-il23-inhibitor-with-20251027.jpg", "site": "prnewswire.com", "text": "Clinical remission rates were over 85% for both TREMFYA maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA is the only IL-23 inhibitor to demonstrate durable endoscopic and clinical remission with a fully subcutaneous regimen in moderately to severely active Crohn's disease PHOENIX , Oct. 27, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new 96-week data from the long-term extensions (LTE) of the Phase 3GRAVITI, GALAXI 2 and GALAXI 3 studies, which show the durability ofTREMFYA  (guselkumab) in adults with moderately to severely active Crohn's disease (CD) at two years.1 These findings are among 23 Johnson & Johnson abstracts being presented at the 2025 American College of Gastroenterology Annual Scientific Meeting (ACG). TREMFYA is the first and only approved, dual-acting monoclonal antibody that blocks IL-23 while also binding to CD64, a receptor on cells that produce IL-23.", "url": "https://www.prnewswire.com/news-releases/tremfya-guselkumab-the-first-and-only-il-23-inhibitor-with-a-fully-subcutaneous-treatment-regimen-demonstrates-durable-remission-in-crohns-disease-at-two-years-302594372.html"}}
{"date": "2025-10-27", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-27 07:30:00", "publisher": "PRNewsWire", "title": "Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety profile in once-daily pill through 28 weeks in ulcerative colitis", "image": "https://images.financialmodelingprep.com/news/icotrokinra-maintains-standout-combination-of-therapeutic-benefit-and-a-favorable-20251027.jpg", "site": "prnewswire.com", "text": "Building on 12-week findings, icotrokinra demonstrated clinically meaningful outcomes at Week 28 with 31.7% of patients achieving clinical remission and 38.1% showing endoscopic improvement versus placebo in the Phase 2b ANTHEM-UC study Results support Phase 3 clinical development of icotrokinra, a first-in-class targeted oral peptide that precisely blocks the IL-23 receptor, in both moderately to severely active ulcerative colitis and Crohn's disease PHOENIX , Oct. 27, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced Week 28 results from the Phase 2b ANTHEM-UC study of icotrokinra, a first-in-class investigational targeted oral peptide that precisely blocks the IL-23 receptor, in adults with moderately to severely active ulcerative colitis (UC). These results underscore the potential of icotrokinra to deliver a combination of therapeutic benefit and a favorable safety profile with once-daily oral dosing and will be featured among Johnson & Johnson's 23 accepted abstracts at the 2025 American College of Gastroenterology Annual Scientific Meeting (ACG).", "url": "https://www.prnewswire.com/news-releases/icotrokinra-maintains-standout-combination-of-therapeutic-benefit-and-a-favorable-safety-profile-in-once-daily-pill-through-28-weeks-in-ulcerative-colitis-302594371.html"}}
{"date": "2025-10-24", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-24 18:32:00", "publisher": "PRNewsWire", "title": "Published in The Lancet: Nipocalimab significantly decreased Sjgren's disease (SjD) activity and severity through substantial reduction in Sjgren's-related autoantibodies", "image": "https://images.financialmodelingprep.com/news/published-in-the-lancet-nipocalimab-significantly-decreased-sjgrens-disease-20251024.jpg", "site": "prnewswire.com", "text": "Nipocalimab, a first-in-class FcRn blocker being investigated for SjD, met its primary endpoint in the Phase 2 DAHLIAS study with statistically significant improvement in ClinESSDAIscore , which is based on 11 key systemic disease domains, at Week 24 versus placebo Critical patient-reported SjD symptoms including dryness, pain and fatigue trended towards greater improvement in the nipocalimab-treated group compared to placebo-treated patients Nipocalimab is the only investigational treatment to be granted Breakthrough Therapy Designation (BTD) by U.S. FDA for the treatment of adults living with moderate-to-severe SjD, and the Phase 3 DAFFODIL study is currently enrolling patients SPRING HOUSE, Pa. , Oct. 24, 2025 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ) today announced findings from the Phase 2 DAHLIAS study published in The Lancet showing that nipocalimab, an investigational FcRn treatment for Sjgren's disease (SjD), significantly decreased disease activity and severity in patients with moderate-to-severe disease.1 The study met its primary endpoint, with statistically significant improvement in ClinESSDAI a score, a key SjD activity index, at Week 24 in the nipocalimab 15 mg/kg Q2W group compared to placebob.1 Reductions in disease activity were supported by favorable changes in key biomarkers when compared to placebo, including lower levels of rheumatoid factor, fewer circulating immune complexes, and decreased inflammatory markers.1 This significant reduction in disease activity suggests nipocalimab may lessen the burden of SjD symptoms for patients impacted by the condition.1Patients who received nipocalimab reported a decrease in symptoms, with numerical improvements compared with placebo in the hallmark symptoms of SjD including dryness of the mouth, eyes, and/or vagina, as well as fatigue and joint pain.1Additionally, an improvement in objective salivary flow (i.e.", "url": "https://www.prnewswire.com/news-releases/published-in-the-lancet-nipocalimab-significantly-decreased-sjogrens-disease-sjd-activity-and-severity-through-substantial-reduction-in-sjogrens-related-autoantibodies-302594367.html"}}
{"date": "2025-10-24", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-24 11:29:19", "publisher": "24/7 Wall Street", "title": "I have invested in dividends for 25 yearsThese stocks prove long-term dividend investing works", "image": "https://images.financialmodelingprep.com/news/i-have-invested-in-dividends-for-25-yearsthese-stocks-prove-20251024.jpg", "site": "247wallst.com", "text": "McDonald's (MCD), Johnson & Johnson (JNJ), and Walmart (WMT) have lengthy histories of dividend growth. Sticking to a dividend reinvestment plan with these three stocks yielded amazing results over the long term.", "url": "https://247wallst.com/investing/2025/10/24/i-have-invested-in-dividends-for-25-years-these-stocks-prove-long-term-dividend-investing-works/"}}
{"date": "2025-10-24", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-24 08:00:00", "publisher": "PRNewsWire", "title": "Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis", "image": "https://images.financialmodelingprep.com/news/icotrokinra-longterm-results-affirm-promise-of-targeted-oral-peptide-20251024.jpg", "site": "prnewswire.com", "text": "In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ICONIC-TOTAL study 67% of patients treated with icotrokinra achieved overall rates of clear or almost clear skin by Week 24, which was maintained through Week 52 Icotrokinra continues to show potential with its standout combination of exceptional skin clearance and favorable safety profile in a once daily pill SPRING HOUSE, Pa. , Oct. 24, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new long-term 52-week data from the Phase 3 ICONIC-TOTAL studya evaluating icotrokinra, a first-in-class investigational targeted oral peptide that precisely blocks the IL-23 receptor, in adults and pediatric patients 12 years of age and older (adolescents) with plaque psoriasis (PsO) affecting high-impact sites.", "url": "https://www.prnewswire.com/news-releases/icotrokinra-long-term-results-affirm-promise-of-targeted-oral-peptide-with-high-rates-of-durable-skin-clearance-and-favorable-safety-profile-in-difficult-to-treat-scalp-and-genital-psoriasis-302593288.html"}}
{"date": "2025-10-24", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-24 04:30:00", "publisher": "Seeking Alpha", "title": "Smart Acquisitions And Profit Margin Growth Amid Strategic Repositioning", "image": "https://images.financialmodelingprep.com/news/smart-acquisitions-and-profit-margin-growth-amid-strategic-repositioning-20251024.jpg", "site": "seekingalpha.com", "text": "We purchased several new fund holdings across various sectors. Sempra has been shifting its strategic focus from its highly regulated California operations to its growing presence in Texas. Regeneron in our view has a strong balance sheet and a robust product pipeline.", "url": "https://seekingalpha.com/article/4832973-smart-acquisitions-profit-margin-growth-amid-strategic-repositioning"}}
{"date": "2025-10-23", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-23 11:26:57", "publisher": "24/7 Wall Street", "title": "I have invested in dividends for 20 years. These stocks are my top dividend compounders of all time", "image": "https://images.financialmodelingprep.com/news/i-have-invested-in-dividends-for-20-years-these-20251023.jpg", "site": "247wallst.com", "text": "In the world of investing, dividends have long been a popular way to earn income alongside growth opportunities with stocks.", "url": "https://247wallst.com/investing/2025/10/23/i-have-invested-in-dividends-for-20-years-these-stocks-are-my-top-dividend-compounders-of-all-time/"}}
{"date": "2025-10-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-22 16:36:00", "publisher": "Business Wire", "title": "Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-7th-annual-wolfe-20251022.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 7th Annual Wolfe Research Healthcare Conference on Monday, November 17th, 2025. Management will participate in a Fireside Chat at 10:40 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be availa.", "url": "https://www.businesswire.com/news/home/20251022905443/en/Johnson-Johnson-to-Participate-in-the-7th-Annual-Wolfe-Research-Healthcare-Conference/"}}
{"date": "2025-10-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-22 14:00:09", "publisher": "Forbes", "title": "Johnson & Johnson Stock To $134?", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-stock-to-134-20251022.jpg", "site": "forbes.com", "text": "Our machine-driven multifactor analysis suggests it may be time to sell JNJ stock, as we hold a pessimistic outlook with a potential target price of $134. The company's Moderate operating performance and financial health, combined with its High valuation, make the stock appear Unattractive.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/22/johnson--johnson-stock-to-134/"}}
{"date": "2025-10-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-22 10:00:23", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-attracting-investor-attention-here-is-20251022.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.", "url": "https://www.zacks.com/stock/news/2773885/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2773885"}}
{"date": "2025-10-21", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-21 16:49:22", "publisher": "The Motley Fool", "title": "Johnson & Johnson Draws Long-Term Buyers as Markets Turn Cautious", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-draws-longterm-buyers-as-markets-turn-cautious-20251021.jpg", "site": "fool.com", "text": "Added 91,615 shares in Johnson & Johnson; estimated transaction value of ~$15.70 million Trade represents an increase of 2.13% of the fund's reportable U.S. equity AUM Post-trade stake: 102,375 shares valued at $18.98 million as of September 30, 2025 Johnson & Johnson now accounts for 2.58% of CADINHA & CO LLC's reportable equity AUM, placing it outside the fund's top five holdings", "url": "https://www.fool.com/coverage/filings/2025/10/21/johnson-and-johnson-draws-long-term-buyers-as-markets-turn-cautious/"}}
{"date": "2025-10-21", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-21 10:17:01", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson Targets Accelerated Growth Across Segments in 2026", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-targets-accelerated-growth-across-segments-in-2026-20251021.jpg", "site": "zacks.com", "text": "J&J projects faster 2026 growth in Innovative Medicine and MedTech, topping consensus estimates on both revenues and EPS.", "url": "https://www.zacks.com/stock/news/2772950/johnson-johnson-targets-accelerated-growth-across-segments-in-2026?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2772950"}}
{"date": "2025-10-20", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-20 11:16:43", "publisher": "24/7 Wall Street", "title": "Goldman Sachs Reveals Sectors With Top 2026 Payouts: 5 Strong Buys", "image": "https://images.financialmodelingprep.com/news/goldman-sachs-reveals-sectors-with-top-2026-payouts-5-strong-20251020.jpg", "site": "247wallst.com", "text": "Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest United States corporations by total revenue.", "url": "https://247wallst.com/investing/2025/10/20/goldman-sachs-reveals-sectors-with-top-2026-payouts-grab-5-strong-buys-now/"}}
{"date": "2025-10-19", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-19 10:30:00", "publisher": "PRNewsWire", "title": "Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer", "image": "https://images.financialmodelingprep.com/news/subcutaneous-amivantamab-delivers-promising-45-percent-overall-response-rate-20251019.jpg", "site": "prnewswire.com", "text": "Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength of RYBREVANT (amivantamab-vmjw) in non-small cell lung cancer and broadens its potential across additional solid tumors RARITAN, N.J. , Oct. 19, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients withhuman papillomavirus (HPV)-unrelated, recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) after disease progression on a checkpoint inhibitor and platinum-based chemotherapy.", "url": "https://www.prnewswire.com/news-releases/subcutaneous-amivantamab-delivers-promising-45-percent-overall-response-rate-with-median-duration-of-7-2-months-in-recurrent-or-metastatic-head-and-neck-cancer-302588232.html"}}
{"date": "2025-10-18", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-18 12:04:51", "publisher": "MarketBeat", "title": "Johnson & Johnson's M&A Strategy Is the Real Story for Investors", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-ma-strategy-is-the-real-story-for-investors-20251018.jpg", "site": "marketbeat.com", "text": "Recent market speculation linkingJohnson & Johnson NYSE: JNJ to a complete acquisition of its partner, Protagonist Therapeutics NASDAQ: PTGX, offers a valuable glimpse into a core corporate strategy. For a healthcare sector giant of Johnson & Johnson's scale, such moves are not about chasing short-term stock pops.", "url": "https://www.marketbeat.com/stock-ideas/johnson-and-johnsons-m-and-a-strategy-is-the-real-story-for-investors/"}}
{"date": "2025-10-17", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-17 13:15:19", "publisher": "Zacks Investment Research", "title": "Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-sell-or-hold-jj-stock-after-20251017.jpg", "site": "zacks.com", "text": "JNJ's strong Q3 results, upbeat sales outlook and expanding drug pipeline highlight resilience despite Stelara LOE.", "url": "https://www.zacks.com/stock/news/2771349/should-you-buy-sell-or-hold-j-j-stock-after-robust-q3-earnings?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2771349"}}
{"date": "2025-10-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-16 17:45:39", "publisher": "Investopedia", "title": "S&P 500 Gains and Losses Today: Regional Banks Slump on Worries About Bad Loans; Data Storage Stocks Surge", "image": "https://images.financialmodelingprep.com/news/sp-500-gains-and-losses-today-regional-banks-slump-on-20251016.jpg", "site": "investopedia.com", "text": "Reports of elevated loan losses from regional banks weighed on the sector, while expectations of AI-driven growth helped lift shares of companies in the data storage and memory chip businesses.", "url": "https://www.investopedia.com/s-and-p-500-gains-and-losses-today-regional-banks-slump-on-worries-about-bad-loans-data-storage-stocks-surge-11831378"}}
{"date": "2025-10-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-16 14:06:11", "publisher": "Zacks Investment Research", "title": "J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan", "image": "https://images.financialmodelingprep.com/news/jj-bets-on-medtech-growth-with-orthopaedics-unit-spinoff-20251016.jpg", "site": "zacks.com", "text": "J&J's surprise plan to spin off its Orthopaedics unit as DePuy Synthes is aimed at sharpening MedTech focus and boosting growth margins.", "url": "https://www.zacks.com/stock/news/2770490/j-j-bets-on-medtech-growth-with-orthopaedics-unit-spin-off-plan?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2770490"}}
{"date": "2025-10-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-16 11:14:31", "publisher": "The Motley Fool", "title": "Jamison Loads Up on Johnson & Johnson (JNJ) Stock With a 39K Share Purchase", "image": "https://images.financialmodelingprep.com/news/jamison-loads-up-on-johnson-johnson-jnj-stock-with-a-20251016.png", "site": "fool.com", "text": "Jamison Private Wealth Management, Inc. disclosed a purchase of Johnson & Johnson shares valued at $6,762,412 in its SEC filing for the period ended Q3 2025, submitted on October 14, 2025.", "url": "https://www.fool.com/coverage/filings/2025/10/16/jamison-loads-up-on-johnson-and-johnson-jnj-stock-with-a-39k-share-purchase/"}}
{"date": "2025-10-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-16 09:56:16", "publisher": "Zacks Investment Research", "title": "ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook", "image": "https://images.financialmodelingprep.com/news/etfs-to-watch-post-jnjs-q3-earnings-surprise-bullish-outlook-20251016.jpg", "site": "zacks.com", "text": "JNJ's Q3 earnings beat and raised 2025 sales outlook could lift healthcare ETFs like IHE, XLV and IYH, heavily weighted toward the drugmaker.", "url": "https://www.zacks.com/stock/news/2769965/etfs-to-watch-post-jnj-s-q3-earnings-surprise-bullish-outlook?cid=CS-STOCKNEWSAPI-FT-etf_news_and_commentary-2769965"}}
{"date": "2025-10-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-16 08:00:00", "publisher": "PRNewsWire", "title": "TECVAYLI plus DARZALEX FASPRO combination regimen significantly improves progression-free survival and overall survival versus standard of care", "image": "https://images.financialmodelingprep.com/news/tecvayli-plus-darzalex-faspro-combination-regimen-significantly-improves-progressionfree-survival-20251016.jpg", "site": "prnewswire.com", "text": "First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line Independent Data Monitoring Committee (IDMC) recommended unblinding the study based on statistically significant results RARITAN, N.J. , Oct. 16, 2025 /PRNewswire/ -- Johnson & Johnson(NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study.", "url": "https://www.prnewswire.com/news-releases/tecvayli-plus-darzalex-faspro-combination-regimen-significantly-improves-progression-free-survival-and-overall-survival-versus-standard-of-care-302585407.html"}}
{"date": "2025-10-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-16 06:45:00", "publisher": "The Motley Fool", "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.", "image": "https://images.financialmodelingprep.com/news/want-decades-of-passive-income-3-stocks-to-buy-now-20251016.jpg", "site": "fool.com", "text": "The idea of steady money flowing in, year after year, should appeal to nearly everyone. This isn't an unrealistic dream; investing in stocks that pay reliable dividends can make it a reality.", "url": "https://www.fool.com/investing/2025/10/16/want-decades-of-passive-income-3-stocks-to-buy-now/"}}
{"date": "2025-10-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-16 04:21:00", "publisher": "Proactive Investors - Finance", "title": "Johnson & Johnson faces UK lawsuit over talcum baby powder", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-faces-uk-lawsuit-over-talcum-baby-powder-20251016.jpeg", "site": "proactiveinvestors.com", "text": "A group of around 3,000 people in the UK has filed a legal claim against Johnson & Johnson (NYSE:JNJ), accusing the pharmaceutical company of selling...", "url": "https://www.proactiveinvestors.com/companies/news/1080474/johnson-johnson-faces-uk-lawsuit-over-talcum-baby-powder-1080474.html"}}
{"date": "2025-10-16", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-16 03:23:51", "publisher": "Proactive Investors", "title": "Johnson & Johnson faces UK lawsuit over talcum baby powder", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-faces-uk-lawsuit-over-talcum-baby-powder-20251016.jpeg", "site": "proactiveinvestors.co.uk", "text": "A group of around 3,000 people in the UK has filed a legal claim against Johnson & Johnson (NYSE:JNJ), accusing the pharmaceutical company of selling talcum-based baby powder contaminated with asbestos. The case draws on internal documents and scientific studies dating back to the 1960s, which allegedly show the company knew its product contained minerals such as tremolite and actinolite.", "url": "https://www.proactiveinvestors.co.uk/companies/news/1080474"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 19:03:36", "publisher": "Reuters", "title": "J&J faces first UK lawsuits alleging its baby powder caused cancer", "image": "https://images.financialmodelingprep.com/news/jj-faces-first-uk-lawsuits-alleging-its-baby-powder-caused-20251015.jpg", "site": "reuters.com", "text": "Johnson & Johnson is facing the first lawsuits in Britain over allegations that its talc products cause cancer, as it fights tens of thousands of similar claims in the United States.", "url": "https://www.reuters.com/sustainability/boards-policy-regulation/jj-faces-first-uk-lawsuits-alleging-its-baby-powder-caused-cancer-2025-10-15/"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 18:51:43", "publisher": "Zacks Investment Research", "title": "Markets Mostly Up, Russell 2000 Sets New Closing High", "image": "https://images.financialmodelingprep.com/news/markets-mostly-up-russell-2000-sets-new-closing-high-20251015.webp", "site": "zacks.com", "text": "The biggest movers on the day were the Nasdaq, +148 points or +0.66%, and the small-cap Russell 2000 +24 points, +0.97%.", "url": "https://www.zacks.com/stock/news/2769677/markets-mostly-up-russell-2000-sets-new-closing-high?cid=CS-STOCKNEWSAPI-FT-ahead_of_wall_street-2769677"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 14:04:28", "publisher": "Benzinga", "title": "These Analysts Boost Their Forecasts On Johnson & Johnson After Upbeat Q3 Earnings", "image": "https://images.financialmodelingprep.com/news/these-analysts-boost-their-forecasts-on-johnson-johnson-after-20251015.jpeg", "site": "benzinga.com", "text": "Johnson & Johnson (NYSE:JNJ) on Tuesday reported better-than-expected third-quarter earnings on Tuesday.", "url": "https://www.benzinga.com/news/25/10/48234237/these-analysts-boost-their-forecasts-on-johnson-johnson-after-upbeat-q3-earnings"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 13:56:28", "publisher": "Benzinga", "title": "Johnson & Johnson Rules Out Big Acquisitions, Reiterates Focus On Small Deals: Analyst", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-rules-out-big-acquisitions-reiterates-focus-on-20251015.jpeg", "site": "benzinga.com", "text": "On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter 2025 adjusted earnings of $2.80 per share, up 15.7% year over year, beating theconsensus of $2.75.", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48234008/johnson-johnson-rules-out-big-acquisitions-reiterates-focus-on-small-deals-analyst"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 12:49:58", "publisher": "Proactive Investors", "title": "Johnson & Johnson's MedTech spin-off could boost focus, Bank of America says", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-medtech-spinoff-could-boost-focus-bank-of-20251015.jpeg", "site": "proactiveinvestors.com", "text": "Bank of America maintained a Neutral' rating on Johnson & Johnson (NYSE:JNJ) after the company posted third-quarter results slightly above expectations and hinted at a strategic MedTech shake-up. In a note Wednesday, the bank highlighted that J&J's third-quarter revenue and earnings per share beat consensus by roughly 1%, driven largely by stronger-than-expected performance from its Stelara biologic.", "url": "https://www.proactiveinvestors.com/companies/news/1080418"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 12:16:27", "publisher": "MarketBeat", "title": "Johnson & Johnson Stock Can Keep Rising as Strategy Pays Off", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-stock-can-keep-rising-as-strategy-pays-20251015.jpg", "site": "marketbeat.com", "text": "Johnson & Johnson's NYSE: JNJ stock price can continue to advance because its strategy to reinvigorate growth andwiden margins is working. The plan centers on divesting underperforming healthcare businesses to focus on higher-margin, more potent growth markets.", "url": "https://www.marketbeat.com/stock-ideas/johnson-and-johnson-stock-can-keep-rising-as-strategy-pays-off/"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 08:45:00", "publisher": "Proactive Investors - Finance", "title": "Johnson & Johnsons MedTech spin-off could boost focus, Bank of America says", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-medtech-spinoff-could-boost-focus-bank-of-america-20251015.jpeg", "site": "proactiveinvestors.com", "text": "Bank of America maintained a Neutral rating on Johnson & Johnson (NYSE:JNJ) after the company posted third-quarter results slightly above expectations and...", "url": "https://www.proactiveinvestors.com/companies/news/1080418/johnson-johnson-s-medtech-spin-off-could-boost-focus-bank-of-america-says-1080418.html"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 07:51:03", "publisher": "Fast Company", "title": "Johnson & Johnson reveals 2025 sales forecast and plans for its orthopedics business", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reveals-2025-sales-forecast-and-plans-for-20251015.jpg", "site": "fastcompany.com", "text": "Johnson & Johnson on Tuesday raised its 2025 sales forecast after reporting quarterly earnings that topped Wall Street expectations, and announced plans to spin off its orthopedics business into a standalone company.", "url": "https://www.fastcompany.com/91421757/johnson-johnson-reveals-2025-sales-forecast-plans-orthopedics-business"}}
{"date": "2025-10-15", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-15 05:20:00", "publisher": "The Motley Fool", "title": "This 2.7%-Yielding Dividend King Remains One of the Healthiest Income Stocks You Can Buy", "image": "https://images.financialmodelingprep.com/news/this-27yielding-dividend-king-remains-one-of-the-healthiest-20251015.jpg", "site": "fool.com", "text": "Johnson & Johnson (JNJ -0.02%) is one of the world's best dividend stocks. The healthcare giant has increased its dividend payment for 63 consecutive years.", "url": "https://www.fool.com/investing/2025/10/15/this-27-yielding-dividend-king-remains-one-of-the/"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 19:30:08", "publisher": "Fox Business", "title": "'NEVER BEEN STRONGER': Johnson & Johnson leader touts latest innovations", "image": "https://images.financialmodelingprep.com/news/never-been-stronger-johnson-johnson-leader-touts-latest-innovations-20251014.jpg", "site": "youtube.com", "text": "Johnson & Johnson CFO and Executive Vice President Joe Wolk addresses the decision to spin off its orthopedics business, explains its innovations and more on The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #johnsonandjohnson #joewolk #innovation #healthcare #business #pharma #medical #biotech #technology #orthopedics #science #research #corporate #leadership #economy #growth #investment #health #companynews", "url": "https://www.youtube.com/watch?v=QS0a_7lx3-w"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 13:01:36", "publisher": "Zacks Investment Research", "title": "JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit", "image": "https://images.financialmodelingprep.com/news/jnj-beats-on-q3-earnings-ups-sales-view-to-20251014.jpg", "site": "zacks.com", "text": "J&J tops Q3 forecasts, lifts 2025 sales outlook and plans to spin off its struggling Orthopaedics business.", "url": "https://www.zacks.com/stock/news/2768552/jnj-beats-on-q3-earnings-ups-sales-view-to-spin-off-orthopaedics-unit?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2768552"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 12:47:35", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-a-top-dividend-stock-right-20251014.jpg", "site": "zacks.com", "text": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?", "url": "https://www.zacks.com/stock/news/2768515/johnson-johnson-jnj-is-a-top-dividend-stock-right-now-should-you-buy?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_5-2768515"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 12:36:37", "publisher": "Seeking Alpha", "title": "Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-q3-2025-earnings-call-transcript-20251014.png", "site": "seekingalpha.com", "text": "Johnson & Johnson (NYSE:JNJ ) Q3 2025 Earnings Call October 14, 2025 8:30 AM EDT Company Participants Darren Snellgrove - Vice President of Investor Relations Joaquin Duato - CEO & Chairman Joseph Wolk - Executive VP & CFO Jennifer Taubert - Executive VP & Worldwide Chairman of Innovative Medicine Tim Schmid - Executive VP & Worldwide Chairman of MedTech John Reed - Executive Vice President of Innovative Medicine, R&D Conference Call Participants Alexandria Hammond - Wolfe Research, LLC Danielle Antalffy - UBS Investment Bank, Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Asad Haider - Goldman Sachs Group, Inc., Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Terence Flynn - Morgan Stanley, Research Division Jayson Bedford - Raymond James & Associates, Inc., Research Division Vamil Divan - Guggenheim Securities, LLC, Research Division Matthew Miksic - Barclays Bank PLC, Research Division David Risinger - Leerink Partners LLC, Research Division Presentation Operator Good morning, and welcome to Johnson & Johnson's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded.", "url": "https://seekingalpha.com/article/4829833-johnson-and-johnson-jnj-q3-2025-earnings-call-transcript"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 11:25:27", "publisher": "24/7 Wall Street", "title": "3 Dividend Aristocrats to Buy that Continued to Beat the Market", "image": "https://images.financialmodelingprep.com/news/3-dividend-aristocrats-to-buy-that-continued-to-beat-20251014.jpg", "site": "247wallst.com", "text": "Finding top dividend stocks to invest in is one thing. Finding companies that can pay that dividend for years, and potentially decades, to come is a whole other story.", "url": "https://247wallst.com/investing/2025/10/14/3-dividend-aristocrats-to-buy-that-continued-to-beat-the-market/"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 10:31:28", "publisher": "Zacks Investment Research", "title": "Compared to Estimates, Johnson & Johnson (JNJ) Q3 Earnings: A Look at Key Metrics", "image": "https://images.financialmodelingprep.com/news/compared-to-estimates-johnson-johnson-jnj-q3-earnings-a-20251014.jpg", "site": "zacks.com", "text": "Although the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.", "url": "https://www.zacks.com/stock/news/2768216/compared-to-estimates-johnson-johnson-jnj-q3-earnings-a-look-at-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2768216"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 10:05:05", "publisher": "Schaeffers Research", "title": "Johnson & Johnson Stock Brushes Off Beat-and-Raise", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-stock-brushes-off-beatandraise-20251014.jpg", "site": "schaeffersresearch.com", "text": "Johnson & Johnson (NYSE:JNJ) stock is down 1.2% to trade at $188.54 at last glance, brushing off an earnings and revenue beat for the third quarter.", "url": "https://www.schaeffersresearch.com/content/news/2025/10/14/johnson-johnson-stock-brushes-off-beat-and-raise"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 10:01:27", "publisher": "Schwab Network", "title": "Citi (C) Posts Strong Earnings, Stuffed Crust Strengthens DPZ, JNJ Slides", "image": "https://images.financialmodelingprep.com/news/citi-c-posts-strong-earnings-stuffed-crust-strengthens-dpz-20251014.jpg", "site": "youtube.com", "text": "While big banks as a group posted strong earnings, Diane King Hall notes Citigroup (C) as a standout. She talks about how stronger IPO and dealmaking markets added muscle for the company.", "url": "https://www.youtube.com/watch?v=r7kF8RDE4-w"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 09:54:03", "publisher": "Proactive Investors", "title": "Johnson & Johnson reports Q3 beat, plans orthopaedics spin-off", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-q3-beat-plans-orthopaedics-spinoff-20251014.jpg", "site": "proactiveinvestors.com", "text": "Johnson & Johnson (NYSE:JNJ) posted third-quarter revenue and earnings that beat Wall Street estimates, driven by strength in its pharmaceuticals and medical devices businesses. The healthcare giant reported revenue of $23.99 billion for the quarter, up 6.8% from a year ago and slightly above analysts' expectations of $23.74 billion.", "url": "https://www.proactiveinvestors.com/companies/news/1080311"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 08:58:15", "publisher": "Seeking Alpha", "title": "Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-q3-earnings-surprise-icotrokinra-shines-again-20251014.jpg", "site": "seekingalpha.com", "text": "Today, Johnson & Johnson released its financial results for Q3 2025, which once again stunned Wall Street. So, sales of Rybrevant/Lazcluze, the 'diamond' in its oncology franchise, reached $198 million, up 122.5% from Q3 2024. JNJ increased its 2025 reported sales guidance from $93.2-$93.6 billion to $93.5-$93.9 billion.", "url": "https://seekingalpha.com/article/4829768-johnson-and-johnson-q3-earnings-surprise-icotrokinra-shines-again"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 08:56:48", "publisher": "Invezz", "title": "Johnson & Johnson to spin off orthopedics unit after raising 2025 sales forecast", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-spin-off-orthopedics-unit-after-raising-20251014.jpg", "site": "invezz.com", "text": "Johnson & Johnson on Tuesday lifted its 2025 revenue guidance after posting stronger-than-expected third-quarter earnings and revealed plans to spin off its orthopedics business into a standalone company, its second major separation in two years. The New Jersey-based healthcare conglomerate said it now expects product revenue between $93.5 billion and $93.", "url": "https://invezz.com/news/2025/10/14/johnson-johnson-to-spin-off-orthopedics-unit-after-raising-2025-sales-forecast/"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 08:51:28", "publisher": "Benzinga", "title": "Johnson & Johnson To Separate Orthopedics Business, Boosts Annual Sales Outlook", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-separate-orthopedics-business-boosts-annual-sales-20251014.jpg", "site": "benzinga.com", "text": "Johnson & Johnson (NYSE:JNJ) on Tuesdayreported a third-quarter 2025 adjusted earnings of $2.80 per share, up 15.7% year over year, beating theconsensus of $2.75.", "url": "https://www.benzinga.com/markets/earnings/25/10/48196108/johnson-johnson-to-separate-orthopedics-business-boosts-annual-sales-outlook"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 08:31:07", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Beats Q3 Earnings and Revenue Estimates", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-beats-q3-earnings-and-revenue-estimates-20251014.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.77 per share. This compares to earnings of $2.42 per share a year ago.", "url": "https://www.zacks.com/stock/news/2768049/johnson-johnson-jnj-beats-q3-earnings-and-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2768049"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 07:44:00", "publisher": "Market Watch", "title": "Johnson & Johnson's stock heads for a record after a profit beat and plans for another spinoff", "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-stock-heads-for-a-record-after-a-20251014.jpg", "site": "marketwatch.com", "text": "Johnson & Johnson's stock rose toward a record after a beat-and-raise earnings report and announcement of plans to separate its orthopedics business.", "url": "https://www.marketwatch.com/story/johnson-johnsons-stock-heads-for-a-record-after-a-profit-beat-and-plans-for-another-spinoff-af403f00"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 07:33:04", "publisher": "CNBC Television", "title": "J&J CEO Joaquin Duato on Q3 results: We are entering an era of accelerated growth", "image": "https://images.financialmodelingprep.com/news/jj-ceo-joaquin-duato-on-q3-results-we-are-20251014.jpg", "site": "youtube.com", "text": "Johnson & Johnson chairman and CEO Joaquin Duato joins 'Squawk Box' to discuss the company's quarterly earnings results, adding warning labels to its multiple myeloma treatment Carvykti, the decision to spin off its orthopedics business, state of the company talc lawsuits, and more.", "url": "https://www.youtube.com/watch?v=r6gcsWarFMU"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 06:32:00", "publisher": "WSJ", "title": "J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains", "image": "https://images.financialmodelingprep.com/news/jj-lifts-fullyear-sales-outlook-fueled-by-pharma-meddevice-20251014.jpg", "site": "wsj.com", "text": "Johnson & Johnson raised its full-year sales outlook as it posted gains in both its prescription-drug and medical-device businesses in the latest quarter.", "url": "https://www.wsj.com/business/earnings/j-j-lifts-full-year-sales-outlook-fueled-by-pharma-med-device-gains-ef200967"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 06:30:00", "publisher": "Business Wire", "title": "Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-quarterly-dividend-for-fourth-quarter-2025-20251014.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Q4 dividend.", "url": "https://www.businesswire.com/news/home/20251014059893/en/Johnson-Johnson-Announces-Quarterly-Dividend-for-Fourth-Quarter-2025/"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 06:26:36", "publisher": "Reuters", "title": "J&J to spin off orthopedics business, raises full-year forecast", "image": "https://images.financialmodelingprep.com/news/jj-to-spin-off-orthopedics-business-raises-fullyear-forecast-20251014.jpg", "site": "reuters.com", "text": "Johnson & Johnson on Tuesday said it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff since 2023.", "url": "https://www.reuters.com/legal/litigation/jj-spin-off-orthopedics-business-raises-full-year-forecast-2025-10-14/"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 06:21:00", "publisher": "Business Wire", "title": "Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-intent-to-separate-its-orthopaedics-business-20251014.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (the Company) (NYSE: JNJ) today announced the Company's intent to separate its Orthopaedics business to enhance the strategic and operational focus of each company and drive value for stakeholders. The intended separation would further strengthen the focus of Johnson & Johnson as an innovation powerhouse, serving areas of high unmet needs across Innovative Medicine and MedTech, accelerating the ongoing shift of the Company's MedT.", "url": "https://www.businesswire.com/news/home/20251014819650/en/Johnson-Johnson-Announces-Intent-to-Separate-Its-Orthopaedics-Business/"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 06:20:00", "publisher": "Business Wire", "title": "Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-q3-2025-results-raises-2025-sales-20251014.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2025. Johnson & Johnson delivered another strong performance in the third quarter fueled by the depth and strength of our portfolio and significant progress across our pipeline, said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. With a sharpened focus on the six priority areas of Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vis.", "url": "https://www.businesswire.com/news/home/20251013198483/en/Johnson-Johnson-Reports-Q3-2025-Results-Raises-2025-Sales-Outlook/"}}
{"date": "2025-10-14", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-14 06:20:00", "publisher": "WSJ", "title": "Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-said-tuesday-it-plans-to-separate-its-20251014.jpg", "site": "wsj.com", "text": "The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.", "url": "https://www.wsj.com/health/healthcare/johnson-johnson-to-split-off-orthopedics-business-2b9f3d62"}}
{"date": "2025-10-13", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-13 18:47:00", "publisher": "The Motley Fool", "title": "Big Money Move: Investment Manager Buys $6.9 Million Worth of Johnson & Johnson Shares, According to Recent Filing", "image": "https://images.financialmodelingprep.com/news/big-money-move-investment-manager-buys-69-million-worth-20251013.jpg", "site": "fool.com", "text": "Cyndeo Wealth Partners, LLC purchased 40,238 shares of Johnson & Johnson (JNJ 0.09%) for an estimated $6.89 million during the quarter ended September 30, 2025, according to its October 10, 2025 SEC filing.", "url": "https://www.fool.com/coverage/filings/2025/10/13/big-money-move-investment-manager-buys-usd6-9-million-worth-of-johnson-and-johnson-shares-according-to-recent-filing/"}}
{"date": "2025-10-13", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-13 12:27:44", "publisher": "Benzinga", "title": "Johnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-q3-preview-with-stock-near-alltime-highs-20251013.jpeg", "site": "benzinga.com", "text": "Health care giant Johnson & Johnson (NYSE:JNJ) has had a good year with its shares trading near all-time highs. The company looks to keep a trend of beating analyst estimates when third-quarter financial results are reported before market open Tuesday.", "url": "https://www.benzinga.com/trading-ideas/previews/25/10/48181033/johnson-johnson-q3-preview-with-stock-near-all-time-highs-heres-what-to-watch"}}
{"date": "2025-10-13", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-13 09:21:05", "publisher": "Zacks Investment Research", "title": "Is J&J's MedTech Segment Set for Another Quarter of Growth?", "image": "https://images.financialmodelingprep.com/news/is-jjs-medtech-segment-set-for-another-quarter-of-20251013.jpg", "site": "zacks.com", "text": "J&J's MedTech sales are gaining traction in Cardiovascular, Surgery, and Vision, even as China???s VBP program continues to weigh on growth.", "url": "https://www.zacks.com/stock/news/2767192/is-j-j-s-medtech-segment-set-for-another-quarter-of-growth?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2767192"}}
{"date": "2025-10-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-12 15:14:54", "publisher": "The Motley Fool", "title": "Douglas Lane Adds $6 Million in J&J Stock Ahead of Earnings and Possible Biotech Deal", "image": "https://images.financialmodelingprep.com/news/douglas-lane-adds-6-million-in-jj-stock-ahead-of-20251012.png", "site": "fool.com", "text": "Douglas Lane & Associates, LLC disclosed a purchase of 34,948 shares of Johnson & Johnson (JNJ -0.24%) in an SEC filing on Friday, representing an estimated $6 million transaction based on average prices during the third quarter.", "url": "https://www.fool.com/coverage/filings/2025/10/12/douglas-lane-adds-usd6-million-in-j-and-j-stock-ahead-of-earnings-and-possible-biotech-deal/"}}
{"date": "2025-10-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-12 09:00:00", "publisher": "Seeking Alpha", "title": "Johnson & Johnson To Acquire Protagonist? It'd Be A Good Deal To Make", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-acquire-protagonist-itd-be-a-good-deal-20251012.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson (JNJ) is rumored to be in talks to acquire Protagonist Therapeutics (PTGX), following significant buyout speculation and a 30% PTGX stock surge. PTGX's value is underpinned by its oral immunology drug icotrokinra and blockbuster potential of rusfertide for polycythemia vera, both with strong partnership structures. A JNJ acquisition could save milestone payments, secure future royalties, and add derisked, late-stage assets to JNJ's portfolio, supporting long-term growth.", "url": "https://seekingalpha.com/article/4829332-johnson-and-johnson-to-acquire-protagonist-itd-be-good-deal-to-make"}}
{"date": "2025-10-12", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-12 06:57:44", "publisher": "Seeking Alpha", "title": "Wall Street Week Ahead", "image": "https://images.financialmodelingprep.com/news/wall-street-week-ahead-20251012.jpg", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.", "url": "https://seekingalpha.com/article/4829366-wall-street-week-ahead"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 22:11:04", "publisher": "Zacks Investment Research", "title": "3 Defensive Stocks to Watch as Trade Tensions Resurface: GILD, JNJ, KR", "image": "https://images.financialmodelingprep.com/news/3-defensive-stocks-to-watch-as-trade-tensions-resurface-20251010.jpg", "site": "zacks.com", "text": "Resurfaced tensions between the U.S. and China caught the market off guard in Friday's trading session, with the S&P 500 and Nasdaq falling over 2% on news that President Trump plans to impose an additional 100% tariff on Chinese goods starting November 1st.", "url": "https://www.zacks.com/stock/news/2766735/3-defensive-stocks-to-watch-as-trade-tensions-resurface-gild-jnj-kr?cid=CS-STOCKNEWSAPI-FT-stocks_in_the_news-2766735"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 18:36:02", "publisher": "Reuters", "title": "US FDA adds boxed warning to J&J, Legend Biotech's cancer therapy", "image": "https://images.financialmodelingprep.com/news/us-fda-adds-boxed-warning-to-jj-legend-biotechs-20251010.jpg", "site": "reuters.com", "text": "The U.S. Food and Drug Administration on Friday approved labeling changes for Johnson & Johnson and its partner Legend Biotech's blood cancer therapy to include a boxed warning for a potentially fatal gastrointestinal condition.", "url": "https://www.reuters.com/legal/litigation/us-fda-adds-boxed-warning-jj-legend-biotechs-cancer-therapy-2025-10-10/"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 16:20:00", "publisher": "Business Wire", "title": "Johnson & Johnson recommends shareholders reject mini-tender offer by Tutanota", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-recommends-shareholders-reject-minitender-offer-by-tutanota-20251010.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC, a limited liability company established pursuant to the laws of the Island of Nevis to purchase up to 500,000 shares of Johnson & Johnson common stock at a price of $145.00 per share in cash. Tutanota's offer price of $145.00 per share was well below the closing price of Johnson & Johnson common stock on September 26, 20.", "url": "https://www.businesswire.com/news/home/20251010467484/en/Johnson-Johnson-recommends-shareholders-reject-%E2%80%9Cmini-tender%E2%80%9D-offer-by-Tutanota/"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 13:21:26", "publisher": "CNBC Television", "title": "RTW Investments' Rod Wong: Expect more deals in biotech space", "image": "https://images.financialmodelingprep.com/news/rtw-investments-rod-wong-expect-more-deals-in-biotech-space-20251010.jpg", "site": "youtube.com", "text": "Rod Wong, RTW Investments CIO & Managing Director, joins CNBC's 'Money Movers' to discuss J&J's reported interest in buying Protagonist Therapeutics, whether he expects more consolidation in the sector, and much more.", "url": "https://www.youtube.com/watch?v=wM_roCJcbKQ"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 13:10:58", "publisher": "Zacks Investment Research", "title": "Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know", "image": "https://images.financialmodelingprep.com/news/buying-jj-stock-ahead-of-q3-earnings-heres-what-you-20251010.jpg", "site": "zacks.com", "text": "J&J gears up for Q3 results with solid gains from Darzalex, Tremfya and MedTech, even as Stelara faces fierce biosimilar pressure.", "url": "https://www.zacks.com/stock/news/2766512/buying-j-j-stock-ahead-of-q3-earnings-here-s-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2766512"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 13:06:05", "publisher": "Benzinga", "title": "Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-in-talks-to-acquire-protagonist-therapeutics-report-20251010.jpeg", "site": "benzinga.com", "text": "Johnson & Johnson (NYSE:JNJ) is reportedly in discussions to acquire Protagonist Therapeutics (NASDAQ:PTGX).", "url": "https://www.benzinga.com/m-a/25/10/48155373/johnson-johnson-in-talks-to-acquire-protagonist-therapeutics-report"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 11:25:40", "publisher": "Reuters", "title": "Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-in-talks-to-acquire-protagonist-therapeutics-wsj-20251010.jpg", "site": "reuters.com", "text": "Johnson & Johnson is in discussions to buy Protagonist Therapeutics , the Wall Street Journal reported on Friday, citing people familiar with the matter.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-talks-acquire-protagonist-therapeutics-wsj-reports-2025-10-10/"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 11:13:00", "publisher": "WSJ", "title": "Johnson & Johnson in Talks to Buy Protagonist Therapeutics", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-20251010.jpg", "site": "wsj.com", "text": "The two companies are already codeveloping a treatment for ulcerative colitis.", "url": "https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 07:48:43", "publisher": "Seeking Alpha", "title": "Johnson & Johnson: A Safe Haven That's Quietly Becoming A Bit Overpriced", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-a-safe-haven-thats-quietly-becoming-a-bit-20251010.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson is currently overvalued, with limited upside and mid-to-high single-digit long-term return potential amid ongoing sector risks. Despite solid recent earnings and raised guidance, JNJ faces headwinds from potential tariffs, drug price pressures, and declining Stelara sales. Management projects strong oncology growth, but analyst consensus remains cautious, forecasting more modest earnings growth than company targets.", "url": "https://seekingalpha.com/article/4829076-johnson-and-johnson-safe-haven-quietly-becoming-overpriced"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 07:30:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-highlight-breadth-of-its-major-depressive-20251010.jpg", "site": "prnewswire.com", "text": "17 abstracts from across the Company's portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression New post-hoc analysis of CAPLYTA (lumateperone) Phase 3 data evaluates the impact on sexual function in MDD, reinforcing potential to reset treatment expectations European Union and United Kingdom sub-group analyses of Phase 3 data evaluate efficacy of adjunctive seltorexant compared to adjunctive quetiapine XR in MDD with insomnia symptoms New data from post-hoc analysis of ESCAPE-TRD explores association of patient characteristics and remission with SPRAVATO (esketamine) versus quetiapine XR in treatment-resistant depression TITUSVILLE, N.J. , Oct. 10, 2025 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ) announced today that 17 abstracts featuring new clinical and real-world data will be presented at the annual European College of Neuropsychopharmacology (ECNP) Congress, taking place October 11-14 in Amsterdam, The Netherlands.", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-to-highlight-breadth-of-its-major-depressive-disorder-portfolio-at-2025-ecnp-congress-302580374.html"}}
{"date": "2025-10-10", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-10 02:42:46", "publisher": "Benzinga", "title": "Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-gears-up-for-q3-print-here-are-the-20251010.jpeg", "site": "benzinga.com", "text": "Johnson & Johnson (NYSE:JNJ) will release earnings results for the third quarter, before the opening bell on Tuesday, Oct. 14.", "url": "https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/48141839/johnson-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts-3"}}
{"date": "2025-10-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-09 16:24:00", "publisher": "Business Wire", "title": "Johnson & Johnson to Participate in the UBS Global Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-ubs-global-healthcare-20251009.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the UBS Global Healthcare Conference on Tuesday, November 11th, 2025. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available approximat.", "url": "https://www.businesswire.com/news/home/20251009718064/en/Johnson-Johnson-to-Participate-in-the-UBS-Global-Healthcare-Conference/"}}
{"date": "2025-10-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-09 10:15:33", "publisher": "Zacks Investment Research", "title": "Wall Street's Insights Into Key Metrics Ahead of Johnson & Johnson (JNJ) Q3 Earnings", "image": "https://images.financialmodelingprep.com/news/wall-streets-insights-into-key-metrics-ahead-of-johnson-20251009.jpg", "site": "zacks.com", "text": "Evaluate the expected performance of Johnson & Johnson (JNJ) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.", "url": "https://www.zacks.com/stock/news/2765283/wall-street-s-insights-into-key-metrics-ahead-of-johnson-johnson-jnj-q3-earnings?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-2765283"}}
{"date": "2025-10-09", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-09 10:01:16", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-a-trending-stock-facts-to-20251009.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "url": "https://www.zacks.com/stock/news/2765226/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2765226"}}
{"date": "2025-10-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-08 15:11:26", "publisher": "Proactive Investors", "title": "Goldman Sachs expects another quarter of outperformance from J&J in Q3", "image": "https://images.financialmodelingprep.com/news/goldman-sachs-expects-another-quarter-of-outperformance-from-jj-20251008.jpeg", "site": "proactiveinvestors.com", "text": "Johnson & Johnson (NYSE:JNJ)'s strong year-to-date performance is likely to continue when the healthcare giant reports third quarter earnings on October 14, according to analysts at Goldman Sachs. The firm wrote in a note to clients that the stock's 31% gain this year, which is more than double the S&P 500's 14% rise, reflects impressive execution across the Innovative Medicines segment, which has driven sales and earnings estimates higher relative to peers.", "url": "https://www.proactiveinvestors.com/companies/news/1079975"}}
{"date": "2025-10-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-08 13:11:16", "publisher": "Zacks Investment Research", "title": "Why Johnson & Johnson (JNJ) is Poised to Beat Earnings Estimates Again", "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-jnj-is-poised-to-beat-earnings-20251008.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "url": "https://www.zacks.com/stock/news/2764763/why-johnson-johnson-jnj-is-poised-to-beat-earnings-estimates-again?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_7-2764763"}}
{"date": "2025-10-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-08 09:50:19", "publisher": "Zacks Investment Research", "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar", "image": "https://images.financialmodelingprep.com/news/these-2-medical-stocks-could-beat-earnings-why-they-20251008.jpg", "site": "zacks.com", "text": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.", "url": "https://www.zacks.com/stock/news/2764298/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_earnings_esp-2764298"}}
{"date": "2025-10-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-08 09:46:10", "publisher": "Zacks Investment Research", "title": "3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal", "image": "https://images.financialmodelingprep.com/news/3-large-drug-stocks-to-watch-as-industry-recovers-20251008.jpg", "site": "zacks.com", "text": "Pfizer's landmark pricing deal with Trump sparks a pharma rally as J&J, Bayer and Novartis emerge as strong contenders for inclusion in one's portfolio.", "url": "https://www.zacks.com/stock/news/2764279/3-large-drug-stocks-to-watch-as-industry-recovers-after-pfe-trump-deal?cid=CS-STOCKNEWSAPI-FT-analyst_blog|investment_ideas-2764279"}}
{"date": "2025-10-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-08 07:17:01", "publisher": "MarketBeat", "title": "Why AbbVie and Johnson & Johnson Could Outperform Pfizer", "image": "https://images.financialmodelingprep.com/news/why-abbvie-and-johnson-johnson-could-outperform-pfizer-20251008.jpg", "site": "marketbeat.com", "text": "Pfizer Inc. NYSE: PFE made a strong move higher after it became the first drug manufacturer to sign on as part of the TrumpRx platform. PFE stock is up nearly 14% since its closing price of around $23.61 on Sept.", "url": "https://www.marketbeat.com/stock-ideas/why-abbvie-and-johnson-and-johnson-could-outperform-pfizer/"}}
{"date": "2025-10-08", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-08 02:42:08", "publisher": "New York Post", "title": "Johnson & Johnson ordered to pay $966 million in talc cancer case after jury finds company liable", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-ordered-to-pay-966-million-in-talc-cancer-20251008.jpg", "site": "nypost.com", "text": "A Los AngelesjuryorderedJohnson&Johnsontopay$966millionto the family of a woman who died from mesothelioma, finding thecompanyliablein the latest trial alleging itstalcproducts causecancer.", "url": "https://nypost.com/2025/10/08/business/johnson-and-johnson-ordered-to-pay-966-million-in-mae-moore-baby-powder-cancer-lawsuit/"}}
{"date": "2025-10-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-07 20:58:00", "publisher": "The Motley Fool", "title": "Worried About a Recession? 2 Stocks to Buy Now to Prepare Your Portfolio", "image": "https://images.financialmodelingprep.com/news/worried-about-a-recession-2-stocks-to-buy-now-20251007.jpg", "site": "fool.com", "text": "It's impossible to predict with certainty whether a recession is coming, but certain developments sure make it more likely. President Donald Trump's tariff policies could lead to increased prices and plunge the economy into a downturn.", "url": "https://www.fool.com/investing/2025/10/07/worried-about-a-recession-2-stocks-to-buy-now-to-p/"}}
{"date": "2025-10-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-07 16:19:00", "publisher": "Business Wire", "title": "LA County Jury Hits Johnson & Johnson with Nearly $1 Billion Verdict", "image": "https://images.financialmodelingprep.com/news/la-county-jury-hits-johnson-johnson-with-nearly-1-billion-20251007.jpg", "site": "businesswire.com", "text": "LOS ANGELES--(BUSINESS WIRE)--A Los Angeles County jury has returned damages totaling $966 million, including $950 million in punitive damages, to the family of Mae Moore, who died of mesothelioma in 2021 after using Johnson & Johnson's iconic baby powder. Lawyers for the family say this is the largest verdict ever against Johnson & Johnson in a mesothelioma case linked to talc products. Ms. Moore, the wife of a pastor and a mother of three, regularly used Johnson & Johnson's baby p.", "url": "https://www.businesswire.com/news/home/20251007971192/en/LA-County-Jury-Hits-Johnson-Johnson-with-Nearly-1-Billion-Verdict/"}}
{"date": "2025-10-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-07 10:50:31", "publisher": "Reuters", "title": "Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer case", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-ordered-to-pay-966-million-after-jury-20251007.jpg", "site": "reuters.com", "text": "A Los Angeles jury late on Monday ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest lawsuit alleging its baby powder products cause cancer.", "url": "https://www.reuters.com/legal/litigation/johnson-johnson-ordered-pay-966-million-after-jury-finds-company-liable-talc-2025-10-07/"}}
{"date": "2025-10-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-07 08:05:00", "publisher": "PRNewsWire", "title": "Icotrokinra data in ulcerative colitis show potential for a standout combination of therapeutic benefit and a favorable safety profile in once-daily pill", "image": "https://images.financialmodelingprep.com/news/icotrokinra-data-in-ulcerative-colitis-show-potential-for-a-20251007.jpg", "site": "prnewswire.com", "text": "Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated with the highest dose achieving endoscopic improvement at Week 12 in the Phase 2b ANTHEM-UC study These data support the promise of a first-in-class targeted oral peptide that selectively blocks the IL-23 receptor as a potential new option for people with moderately to severely active ulcerative colitis SPRING HOUSE, Pa. , Oct. 7, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ)today announced additional Week 12 results from the Phase 2b ANTHEM-UC study of icotrokinra, a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor, in adults with moderately to severely active ulcerative colitis (UC).", "url": "https://www.prnewswire.com/news-releases/icotrokinra-data-in-ulcerative-colitis-show-potential-for-a-standout-combination-of-therapeutic-benefit-and-a-favorable-safety-profile-in-once-daily-pill-302576329.html"}}
{"date": "2025-10-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-07 08:05:00", "publisher": "PRNewsWire", "title": "TREMFYA (guselkumab) is first and only IL-23 inhibitor to demonstrate sustained clinical and endoscopic outcomes with a fully subcutaneous regimen through 48 weeks in ulcerative colitis", "image": "https://images.financialmodelingprep.com/news/tremfya-guselkumab-is-first-and-only-il23-inhibitor-to-20251007.jpg", "site": "prnewswire.com", "text": "Patients treated with subcutaneous TREMFYA achieved clinically meaningful results in both clinical remission (36.7%) and endoscopic remission (25.9%) at Week 48 in the Phase 3 ASTRO study Clinical and endoscopic outcomes were demonstrated across both biologic-nave and biologic-refractory sub-groups TREMFYA  is the only IL-23 inhibitor with a fully subcutaneous regimen, following recent FDA approval of SC induction in adults with ulcerative colitis SPRING HOUSE, Pa. , Oct. 7, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new 48-week data from the Phase 3 ASTRO study evaluating TREMFYA (guselkumab) subcutaneous (SC) induction and maintenance therapy in adults with moderately to severely active ulcerative colitis (UC).", "url": "https://www.prnewswire.com/news-releases/tremfya-guselkumab-is-first-and-only-il-23-inhibitor-to-demonstrate-sustained-clinical-and-endoscopic-outcomes-with-a-fully-subcutaneous-regimen-through-48-weeks-in-ulcerative-colitis-302576330.html"}}
{"date": "2025-10-07", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-07 08:00:00", "publisher": "PRNewsWire", "title": "Johnson & Johnson Unveils New Data Demonstrating Superior Clarity of Vision and Comfort of ACUVUE OASYS MAX 1-Day for ASTIGMATISM, and MULTIFOCAL for ASTIGMATISM Contact Lenses", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-unveils-new-data-demonstrating-superior-clarity-of-20251007.jpg", "site": "prnewswire.com", "text": "Studies presented at#Academy25 reveal that ACUVUE OASYS MAX 1-Day for ASTIGMATISM outperformed Dailies Total1 for Astigmatism in patient reported outcomes related to vision and comfort. Research highlights that the latestACUVUEcontact lens innovation OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM broadens the range of patients who can benefit from daily disposable multifocal contact lenses, especially those with astigmatism.", "url": "https://www.prnewswire.com/news-releases/johnson--johnson-unveils-new-data-demonstrating-superior-clarity-of-vision-and-comfort-of-acuvue-oasys-max-1-day-for-astigmatism-and-multifocal-for-astigmatism-contact-lenses-302576236.html"}}
{"date": "2025-10-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-06 16:00:00", "publisher": "Business Wire", "title": "Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-guggenheim-securities-2nd-20251006.jpg", "site": "businesswire.com", "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Guggenheim Securities 2nd Annual Healthcare Innovation Conference on Tuesday, November 11th, 2025. Management will participate in a Fireside Chat at 10:30 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast re.", "url": "https://www.businesswire.com/news/home/20251006464790/en/Johnson-Johnson-to-Participate-in-the-Guggenheim-Securities-2nd-Annual-Healthcare-Innovation-Conference/"}}
{"date": "2025-10-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-06 14:21:31", "publisher": "MarketBeat", "title": "Trump's Drug Price Cuts: Boom or Bust for These 3 Pharma Giants", "image": "https://images.financialmodelingprep.com/news/trumps-drug-price-cuts-boom-or-bust-for-these-20251006.png", "site": "marketbeat.com", "text": "When investors hear that a company will lower prices on its products, their instinctive reaction is to expect a sequential decline in margins and profits, which is not entirely incorrect. However, sometimes these price decreases end up attracting new business, expanding market share, and more than making up for the lost ticket price in the top-line revenue.", "url": "https://www.marketbeat.com/stock-ideas/trumps-drug-price-cuts-boom-or-bust-for-these-3-pharma-giants/"}}
{"date": "2025-10-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-06 13:29:00", "publisher": "Seeking Alpha", "title": "My Top 5 Biotech Stocks Big Pharma Could Buy Next", "image": "https://images.financialmodelingprep.com/news/my-top-5-biotech-stocks-big-pharma-could-buy-20251006.jpg", "site": "seekingalpha.com", "text": "While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of Mr. Market's interest zone. Since the exclusivity of key blockbusters of 'giants', including Merck andPfizer, expires in the next 4 years, there is an urgent need to continue rejuvenating their portfolios of drugs.", "url": "https://seekingalpha.com/article/4828107-my-top-5-biotech-stocks-big-pharma-could-buy-next"}}
{"date": "2025-10-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-06 09:37:07", "publisher": "Zacks Investment Research", "title": "How J&J's Innovative Medicines Segment is Poised Ahead of Q3 Results", "image": "https://images.financialmodelingprep.com/news/how-jjs-innovative-medicines-segment-is-poised-ahead-of-20251006.jpg", "site": "zacks.com", "text": "JNJ's Innovative Medicine sales face biosimilar pressure and IRA headwinds, but growth drivers like Darzalex, Tremfya and Erleada may have ensured steady Q3 momentum.", "url": "https://www.zacks.com/stock/news/2762487/how-j-j-s-innovative-medicines-segment-is-poised-ahead-of-q3-results?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2762487"}}
{"date": "2025-10-06", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-06 06:33:01", "publisher": "24/7 Wall Street", "title": "5 Dividend Kings Are Our Top High-Yield Dividend Picks For October", "image": "https://images.financialmodelingprep.com/news/5-dividend-kings-are-our-top-highyield-dividend-picks-for-20251006.jpg", "site": "247wallst.com", "text": "Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.", "url": "https://247wallst.com/investing/2025/10/06/5-dividend-kings-are-our-top-high-yield-dividend-picks-for-october/"}}
{"date": "2025-10-04", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-04 12:18:07", "publisher": "Seeking Alpha", "title": "October Dogs Of The Dow Flash One Ideal 'Safer' Dividend Buy", "image": "https://images.financialmodelingprep.com/news/october-dogs-of-the-dow-flash-one-ideal-safer-dividend-20251004.jpg", "site": "seekingalpha.com", "text": "Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price. Analyst forecasts suggest top-ten Dow Dogs could deliver average net gains of 20% by October 2026, with VZ among the safer high-yield picks. Most Dow Dogs remain overpriced relative to their dividends, but market pullbacks could create fair-value opportunities for income-focused investors.", "url": "https://seekingalpha.com/article/4827877-october-dogs-of-dow-flash-one-ideal-safer-dividend-buy"}}
{"date": "2025-10-03", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-03 18:46:30", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-rises-higher-than-market-key-facts-20251003.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) closed the most recent trading day at $188.64, moving +1.43% from the previous trading session.", "url": "https://www.zacks.com/stock/news/2761854/johnson-johnson-jnj-rises-higher-than-market-key-facts?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2761854"}}
{"date": "2025-10-03", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-03 16:00:43", "publisher": "Schwab Network", "title": "Examining JNJ Breakout: Bull Flag & Options Show Upside Potential", "image": "https://images.financialmodelingprep.com/news/examining-jnj-breakout-bull-flag-options-show-upside-potential-20251003.jpg", "site": "youtube.com", "text": "Johnson & Johnson (JNJ) has shined in the healthcare space, rallying 5% this week and 30% in 2025. An upgrade from Wells Fargo added momentum to the stock rally on Friday.", "url": "https://www.youtube.com/watch?v=pdhofX6udqs"}}
{"date": "2025-10-03", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-03 09:11:21", "publisher": "24/7 Wall Street", "title": "2 Dividend Stocks That Jim Cramer Wants Every Retiree to Own", "image": "https://images.financialmodelingprep.com/news/2-dividend-stocks-that-jim-cramer-wants-every-retiree-20251003.jpg", "site": "247wallst.com", "text": "Retirees and older individuals are among the biggest demographics who tune into Jim Cramer's Mad Money show.", "url": "https://247wallst.com/investing/2025/10/03/2-dividend-stocks-that-jim-cramer-wants-every-retiree-to-own/"}}
{"date": "2025-10-02", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-02 15:15:08", "publisher": "24/7 Wall Street", "title": "The 5 Highest-Yielding Dogs of the Dow Are Among Our Top Q4 Picks", "image": "https://images.financialmodelingprep.com/news/the-5-highestyielding-dogs-of-the-dow-are-among-our-20251002.jpg", "site": "247wallst.com", "text": "The Dogs of the Dow is a well-known strategy first published in 1991 by Michael O'Higgins.", "url": "https://247wallst.com/investing/2025/10/02/the-5-highest-yielding-dogs-of-the-dow-are-among-our-top-q4-picks/"}}
{"date": "2025-10-01", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-10-01 16:15:00", "publisher": "GlobeNewsWire", "title": "NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer", "image": "https://images.financialmodelingprep.com/news/nanobiotix-announces-first-data-from-phase-1-study-evaluating-20251001.jpeg", "site": "globenewswire.com", "text": "Data presented at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO) on October 1 st", "url": "https://www.globenewswire.com/news-release/2025/10/01/3159946/0/en/NANOBIOTIX-Announces-First-Data-From-Phase-1-Study-Evaluating-JNJ-1900-NBTXR3-for-Patients-With-Esophageal-Cancer.html"}}
{"date": "2025-09-30", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-30 09:45:11", "publisher": "Forbes", "title": "Why JNJ Stock Defines Shareholder Supremacy In Healthcare", "image": "https://images.financialmodelingprep.com/news/why-jnj-stock-defines-shareholder-supremacy-in-healthcare-20250930.jpg", "site": "forbes.com", "text": "Over the past ten years, Johnson & Johnson (NYSE: JNJ) has delivered an impressive $157 Bil back to its investors through cash distributions via dividends and buybacks. This commitment to shareholder value has translated into exceptional market performance in 2025, with the stock delivering a remarkable 26% year-to-date return, significantly outpacing the broader healthcare sector and demonstrating the defensive strength that has made JNJ a cornerstone holding for income-focused investors.", "url": "https://www.forbes.com/sites/greatspeculations/2025/09/30/why-jnj-stock-defines-shareholder-supremacy-in-healthcare/"}}
{"date": "2025-09-30", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-30 08:41:39", "publisher": "24/7 Wall Street", "title": "3 Ultra-Safe Dividend Stocks to Buy Now, If You're Concerned About Volatility Ahead", "image": "https://images.financialmodelingprep.com/news/3-ultrasafe-dividend-stocks-to-buy-now-if-youre-20250930.jpg", "site": "247wallst.com", "text": "Investors who find themselves awake at night thinking about their portfolios, fear not.", "url": "https://247wallst.com/investing/2025/09/30/3-ultra-safe-dividend-stocks-to-buy-now-if-youre-concerned-about-volatility-ahead/"}}
{"date": "2025-09-29", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-29 18:30:00", "publisher": "GlobeNewsWire", "title": "NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Nave or Resistant R/M-HNSCC", "image": "https://images.financialmodelingprep.com/news/nanobiotix-announces-updated-phase-1-results-continuing-to-support-jnj1900-20250929.jpeg", "site": "globenewswire.com", "text": "Data presented as a Top-rated Abstract in Head and Neck Cancer at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO) on September 29th", "url": "https://www.globenewswire.com/news-release/2025/09/29/3158214/0/en/NANOBIOTIX-Announces-Updated-Phase-1-Results-Continuing-to-Support-JNJ-1900-NBTXR3-Plus-Anti-PD-1-as-a-Potential-New-1L-or-2L-Option-in-Anti-PD-1-Na%C3%AFve-or-Resistant-R-M-HNSCC.html"}}
{"date": "2025-09-29", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-29 08:00:00", "publisher": "PRNewsWire", "title": "U.S. FDA approves TREMFYA (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor", "image": "https://images.financialmodelingprep.com/news/us-fda-approves-tremfya-guselkumab-for-the-treatment-of-20250929.jpg", "site": "prnewswire.com", "text": "TREMFYAis now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children six years and older, weighing at least 40 kg Approval was based on PROTOSTAR study, which showed pediatric patients receiving TREMFYA  achieved high levels of skin clearance vs. placebo at Week 16 HORSHAM, Pa.", "url": "https://www.prnewswire.com/news-releases/us-fda-approves-tremfya-guselkumab-for-the-treatment-of-pediatric-plaque-psoriasis-and-active-psoriatic-arthritis-marking-a-first-and-only-approval-for-an-il-23-inhibitor-302569442.html"}}
{"date": "2025-09-28", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-28 18:15:00", "publisher": "The Motley Fool", "title": "Why Johnson & Johnson Could Be the Ultimate Dividend King", "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-could-be-the-ultimate-dividend-king-20250928.jpg", "site": "fool.com", "text": "Some stocks simply pay a regular dividend. The smarter ones also raise their dividend payout every year, putting more cash in their shareholders' pockets.", "url": "https://www.fool.com/investing/2025/09/28/why-johnson-could-be-the-ultimate-dividend-stock/"}}
{"date": "2025-09-28", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-28 01:00:00", "publisher": "Seeking Alpha", "title": "Best Dividend Aristocrats For October 2025", "image": "https://images.financialmodelingprep.com/news/best-dividend-aristocrats-for-october-2025-20250928.jpg", "site": "seekingalpha.com", "text": "Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristocrats already raising payouts in 2025 at an average rate of 5.19%, nearing last year's pace. 22 Dividend Aristocrats appear both undervalued and offer a projected long-term annualized return of at least 10%, based on dividend yield theory and earnings growth.", "url": "https://seekingalpha.com/article/4826409-best-dividend-aristocrats-for-october-2025"}}
{"date": "2025-09-26", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-26 22:18:41", "publisher": "CNBC Television", "title": "'I'm an optimist,' says Johnson & Johnson CEO on its R&D investment", "image": "https://images.financialmodelingprep.com/news/im-an-optimist-says-johnson-johnson-ceo-on-its-rd-20250926.jpg", "site": "youtube.com", "text": "CNBC's Jim Cramer sits down with Johnson & Johnson CEO Joaquin Duato to talk about the company's outlook, President Trump's 100% tariff on some pharmaceutical imports, cancer treatment innovation and more.", "url": "https://www.youtube.com/watch?v=z4JLisTTzMQ"}}
{"date": "2025-09-26", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-26 20:43:29", "publisher": "CNBC Television", "title": "Watch Jim Cramer's interview with Johnson & Johnson CEO Joaquin Duato", "image": "https://images.financialmodelingprep.com/news/watch-jim-cramers-interview-with-johnson-johnson-ceo-joaquin-duato-20250926.jpg", "site": "youtube.com", "text": "CNBC's Jim Cramer sits down with Johnson & Johnson CEO Joaquin Duato to talk about the company's outlook, President Trump's 100% tariff on some pharmaceutical imports, cancer treatment innovation and more.", "url": "https://www.youtube.com/watch?v=vfC1xkmjAvU"}}
{"date": "2025-09-26", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-26 18:46:26", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-surpasses-market-returns-some-facts-worth-20250926.jpg", "site": "zacks.com", "text": "Johnson & Johnson (JNJ) closed at $179.71 in the latest trading session, marking a +1.11% move from the prior day.", "url": "https://www.zacks.com/stock/news/2758015/johnson-johnson-jnj-surpasses-market-returns-some-facts-worth-knowing?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2758015"}}
{"date": "2025-09-26", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-26 07:21:00", "publisher": "The Motley Fool", "title": "Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?", "image": "https://images.financialmodelingprep.com/news/could-this-single-dividend-king-make-your-portfolio-worth-20250926.jpg", "site": "fool.com", "text": "Johnson & Johnson (JNJ 0.57%) is a longtime healthcare leader with numerous positive qualities. These include its 62 consecutive years of dividend increases, which surpass the 50 required to be recognized as a Dividend King.", "url": "https://www.fool.com/investing/2025/09/26/could-single-dividend-king-make-you-millions/"}}
{"date": "2025-09-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-25 12:46:31", "publisher": "Zacks Investment Research", "title": "Johnson & Johnson (JNJ) Could Be a Great Choice", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-could-be-a-great-choice-20250925.jpg", "site": "zacks.com", "text": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?", "url": "https://www.zacks.com/stock/news/2757188/johnson-johnson-jnj-could-be-a-great-choice?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_5-2757188"}}
{"date": "2025-09-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-25 10:00:18", "publisher": "Zacks Investment Research", "title": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know", "image": "https://images.financialmodelingprep.com/news/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-20250925.jpg", "site": "zacks.com", "text": "Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.", "url": "https://www.zacks.com/stock/news/2756862/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2756862"}}
{"date": "2025-09-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-25 04:52:00", "publisher": "The Motley Fool", "title": "These 3 Dow Stocks Are Set to Soar in 2025 and Beyond", "image": "https://images.financialmodelingprep.com/news/these-3-dow-stocks-are-set-to-soar-in-20250925.jpg", "site": "fool.com", "text": "The Dow Jones Industrial Average (^DJI -0.37%) hasn't been the stock market's go-to index for a long, long time. It's since been replaced by the broader S&P 500 (^GSPC -0.28%), and for tech-minded growth investors, the Nasdaq Composite (^IXIC -0.34%).", "url": "https://www.fool.com/investing/2025/09/25/these-3-dow-stocks-are-set-to-soar-in-2025-and-bey/"}}
{"date": "2025-09-25", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-25 03:15:00", "publisher": "The Motley Fool", "title": "3 Exceptional High-Yielding Dividend Kings That Have Been Increasing Their Payouts for Over 60 Years", "image": "https://images.financialmodelingprep.com/news/3-exceptional-highyielding-dividend-kings-that-have-been-increasing-their-20250925.jpg", "site": "fool.com", "text": "Stocks that pay dividends can make for great long-term investments. The best reason to invest in them is that they can generate recurring cash flow for you on an ongoing basis.", "url": "https://www.fool.com/investing/2025/09/25/3-exceptional-high-yielding-dividend-kings-that-ha/"}}
{"date": "2025-09-24", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-24 17:17:41", "publisher": "Seeking Alpha", "title": "Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript", "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-presents-at-bernstein-2nd-annual-global-20250924.jpg", "site": "seekingalpha.com", "text": "Johnson & Johnson (NYSE:JNJ ) Bernstein 2nd Annual Global Healthcare Conference September 24, 2025 1:10 PM EDT Company Participants Tom Cavanaugh - Company Group Chairman for North America Innovative Medicine Conference Call Participants Lee Hambright - Sanford C. Bernstein & Co., LLC.", "url": "https://seekingalpha.com/article/4825596-johnson-and-johnson-jnj-presents-at-bernstein-2nd-annual-global-healthcare-conference"}}
{"date": "2025-09-24", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-24 10:31:12", "publisher": "Zacks Investment Research", "title": "Should You Invest in Johnson & Johnson (JNJ) Based on Bullish Wall Street Views?", "image": "https://images.financialmodelingprep.com/news/should-you-invest-in-johnson-johnson-jnj-based-on-20250924.jpg", "site": "zacks.com", "text": "Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?", "url": "https://www.zacks.com/stock/news/2756299/should-you-invest-in-johnson-johnson-jnj-based-on-bullish-wall-street-views?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|average_broker_rating-2756299"}}
{"date": "2025-09-23", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-23 05:52:14", "publisher": "Reuters", "title": "J&J to withdraw acid reflux device from non-US markets, Bloomberg News reports", "image": "https://images.financialmodelingprep.com/news/jj-to-withdraw-acid-reflux-device-from-nonus-markets-bloomberg-20250923.jpg", "site": "reuters.com", "text": "Johnson & Johnson will withdraw a device to treat acid reflux disease from markets outside the U.S., Bloomberg News reported on Tuesday, citing a company letter sent to doctors.", "url": "https://www.reuters.com/sustainability/boards-policy-regulation/jj-withdraw-acid-reflux-device-non-us-markets-bloomberg-news-reports-2025-09-23/"}}
{"date": "2025-09-23", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-23 04:05:00", "publisher": "The Motley Fool", "title": "The Ultimate Dividend King Drug Stock to Buy With $1,000 Right Now", "image": "https://images.financialmodelingprep.com/news/the-ultimate-dividend-king-drug-stock-to-buy-with-20250923.jpg", "site": "fool.com", "text": "The healthcare sector is both large and important, and one of its most exciting areas is the pharmaceutical niche. That's always true from a development standpoint.", "url": "https://www.fool.com/investing/2025/09/23/the-ultimate-dividend-king-drug-stock-to-buy-1000/"}}
{"date": "2025-09-22", "symbol": "JNJ", "type": "stock_news", "result": {"symbol": "JNJ", "publishedDate": "2025-09-22 10:21:47", "publisher": "Zacks Investment Research", "title": "J&J Adds $63B in Market Cap in 3 Months: Time to Buy the Stock?", "image": "https://images.financialmodelingprep.com/news/jj-adds-63b-in-market-cap-in-3-months-time-20250922.jpg", "site": "zacks.com", "text": "J&J shares gain 17.7% in three months, adding $63B to its market cap. Technical and pipeline momentum fuel investor interest.", "url": "https://www.zacks.com/stock/news/2754665/j-j-adds-63b-in-market-cap-in-3-months-time-to-buy-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2754665"}}
